Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1( L ) ASCORBATO DI CALCIO1件: Calcium---2件: 96, 97 💬
2(+) erythromefloquine----1件: 46 💬
3(+) isomer of racemic mefloquine1件: Mefloquine1件: Mefloquine 💬--1件: 46 💬
4(+) isomer or racemic mefloquine1件: Mefloquine1件: Mefloquine 💬--1件: 46 💬
5(+)- Epicatechin1件: Epicatechin---1件: 113 💬
6(+)-(S)-2-(6-methoxynaphthalen-2-yl) propanoic acid1件: Propanoic acid---1件: 271 💬
7(-)-3-(4-Aminophenyl)-2-methoxypropionic acid----1件: 97 💬
8(1-13C) Sodium Acetate2件: Acetate,
Sodium acetate		1件: Sodium acetate 💬--1件: 251 💬
9(1-3)-beta-D-Glucan (BDG) assay (Fungitell)----1件: 107 💬
10(1-3)-ß-D-Glucan (BDG) assay (Fungitell)----1件: 107 💬
11(11C)PE2I----1件: 6 💬
12(18)F-FDG----1件: 85 💬
13(18F)FPGLU----1件: 86 💬
14(1R,3S,5R)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide----1件: 11 💬
15(2-chloro-5-[11C]methoxy-N-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide)----1件: 6 💬
16(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-y1] butanamide----1件: 309 💬
17(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide----1件: 309 💬
18(3beta, 5beta, 25R)-spirostan-3-ol----1件: 6 💬
19(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-----1件: 46 💬
20(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile,----1件: 46 💬
21(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-ß-oxo-1-----1件: 46 💬
22(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo [2,3-d]pyrimidin-4-ylamino)-ß-oxo-1-piperidinepropanenitrile,----1件: 46 💬
23(3R,4R)-4-metil-3-(metil-1H-pirrolo [2,3-d]pirimidin-4-ilamino)-beta-oxo-1-----1件: 46 💬
24(3R,4R)-4-metil-3-(metil-1H-pirrolo [2,3-d]pirimidin-4-ilamino)-ß-oxo-1-----1件: 46 💬
25(3ß, 5ß, 25R)-spirostan-3-ol----1件: 6 💬
26(4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile----1件: 231 💬
27(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4’-----1件: 79 💬
28(6R)-4, 5, 6, 7 - tetrahydro-N6-propyl-2,6-benzothiazolidiamine dihydrochloride monohydrate----1件: 2 💬
29(6S)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol----1件: 6 💬
30(7R,8R,9R)-2.3-Dimethyl-8-hydroxy-7(2-methoxyethoxy)- 9-phenyl-7.8.9.10-tetrahydro-imidazo-[1.2-h].[1.7].- naphthyridine----1件: 301 💬
31(E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime----1件: 161 💬
32(IM) AVONEX®1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
33(minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate----1件: 6 💬
34(Pyr1)apelin-13----1件: 86 💬
35(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide----1件: 13 💬
36(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-1件: Pyrazole---1件: 75 💬
37(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75 💬
38(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75 💬
39(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4YL)SULFONYL)4,4A,5,6,7,8HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN4AYL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE1件: Pyrazole---1件: 75 💬
40(R)-3-(1-oxo-propoxy)-4-(N,N,N-trimethyl amonium chloride)-butanoic acid2件: Butyric Acid,
Chloride ion		---1件: 97 💬
41(R)-[N-metil-11C1-PK11195(PK)----1件: 127 💬
42(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE1件: Pyrazole---1件: 58 💬
43(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1METHYL-1H-PYRAZOLE-4-CARBOXAMIDE1件: Pyrazole---1件: 58 💬
44(R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1METHYL-1HPYRAZOLE-4-CARBOXAMIDE----1件: 58 💬
45(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4- yl)pyridine-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate sesquisuccinate1件: Piperazine1件: Piperazine 💬--1件: 272 💬
46(R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4- yl)pyridine-2yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate1件: Piperazine1件: Piperazine 💬--1件: 272 💬
47(RS)-baclofen1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 10 💬
48(RS)-baclofen, naltrexone hydrochloride and D-sorbitol3件: Baclofen,
Naltrexone,
Sorbitol		3件: Sorbitol solution ,
Baclofen ,
Naltrexone 💬		5件: GABBR1,
GABBR2,
OPRD1,
OPRK1,
OPRM1 💬		9件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 10 💬
49(S)- 2- Amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol----1件: 6 💬
50(S)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate----1件: 6 💬
51(S)-(-)-3-(4-Aminophenyl)-2-methoxypropionic Acid----1件: 97 💬
52(S)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid----1件: 86 💬
53(S)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3H)-one----1件: 240 💬
54(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2- YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM----1件: 86 💬
55(S)-3-((3-(1-((6-(3,4-DIMETHOXYPHENYL)PRYAZIN-2-YL)AMINO)ETHYL)PHENYL)CARBAMOYL)-5-METHYLPRIDIN-1-IUM----1件: 86 💬
56(S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazo----1件: 284 💬
57(S)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide3件: Hydroxide ion,
Magnesium,
Magnesium hydroxide		1件: Magnesium hydroxide 💬--1件: 284 💬
58(S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-m----1件: 284 💬
59(S)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide3件: Hydroxide ion,
Magnesium,
Magnesium hydroxide		1件: Magnesium hydroxide 💬--1件: 284 💬
60(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5- yl)-2-isopropoxybenzonitrile hydrochloride----1件: 97 💬
61(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben----1件: 97 💬
62(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride----1件: 97 💬
63* D.3.4 Solution for infusion in pre-filled syringe----1件: 97 💬
64* D.3.4 Solution for injection in pre-filled syringe----1件: 97 💬
65* D.3.4 Solution for injection/infusion in pre-filled syringe----1件: 97 💬
66* D.3.6.2.1 - valore : Every 4 weeks dosing of 200 mg----1件: 41 💬
67* D.3.6.2.1 - valore :Every 4 weeks dosing of 400 mg----1件: 41 💬
68**Comment**- IMP inhalation solution identical to ventavis inhalation solution, but IMP is in a different volume presentation. Please see covering letter.1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
690 mg Prednisone1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 44 💬
700 mg tropicamide1件: Tropicamide1件: Tropicamide 💬5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
710,25 mg RPC1063----1件: 96 💬
720,5 mg Fingolimod1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
730,5 mg Prevenar i.m.----1件: 51 💬
740,5 mg seasonal influenza vaccine i.m.----1件: 51 💬
750.005% Lacripep----1件: 53 💬
760.01% Lacripep----1件: 53 💬
770.02% Fm, SH----1件: 53 💬
780.02% Fm, SH, 0.05% CsA----1件: 53 💬
790.02% Fm, SH, AS----1件: 53 💬
800.04 mg Lu AE04621----1件: 6 💬
810.08 mg Lu AE04621----1件: 6 💬
820.12% saline----1件: 299 💬
830.15mg KPG-818 dose----1件: 49 💬
840.2 mg Lu AE04621----1件: 6 💬
850.25 mg RPC103----1件: 97 💬
860.25 mg RPC1063----3件: 13, 96, 97 💬
870.3 mg tropicamide1件: Tropicamide1件: Tropicamide 💬5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
880.4 mg Lu AE04621----1件: 6 💬
890.5 mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
900.5 mg RPC1063----2件: 13, 97 💬
910.5% marcaine----1件: 70 💬
920.5mg RPC1063----1件: 13 💬
930.6 mg Lu AE04621----1件: 6 💬
940.7mL prefilled syringes----1件: 107 💬
950.8 mg Lu AE04621----1件: 6 💬
960.9% Isotonic Saline (IS)----1件: 299 💬
970.9% Isotonic Saline (IS), 4mL----1件: 299 💬
980.9% normal saline (control)----1件: 299 💬
990.9% physiological saline----1件: 266 💬
1000.9% saline----2件: 6, 70 💬
1010.9% sodium chloride2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--4件: 6, 14, 51, 53 💬
1020.9% sodium chloride (normal saline)2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 6 💬
1030.9% Sodium Chloride Injection2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 168 💬
1040.9% w/v isotonic sodium chloride solution2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 50 💬
1050.9% w/v sodium chloride solution2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 299 💬
106009-1----1件: 6 💬
107009-5----1件: 6 💬
1080109-0012A 100 mg/ml----1件: 46 💬
1090109-0012A 25 mg/ml----1件: 46 💬
1100109-0012A 50 mg/ml----1件: 46 💬
1111 - Andrographis paniculata p/st extract----1件: 13 💬
1121 mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1131 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1141 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
1151 mg RPC1063----2件: 13, 97 💬
1161 mg tropicamide1件: Tropicamide1件: Tropicamide 💬5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
1171 mg/kg CNTO 136----1件: 49 💬
1181 ml 0.9 % NaCl----1件: 46 💬
1191 Serving of broccoli sprouts1件: Broccoli---1件: 97 💬
1201% lignocaine1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 84 💬
1211% Steroid Cream----1件: 13 💬
1221) Inosine 5'-monophosphate1件: Inosine1件: Inosine 💬--1件: 17 💬
1231,2-Dihexadecanoyl-sn-Glycero-3-Phospho-(1-raac-glycerol)1件: Glycerin1件: Glycerin 💬--1件: 79 💬
1241,5 (Butylimino)-1,5-dideoxy-D-glucitol1件: Sorbitol1件: Sorbitol solution 💬--1件: 299 💬
1251,5-anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3- (trifluoromethyl)-1,6-naphthyridin-6(5H)-yl]c----1件: 46 💬
1261- Deoxygalactonojirimycin----1件: 19 💬
1271-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one----1件: 17 💬
1281-(6-BENZOTHIAZOLYLSULFONYL)-5-CHLORO-1H-INDOLE-2-BUTANOIC ACID2件: Butyric Acid,
Indole		---1件: 51 💬
1291-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid----1件: 299 💬
1301-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone----1件: 13 💬
1311. Tesofensine (NS 2330)1件: Tesofensine---1件: 6 💬
1321.0 mg Lu AE04621----1件: 6 💬
1331.0 mg rasagiline mesylate1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1341.0 mg RPC103----1件: 97 💬
1351.0 mg RPC1063----1件: 97 💬
1361.0 MIU IL-2 per day1件: Human interleukin-2---1件: 2 💬
1371.2 mg Lu AE04621----1件: 6 💬
1381.2 mg ZGN-440 for injectable suspension----1件: 193 💬
1391.8 mg ZGN-440 for injectable suspension----1件: 193 💬
14010 mg----1件: 96 💬
14110 mg Natura-alpha capsule----1件: 97 💬
14210 mg/kg CNTO 136----1件: 49 💬
14310 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
14410% intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---1件: 14 💬
14510% liquid formulation of human immunoglobulin----1件: 14 💬
14610% Metronidazole Ointment1件: Metronidazole1件: Metronidazole 💬--1件: 96 💬
14710% nifedipine cream1件: Nifedipine1件: Nifedipine 💬4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 50 💬
14810% Nitroglycerine in Propylene Glycol, USP2件: Nitroglycerin,
Propylene glycol		2件: Propylene glycol ,
Nitroglycerin 💬		--1件: 51 💬
14910-mg dose of E5501 2G tablet----1件: 63 💬
15010-mg dose of E5501 cyclodextrin oral solution----1件: 63 💬
15110-mg dose of E5501 lipid-based oral----1件: 63 💬
15210-mg dose of E5501-P21% powder----1件: 63 💬
15310-nitro-9(E)-octadec-9-enoic acid----1件: 86 💬
154100 mg----1件: 97 💬
155100 mg AP1189----2件: 46, 222 💬
156100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC----1件: 299 💬
157100 mg ELX /50 mg TEZ /75 mg IVA FDC----1件: 299 💬
158100 mg ELX/50 mg TEZ /75 mg IVA FDC----1件: 299 💬
159100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination----1件: 299 💬
160100 mg LX3305 QD----1件: 46 💬
161100 mg TEZ/150 mg IVA FDC----1件: 299 💬
162100 mg VX-445 /50 mg TEZ/75 mg IVA FDC----1件: 299 💬
163100 mg VX-445/50 mg TEZ /75 mg IVA FDC----1件: 299 💬
164100 mg/m2 dose----1件: 299 💬
165100 µg Brimonidine Tartrate Implant1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
166100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC----1件: 299 💬
167100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC----1件: 299 💬
168100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC----1件: 299 💬
169100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC----1件: 299 💬
170100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC----1件: 299 💬
171100-mg VX-445 /50-mg TEZ/75-mg----1件: 299 💬
172100-mg VX-445/50-mg TEZ/75-mg IVA FDC----1件: 299 💬
173100g ELX / 50mg TEZ / 75mg IVA----1件: 299 💬
174100mcg rhPTH(1-84)1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
175100mg ELX/50mg TEZ /75mg IVA----1件: 299 💬
176100mg VX-445/50mg TEZ /75mg IVA FDC----1件: 299 💬
17711-beta-hydroxysteroid dehydrogenase type 1----1件: 75 💬
17811-ß-hydroxysteroid dehydrogenase type 1----1件: 75 💬
17911C-BMS-986196----1件: 13 💬
18011C-MC1----1件: 6 💬
18111C-MCI----1件: 13 💬
18211C]-methionine1件: Methionine1件: Methionine 💬--1件: 34 💬
18311C]-PK-11195----1件: 13 💬
18412 mg/kg GSK2402968----1件: 113 💬
185120 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
186124I-labeled monoclonal antibody Mu 11-1F4----1件: 28 💬
187124I-p5+14 Injection----1件: 28 💬
18813-15mg/kg/d Ursodeoxycholic----1件: 93 💬
18913-PCV Booster----1件: 13 💬
19013-valent pneumococcal conjugate vaccine (13-PCV)----1件: 13 💬
19114C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration----3件: 13, 96, 97 💬
19215 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
19315 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
19415 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
19515 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
19615 or 45 mg----1件: 67 💬
19715-O labeled water1件: Water1件: Water 💬--1件: 46 💬
198150 mg double-blinded secukinumab1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
199150 mg GSK1265744B----1件: 265 💬
200150 mg Induction/Chronic----1件: 97 💬
201150 mg LX3305 QD----1件: 46 💬
202150 mg open-label secukinumab1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
203150-mg IVACAFTOR1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
2041500mg mesalazine pellets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
205150mg CXA-101件: CXA-10---1件: 86 💬
20615N ammonium chloride (15NH4Cl)2件: Ammonium chloride,
Chloride ion		1件: Ammonium chloride 💬--1件: 251 💬
20716,5% Cutaquig----1件: 65 💬
2081639325-43-1----1件: 254 💬
2091643368-58-4----2件: 53, 160 💬
21017,21-Dihydroxypregna-1,4-diene-3,11,20-trione----1件: 41 💬
21117beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one----1件: 75 💬
21217ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one----1件: 75 💬
21318-F]DPA-714----1件: 127 💬
21418F- DTBZ----1件: 6 💬
21518F-AV-1331件: Florbenazine F-18---1件: 6 💬
21618F-AV-1451----3件: 5, 7, 127 💬
21718F-DPA-714 and 18F-FDG1件: Fludeoxyglucose (18F)---1件: 13 💬
21818F-DTBZ AV-133----1件: 6 💬
21918F-FTC-146----1件: 206 💬
22018F-OP-801----1件: 2 💬
22118F] LBT-999----1件: 6 💬
22218F]-(E)-N-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane----1件: 6 💬
22318F]DPA-714----2件: 13, 127 💬
22418F]MC225----1件: 6 💬
2251[(6- Allyl- 8beta- erg----1件: 6 💬
2261[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6 💬
2271[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6 💬
2281[(6- Allyl- 8ß- erg----1件: 6 💬
2291[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-----1件: 6 💬
2301[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6 💬
2311mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
2322 - Excipients----1件: 13 💬
2332 mg perampanel1件: Perampanel1件: Perampanel 💬4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 6 💬
2342 million hMSC/kg----1件: 46 💬
2352 x 10 mg Natura-alpha capsules----1件: 97 💬
2362% Chlorhexidine solution wipes1件: Chlorhexidine1件: Chlorhexidine 💬--1件: 299 💬
2372% lignocaine1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 84 💬
2382% sodium chondroitin sulfate2件: Chondroitin sulfate,
Sulfate ion		---1件: 226 💬
2392',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid1件: Diflunisal1件: Diflunisal 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 28 💬
2402'-O-(2-METHOXYETHYL)-D-RIBOSE ANTISENSE OLIGONUCLEOTIDE TARGETING1件: Ribose---1件: 131 💬
2412'-O-(2-METHOXYETHYL)-D-RIBOSE ANTISENSE OLIGONUCLEOTIDE TARGETING GLIAL FIBRILLARY ACIDIC PROTEIN MESSENGER RIBONUCLEIC ACID1件: Ribose---1件: 131 💬
2422(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACID----2件: 19, 65 💬
2432,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide----1件: 6 💬
2442-(((2E)-3-(3-methoxy-4-(2-propyn-1-yloxy)phenyl)-1-oxo-2-propen-1-yl)amino)benzoic acid1件: Benzoic acid1件: Benzoic acid 💬--1件: 51 💬
2452-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester1件: Famciclovir1件: Famciclovir 💬--1件: 13 💬
2462-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylat----1件: 28 💬
2472-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate----1件: 28 💬
2482-(4-[5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy)-N-(methylsulfonyl)actamide----1件: 86 💬
2492-[[[(2R)-1-[1-[(4-CHLORO-3-METHYLPHENYL)METHYL]-4- PIPERIDINYL]-5-OXO-2-PYRROLIDINYL]CARBONYL]AMINO]- N,N,6-TRIMETHYL-4-PYRIDINECARBOXAMIDE,DIHYDROCHLORIDE----2件: 6, 162 💬
2502-amino-4-(methyl[11C]sulfanyl)butanoic acid1件: Butyric Acid---1件: 34 💬
2512-CdA, 2-chloro-2'-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2522-CdA, 2-chloro-2'-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2532-CdA, 2-chloro-2?-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2542-CdA, 2-chloro-2?-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2552-CdA, 2-chloro-2’-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2562-CdA, 2-chloro-2’-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2572-chloro-2'-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2582-chloro-2'-deoxyadenosine, 2CdA1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2592-chloro-2?-deoxy-beta-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2602-chloro-2’-deoxy-beta-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2612-chloro-2’-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2622-deoxy-2 [F-18] fluoro-2-d-glucose2件: D-glucose,
Dextrose, unspecified form		1件: Glucose 💬--1件: 49 💬
2632-HYDROXYPROPYL-BETA-CYCLODEXTRIN2件: Betadex,
Hydroxypropyl betadex		1件: Betadex 💬--1件: 19 💬
2642-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl) acetamide1件: Acetamide---1件: 86 💬
2652-{7-[1,1-dimethyl-3-(4-sulfobutyl)-benz[e]indolin-2-ylidene]-1,3,5-heptatrienyl}-1,1-dimethyl-3-(sulfobutyl)-1H-benz[e]-indolium hydroxide,inner salt1件: Hydroxide ion---1件: 46 💬
2662.0 MIU IL-2 per day1件: Human interleukin-2---1件: 2 💬
26720 mg----1件: 97 💬
26820 mg BID of PF-02545920----1件: 8 💬
26920 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
27020 mg GA----1件: 13 💬
27120 mg MitoQ----1件: 13 💬
27220 mg sildenafil citrate by mouth1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
27320 mg/ml Treprostinil1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
274200 mg BIA 6-5121件: BIA---1件: 6 💬
275200 mg LX3305 QD----1件: 46 💬
276200 mg/m2 dose----1件: 299 💬
277200 µg Brimonidine Tartrate Implant1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
278200106 or EMD 28162----1件: 13 💬
279200mg Cannabidiol by capsules twice daily1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 46 💬
28020mg/0.5ml GA----1件: 13 💬
28120mg/0.5ml glatiramer acetate2件: Acetate,
Glatiramer		---1件: 13 💬
28225 mg BIA9 1067----1件: 6 💬
28325 mg Ongentys1件: Opicapone1件: Opicapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
28425 mg Ontamalimab1件: Ontamalimab---2件: 96, 97 💬
28525% MTD sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
28625(OH)D3----1件: 13 💬
287250 mg CK-2017357----2件: 2, 11 💬
288250 mg LX3305 BID----1件: 46 💬
289250 mg LX3305 QD----1件: 46 💬
290250mg mesalazine pellets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
29125mcg rhPTH(1-84)1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
29226 common Fabry mutation types in Taiwan----1件: 19 💬
29329180.00.00, 34681.00.00, 34681.01.00, 34681.02.00----1件: 113 💬
2942mg budesonide effervescent tablet for orodispersible use1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
2952S,4R-(-)-ketoconazole, levoketoconazole2件: Ketoconazole,
Levoketoconazole		2件: Ketoconazole ,
Levoketoconazole 💬		3件: CYP11A1,
CYP11B1,
CYP17A1 💬		7件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75 💬
2963 mg [14C]-A4250 capsule----3件: 93, 297, 338 💬
2973 mg Melatonin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13 💬
2983 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
2993 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
3003 mg tropicamide1件: Tropicamide1件: Tropicamide 💬5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
3013 mg/kg GSK2402968----1件: 113 💬
3023 MPDN pulse + PDN----1件: 50 💬
3033 MPDN pulse + PDN + CSA----1件: 50 💬
3043 MPDN pulse + PDN + MTX----1件: 50 💬
3053 Servings of broccoli sprouts1件: Broccoli---1件: 97 💬
3063- (9,10- Didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate----1件: 6 💬
3073-(3-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)PROPOXY)-4-FLUOROBENZOIC ACID1件: Pyrazole---1件: 28 💬
3083-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-----1件: 93 💬
3093-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid----1件: 93 💬
3103-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt----2件: 51, 85 💬
3113-hydroxy-2-methyl-4H-pyrane-4-one iron (III) complex (3:1), Ferric (3-hydroxy-2-methyl-4-pyrone), Tris-maltol-iron (III), Tri=maltol-iron (III)1件: Tromethamine1件: Tromethamine 💬--2件: 96, 97 💬
3123-methyl-1-phenyl-4, 5-dihydro-1H-pyrazol-5-one.1件: Pyrazole---1件: 2 💬
31330 or 60 mg----1件: 67 💬
31430 or 90 mg----1件: 67 💬
315300 mg double-blinded secukinumab1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
316300 mg LX3305 QD----1件: 46 💬
317331731-18-1----4件: 46, 96, 97, 271 💬
3183a,7a-dihydroxy-6a-ethyl-5betacholan-24-oic acid----1件: 93 💬
3193a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid----1件: 93 💬
3204 cholesten-3-one, oxime----1件: 2 💬
3214 mg perampanel1件: Perampanel1件: Perampanel 💬4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 6 💬
3224 mg/kg CNTO 136----1件: 49 💬
3234 million hMSC/kg----1件: 46 💬
3244% chlorhexidine gluconate liquid skin cleanser1件: Chlorhexidine1件: Chlorhexidine 💬--1件: 299 💬
3254'-chloro-2'-cyano-N-(trans-4-hydroxy-4-methylcyclohexyl)-biphenyl-4-sulphonamide----1件: 46 💬
3264-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-benzamide, methane sulphonic acid salt. AB1010base1件: Methane---1件: 2 💬
3274-[5-(4-methylphenyl)-3-(trifluoromethyl)- 1H-pyrazol-1-yl] benzenesulfonamide1件: Pyrazole---1件: 46 💬
3284-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide1件: Pyrazole---1件: 46 💬
3294-benzyl-2-naphtalen-1-yl-1,2,4-thiadiazolidine-3,5-dione----1件: 5 💬
3304-Benzyl-2-naphthalen-1-yl-1,2,4- thiadiazolidine-3,5-dione----1件: 113 💬
3314-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione----1件: 113 💬
3324-cholesten-3-one, oxime----2件: 2, 3 💬
3334-cholesten-3-one,oxime----1件: 3 💬
3344-Methylpyrazole1件: Fomepizole1件: Fomepizole 💬3件: ADH1A,
ADH1B,
ADH1C 💬		9件: Alcoholic liver disease, Drug metabolism - cytochrome P450, Fatty acid degradation, Glycolysis / Gluconeogenesis, Metabolic pathways, Metabolism of xenobiotics by cytochrome P450, Pyruvate metabolism, Retinol metabolism, Tyrosine metabolism 💬1件: 301 💬
3354-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide----1件: 46 💬
3364.2% NaCl/Inhalation solution----1件: 299 💬
3374.5 mg Naltrexone1件: Naltrexone1件: Naltrexone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
33840 mg----1件: 96 💬
33940 mg GA----2件: 2, 13 💬
34040 mg glatiramer acetate2件: Acetate,
Glatiramer		---2件: 2, 13 💬
34140 mg Glatiramer acetato1件: Glatiramer---1件: 13 💬
34240 mg MSB11022----5件: 46, 96, 97, 107, 271 💬
34340 mg QD Alogabat----1件: 201 💬
34440 MG- SOLUZIONE INIETTABILE IN SIRINGHE PRE-RIEMPITE- USO SOTTOCUTANEO- SIRINGA PRERIEMPITA (0,4ML)- 2 SIRINGHE PRE-RIEMPITE + 2 TAMPONI IMBEVUTI DI ALCOOL----1件: 107 💬
345400 mg BIA 5-10581件: BIA---1件: 86 💬
346400 mg LX3305 QD----1件: 46 💬
347400 µg Brimonidine Tartrate Implant1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
348400mg Cannabidiol by capsules twice daily1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 46 💬
34940mg of MitoQ----1件: 13 💬
35044/154/85-C----1件: 50 💬
35144/196/81-C----1件: 50 💬
35245 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
353450 mg Induction/Chronic----1件: 97 💬
3544cc of lidocaïne®----1件: 149 💬
3554D-125 IVT Injection----1件: 90 💬
3564D-710----1件: 299 💬
3575 ASA, enemas, suppositories, corticosteroids----1件: 97 💬
3585 mg Melatonin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13 💬
3595 mg Montelukast1件: Montelukast1件: Montelukast 💬1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 98 💬
3605 mg Prednisone1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 44 💬
3615% glucose water solution2件: Dextrose, unspecified form,
Water		1件: Water 💬--1件: 2 💬
3625% lidocaine/5 mg/ml 0.02% estradiol compound cream2件: Estradiol,
Lidocaine		3件: Estradiol ,
Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		7件: ESR1,
ESR2,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		13件: Adrenergic signaling in cardiomyocytes, Breast cancer, Chemical carcinogenesis - receptor activation, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 💬1件: 226 💬
3635% sildenafil cream1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 50 💬
3645,6,7,8-tetrahydrobiopterin1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
3655-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole----1件: 113 💬
3665-[4-[2-(5-(1-hydroxyethyl)-2- pyridinyl)ethoxy]benzyl]-2,4- thiazolidinedione hydrochloride1件: 2,4-thiazolidinedione---1件: 20 💬
3675-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride1件: 2,4-thiazolidinedione---1件: 20 💬
3685-[[4-[2-[5-(1-HYDROXYETHYL)-2-PYRIDINYL]ETHOXY]PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE HYDROCHLORIDE1件: 2,4-thiazolidinedione---1件: 20 💬
3695-amino salicylic acid (5-ASA)2件: Mesalazine,
Salicylic acid		2件: Salicylic acid ,
Mesalamine 💬		--1件: 97 💬
3705-aminosalicylate (Pentasa, Ferring)----2件: 96, 97 💬
3715-Aminosalicylic acid (5-ASA)2件: Aminosalicylic acid,
Mesalazine		2件: Aminosalicylic acid ,
Mesalamine 💬		--1件: 97 💬
3725-ASA (5-Aminosalicylate)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3735-ASA MMx1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3745-Chlor-6'-methyl- 3-[4-(methylsulfonyl)phenyl]- 2,3'-bipyridin1件: Chlorine---2件: 46, 271 💬
3755-Chloro-1,2-dihydro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide sodium----1件: 8 💬
3765-Hydroxytryptophan / Vitamin B61件: Pyridoxine1件: Pyridoxine 💬--1件: 206 💬
3775-Methyl-1-Phenyl-2-1-(H)-Pyridone----1件: 228 💬
3785-methyltetrahydrofolate and vitamin B121件: Cyanocobalamin4件: Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--1件: 299 💬
3795-MTHF----1件: 337 💬
38050 mg----1件: 97 💬
38150 mg AP1189----1件: 46 💬
38250 mg BIA 9 10671件: BIA---1件: 6 💬
38350 mg ELX/25 mg TEZ/37.5 mg IVA----1件: 299 💬
38450 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination----1件: 299 💬
38550 mg Etanercept1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
38650 mg Induction/Chronic----1件: 97 💬
38750 mg LX3305 QD----1件: 46 💬
38850 mg Ongentys1件: Opicapone1件: Opicapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
389500 mg CK-2017357----2件: 2, 11 💬
390500 mg LX3305 QD----1件: 46 💬
3915000 IU of cholecalciferol1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299 💬
392500mg mesalazine pellets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
39350mcg rhPTH(1-84)1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
394534-1508----1件: 85 💬
39556/104/75-C----1件: 50 💬
3966 alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747----1件: 93 💬
3976 Mercaptopurine1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 96, 97 💬
3986 mg/kg GSK2402968----1件: 113 💬
3996 million hMSC/kg----1件: 46 💬
4006% Hypertonic Saline (HS), 4mL----1件: 299 💬
4016-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine----1件: 38 💬
4026-(nitrooxy)hexyl(2Z)-4-(acetyloxy)-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoate----1件: 46 💬
4036-[(methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine----1件: 96 💬
4046-[18F]Fluorodopa----1件: 6 💬
4056-[18F]Fluorodopamine----1件: 6 💬
4066-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid----1件: 97 💬
4076-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one----1件: 2 💬
4086-Mercaptopurine1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬3件: 96, 97, 164 💬
4096-Mercaptopurine (Puri-Nethol)1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96 💬
4106-MP1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 96, 97 💬
41160 mg QD Alogabat----1件: 201 💬
41266215-101----1件: 86 💬
41368Ga-BMV101----1件: 85 💬
41468Ga-BNOTA-PRGD2----1件: 46 💬
41568GaNOTA-Anti-MMR-VHH2----1件: 84 💬
4166?-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4176a-ethylchenodeoxycholic acid (6-ECDCA), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4186a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4196a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4206a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4216a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4226a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4236a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4246a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4256a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5betacholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4266a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4276a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
4286abeta - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4296aß - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4306R-BH41件: Sapropterin1件: Sapropterin 💬--3件: 86, 124, 240 💬
4317 mg QD Alogabat----1件: 201 💬
4327 mg QD to 15 mg QD PF-066497511件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
4337 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
4347% Hypertonic Saline (HS)----1件: 299 💬
4357% NaCl----1件: 299 💬
4367% saline----1件: 299 💬
4377-beta-Hydroxyepiandrosterone1件: 7-beta-Hydroxyepiandrosterone---1件: 6 💬
43875 mg Ontamalimab1件: Ontamalimab---2件: 96, 97 💬
43975-mg IVACAFTOR1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
440750 mg metformin and 7.5 g L-citrulline daily p.o.2件: Citrulline,
Metformin		1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
441750mg mesalazine pellets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
44275mg CXA-101件: CXA-10---1件: 86 💬
4438-OHdG1件: 8-hydroxy-2'-deoxyguanosine---1件: 6 💬
44480 mg DR-6MP----1件: 96 💬
445800 mg ibuprofen/26.6 mg famotidine2件: Famotidine,
Ibuprofen		2件: Ibuprofen ,
Famotidine 💬		3件: HRH2,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 107 💬
44680mg ELX / 40mg TEZ / 60mg IVA----1件: 299 💬
44789 Zirconium Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) (radiolabeled)----1件: 19 💬
44889ZR-BEVACIZUMAB2件: Bevacizumab,
Bevacizumab zirconium Zr-89		1件: Bevacizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 34 💬
44989Zr-SBC-103----1件: 19 💬
45089Zr]Zr-Df-crefmirlimab berdoxam----2件: 51, 53 💬
4519 mg/kg GSK2402968----1件: 113 💬
4529-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxaline----1件: 46 💬
4539-CIS, 12-CIS-11,11-D2-LINOLEIC ACID ETHYL ESTER1件: Linoleic acid---2件: 2, 5 💬
45490 mg hydrocortisone acetate suppository with Sephure suppository applicator3件: Acetate,
Hydrocortisone,
Hydrocortisone acetate		2件: Hydrocortisone ,
Hydrocortisone acetate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
45590 mg idrocortisone acetato in supposta con appli----1件: 97 💬
45690 mg idrocortisone acetato in supposta con applicatore per supposte Sephure----1件: 97 💬
45790 mg sodium nitrite inhalation solution1件: Nitrite---1件: 86 💬
45895% Pure ECGC capsules 200mg----1件: 13 💬
45998% dehydrated alcohol1件: Ethanol1件: Ethanol 💬--1件: 298 💬
46099mTc-rhAnnexin V-128----2件: 46, 271 💬
461: 2-{4-[(5,6-difenilpirazin-2-yl)(isopropil)amino]butoxi}-N-----1件: 86 💬
462: immunoglobulina umana normale 10% per somministrazione endovenosa----1件: 14 💬
463[11C]-GSK2256098 500 MBq1件: GSK2256098---1件: 86 💬
464[11C]-PIB----1件: 6 💬
465[11C]MPC6827----1件: 2 💬
466[11C]PXT012253----1件: 6 💬
467[123I] 5-IA----1件: 6 💬
468[123I] IBVM and SPECT imaging----1件: 6 💬
469[123I] mZINT injection and serial dynamic SPECT imaging----1件: 6 💬
470[123I]-IBVM----1件: 6 💬
471[123I]B-CIT----1件: 6 💬
472[123I]B-CIT SPECT imaging----1件: 6 💬
473[123I]beta CIT----1件: 6 💬
474[123I]beta CIT and SPECT imaging----1件: 6 💬
475[123I]beta-CIT----1件: 6 💬
476[123I]beta-CIT and SPECT imaging----1件: 6 💬
477[123I]CLINDE----2件: 6, 13 💬
478[123I]MNI-420----2件: 6, 8 💬
479[123I]ß CIT----1件: 6 💬
480[123I]ß CIT and SPECT imaging----1件: 6 💬
481[123I]ß-CIT----1件: 6 💬
482[123I]ß-CIT and SPECT imaging----1件: 6 💬
483[124I]IB PF 06687234----2件: 96, 97 💬
484[14C] AT1001----1件: 19 💬
485[14C]-BIA 9-10671件: BIA---1件: 6 💬
486[15-O]water1件: Water1件: Water 💬--1件: 206 💬
487[18F] CFPyPB----1件: 6 💬
488[18F] FES----1件: 86 💬
489[18F] GE-180----1件: 2 💬
490[18F] LBT-999 PET----1件: 6 💬
491[18F] PBR06----2件: 6, 13 💬
492[18F] PI-2620----1件: 6 💬
493[18F]-FBA-A20FMDV2----1件: 85 💬
494[18F]-FEPPA----2件: 6, 13 💬
495[18F]-FLT-PET/CT scans----1件: 34 💬
496[18F]-PI2620----1件: 5 💬
497[18F]DPA-714 PET----1件: 2 💬
498[18F]DPA-714 PET scan----1件: 6 💬
499[18F]FDOPA----2件: 6, 17 💬
500[18F]FDOPA PET/CT----1件: 6 💬
501[18F]Florbetaben----1件: 28 💬
502[18F]Florbetapir----1件: 5 💬
503[18F]Florbetapir PET imaging----1件: 13 💬
504[18F]flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 206 💬
505[18F]Fluoro-2-deoxy-2-D-glucose2件: D-glucose,
Dextrose, unspecified form		1件: Glucose 💬--2件: 86, 88 💬
506[18F]FP-R01-MG-F2----2件: 85, 94 💬
507[18F]FPEB----3件: 6, 8, 206 💬
508[18F]FPEB PET imaging----1件: 206 💬
509[18F]FSPG----2件: 96, 97 💬
510[18F]MK-9470----1件: 6 💬
511[18F]MNI-1126----1件: 6 💬
512[18F]MNI-815 (MNI-815)----1件: 5 💬
513[18F]MNI-952----1件: 5 💬
514[18F]MNI-958----1件: 5 💬
515[18F]MPPF----1件: 6 💬
516[18F]P17-059----1件: 6 💬
517[18F]PBR06----1件: 2 💬
518[18F]PI-2620----2件: 6, 127 💬
519[18F]T807 ([18F]MNI-777)----2件: 5, 6 💬
520[18F]UCB-2897----1件: 6 💬
521[21CFR640.30] Plasma from 18 - 25 year old volunteer donors----1件: 6 💬
522[C-11]Methylreboxetine----1件: 13 💬
523[C-11]PBR28----1件: 13 💬
524[C11]PK-1195 PET scan----1件: 13 💬
525[F-18]PBR06----1件: 13 💬
526[F-18]SDM-8----1件: 13 💬
527[Zr-89]Oxine-labeled leukocytes PET/MRI1件: Oxyquinoline1件: Oxyquinoline 💬--1件: 13 💬
528A (migalastat)1件: Migalastat1件: Migalastat 💬--1件: 19 💬
529A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: Clarithromycin ,
Clofazimine ,
Rifabutin 💬		--1件: 96 💬
530A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)----1件: 60 💬
531A multistrain probiotic product (DSF)----1件: 97 💬
532A Natural Remedy for Rheumatoid Arthritis vs. Common Drugs----1件: 46 💬
533A novel synthetic, orally-administered, non-peptide small molecule, which acts as----1件: 254 💬
534A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R)----1件: 51 💬
535A single blood sample for HLA typing----3件: 35, 38, 162 💬
536A-1293543.74----1件: 96 💬
537A-623 or AMG 623----1件: 66 💬
538A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (NEOGAA)1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
539A4250 (1200 µg)----1件: 338 💬
540A4250 (odevixibat)1件: Odevixibat1件: Odevixibat 💬1件: SLC10A2 💬1件: Bile secretion 💬1件: 338 💬
541A: 1 dosis----1件: 97 💬
542A: PTH (1-84)----1件: 235 💬
543Aadipose-Derived Mesenchymal Stem Cells----1件: 6 💬
544AAV BBP-631----1件: 81 💬
545AAV-GAD Dose 1----1件: 6 💬
546AAV2/5-hPDE6B----1件: 90 💬
547AAV2/5-hRKp.RPGR----1件: 90 💬
548AAV2/5-RPGR----1件: 90 💬
549AAV2CUhCLN2 (3x10^12 particle units)----1件: 19 💬
550AAV9 BBP-8121件: BBP-812---1件: 307 💬
551AAVrh.10-hMPSIIIA----1件: 19 💬
552AAVrh.10cuARSA----1件: 19 💬
553AAVrh.10CUCLN2----1件: 19 💬
554AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies----1件: 19 💬
555AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies----1件: 19 💬
556AB 1003----1件: 2 💬
557AB-1001 Gene Therapy----1件: 8 💬
558ABA, open-label (OL)----1件: 46 💬
559Abacavir sulfate, Lamivudine and Zidovudine4件: Abacavir,
Lamivudine,
Sulfate ion,
Zidovudine		3件: Lamivudine ,
Zidovudine ,
Abacavir 💬		--1件: 265 💬
560Abalimumab bio-originatore----1件: 107 💬
561Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)2件: Abatacept,
Methotrexate		2件: Methotrexate ,
Abatacept 💬		4件: CD80,
CD86,
DHFR,
DHFR2 💬		18件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
562Abatacept (BMS-188667)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
563Abatacept (M3-M12)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
564Abatacept + csDMARD1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
565Abatacept + Methotrexate2件: Abatacept,
Methotrexate		2件: Methotrexate ,
Abatacept 💬		4件: CD80,
CD86,
DHFR,
DHFR2 💬		18件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
566Abatacept + Vaccines1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
567Abatacept also known as Orencia also known as CTLA4-Ig1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 49 💬
568Abatacept Delayed-Onset Treatment1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 50 💬
569Abatacept, rituximab or tocilizumab3件: Abatacept,
Rituximab,
Tocilizumab		3件: Tocilizumab ,
Rituximab ,
Abatacept 💬		4件: CD80,
CD86,
IL6R,
MS4A1 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
570ABBV-105----2件: 46, 49 💬
571ABBV-105, A-1519938.0----1件: 46 💬
572ABBV-119----1件: 299 💬
573ABBV-154----2件: 46, 96 💬
574ABBV-323 Dose B----1件: 97 💬
575ABBV-576----1件: 299 💬
576ABBV-CLS-7262----1件: 2 💬
577ABC/DTG/3TC STR - Tablet----1件: 256 💬
578Abelmoschus manihot----1件: 66 💬
579AbGn-168H----1件: 97 💬
580ABI-M201----1件: 97 💬
581Abituzumab 1500 mg1件: Abituzumab---1件: 51 💬
582Abituzumab 500 mg1件: Abituzumab---1件: 51 💬
583ABO-101----1件: 19 💬
584ABO-102----1件: 19 💬
585ABP 501----1件: 46 💬
586ABP 710----1件: 46 💬
587ABP 710 - Biosimilar to infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
588ABP 798----1件: 46 💬
589ABP 798 - Biosimilar to rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
590ABP 798 Biosimilar to Rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
591ABP 959 - biosimilar to eculizumab1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
592ABP 959 - proposed biosimilar to eculizumab1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
593Abrocitinib 200 mg1件: Abrocitinib1件: Abrocitinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 84 💬
594ABT 494 12mg----2件: 46, 96 💬
595ABT-122----1件: 46 💬
596ABT-199----1件: 49 💬
597ABT-494 15mg----1件: 46 💬
598ABT-555----1件: 13 💬
599ABT-874/Human monoclonal antibody against IL-12----1件: 13 💬
600ABX-14311件: ABX-1431---1件: 13 💬
601ABX-1431 HCl1件: ABX-1431---1件: 13 💬
602ABX464 100mg----2件: 46, 97 💬
603ABX464 50mg----2件: 46, 97 💬
604AC-203 1% Topical Ointment----1件: 162 💬
605Accelerated 1 hour-infusion----2件: 96, 97 💬
606Accelerated 30 minutes-infusion----2件: 96, 97 💬
607Access program - sildenafil citrate, Viagra, Revatio1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
608Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
609Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
610Accordion Pill? Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
611Accordion Pill? Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
612Accordion Pill¿ Carbidopa/levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
613Accordion Pill™ Carbidopa/Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
614Accordion Pill™ Carbidopa/Levodopa 50/400 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
615Accordion Pill™ Carbidopa/Levodopa 50/500 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
616ACE I, ATA II and Statins----1件: 218 💬
617ACE inhibitor + statin----1件: 66 💬
618ACE Inhibitor or Angiotensin receptor antagonist1件: Angiotensin II2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
619ACE-011 / MK - 7962----1件: 86 💬
620ACE-011 / MK-7962----1件: 86 💬
621ACE-011/ MK-7962----1件: 86 💬
622ACE-031 (Extension of cohort 1 from core study, A031-03)----1件: 113 💬
623ACE-031 (Extension of cohort 2 from core study, A031-03)----1件: 113 💬
624ACE-031 (Extension of cohort 3 from core study, A031-03)----1件: 113 💬
625ACE-031 0.5 mg/kg q4wk----1件: 113 💬
626ACE-031 1.0 mg/kg q2wk----1件: 113 💬
627ACER-002 (celiprolol) 200 mg BID1件: Celiprolol1件: Celiprolol 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 168 💬
628Acetohydroxamic Acid Oral Tablet [Lithostat]1件: Acetohydroxamic acid1件: Acetohydroxamic acid 💬--1件: 251 💬
629ACETYL- L- CARNITINE1件: Levocarnitine1件: Levocarnitine 💬--1件: 265 💬
630Acetyl-L-carnitine 1000mg 2X per day for 3 months2件: Acetylcarnitine,
Levocarnitine		1件: Levocarnitine 💬--1件: 298 💬
631Acetylsalicylic acid at 1st visit,1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
632ACHIM as solute (10^9 intestinal microbes/ml)----1件: 51 💬
633Acid mycophenolic (Myfortic)1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222 💬
634ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable----1件: 299 💬
635Acido Micofenolico1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49 💬
636Acido Obeticolico----2件: 93, 94 💬
637Acido Sialico - Sialic acid (INN: aceneuramic acid)1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
638Aclasta 5 mg Infusionslösung1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
639Aclasta 5mg solution for infusion----1件: 13 💬
640ACOMPLIA 20 mg film-coated tablets1件: Rimonabant1件: Rimonabant 💬1件: CNR1 💬4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 193 💬
641Acoziborole (SCYX-7158)1件: Acoziborole---1件: 65 💬
642ACP-103----1件: 6 💬
643ACR16 10 mg----1件: 8 💬
644ACR16 22.5 mg----1件: 8 💬
645ACR16 45 mg----1件: 8 💬
646ACR16 hydrochloride, ASP2314 hydrochloride, FR310826----1件: 8 💬
647ACT - 064992----1件: 86 💬
648ACT-064992 (macitentan)1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
649ACT-064992 / JNJ-67896062----1件: 86 💬
650ACT-064992/ JNJ-67896062----1件: 86 💬
651ACT-1----1件: 13 💬
652ACT-128800----1件: 13 💬
653ACT-128800 Dose 1----1件: 13 💬
654ACT-128800 Dose 2----1件: 13 💬
655ACT-128800 Dose 3----1件: 13 💬
656ACT-178418----1件: 86 💬
657ACT-293987 / JNJ-67896049----1件: 84 💬
658ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 61, 62 💬
659Actemra, MRA1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 107 💬
660ACTH (Acthar) Gel1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 66 💬
661ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---2件: 62, 66 💬
662Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily.----1件: 276 💬
663Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.----1件: 6 💬
664Active drug: pimavanserin 17mg (2 strength tablets)1件: Pimavanserin---1件: 6 💬
665Active topical NS2 1% dermatologic cream----1件: 160 💬
666Active Treatment Group 7% Hypertonic Saline----1件: 299 💬
667Actonel 5mg Film Coated Tablets1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
668Actonel Once a Week 35 mg film-coated tablets1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
669Actonel Once a week 5mg film coated tablets1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 113 💬
670Actonel/Optinate 5mg film-coated tablets1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
671Actos 15 mg1件: Pioglitazone1件: Pioglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2 💬
672Actos 30 mg1件: Pioglitazone1件: Pioglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2 💬
673Actos 45 mg1件: Pioglitazone1件: Pioglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 2 💬
674Actrapid 100 IU/ml, Solution for injection in a vial----1件: 299 💬
675Actrapid Penfill 100UI/ml----1件: 299 💬
676ACTUS-101----1件: 256 💬
677ACZ885 150 mg (Canakinumab)1件: Canakinumab1件: Canakinumab 💬1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 107 💬
678ACZ885, 150mg/1.0ml----2件: 266, 267 💬
679AD 452 18 mg tablet----1件: 46 💬
680AD 452 4.5 mg Tablet----1件: 46 💬
681AD 452 9 mg tablet----1件: 46 💬
682ADA Umbilical Cord Blood Cells----1件: 65 💬
683Adalimuab, Etanercept, Tocilizumab, or Abatacept3件: Abatacept,
Etanercept,
Tocilizumab		3件: Etanercept ,
Tocilizumab ,
Abatacept 💬		5件: CD80,
CD86,
IL6R,
LTA,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
684Adalimumab (up to 9 months exposure)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
685Adalimumab - GP20171件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
686Adalimumab - US licensed Humira1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
687Adalimumab 40 mg1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
688Adalimumab 40 mg eow or ew1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
689Adalimumab 40 mg sc every other week1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
690Adalimumab 40 mg subcutaneous (SC) every other week (EOW)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
691Adalimumab 80 mg1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
692Adalimumab and its biosimilars1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
693Adalimumab biosimilare1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
694Adalimumab with methotrexate2件: Adalimumab,
Methotrexate		2件: Methotrexate ,
Adalimumab 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
695Adalimumab, current formulation1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
696Adalimumab, Etanercept, Golimumab or infliximab4件: Adalimumab,
Etanercept,
Golimumab,
Infliximab		4件: Etanercept ,
Adalimumab ,
Infliximab ,
Golimumab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
697Adalimumab, new formulation1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
698Adalimumab, plus prednisone2件: Adalimumab,
Prednisone		2件: Prednisone ,
Adalimumab 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
699Adalimumab, Solution for Injection 40 mg/ (0.8 ml) Pre-filled Syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
700ADCIRCA 20 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
701Adderall XR 10 mg----1件: 13 💬
702Adderall XR 5mg----1件: 13 💬
703Adempas (Riociguat, BAY63-2521)1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 88 💬
704ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
705ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
706ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
707ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
708ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
709Adempas 0.125 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 299 💬
710Adempas 0.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299 💬
711Adempas 0.5 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
712Adempas 1 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
713Adempas 1.0 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299 💬
714Adempas 1.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
715Adempas 1.5 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
716Adempas 2 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
717Adempas 2.0 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299 💬
718Adempas 2.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
719Adempas 2.5 mg Film Coated Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
720Adempas® 0.5 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
721Adempas® 1.0 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
722Adempas® 1.5 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
723Adempas® 2.0 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
724Adempas® 2.5 mg film-coated tablets1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
725Adempas¿ 0.5 mg compressa rivestita con film1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
726Adempas¿ 1.01件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
727Adempas¿ 1.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
728Adempas¿ 2.0 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
729Adempas¿ 2.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
730ADENO-ASSOCIATED VIRAL (AAV) SEROTYPE 8 (AAV2/8) VECTOR WITH LIVER-SPECIFIC THYROXINE-BINDING GLOBULIN (TBG) PROMOTER, DRIVING THE EXPRESSION OF THE HUMAN ARSB GENE1件: Levothyroxine1件: Levothyroxine 💬2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 19 💬
731Adeno-associated viral vector serotype 8 containing the human MD1 gene----1件: 113 💬
732Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene----1件: 113 💬
733Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-betagal)----1件: 19 💬
734Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-ßgal)----1件: 19 💬
735Adeno-associated virus serotype 2/6 encoding Human Iduronate 2-sulfatase (hIDS) gene donor vector, SB-A6P-HNT Donor Vector1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
736Adeno-associated virus serotype 2/6 encoding human iduronidase (hIDUA) gene donor vector, SB-A6P-HRL Donor Vector----1件: 19 💬
737Adeno-associated virus serotype 2/6 encoding Left side-zinc finger nuclease (ZFN1), SB-A6P-ZLEFT Vector----1件: 19 💬
738Adeno-associated virus serotype 2/6 encoding Right side-zinc finger nuclease (ZFN2), SB-A6P-ZRIGHT Vector----1件: 19 💬
739ADENO-ASSOCIATED VIRUS SEROTYPE 5 ENCODING A MICRORNA TARGETED TO HUMAN HUNTINGTIN GENE----1件: 8 💬
740Adeno-associated virus serotype 9 carrying the human fukutin-related protein and target sequence of the miR-208a----1件: 113 💬
741Adeno-associated virus serotype rh.10 expressing beta-galactosidase1件: Tilactase1件: Lactase 💬--1件: 19 💬
742ADENO-ASSOCIATED VIRUS SEROTYPE RH74 CONTAINING THE HUMAN MICRO-DYSTROPHIN GENE----1件: 113 💬
743Adeno-associated virus type 2 vector encoding Rab escort protein 1----1件: 90 💬
744Adenoviral Vector-Mediated Gene Transfer----1件: 251 💬
745Adipose derived allogenic mesenchymal stem cells (adAMSC)----1件: 96 💬
746Adipose derived mesenchymal stem cell----1件: 3 💬
747Adipose derived mesenchymal stem cells----1件: 86 💬
748Adipose derived, autologous mesenchymal stem cells----1件: 97 💬
749Adipose tissue-derived mesenchymal stem cells----1件: 97 💬
750Adipose-cord mesenchymal stromal cells (A-MSCs)1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 97 💬
751Administration of a high dose of desipramine1件: Desipramine1件: Desipramine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156 💬
752Administration of a low dose of desipramine1件: Desipramine1件: Desipramine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 156 💬
753Administration of an ACE-inhibitor or not----1件: 210 💬
754Administration of Cimzia®1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
755Administration of drug (Interferon-gamma 1-b) subcutaneously----1件: 65 💬
756Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil4件: Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		4件: Methylprednisolone ,
Prednisone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 49 💬
757Administration of methylprednisolone, paracetamol and dexchlorpheniramine3件: Acetaminophen,
Dexchlorpheniramine,
Methylprednisolone		3件: Acetaminophen ,
Methylprednisolone ,
Dexchlorpheniramine 💬		4件: HRH1,
NR3C1,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49 💬
758Administration of rituximab and methylprednisolone2件: Methylprednisolone,
Rituximab		2件: Methylprednisolone ,
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 51 💬
759Administration of stable isotope-labelled leucine-1件: Leucine1件: Leucine 💬--1件: 6 💬
760Adrenergic receptor binder (ARB)----1件: 224 💬
761Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
762ADS-5102----2件: 6, 13 💬
763ADS-5102 (extended release amantadine HCl)1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
764ADS-5102, 137 mg----1件: 13 💬
765ADS-5102, 274 mg----1件: 13 💬
766Adult human mesenchymal stem cells1件: Remestemcel-L1件: Remestemcel-L 💬--2件: 85, 96 💬
767Advagraf 0,5mg1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
768Advagraf 1mg1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
769Advagraf 5mg1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
770ADVATE (rAHF - PFM)1件: Antihemophilic factor, human recombinant---1件: 288 💬
771ADVATE 1000 IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant---1件: 288 💬
772ADVATE 1000IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant---1件: 288 💬
773ADVATE 500 IU powder and solvent for solution for injection1件: Antihemophilic factor, human recombinant---1件: 288 💬
774Adverse Reactions of Gammagard subcutaneously at Week 12----1件: 65 💬
775Adverse Reactions of Gammagard subcutaneously at Week 24----1件: 65 💬
776Adverse Reactions of Gammagard subcutaneously at Week 36----1件: 65 💬
777Adverse Reactions of Gammagard subdermally at Week 12----1件: 65 💬
778Adverse Reactions of Gammagard subdermally at Week 24----1件: 65 💬
779Adverse Reactions of Gammagard subdermally at Week 36----1件: 65 💬
780ADX-102 1% Topical Dermal Cream (reproxalap)1件: Reproxalap1件: Reproxalap 💬--1件: 160 💬
781AEGR-733----1件: 79 💬
782Aerolised Liposomal Ciclosporin A 10mg1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
783Aerolised Liposomal Ciclosporin A 5mg1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
784Aerosolized human Alpha-1 Antitrypsin----1件: 231 💬
785Aerosolized, human, plasma-derived Alpha-1 Antitrypsin----1件: 299 💬
786AERT, (R)-Baclofen1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
787Aesculus Hippocastanum / Horse Chestnut1件: Horse chestnut1件: Horse chestnut 💬--1件: 210 💬
788AEZS-130----1件: 78 💬
789AEZS-130 (formerly ARD-07)----1件: 78 💬
790AF37702, Hematide1件: Peginesatide1件: Peginesatide 💬1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283 💬
791Afamelanotide (16 mg implant)1件: Afamelanotide1件: Afamelanotide 💬1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 159 💬
792AFFITOPE® PD01A----1件: 6 💬
793AFFITOPE® PD01A + Adjuvant----2件: 6, 17 💬
794AFFITOPE® PD03A + Adjuvant----1件: 17 💬
795Afimetoran (10mg)1件: Afimetoran1件: Afimetoran 💬--1件: 49 💬
796Afimetoran (2.5mg)1件: Afimetoran1件: Afimetoran 💬--1件: 49 💬
797Afinitor 5mg Tablets1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 89, 158 💬
798Afucosylated IgG1 kappa monoclonal antibody----1件: 300 💬
799AG011 - Capsules----1件: 97 💬
800AG011 - Enema----1件: 97 💬
801AGALSIDASE BETA1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
802Agalsidase beta (GZ419828)1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
803Agalsidase beta (recombinant form)1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
804Agalsidase beta from Biosidus 1 mg/kg1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
805AGALSIDASI BETA----1件: 19 💬
806AGLE 102----1件: 36 💬
807AGM 719----1件: 46 💬
808Agomelatine or PIacebo1件: Agomelatine1件: Agomelatine 💬3件: HTR2C,
MTNR1A,
MTNR1B 💬		6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
809AGT-181----1件: 19 💬
810AGT-181 (HIRMAb-IDUA)----1件: 19 💬
811AGT-182----1件: 19 💬
812AIDSVAX® B/E----1件: 49 💬
813AIN457, 150 mg----1件: 271 💬
814AIN457, 150mg----1件: 37 💬
815AIN457, 75 mg----1件: 271 💬
816AK1320 MS----1件: 70 💬
817Aknemin 50----1件: 201 💬
818AKR-501, YM-477----1件: 63 💬
819AL-108----1件: 5 💬
820ALAC, inulin, FOS, and sodium butyrate2件: Butyric Acid,
Inulin		1件: Inulin 💬--1件: 156 💬
821Albumin (Human) 20%, United States Pharmacopeia (USP)----1件: 231 💬
822Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14 💬
823Albunorm® 5%,----1件: 20 💬
824Albutein 5%1件: Albumin human1件: Albumin human 💬--1件: 2 💬
825Albúmina humana----1件: 2 💬
826ALD518 monoclonal antibody (anti IL-6 mAb)----1件: 46 💬
827ALDURAZYME*INFUS 1FL 5ML 500U1件: Laronidase1件: Laronidase 💬1件: IDUA 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
828Alemtuzumab (already received by alemtuzumab cohort between 1991 and 19941件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 46 💬
829Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994)1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 46 💬
830Alemtuzumab 0.2 mg1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-2件: 65, 164 💬
831Alemtuzumab 0.3 mg1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-2件: 65, 164 💬
832Alemtuzumab 12 mg1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
833Alemtuzumab 24 mg1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
834Alemtuzumab, Rituximab2件: Alemtuzumab,
Rituximab		2件: Alemtuzumab ,
Rituximab 💬		2件: CD52,
MS4A1 💬		1件: Hematopoietic cell lineage 💬1件: 63 💬
835Alendronate versus alfacalcidol (1-alpha OH vitamin D)3件: Alendronic acid,
Alfacalcidol,
Vitamin D		2件: Alfacalcidol ,
Alendronic acid 💬		2件: FDPS,
VDR 💬		9件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬3件: 41, 46, 50 💬
836Alfa-manosidadas humana recombinante----1件: 19 💬
837Alfacalcidol 2 micrograms/ml1件: Alfacalcidol1件: Alfacalcidol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 50, 107 💬
838Alga Dunaliella Bardawil----1件: 90 💬
839Alga Dunaliella Bardawil powder----1件: 90 💬
840Alga Dunaliella Bardawill----1件: 90 💬
841Alginate oligosaccharide1件: Alginic acid1件: Alginic acid 💬--1件: 299 💬
842ALGLUCOSIDASE ALFA (MYOZYME)1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
843ALISERIN - 25 MG GRANULATO EFFERVESCENTE 20 BUSTINE----1件: 19 💬
844ALKS 8700 Delayed Release (DR) Capsule1件: Manganese citrate---1件: 13 💬
845All patients in the study will be treated with ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
846All subjects will receive maraviroc 300mg orally twice a day for 6 weeks1件: Maraviroc1件: Maraviroc 💬1件: CCR5 💬11件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 84 💬
847All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine----1件: 2 💬
848All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-Pthioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-----1件: 2 💬
849Allo-APZ2-OTS----1件: 36 💬
850Allogeneic adipose tissue-derived mesenchymal stem cells----1件: 97 💬
851ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED----5件: 36, 38, 53, 96, 162 💬
852Allogeneic adipose tissue-derived MSC----1件: 36 💬
853Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)1件: Remestemcel-L1件: Remestemcel-L 💬--1件: 85 💬
854Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs)----1件: 96 💬
855Allogeneic bone marrow transplant----1件: 49 💬
856Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg)----1件: 6 💬
857Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg)----1件: 6 💬
858Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg)----1件: 6 💬
859Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg)----1件: 6 💬
860Allogeneic Cardiosphere-Derived Cells (CAP-1002)1件: CAP-1002---1件: 113 💬
861Allogeneic donor derived B-lymphocytes----1件: 60 💬
862Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells----1件: 13 💬
863ALLOGENEIC MESENCHYMAL PRECURSOR CELLS----1件: 46 💬
864Allogeneic mesenchymal stem cell transplantation----1件: 171 💬
865Allogeneic Mesenchymal Stem Cells----1件: 47 💬
866Allogeneic Mesenchymal Stem Cells (AlloMSC)----2件: 51, 53 💬
867Allogeneic mesenchymal stromal cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36 💬
868ALLOGENEIC MESENCHYMAL STROMAL CELLS DERIVED FROM THE UMBILICAL CORD1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 49 💬
869Allogeneic MSC (AlloMSC)----1件: 49 💬
870Allogeneic peripheral blood stem cell----1件: 65 💬
871Allogeneic skin-derived ABCB5-positive mesenchymal stem cells----1件: 36 💬
872Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation----1件: 17 💬
873Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation----1件: 17 💬
874Allogeneic umbilical cord mesenchymal stem cells----1件: 13 💬
875Allogenic eASCs 5 milion cells/ml suspension for injection. Cx601----1件: 96 💬
876Allogenic eASCs 5 million cells/ml suspension for injection CX601----1件: 96 💬
877Allogenic eASCs 5 million cells/ml suspension for injection. CX601----1件: 96 💬
878Allogenic eASCs 5 million/ml suspension for injection.----1件: 96 💬
879Allogenic mesenchymal stem cell isolated from adipose tissue----3件: 38, 96, 162 💬
880Allogenic mesenchymal stromal cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36 💬
881Allopurinol Sandoz 100 mg, tabletten1件: Allopurinol1件: Allopurinol 💬1件: XDH 💬6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬1件: 96 💬
882ALN-51547----1件: 28 💬
883ALN-77412----1件: 231 💬
884Aloe Barbadensis Miller1件: Aloe vera leaf---1件: 97 💬
885Alpelisib (BYL719)1件: Alpelisib1件: Alpelisib 💬1件: PIK3CA 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 138 💬
886Alpha 1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231 💬
887Alpha 1-proteinase inhibitor (human)1件: Alpha-1-proteinase inhibitor---1件: 231 💬
888Alpha beta depletion----2件: 60, 284 💬
889Alpha-1 Antitrypsin (AAT)----1件: 231 💬
890Alpha-1 Antitrypsin (human)----1件: 231 💬
891Alpha-1 HC 100 mg----1件: 299 💬
892Alpha-1 HC 200 mg----1件: 299 💬
893Alpha-1 MP----1件: 231 💬
894Alpha-1 proteinase inhibitor (human)----1件: 231 💬
895ALPHA-1-ANTITRYPSIN1件: Alpha-1-proteinase inhibitor---1件: 231 💬
896Alphanate 1000 I.U.3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
897Alphanate 1500 I.U.3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
898ALPHANATE*INF 1F 1000UI+F 10ML2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
899ALPHANATE*INF 1F 1500UI+F 10ML2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
900ALPHANATE*INF 1F 250UI+F 5ML2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
901ALPHANATE*INF 1F 500UI+F 5ML2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
902ALPN-101----1件: 49 💬
903ALRN-5281 0.015 mg/kg----1件: 78 💬
904ALRN-5281 0.05 mg/kg----1件: 78 💬
905ALRN-5281 0.15 mg/kg----1件: 78 💬
906Also referred to as 'MEDI2070'----2件: 96, 97 💬
907Also referred to as MED2070----1件: 96 💬
908Also referred to as MEDI2070----2件: 96, 97 💬
909Alternative osteoporosis medications----1件: 274 💬
910ALTH12-1:4----1件: 97 💬
911Altropane (123I) Injection1件: Altropane---1件: 6 💬
912ALTU-1351件: ALTU-135---1件: 299 💬
913ALTUS-135----1件: 299 💬
914Alvelestat oral tablet - dose 11件: Alvelestat---1件: 231 💬
915Alvelestat oral tablet - dose 21件: Alvelestat---1件: 231 💬
916ALX-0061 150 mg/mL----1件: 49 💬
917ALZT-OP1a (cromolyn)1件: Cromoglicic acid1件: Cromoglicic acid 💬--1件: 2 💬
918Amantadin-ratiopharm 100mg----1件: 6 💬
919Amantadine 300 mg1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
920Ambrisentan - high dose1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
921Ambrisentan - low dose1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
922Ambrisentan 5 mg1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 88 💬
923Ambrisentan 5 mg film-coated tablets1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
924Ambrisentan 5mg film-coated tablets [marketed product]1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
925AMBROXOL HYDROCHLORIDE PH. EUR.1件: Ambroxol1件: Ambroxol 💬--1件: 19 💬
926American ginseng extract HT-10012件: Ginseng,
Panax quinquefolius whole		1件: Ginseng 💬--1件: 13 💬
927AMG 1081件: AMG 108---1件: 46 💬
928AMG 139----1件: 96 💬
929AMG 145----1件: 79 💬
930AMG 1571件: Tezepelumab1件: Tezepelumab 💬1件: TSLP 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 98 💬
931AMG 162----2件: 46, 274 💬
932AMG 181----2件: 96, 97 💬
933AMG 531----1件: 63 💬
934AMG 557----1件: 49 💬
935AMG 557/MEDI5872----1件: 53 💬
936AMG 570----2件: 46, 49 💬
937AMG 592----3件: 46, 49, 97 💬
938AMG 714----1件: 46 💬
939AMG 719----1件: 46 💬
940AMG 785----1件: 274 💬
941AMG 827 140 mg----1件: 46 💬
942AMG 827 210 mg----2件: 46, 96 💬
943AMG 827 350 MG----1件: 96 💬
944AMG 827 70 mg----1件: 46 💬
945AMG 827 700 MG----1件: 96 💬
946AMGEVITA (Adalimumab biosimilar )1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
947Amgevita 40 mg Injektionslösung im Fertigpen1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
948Amgevita 40 mg Injektionslösung in einer Fertigspritze1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
949Amifampridine Phosphate 10 MG Oral Tablet2件: Amifampridine,
Phosphate ion		1件: Amifampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 3 💬
950Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami1件: Amikacin1件: Amikacin 💬--1件: 299 💬
951Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami1件: Amikacin1件: Amikacin 💬--1件: 299 💬
952Amiloride Hcl 5mg Tab1件: Amiloride1件: Amiloride 💬3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 67 💬
953AMILORIDE HYDROCHLORIDE, 2 H2O1件: Amiloride1件: Amiloride 💬3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13 💬
954Amitriptyline, fluoxetine and tramadol alone (control group)3件: Amitriptyline,
Fluoxetine,
Tramadol		3件: Fluoxetine ,
Amitriptyline ,
Tramadol 💬		3件: OPRM1,
SLC6A2,
SLC6A4 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 78 💬
955Ammonium (15N) chloride1件: Chloride ion---1件: 251 💬
956Amniotic membrane extract eye drops (AMEED)----1件: 53 💬
957Amoxapine & dipyridamole2件: Amoxapine,
Dipyridamole		2件: Amoxapine ,
Dipyridamole 💬		4件: PDE4A,
PDE5A,
SLC6A2,
SLC6A4 💬		8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
958Amoxicillin, metronidazole and doxycycline3件: Amoxicillin,
Doxycycline,
Metronidazole		5件: Amoxicillin ,
Doxycycline ,
Metronidazole ,
Amoxicillin ,
Doxycycline 💬		--1件: 97 💬
959AMP-110----1件: 46 💬
960Amphotericin B1件: Amphotericin B1件: Amphotericin B 💬--1件: 299 💬
961AMPHOTERICINE B, LIPOSOME----1件: 60 💬
962Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene----1件: 265 💬
963AMT-101----2件: 46, 97 💬
964AMT-101 (oral)----1件: 97 💬
965AMT-1301件: AMT-130---1件: 8 💬
966AN100226, BG00002----1件: 13 💬
967ANA001XHCl (Syntagon) or VEXA-04 (Patheon)----1件: 156 💬
968Anaerobically Cultivated Human Intestinal Microbiota----1件: 51 💬
969Anaerobically Cultivated medium----1件: 51 💬
970Anakinra (r-metHuIL-1ra)1件: Anakinra1件: Anakinra 💬2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 46 💬
971Anakinra / kineret1件: Anakinra1件: Anakinra 💬2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 107 💬
972Analysis of gamma globulin----1件: 84 💬
973Analysis of selected single nucleotide polymorphisms (SNPs)----1件: 46 💬
974Anatomical Landmark-guided Suprascapular Nerve Block----1件: 149 💬
975ANAVEX2-73----2件: 6, 156 💬
976ANAVEX2-73 (blarcamesine)1件: Blarcamesine1件: Blarcamesine 💬6件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
SIGMAR1 💬		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 156 💬
977ANAVEX2-73 oral liquid----1件: 156 💬
978AndroGel 1 % Topical Gel----1件: 13 💬
979Androgel 10 grams of gel containing 100 mg of testosterone1件: Testosterone1件: Testosterone 💬1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13 💬
980Angiotensin blockade1件: Angiotensin II2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
981Angiotensin receptor blockers1件: Angiotensin II2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 46 💬
982Angiotensin-(1-7)1件: Angiotensin II2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 17 💬
983Angiotensin-converting enzyme (ACE) inhibitor1件: Angiotensin II2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 224 💬
984Anifrolumab (MEDI-546)1件: Anifrolumab1件: Anifrolumab 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 46 💬
985Anifrolumab 1000 mg1件: Anifrolumab1件: Anifrolumab 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 49 💬
986Anifrolumab 300 mg1件: Anifrolumab1件: Anifrolumab 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 49 💬
987Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal----1件: 46 💬
988ANK-700----1件: 13 💬
989Anti BAFF (B cell activating factor)----1件: 49 💬
990Anti Beta7----1件: 97 💬
991Anti CD3 monoclonal antibody----1件: 97 💬
992Anti human granulocyte-macrophage colo----1件: 46 💬
993Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) MONOCLONAL----1件: 46 💬
994Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody----1件: 46 💬
995Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal----1件: 46 💬
996Anti IL 6 mAb----1件: 46 💬
997Anti IL-1beta antibody----1件: 46 💬
998Anti IL-1beta antibody, subclass IgG4----1件: 46 💬
999Anti IL-1ß antibody----1件: 46 💬
1000Anti IL-1ß antibody, subclass IgG4----1件: 46 💬
1001Anti LP40 antibody, subclass IgG4----1件: 49 💬
1002Anti LP40 antibody, subclass IgG4 LA294----2件: 13, 46 💬
1003Anti LP40 anticuerpo, subclase IgG4----1件: 49 💬
1004Anti TNF + Meth----1件: 46 💬
1005Anti-(complement C5a) IgG4 chimeric monoclonal antibody----1件: 269 💬
1006Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain)----1件: 271 💬
1007Anti-(misfolded human superoxide dismutase 1) human IgG1m3 monoclonal antibody----1件: 2 💬
1008Anti-BAFFR antibody----1件: 95 💬
1009Anti-Beta Interferon (PF-06823859)----1件: 50 💬
1010Anti-blood dendritic cell antigen 2----1件: 49 💬
1011Anti-CD20 B cell depletion with Truxima----1件: 49 💬
1012Anti-CD20 small modular immunopharmaceutical, WYE-400087----1件: 46 💬
1013Anti-CD25 Humanized Monoclonal Antibody----1件: 13 💬
1014Anti-CD3 Monoclonal antibody1件: Muromonab---2件: 96, 97 💬
1015Anti-CD52 monoclonal antibody----1件: 13 💬
1016Anti-CT51 antigen mAb----1件: 51 💬
1017Anti-human immunoglobulin, equine----1件: 60 💬
1018Anti-Human Interleukin-23 Monoclonal Antibody----1件: 271 💬
1019Anti-hypertensive medications----1件: 67 💬
1020Anti-IL-12----2件: 13, 96 💬
1021Anti-IL-20 (109-0012)1件: Fletikumab1件: Fletikumab 💬1件: IL20 💬3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
1022Anti-IL-23 monoclonal antibody----1件: 96 💬
1023Anti-IL-36R monoclonal antibody----1件: 37 💬
1024Anti-IL-6 mAb----2件: 46, 96 💬
1025Anti-integrin alphaV mAb----1件: 51 💬
1026Anti-Interferon-gamma monoclonal antibody----1件: 96 💬
1027Anti-interleukin 5 (IL-5) humanized monoclonal----2件: 44, 45 💬
1028Anti-interleukin-1B monoclonal antibody----1件: 106 💬
1029Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma----2件: 96, 97 💬
1030Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human----2件: 96, 97 💬
1031Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----2件: 96, 97 💬
1032Anti-Interleukin-6 Monoclonal----1件: 46 💬
1033Anti-Interleukin-6 Monoclonal Antibody----2件: 46, 96 💬
1034Anti-IP-10 Antibody----1件: 97 💬
1035Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody----1件: 49 💬
1036Anti-MAdCAM antibody----2件: 96, 97 💬
1037Anti-Mullerian hormone (AMH) level----1件: 13 💬
1038Anti-myostati----1件: 113 💬
1039Anti-Myostatin Adnectin----1件: 113 💬
1040Anti-Parkinson medication----5件: 5, 6, 7, 8, 17 💬
1041ANTI-SCLEROSTIN MONOCLONAL ANTIBODY----1件: 274 💬
1042Anti-Thymocyte Globulin, Rabbit1件: Rabbit---1件: 51 💬
1043Anti-TNF biologics----2件: 46, 271 💬
1044Anti-TNF Biologics Therapy----1件: 46 💬
1045Anti-TNF discontinuation: Physiological saline solution----2件: 96, 97 💬
1046Anti-TNF humanized antibody Fab fragment - PEG conjugate----1件: 46 💬
1047Anti-TNF humanized antibody Fab' fragment - PEG conjugate----1件: 46 💬
1048Anti-TNF therapy (etanercept or adalimumab)2件: Adalimumab,
Etanercept		2件: Etanercept ,
Adalimumab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
1049Anti-TNF: Infliximab (Infusion)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
1050Anti-Tumor Necrosing Factor (TNF) Therapy----1件: 46 💬
1051Anti-tumor necrosis factor alpha monoclonal antibody----1件: 107 💬
1052Anti-von Willebrand Factor Nanobody, Caplacizumab2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
1053Anti-von Willebrand Factor Nanobody, INN = Caplacizumab2件: Caplacizumab,
Von Willebrand factor human		1件: Caplacizumab 💬1件: VWF 💬8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬1件: 64 💬
1054Anticholinergic medication----1件: 13 💬
1055Anticorpo monoclonale anti GM-CSF umano----1件: 46 💬
1056Anticorpo monoclonale anti IL-23----1件: 96 💬
1057Anticorpo monoclonale anti-IL-23----1件: 96 💬
1058Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2)----1件: 96 💬
1059Anticuerpo monoclonal anti-humano recombinante humanizado, receptor de IL-6R.----1件: 46 💬
1060Anticuerpo monoclonal anti-LINGO-1 humano----1件: 13 💬
1061Antiepileptic drug (1 to 3 only)----1件: 158 💬
1062Antihistamine (cetirizine or equivalent)1件: Cetirizine1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 35 💬
1063Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal----1件: 46 💬
1064Antimicrobial therapy: Co-trimoxazole or Doxycycline1件: Doxycycline2件: Doxycycline ,
Doxycycline 💬		--1件: 85 💬
1065Antisense oligonucleotide----1件: 5 💬
1066Antistaminici H1 - H2----1件: 299 💬
1067ANTOX (vers) 1.2----1件: 298 💬
1068ANTOX (vers.)1.2----1件: 298 💬
1069Antox version 1.2----1件: 298 💬
1070Any other approved Antiepileptic Drug----1件: 144 💬
1071AOC 1001----1件: 113 💬
1072AOC 1020----1件: 113 💬
1073AOC 1044----1件: 113 💬
1074AODG (Apigenin-7-O-glucuronide)1件: Apigenin---1件: 97 💬
1075AP-101----1件: 2 💬
1076AP1189, 100 mg----1件: 46 💬
1077AP1189, 60 mg----1件: 46 💬
1078AP1189, 80 mg----1件: 46 💬
1079APCC, aPCC + TXA----1件: 288 💬
1080API-AAT, AD00370, ARC-AAT, API drug Substance----1件: 231 💬
1081Apitox - pure honeybee toxin----1件: 13 💬
1082APL-130277----1件: 6 💬
1083APL-1401----1件: 97 💬
1084Aplindore MR tablets1件: Aplindore---1件: 6 💬
1085Apomorphine 0.25% (2.5mg/ml)1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1086Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1087Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1088Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1089Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1090ApoTamox 10mg----1件: 111 💬
1091Application of Adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1092Apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side1件: Sinecatechins1件: Sinecatechins 💬--1件: 160 💬
1093Apraclonidine Hcl 0.5% Oph Soln1件: Apraclonidine1件: Apraclonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 11 💬
1094Apremilast (CC-10004)1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 56 💬
1095Apremilast 10 mg1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 56, 107 💬
1096Apremilast 20 mg1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬3件: 46, 56, 107 💬
1097Apremilast 30 mg1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬3件: 46, 56, 107 💬
1098Apremilast tablet 20 mg1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 271 💬
1099Apremilast tablet 30 mg BID1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 271 💬
1100APRISO 375 mg extended-release capsules1件: Manganese citrate---1件: 97 💬
1101Aprovel (150 mg)1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
1102Aprovel 150 mg Tablets1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
1103APT-1011----1件: 98 💬
1104APT-1011 - 3 mg----1件: 98 💬
1105APT-1011 3 mg HS----1件: 98 💬
1106AQX-11251件: AQX-1125---1件: 226 💬
1107AQX-1125 100 mg1件: AQX-1125---1件: 226 💬
1108AQX-1125 200 mg1件: AQX-1125---1件: 226 💬
1109Arava 20 mg filmdrasjerte tabletter----1件: 46 💬
1110Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.)1件: Leflunomide1件: Leflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 46 💬
1111Arbaclofen placarbil 15 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: Arbaclofen placarbil ,
Arbaclofen 💬		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1112Arbaclofen placarbil 30 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: Arbaclofen placarbil ,
Arbaclofen 💬		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1113Arbaclofen placarbil 45 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: Arbaclofen placarbil ,
Arbaclofen 💬		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1114ARC 1779----2件: 64, 288 💬
1115ARC1905 20 MG/ML----1件: 301 💬
1116ARCOXIA 90 mg comprimidos recubiertos con película----1件: 271 💬
1117ARGX-113----5件: 11, 14, 35, 53, 63 💬
1118ARGX-117----1件: 14 💬
1119ARGX-117 IV----1件: 14 💬
1120Aricept 10 mg1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
1121Aricept 10 mg filmdragerade tabletter1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
1122Aricept 5 mg1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
1123Aricept 5 mg filmdragerade tabletter1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
1124Aricept 5 mg-Filmtabletten----1件: 6 💬
1125ARICEPT 5*28 CPR 5 MG1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 124 💬
1126Aricept 5mg-Filmtabletten----1件: 6 💬
1127Aridol or Osmohale1件: Mannitol1件: Mannitol 💬--1件: 299 💬
1128Arikayce™ 140 mg1件: Amikacin1件: Amikacin 💬--1件: 299 💬
1129Arikayce™ 560 mg1件: Amikacin1件: Amikacin 💬--1件: 299 💬
1130Arikayce™ 70 mg1件: Amikacin1件: Amikacin 💬--1件: 299 💬
1131ARINA-1----2件: 228, 299 💬
1132Arm 1 - GEH120714 (18F) Injection----1件: 13 💬
1133Arm B: Rituxan®/Mabthera®1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
1134ARO-MMP7 Inhalation Solution----1件: 85 💬
1135ARRY-371797, p38 inhibitor----2件: 46, 271 💬
1136ARRY-438162, MEK inhibitor----1件: 46 💬
1137ART-123----1件: 85 💬
1138Artamin 150 mg----1件: 171 💬
1139Artamin 250 mg----1件: 171 💬
1140Artesunate Oral Product1件: Artesunate1件: Artesunate 💬--1件: 18 💬
1141Arthroscopy & saline irrigation alone----1件: 46 💬
1142ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1143ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1144Asacol (mesalamine)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
1145Asacol (mesalamine) Delayed-release Tablets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
1146Asacol 400 mg----1件: 97 💬
1147Asacol 400 mg (mesalamine)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
1148Asacol 400 mg tablet1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
1149Asacol 800 mg (mesalamine)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
1150Asacol 800 mg tablet1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
1151Asacol® 400 mg----1件: 97 💬
1152ASC42 10 mg----1件: 93 💬
1153ASC42 15 mg----1件: 93 💬
1154ASC42 5 mg----1件: 93 💬
1155Ascal(r) / carbasalate calcium2件: Calcium,
Carbaspirin calcium		1件: Carbaspirin calcium 💬--1件: 46 💬
1156Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E)3件: Ascorbic acid,
Tocopherol,
Vitamin E		3件: Ascorbic acid ,
Vitamin E ,
Tocopherol 💬		--1件: 206 💬
1157ASCs: Adipose derived Stem Cells----1件: 96 💬
1158Asendis 50 mg----1件: 46 💬
1159ASF-1096 Cream 0.25%----1件: 49 💬
1160ASF-1096 Cream 0.5%----1件: 49 💬
1161ASF-1096 Cream 1.0%----1件: 49 💬
1162ASK Nr. 21972----1件: 5 💬
1163ASP015K hydrobromide, AS1940150-BR, JKT-201A, 4-{[(1R,2s,3S,5s,7s)-5-Hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide----1件: 46 💬
1164Aspergillus oryzae1件: Aspergillus oryzae---1件: 97 💬
1165Aspirin 650mg Oral Capsule1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
1166Aspirin and meloxicam2件: Acetylsalicylic acid,
Meloxicam		2件: Aspirin ,
Meloxicam 💬		2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 49 💬
1167Assigned Interventions CD19/BCMA CAR T-cells----3件: 49, 51, 53 💬
1168Assigned pulmonary hypertension medication----1件: 86 💬
1169AST-120----2件: 96, 97 💬
1170ASyn Mab----1件: 6 💬
1171AT 10----2件: 6, 85 💬
1172AT-1501----1件: 66 💬
1173AT-GTX-501----1件: 19 💬
1174AT1001 150 mg----1件: 19 💬
1175AT2221 65 mg Formulated Capsules----1件: 256 💬
1176Atacicept 150 mg1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 49 💬
1177Atacicept 25 mg1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 66 💬
1178Atacicept 75 mg1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 49, 66 💬
1179Atacicept 75 milligram (mg)1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1180Atacicept: with loading dose1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
1181Ataluren 1000 mg1件: Ataluren1件: Ataluren 💬--1件: 113 💬
1182Ataluren 1000mg1件: Ataluren1件: Ataluren 💬--1件: 246 💬
1183Ataluren 125 mg1件: Ataluren1件: Ataluren 💬--1件: 113 💬
1184Ataluren 125mg1件: Ataluren1件: Ataluren 💬--1件: 246 💬
1185Ataluren 250 mg1件: Ataluren1件: Ataluren 💬--1件: 113 💬
1186Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)2件: Atazanavir,
Ritonavir		2件: Ritonavir ,
Atazanavir 💬		--1件: 265 💬
1187Atenolol or Propranolol2件: Atenolol,
Propranolol		2件: Atenolol ,
Propranolol 💬		3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167 💬
1188ATGAM plus CsA with or without Eltrombopag1件: Eltrombopag---1件: 60 💬
1189ATH-1017----1件: 6 💬
1190ATH434 dose level 1----1件: 17 💬
1191ATI-450 20mg oral tablet BID----1件: 46 💬
1192ATI-450 50mg oral tablet BID----1件: 46 💬
1193ATN-103----1件: 46 💬
1194ATN-103 10 mg q4wks----1件: 46 💬
1195ATN-103 10 mg q8wks----1件: 46 💬
1196ATN-103 30 mg q4wks----1件: 46 💬
1197ATN-103 80 mg q4wks----1件: 46 💬
1198ATN-103 80 mg q8wks----1件: 46 💬
1199Atorvastatin 10mg1件: Atorvastatin1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63 💬
1200Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet2件: Acetylcysteine,
Atorvastatin		2件: Acetylcysteine ,
Atorvastatin 💬		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 63 💬
1201Atorvastatin tablet 20 mg1件: Atorvastatin1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 46 💬
1202ATR-101----2件: 75, 81 💬
1203ATX-MS-1467----1件: 13 💬
1204ATYR1923 1.0 mg/kg1件: ATYR1923---1件: 84 💬
1205ATYR1923 3.0 mg/kg1件: ATYR1923---1件: 84 💬
1206ATYR1923 5.0 mg/kg1件: ATYR1923---1件: 84 💬
1207AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
1208AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
1209Aubagio 14 mg film-coated tablets1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
1210AUC of MPA measure----1件: 51 💬
1211Aurexis® (tefibazumab)1件: Tefibazumab1件: Tefibazumab 💬--1件: 299 💬
1212Autofluorescent detection + Injection of indocyanine green1件: Indocyanine green1件: Indocyanine green 💬--1件: 235 💬
1213Autologous (self) mononuclear cells derived from umbilical cord blood----1件: 211 💬
1214Autologous adipose derived mesenchymal cells----1件: 13 💬
1215Autologous Adipose Derived MSCs (ADMSCs)----1件: 85 💬
1216Autologous Adipose Mesenchymal Stem Cell Implantation----1件: 17 💬
1217Autologous Adipose-derived Mesenchymal Stromal Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 2 💬
1218Autologous adult bone marrow mononuclear cells (BM-MNC) unexpanded----1件: 2 💬
1219Autologous adult bone marrow mononuclear cells unexpanded----1件: 2 💬
1220Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved----1件: 13 💬
1221Autologous bone marrow mononuclear cell transplantation----1件: 113 💬
1222Autologous bone marrow mononucleated cells----1件: 2 💬
1223Autologous Bone Marrow-Derived Mononuclear Stem Cells----1件: 13 💬
1224Autologous bone marrow-derived stem cells----1件: 2 💬
1225AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR----1件: 65 💬
1226AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE----1件: 19 💬
1227Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA----1件: 19 💬
1228AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA----1件: 20 💬
1229Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy----1件: 65 💬
1230Autologous CD34+ cells transduced with WASP lentiviral vector----1件: 65 💬
1231Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence----1件: 65 💬
1232Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII----1件: 19 💬
1233Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene----1件: 65 💬
1234AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR----1件: 65 💬
1235Autologous CD34-selected peripheral blood stem cells transplant----1件: 96 💬
1236Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope----1件: 13 💬
1237Autologous cell-based delivery----1件: 211 💬
1238Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
1239Autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70----1件: 46 💬
1240Autologous Mesenchymal Cell Product----1件: 13 💬
1241Autologous mesenchymal stem cell transplantation----1件: 13 💬
1242Autologous mesenchymal stem cells----5件: 2, 6, 13, 17, 46 💬
1243Autologous Mesenchymal stem cells (MSCs)----1件: 2 💬
1244Autologous mesenchymal stem cells derived from bone marrow----1件: 85 💬
1245Autologous mesenchymal stromal cell----2件: 96, 298 💬
1246Autologous MSC-NTF cells----1件: 2 💬
1247Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population----1件: 96 💬
1248Autologous Plasmablasts (B cells)----1件: 19 💬
1249Autologous Serum 50%----1件: 53 💬
1250Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells----1件: 51 💬
1251Autologous Umbilical Cord Blood----2件: 211, 294 💬
1252Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)1件: Myelin basic protein---1件: 13 💬
1253AV-1011件: AV-101---2件: 6, 86 💬
1254Avalglucosidase alfa-NGPT (GZ402666) IV1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
1255Avalotcagene ontaparvovec1件: Avalotcagene ontaparvovec---1件: 251 💬
1256AVALOX - 400----1件: 6 💬
1257Avandia administration for 6-12 weeks----1件: 265 💬
1258AVASTIN 25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung1件: Bevacizumab1件: Bevacizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 227 💬
1259Avatrombopag 20 MG1件: Avatrombopag1件: Avatrombopag 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 60 💬
1260Avatrombopag 20 MG Oral Tablet1件: Avatrombopag1件: Avatrombopag 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 60 💬
1261AVATROMBOPAG MALEATE1件: Avatrombopag1件: Avatrombopag 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
1262AVB-114----1件: 96 💬
1263AVB-S6-500----1件: 66 💬
1264AVCN583601 (3% Cannabidiol cream)1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 36 💬
1265Avelox- Moxifloxacin1件: Moxifloxacin1件: Moxifloxacin 💬--1件: 46 💬
1266Aviptadil, 66 microgram/mL1件: Aviptadil1件: Aviptadil 💬--1件: 85 💬
1267Avonex (Interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1268Avonex (interferon beta-1a), Biogen Idec Ltd2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1269AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1270Avonex 30 microgram/0.5 ml Solution for Injection1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1271AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1272Avonex 30 microgramos/0.5 ml Solución para inyección1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1273AVONEX 30 µg/0,5 ml solution for injection1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1274AVONEX IM 4SIR 30MCG/0,5ML 4AG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1275AVONEX*IM 4SIR 30MCG/0,5ML+4AG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1276Avonex/Betaseron/Copaxone/Rebif3件: Glatiramer,
Interferon beta-1a,
Interferon beta-1b		2件: Interferon beta-1b ,
Interferon beta-1a 💬		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1277Avonex® monotherapy (6.0 MIU administered i.m. each week)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1278AVXS-101----1件: 3 💬
1279AVXS-101 (previously known as scAAV9.CB.SMN)----1件: 3 💬
1280AXO-AAV-GM2 Middle Dose----1件: 19 💬
1281AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL----1件: 97 💬
1282AZAFOR 50mg----1件: 97 💬
1283Azathioprin-ratiopharm 25 mg----1件: 96 💬
1284Azathioprin-ratiopharm 50 mg Filmtabletten----1件: 96 💬
1285Azathioprin-ratiopharm® 25 mg Filmtabletten----1件: 44 💬
1286Azathioprine (AZA) caps1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1287Azathioprine (AZA) or 6-mercaptopurine (6-MP)2件: Azathioprine,
Mercaptopurine		3件: Mercaptopurine ,
Azathioprine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 96, 97 💬
1288Azathioprine (Imuran) 50 mg Overencapsulated Tablet1件: Azathioprine1件: Azathioprine 💬--1件: 97 💬
1289Azathioprine + infliximab2件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1290Azathioprine - ratiopharm 50 mg1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1291Azathioprine / 6 Mercaptopurine2件: Azathioprine,
Mercaptopurine		3件: Mercaptopurine ,
Azathioprine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96 💬
1292Azathioprine 25 mg1件: Azathioprine1件: Azathioprine 💬--1件: 44 💬
1293AZATHIOPRINE BP1件: Azathioprine1件: Azathioprine 💬--1件: 97 💬
1294Azathioprine in case of endoscopic recurrence1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1295Azathioprine or 6-mercaptopurine2件: Azathioprine,
Mercaptopurine		3件: Mercaptopurine ,
Azathioprine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 96, 97 💬
1296Azathioprine or adalimumab and infliximab3件: Adalimumab,
Azathioprine,
Infliximab		3件: Azathioprine ,
Adalimumab ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1297Azathioprine OR Mesalazine2件: Azathioprine,
Mesalazine		2件: Azathioprine ,
Mesalamine 💬		--1件: 96 💬
1298AZATHIOPRINE or METHOTREXATE2件: Azathioprine,
Methotrexate		2件: Methotrexate ,
Azathioprine 💬		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 96 💬
1299Azathioprine or Mycophenolate mofetil3件: Azathioprine,
Mycophenolate mofetil,
Mycophenolic acid		3件: Azathioprine ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 162 💬
1300Azathioprine weight-based dose1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1301AZATIOPRINA ASPEN - 50 COMPRESSE1件: Azathioprine1件: Azathioprine 💬--1件: 96 💬
1302AZATIOPRINA HEX. 50CPR 50MG BL1件: Azathioprine1件: Azathioprine 💬--1件: 13 💬
1303AZD3241 100mg----1件: 17 💬
1304AZD3241 300 mg BID----1件: 6 💬
1305AZD3241 600 mg BID----1件: 6 💬
1306AZD3241 Alternative titration scheme with formulation 1 or 2----1件: 6 💬
1307AZD3241 ER formulation 1----1件: 6 💬
1308AZD3241 Extended release tablets 100 mg1件: Manganese citrate---1件: 6 💬
1309AZD3241 Extended release tablets 25 mg1件: Manganese citrate---1件: 6 💬
1310AZD9567 10 mg----1件: 46 💬
1311AZD9567 125 mg----1件: 46 💬
1312AZD9567 155 mg----1件: 46 💬
1313AZD9567 20 mg----1件: 46 💬
1314AZD9567 40 mg----1件: 46 💬
1315AZD9567 80 mg----1件: 46 💬
1316AZD9567 Monohydrat----1件: 46 💬
1317AZD9567 monohydrate----1件: 46 💬
1318AZILECT 1 mg comprimidos1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
1319Azilect 1mg1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1320AZILECT® 1 mg Tabletten1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 2 💬
1321Azithromycin + Metronidazole2件: Azithromycin,
Metronidazole		3件: Metronidazole ,
Azithromycin ,
Azithromycin 💬		--1件: 96 💬
1322Azithromycin + N-acetylcystein + inhaled corticosteroid1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 228 💬
1323Azithromycin 250 mg tablets1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 299 💬
1324Azithromycin 500 mg film-coated tablet1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 299 💬
1325Azithromycin monohydrate1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 84 💬
1326AZITHROMYCINE 250 mg1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 228 💬
1327AZLI 75 mg three times a day (TID)----1件: 299 💬
1328AZLI 75 mg three times daily (TID)----1件: 299 💬
1329AZLI 75 mg two times a day (BID)/ three times a day (TID)----1件: 299 💬
1330AZLI 75 mg two times a day (BID)/three times a day (TID)----1件: 299 💬
1331AZP-531----1件: 193 💬
1332AZP2006 oral solution----1件: 5 💬
1333B (migalastat)1件: Migalastat1件: Migalastat 💬--1件: 19 💬
1334B / Phuket / 3073/2013-like virus)----1件: 53 💬
1335B-Lymphocyte Stimulator (BLyS)----1件: 65 💬
1336B. lactis B94----1件: 193 💬
1337B. theta----1件: 96 💬
1338B6, B12, L-methylfolate1件: Levomefolic acid1件: Levomefolic acid 💬--1件: 6 💬
1339B: 2 dosis----1件: 97 💬
1340Bacille of Calmette-Guerin----1件: 13 💬
1341Baclofen (baclofen Tab. 10mg) treatment1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 70 💬
1342Baclofen 20 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1343Baclofen ER Capsules (GRS) 10 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1344Baclofen ER Capsules (GRS) 20 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1345Baclofen ER Capsules (GRS) 30mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1346Baclofen ER Capsules (GRS) 40mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1347Baclofen ER Capsules (GRS) 50 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1348Baclofen Tablets USP 10 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
1349BAF312 0,25 mg tablet----1件: 13 💬
1350BAF312 0,5 mg tablet----1件: 50 💬
1351BAF312 0.25 mg----1件: 50 💬
1352BAF312 0.25 mg tablet----1件: 50 💬
1353BAF312 0.5 mg----1件: 50 💬
1354BAF312 0.50 mg----1件: 50 💬
1355BAF312 1 mg----1件: 50 💬
1356BAF312 1 mg tablet----2件: 13, 50 💬
1357BAF312 1mg----1件: 50 💬
1358BAF312 1mg tablet----1件: 50 💬
1359BAF312 2 mg----1件: 50 💬
1360BAF312 2 mg tablet----1件: 50 💬
1361BAF312 4 mg tablet----1件: 13 💬
1362BAF312 5 mg tablet----1件: 50 💬
1363Baked Milk1件: Cow milk---1件: 98 💬
1364Baminercept alfa (BG9924)1件: Baminercept1件: Baminercept 💬1件: LTB 💬3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
1365Bardoxolone methyl2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--7件: 66, 67, 84, 85, 86, 218, 222 💬
1366Bardoxolone methyl 10 mg2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--1件: 67 💬
1367Bardoxolone methyl 15 mg2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--1件: 67 💬
1368Bardoxolone methyl 20 mg2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--1件: 67 💬
1369Bardoxolone methyl 5 mg2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--1件: 67 💬
1370Bardoxolone methyl capsules2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--4件: 66, 67, 86, 222 💬
1371Bardoxolone methyl oral capsule2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--1件: 67 💬
1372BARDOXOLONE METHYL, CDDO-Me, CDDO-Methyl Ester, NSC 713200, Chemical Name: Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--1件: 86 💬
1373Bardoxolone Metile1件: Bardoxolone1件: Bardoxolone 💬--1件: 67 💬
1374Baricitinib 2 MG1件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 53 💬
1375Baricitinib 2 MG [Olumiant]1件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 162 💬
1376Baricitinib 4 MG1件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
1377Baricitinib, olumiant®1件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
1378Bascial prescription plus or minus herbs depend on symptoms----1件: 97 💬
1379Baseline disease modifying therapies (DMTs)----1件: 13 💬
1380BASSADO 10CPS 100MG----1件: 23 💬
1381Batoclimab 340 mg SC bi-weekly1件: Batoclimab1件: Batoclimab 💬1件: FCGRT 💬-1件: 11 💬
1382Batoclimab 340 mg SC weekly1件: Batoclimab1件: Batoclimab 💬1件: FCGRT 💬-2件: 11, 14 💬
1383Batoclimab 680 mg SC weekly1件: Batoclimab1件: Batoclimab 💬1件: FCGRT 💬-1件: 11 💬
1384Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly1件: Batoclimab1件: Batoclimab 💬1件: FCGRT 💬-1件: 14 💬
1385Bavisant dihydrochloride monohydrate1件: Bavisant1件: Bavisant 💬1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
1386BAVISANT HYDROCHLORIDE MONOHYDRATE1件: Bavisant1件: Bavisant 💬1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
1387BAX 111----1件: 288 💬
1388BAX930 - RECOMBINANT HUMAN ADAMTS13----1件: 64 💬
1389BAX930 or SHP655----1件: 64 💬
1390BAX930 or SHP655 or TAK755----1件: 64 💬
1391BAY 59-7939----1件: 210 💬
1392BAY 63-2521 coated tablets 0.5 mg----2件: 86, 88 💬
1393BAY 63-2521 coated tablets 1 mg----2件: 86, 88 💬
1394BAY 63-2521 coated tablets 1.5 mg----2件: 86, 88 💬
1395BAY 63-2521 coated tablets 2 mg----2件: 86, 88 💬
1396BAY 63-2521 coated tablets 2.5 mg----2件: 86, 88 💬
1397BAY 63-2521 IR coated tablet 1.0 mg----1件: 88 💬
1398BAY 63-2521 IR coated tablet 1.5 mg----1件: 88 💬
1399BAY 63-2521 IR coated tablet 2.0 mg----1件: 88 💬
1400BAY 63-2521 IR coated tablet 2.5 mg----1件: 88 💬
1401BAY 63-2521 IR tablet 0.5 mg----1件: 88 💬
1402BAY 63-2521 IR tablet 1.0 mg----1件: 88 💬
1403BAY 63-2521 IR tablet 1.5 mg----1件: 88 💬
1404BAY 63-2521 IR tablet 2.0 mg----1件: 88 💬
1405BAY 63-2521 IR tablet 2.5 mg----1件: 88 💬
1406BAY 63-2521 IR tablets 0.5 mg----1件: 86 💬
1407BAY 63-2521 IR tablets 1 mg----1件: 86 💬
1408BAY 63-2521 IR tablets 1.0 mg----1件: 86 💬
1409BAY 63-2521 IR tablets 1.5 mg----1件: 86 💬
1410BAY 63-2521 IR tablets 2.0 mg----1件: 86 💬
1411BAY 63-2521 IR tablets 2.5 mg----1件: 86 💬
1412BAY 63-2521 tablets 0.5 mg----2件: 86, 88 💬
1413BAY 63-2521 tablets 1 mg----2件: 86, 88 💬
1414BAY 63-2521 tablets 1.5 mg----2件: 86, 88 💬
1415BAY 63-2521 tablets 2 mg----2件: 86, 88 💬
1416BAY 63-2521 tablets 2.5 mg----2件: 86, 88 💬
1417BAY 79-4998----1件: 13 💬
1418BAY86-5046----1件: 13 💬
1419BAY86-5046_Interferon-beta-1b----1件: 13 💬
1420BBT-401-1S----1件: 97 💬
1421BBT-401-1S, Multiple doses----1件: 97 💬
1422BBT-401-1S, Single dose----1件: 97 💬
1423BBT-877, Multiple doses----1件: 85 💬
1424BBT-877, Single dose----1件: 85 💬
1425BCD-033 (interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1426BCD-054 180 mcg----1件: 13 💬
1427BCD-054 240 mcg----1件: 13 💬
1428BCD-089, 162 mg, s/c, q2w----1件: 46 💬
1429BCD-089, 162 mg, s/c, qw----1件: 46 💬
1430BCD-132----1件: 13 💬
1431BCD-132, 125 mg----1件: 13 💬
1432BCD-132, 500 mg----1件: 13 💬
1433BCD-148----1件: 62 💬
1434BCX9930 monotherapy----1件: 62 💬
1435BDMARD withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept)5件: Abatacept,
Adalimumab,
Etanercept,
Golimumab,
Infliximab		5件: Etanercept ,
Adalimumab ,
Infliximab ,
Abatacept ,
Golimumab 💬		4件: CD80,
CD86,
LTA,
TNF 💬		74件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1436Beetainterferoni -1a----1件: 13 💬
1437BEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongée----1件: 94 💬
1438Belantamab mafodotin1件: Belantamab mafodotin1件: Belantamab mafodotin 💬10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
1439Belantamab mafodotin 1.9 mg/kg (8 weeks)1件: Belantamab mafodotin1件: Belantamab mafodotin 💬10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
1440Belantamab mafodotin 1.9mg/kg or 2.5mg/kg every 4 weeks, 6 weeks or 8 weeks as determined by Part 1 recommended dosages1件: Belantamab mafodotin1件: Belantamab mafodotin 💬10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
1441Belantamab mafodotin 2.5 mg/kg (4 weeks)1件: Belantamab mafodotin1件: Belantamab mafodotin 💬10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
1442Belantamab mafodotin 2.5 mg/kg (6 weeks)1件: Belantamab mafodotin1件: Belantamab mafodotin 💬10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
1443Belantamab mafodotin 2.5 mg/kg (8 weeks)1件: Belantamab mafodotin1件: Belantamab mafodotin 💬10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Intestinal immune network for IgA production, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 28 💬
1444Belimumab 1 mg/kg1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
1445Belimumab 10 mg1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 222 💬
1446Belimumab 10 mg/kg1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 43, 46, 49 💬
1447Belimumab 10 mg/kg plus standard therapy1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1448Belimumab 100 mg SC1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1449Belimumab 10mg/kg1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1450Belimumab 200 mg SC1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1451Belimumab 200 mg/mL1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1452Belimumab 4 mg/kg1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
1453Belimumab in SLE patients / Rituximab in RA patients2件: Belimumab,
Rituximab		2件: Rituximab ,
Belimumab 💬		2件: MS4A1,
TNFSF13B 💬		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
1454Belimumab Injection [Benlysta]1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1455Belimumab or benlysta1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1456Benazepril hydrochloride 10 milligram (mg) Tab1件: Benazepril1件: Benazepril 💬1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 218 💬
1457Benazepril, Valsartan and Fluvastatin3件: Benazepril,
Fluvastatin,
Valsartan		3件: Valsartan ,
Benazepril ,
Fluvastatin 💬		3件: ACE,
AGTR1,
HMGCR 💬		22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 218 💬
1458Bendamustine, Rituximab2件: Bendamustine,
Rituximab		2件: Rituximab ,
Bendamustine 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 61 💬
1459Benlysta (belimumab)1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 11, 49, 53, 222 💬
1460BENLYSTA - 120 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 120 MG 1 FLACONCINO1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 53 💬
1461Benlysta 400 mg powder for concentrate for solution for infusion1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 43, 49 💬
1462Benlysta 400 mg powder for concentrate for solution for infusions1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1463BENLYSTA? (belimumab)1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1464BENLYSTA® (belimumab)1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 11, 66, 222 💬
1465BENLYSTA™ (belimumab)1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
1466Benzimidazole,5-methoxy-2-[[(4-methoxy- 3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 H-benzimidazole1件: Benzimidazole---1件: 46 💬
1467Benzimidazole,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 H-benzimidazole1件: Benzimidazole---1件: 46 💬
1468Benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala)1件: Alanine1件: Alanine 💬--1件: 298 💬
1469Beraprost Sodium 314d Modified Release Tablets1件: Beraprost1件: Beraprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1470Beraprost Sodium Modified Release1件: Beraprost1件: Beraprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
1471Best Available Therapy (BAT)----1件: 13 💬
1472Best Medical Treatment----1件: 6 💬
1473Best médical treatment----1件: 6 💬
1474Best Supportive Care (BSC)----1件: 331 💬
1475Beta-1,3/1,6-D-Glucan----1件: 97 💬
1476Beta-1b interferoni----1件: 13 💬
1477Beta-Mercaptoethylamine1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
1478Beta-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
1479BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1480BETAFERON 250 mcg1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1481Betaferon 250 microgram/ml1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1482Betaferon 250 microgram/ml, powder and solvent for solution for injection1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1483Betaferon 250 microgram/mL, powder and solvent for solution for injection.1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1484Betaferon 250 microgramos----1件: 13 💬
1485BETAFERON 500 mcg1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1486Betaferon 500 µg----1件: 13 💬
1487Betaferon 500mcg----1件: 13 💬
1488Betaferon 500µg1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1489BETAFERON SC 15F 0,25MG 15SIR1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1490BETAFERON*15CONFEZ 0,25MG/ML+1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1491Betaferon/Betaseron----1件: 13 💬
1492BETAFERON® (interferon beta-1b)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1493Betaloc ZOK 100, 95 mg----1件: 113 💬
1494Betaloc ZOK 25, 23,75 mg----1件: 113 💬
1495Betamethasone Oral Solution Period 1 and Period 21件: Betamethasone1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
1496Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days3件: Acetate,
Betamethasone,
Phosphate ion		1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 2 💬
1497Betamethasone solution as intramuscular injection Period 1 and Period 21件: Betamethasone1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
1498Betaquik MCT supplement----1件: 6 💬
1499Betaseron (Interferon beta-1b, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1500Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1501Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)2件: Bevacizumab,
Imatinib		2件: Bevacizumab ,
Imatinib 💬		4件: ABL1,
KIT,
PDGFRA,
VEGFA 💬		45件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway, Viral myocarditis 💬1件: 87 💬
1502BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA P4件: Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle,
Neisseria meningitidis serogroup b fhbp fusion protein antigen,
Neisseria meningitidis serogroup b nada protein antigen,
Neisseria meningitidis serogroup b nhba fusion protein antigen		---1件: 62 💬
1503BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA PRERIEMPITA (VETRO) - 0.5ML - 1 SIRINGA PRERIEMPITA CON AGO4件: Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle,
Neisseria meningitidis serogroup b fhbp fusion protein antigen,
Neisseria meningitidis serogroup b nada protein antigen,
Neisseria meningitidis serogroup b nhba fusion protein antigen		---1件: 66 💬
1504BEXSERO – Sospensione iniettabile – Siringa preriempita4件: Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle,
Neisseria meningitidis serogroup b fhbp fusion protein antigen,
Neisseria meningitidis serogroup b nada protein antigen,
Neisseria meningitidis serogroup b nhba fusion protein antigen		---2件: 61, 62 💬
1505Bezafibrat Genericon retard 400 mg----1件: 93 💬
1506Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy2件: Bezafibrate,
Ursodeoxycholic acid		2件: Ursodiol ,
Bezafibrate 💬		2件: NR1H4,
PPARA 💬		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 94 💬
1507Bezafibrate 200 MG1件: Bezafibrate1件: Bezafibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
1508Bezafibrate 200 MG Oral Tablet1件: Bezafibrate1件: Bezafibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
1509Bezafibrate 400 MG1件: Bezafibrate1件: Bezafibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
1510Bezafibrate, Beza, BZF, Bezalip1件: Bezafibrate1件: Bezafibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
1511Bezafibrate, Beza, BZF, Bezalip mono1件: Bezafibrate1件: Bezafibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
1512Bezalip mono----1件: 93 💬
1513BF 2.649 10 mg----1件: 6 💬
1514BF 2.649 20 mg----1件: 6 💬
1515BF 2.649 40 mg----1件: 6 💬
1516BF 2.649 5 mg----1件: 6 💬
1517BG-12 120----1件: 13 💬
1518BG00012 (DMF) (Tecfidera®.)----1件: 13 💬
1519BG9418 (interferon beta 1-a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1520BG9418 (interferon beta-1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97 💬
1521BGJ398 (also known as BBP-831)----1件: 276 💬
1522BH4 5mg----1件: 299 💬
1523BHT-3009 0.5 mg----1件: 13 💬
1524BHT-3009 1.5 mg----1件: 13 💬
1525BHV3241, verdiperstat1件: Verdiperstat1件: Verdiperstat 💬1件: MPO 💬5件: Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer 💬1件: 17 💬
1526BI 1015550----1件: 85 💬
1527BI 1015550 18 mg Film Coated Tablet----1件: 85 💬
1528BI 1015550 9 mg Film Coated Tablet----1件: 85 💬
1529BI 1265162----1件: 299 💬
1530BI 1265162 10 µg----1件: 299 💬
1531BI 1265162 100 µg----1件: 299 💬
1532BI 1265162 25 µg----1件: 299 💬
1533BI 1265162 50 µg----1件: 299 💬
1534BI 655064 medium dose----1件: 46 💬
1535BI 655066 10 mg/ml----1件: 96 💬
1536BI 655066 90 mg/ml----2件: 96, 271 💬
1537BI 705564----1件: 49 💬
1538BI 706321----1件: 96 💬
1539BI 730357----1件: 271 💬
1540BI 764198----1件: 222 💬
1541BIA 3-202 (200 mg)1件: BIA---1件: 6 💬
1542BIA 5-10581件: BIA---1件: 86 💬
1543BIA 6-5121件: BIA---1件: 6 💬
1544BIA 6-512 100 mg1件: BIA---1件: 6 💬
1545BIA 6-512 100 mg dose1件: BIA---1件: 6 💬
1546BIA 6-512 200 mg dose1件: BIA---1件: 6 💬
1547BIA 6-512 25 mg1件: BIA---1件: 6 💬
1548BIA 6-512 25 mg dose1件: BIA---1件: 6 💬
1549BIA 6-512 400 mg1件: BIA---1件: 6 💬
1550BIA 6-512 50 mg dose1件: BIA---1件: 6 💬
1551BIA 9-10671件: BIA---1件: 6 💬
1552BIA 9-1067 (test)1件: BIA---1件: 6 💬
1553BIA 9-1067 15 mg1件: BIA---1件: 6 💬
1554BIA 9-1067 25 mg1件: BIA---1件: 6 💬
1555BIA 9-1067 30 mg1件: BIA---1件: 6 💬
1556BIA 9-1067 5 mg1件: BIA---1件: 6 💬
1557BIA 9-1067 micronized1件: BIA---1件: 6 💬
1558BIA 9-1067 non-micronized1件: BIA---1件: 6 💬
1559BIA-5-10581件: BIA---1件: 86 💬
1560Biaxin ( clarithromycin)1件: Clarithromycin1件: Clarithromycin 💬--1件: 299 💬
1561BIBF 1120----2件: 51, 85 💬
1562BIBF 1120 ES----1件: 85 💬
1563BIBR 796 BS----1件: 46 💬
1564BIBR 796 BS, 20 mg----1件: 96 💬
1565BIBR 796 BS, 5 mg----1件: 96 💬
1566Bifidobacterium breve1件: Bifidobacterium breve---1件: 97 💬
1567BIIB017 (Peginterferon beta-1a)1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1568BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957----1件: 13 💬
1569BIIB033 (opicinumab)1件: Opicinumab1件: Opicinumab 💬1件: LINGO1 💬-1件: 13 💬
1570BIIB050 / KNS-760704----1件: 2 💬
1571BIIB050/KNS-760704----1件: 2 💬
1572BIIL 283 BS (Amelubent)----1件: 299 💬
1573BIIL 284 BS high dose----1件: 46 💬
1574BIIL 284 BS low dose----1件: 46 💬
1575BIIL 284 BS medium dose----1件: 46 💬
1576BIIL 284 BS, high dose----1件: 299 💬
1577BIIL 284 BS, high dose, adult patients----1件: 299 💬
1578BIIL 284 BS, high dose, pediatric patients----1件: 299 💬
1579BIIL 284 BS, low dose----1件: 299 💬
1580BIIL 284 BS, low dose, adult patients----1件: 299 💬
1581BIIL 284 BS, low dose, pediatric patients----1件: 299 💬
1582BIIL 284 BS, medium dose, adult patients----1件: 299 💬
1583BIIL 284 BS, medium dose, pediatric patients----1件: 299 💬
1584Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus----1件: 6 💬
1585BINOCRIT*1SIR 40000UI/1ML1件: Erythropoietin---1件: 18 💬
1586Biologic: IC14 (monoclonal antibody against human CD14)----1件: 2 💬
1587Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14 💬
1588Biological disease-modifying antirheumatic drugs (bDMARDs)----1件: 46 💬
1589Biological/Vaccine: Allogeneic HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---1件: 6 💬
1590Biological: Benralizumab, Biological: Placebo to Mepolizumab2件: Benralizumab,
Mepolizumab		2件: Mepolizumab ,
Benralizumab 💬		2件: IL5,
IL5RA 💬		13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 44 💬
1591Biological: Mepolizumab, Biological: Placebo to Benralizumab2件: Benralizumab,
Mepolizumab		2件: Mepolizumab ,
Benralizumab 💬		2件: IL5,
IL5RA 💬		13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 44 💬
1592Biologically active human fecal microbiota----1件: 97 💬
1593BION-1301 Multiple Doses----1件: 66 💬
1594BION-1301 Single Dose----1件: 66 💬
1595Biopsy of the labial salivary gland----1件: 53 💬
1596BIRB 796 BS, high dose----1件: 46 💬
1597BIRB 796 BS, low dose----1件: 46 💬
1598BIRCH BARK EXTRACT1件: Birch bark extract---1件: 36 💬
1599BIS-CHOLINE TETRATHIOMOLYBDATE, bis[(2-Hydroxyethyl)trimethylammonium] tetrathiomolybdate2件: Choline,
Tetrathiomolybdate		1件: Choline 💬--1件: 171 💬
1600Bitterschleifenblume-ganzpflanze 1,5ml/10ml----1件: 97 💬
1601BL-7040----1件: 97 💬
1602Bladder instillation with heparin/ lidocaine2件: Heparin,
Lidocaine		3件: Lidocaine ,
Adomiparin ,
Lidocaine hydrochloride monohydrate 💬		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬		4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬1件: 226 💬
1603Bladder tissue of Interstitial Cystitis and normal bladder tissue----1件: 226 💬
1604Bleomycin + Fibrovein1件: Bleomycin1件: Bleomycin 💬--1件: 279 💬
1605Bleomycin Baxter1件: Bleomycin1件: Bleomycin 💬--1件: 279 💬
1606BLI-1300 high dose----1件: 96 💬
1607BLI-1300 low dose----1件: 96 💬
1608Blinded CDCA 250 mg TID1件: Chenodeoxycholic acid1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 263 💬
1609Blokium 50----1件: 167 💬
1610BLOKIUM 50 mg comprimidos----1件: 167 💬
1611Blood and/or skin biopsy----2件: 90, 301 💬
1612Blood coagulation Factor VIII and vWF, human1件: Beroctocog alfa---1件: 288 💬
1613Blood or Saliva Sample Collection----1件: 299 💬
1614Blood sampling for biological and genetic analysis----1件: 19 💬
1615BLS-M221件: BLS-M22---1件: 113 💬
1616BMN 044 IV 6 mg/kg----1件: 113 💬
1617BMN 044 IV 9 mg/kg----1件: 113 💬
1618BMN 044 SC 6 mg/kg----1件: 113 💬
1619BMN 110----1件: 19 💬
1620BMN 110 - Every Other Week----1件: 19 💬
1621BMN 110 - Weekly----1件: 19 💬
1622BMN 110 Every Other Week----1件: 19 💬
1623BMN 110 Weekly----1件: 19 💬
1624BMN 111----1件: 276 💬
1625BMN 165----1件: 240 💬
1626BMN 165 (rAvPAL-PEG)1件: Pegvaliase1件: Pegvaliase 💬1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
1627BMN 190----1件: 19 💬
1628BMN 701----1件: 256 💬
1629BMN190 recombinant human tripeptidyl peptidase-1 (rhTPP1)----1件: 19 💬
1630BMS 188667 (Abatacept)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 13 💬
1631BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin)5件: Digoxin,
Flurbiprofen,
Midazolam,
Montelukast,
Omeprazole		5件: Digoxin ,
Flurbiprofen ,
Omeprazole ,
Midazolam ,
Montelukast 💬		25件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4,
ATP4A,
ATP4B,
CYSLTR1,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
PTGS1,
PTGS2 💬		49件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
1632BMS-188667----9件: 46, 49, 53, 65, 96, 97, 107, 222, 271 💬
1633BMS-5829491件: BMS-582949---1件: 46 💬
1634BMS-582949 and Methotrexate2件: BMS-582949,
Methotrexate		1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
1635BMS-936557 (Anti-IP-10 Antibody)----1件: 96 💬
1636BMS-986004 1500 mg IV----1件: 63 💬
1637BMS-986004 225 mg IV----1件: 63 💬
1638BMS-986004 675 mg IV----1件: 63 💬
1639BMS-986004 75 mg IV----1件: 63 💬
1640BMS-986089-01 (RO7239361) , anti-myostatin----1件: 113 💬
1641BMS-986089-01 (RO7239361) Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113 💬
1642BMS-986089-01 (RO7239361) Injections, 35 mg/Syringe (50 mg/mL)----1件: 113 💬
1643BMS-986089-01 (RO7239361) Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113 💬
1644BMS-986089-01 (RO7239361) Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113 💬
1645BMS-986089-01 (RO7239361), anti-myostatin----1件: 113 💬
1646BMS-986089-01 Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113 💬
1647BMS-986089-01 Injections, 35 mg/Syringe (50 mg/mL)----1件: 113 💬
1648BMS-986089-01 Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113 💬
1649BMS-986089-01 Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113 💬
1650BMS-986089-01, Anti-myostatin----1件: 113 💬
1651BMS-986256-06, TLR7/8 Antagonist1件: Afimetoran1件: Afimetoran 💬--1件: 49 💬
1652BNP blood sample test----1件: 58 💬
1653BNT162b2, Bivalent----7件: 13, 35, 46, 49, 50, 51, 107 💬
1654Bof-, Mazelen-, Rubellavaccin, poeder voor injectievloeistof----1件: 107 💬
1655Bone balance measurements1件: Isoxaflutole---1件: 81 💬
1656Bone marrow autologous mesenchymal stem cells transplantation----1件: 13 💬
1657Bone Marrow Concentrate----1件: 70 💬
1658Bone marrow derived mesenchymal stem cells----2件: 6, 60 💬
1659Bone Marrow Derived Mesenchymal Stem cells (MSCs)----1件: 96 💬
1660Bone marrow mesenchymal stem cells----1件: 85 💬
1661Bone marrow transplant----1件: 274 💬
1662Bone marrow-derived mesenchymal stem cells----1件: 298 💬
1663Bone marrow-derived mesenchymal stromal cells (MSCs)1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 274 💬
1664Boots High Strength Garlic Odour Controlled1件: Garlic1件: Garlic 💬--1件: 299 💬
1665BORAGE OIL1件: Borage oil---1件: 13 💬
1666BORAGE OIL 20% GLA1件: Borage oil---1件: 13 💬
1667Borage seed oil----1件: 46 💬
1668Bortezomib D-mannitol3件: Bortezomib,
Bortezomib D-mannitol,
Mannitol		2件: Mannitol ,
Bortezomib 💬		1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
1669Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone2件: Bortezomib,
Dexamethasone		2件: Dexamethasone ,
Bortezomib 💬		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
1670Bosentan 125 mg1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51 💬
1671Bosentan 62.5 mg1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51 💬
1672BOSENTAN MONOHIDRATO1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
1673Bosentan monohydrat1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
1674BOSENTAN MONOHYDRATE1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 51, 84, 86, 88 💬
1675BOSENTAN MYLAN1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 41 💬
1676Bosentan, Ambrisentan2件: Ambrisentan,
Bosentan		3件: Bosentan ,
Ambrisentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
1677Bosutinib (Phase 1 part)1件: Bosutinib1件: Bosutinib 💬2件: ABL1,
SRC 💬		49件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 2 💬
1678Boswellic acids (BOSWELAN)----1件: 13 💬
1679BOTOX 100 UNITES ALLERGAN (PR1)1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 2 💬
1680Botox 100 UNT Injection1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1681BOTOX 100U in normal saline1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 226 💬
1682BOTOX® solution1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 51 💬
1683BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1684Botulinum toxin type A (Nabota®) injection into the gastrocnemius muscle1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 70 💬
1685Botulinum toxin type B1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬3件: 2, 6, 51 💬
1686Botulinum toxin type B (2500 units / vial)1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 51 💬
1687Botulinum toxin type B (Myobloc)1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬2件: 2, 6 💬
1688Botulinum toxin(Botox)1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 51 💬
1689Botulinum Toxin: Xeomin1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
1690Bovine intesastinal alkaline phosphatase (bIAP)1件: Alkaline Phosphatase---1件: 46 💬
1691Bovine intestinal alkaline phosphatase (BIAP)1件: Alkaline Phosphatase---1件: 97 💬
1692Bovine-Calf Alkaline Phosphatase (BIAP)1件: Alkaline Phosphatase---1件: 97 💬
1693Bovine-Calf Alkaline Phosphatase BIAP1件: Alkaline Phosphatase---1件: 97 💬
1694BPN14770/ zatolmilast1件: Zatolmilast1件: Zatolmilast 💬1件: PDE4D 💬5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 206 💬
1695BPR277 ointment----1件: 160 💬
1696BPR277 ointment (controlled application)----1件: 160 💬
1697BPS-314d-MR----1件: 86 💬
1698BPS-MR----1件: 86 💬
1699BPS804, UX143----1件: 274 💬
1700BPX-501----3件: 60, 285, 326 💬
1701BPX-501 cells----3件: 60, 285, 326 💬
1702BPX-501 T cells----4件: 65, 284, 285, 326 💬
1703BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML----1件: 299 💬
1704BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML----1件: 299 💬
1705BRAMITOB*NEBUL 56F 300MG/4ML----1件: 299 💬
1706Bramitob® administered by PARI eFlow® rapid electronic nebulizer----1件: 299 💬
1707Bramitob® administered by PARI LC® PLUS nebulizer----1件: 299 💬
1708Brazikumab Maintenance Dose1件: Brazikumab1件: Brazikumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
1709Bredinin tablet 150mg1件: Mizoribine1件: Mizoribine 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 46 💬
1710Bredinin tablet 50mg1件: Mizoribine1件: Mizoribine 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 46 💬
1711Brensocatib 10 mg1件: Brensocatib1件: Brensocatib 💬1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299 💬
1712Brensocatib 25 mg1件: Brensocatib1件: Brensocatib 💬1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299 💬
1713Brepocitinib 25 mg----2件: 96, 97 💬
1714Brepocitinib 5 mg----2件: 96, 97 💬
1715Brepocitinib 5mg----1件: 96 💬
1716Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 90 💬
1717Brivaracetam 25 mg1件: Brivaracetam1件: Brivaracetam 💬1件: SV2A 💬1件: ECM-receptor interaction 💬1件: 309 💬
1718Brivaracetam 50 mg1件: Brivaracetam1件: Brivaracetam 💬1件: SV2A 💬1件: ECM-receptor interaction 💬1件: 309 💬
1719Bromocriptine and other dopamine agonists2件: Bromocriptine,
Dopamine		2件: Bromocriptine ,
Dopamine 💬		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
PRL 💬		15件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
1720Bronchial mucus collection----1件: 299 💬
1721BRV 2.5 mg----1件: 309 💬
1722BRV 25 mg----1件: 309 💬
1723BRV 50 mg----1件: 309 💬
1724Bryostatin 11件: Bryostatin 1---1件: 62 💬
1725BSF 208075 or LU 208075----1件: 86 💬
1726BT-11----2件: 96, 97 💬
1727BT-11 (1000 mg)----1件: 97 💬
1728BT-11 (500 mg)----1件: 97 💬
1729BT-11 (Omilancor)----1件: 96 💬
1730BT-11 1,000 mg----1件: 96 💬
1731BT-11 1000mg----3件: 96, 97, 98 💬
1732BT-11 500 mg----2件: 96, 97 💬
1733BT-11 500mg----1件: 98 💬
1734BT-11 Active----2件: 96, 97 💬
1735BT051 200 mg----1件: 97 💬
1736BT051 3200 mg----1件: 97 💬
1737BT051 800 mg----1件: 97 💬
1738BT061 (CD4 monoclonal antibody)----1件: 46 💬
1739BTT-1023----1件: 46 💬
1740BTT1023 IV Infusion 20 mg/mL, 5 mL Drug Product----1件: 94 💬
1741Budenofalk® suppositories----1件: 97 💬
1742Budenofalk® suppositories (BUS)----1件: 97 💬
1743Budesonide ( Zentacort Capsules 3mg )1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
1744Budesonide (6 mg)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1745Budesonide (9 mg)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1746Budesonide 0.5 mg compresse orodispersibili1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1747Budesonide 0.5 mg orodispersible tablets1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1748Budesonide 0.5mg orodispersible tablet twice daily1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1749Budesonide 1 mg compresse orodispersibili1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1750Budesonide 1 mg orodispersible tablets1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1751Budesonide 1 mg orodispersible tablets (BUL 1 mg)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1752Budesonide 1mg orodispersible tablet twice daily1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1753Budesonide 2 mg orodispersible tablets (BUL 2 mg)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1754Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1755Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1756Budesonide 9 mg capsules, hard (BUX-PV)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1757Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1758Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1759Budesonide [0.4mg/ml] viscous suspension1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1760Budesonide MMX1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1761Budesonide MMX 6 mg Tablet1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1762Budesonide MMX®1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1763Budesonide MMX® 6 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1764Budesonide MMX® 9 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1765Budesonide oral suspension1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1766Budesonide oral suspension [0.2 mg/ml]1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1767Budesonide Orodispersible Tablets (Jorveza)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
1768Budesonide-MMX1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1769Budesonide-MMX®1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1770Budesonide-MMX® 6 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1771Budesonide-MMX® 9 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1772Budesonide-MMX™1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
1773BUET 0.5 mg----1件: 98 💬
1774BUET 1 mg----1件: 98 💬
1775BUET 1mg----1件: 98 💬
1776BUL 0.5 mg----1件: 98 💬
1777BUL 1 mg----1件: 98 💬
1778Bumetanide white, oblong, scored tablet1件: Bumetanide1件: Bumetanide 💬1件: SLC12A2 💬3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6 💬
1779Bupivacaine hydrochloride 0.5% (Marcaine, Pfizer)1件: Bupivacaine1件: Bupivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 46 💬
1780Bupivacaine Injection 0.5%1件: Bupivacaine1件: Bupivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 168 💬
1781Bupivacaine, triamcinolone, and heparin (BTH)3件: Bupivacaine,
Heparin,
Triamcinolone		3件: Triamcinolone ,
Adomiparin ,
Bupivacaine 💬		7件: NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬		5件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction 💬1件: 226 💬
1782Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine3件: Bupivacaine,
Clonidine,
Epinephrine		3件: Epinephrine ,
Clonidine ,
Bupivacaine 💬		14件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 70 💬
1783Bupivacaïne HCl 0,125% / Sufentanil 50 µg flacon à 50 ml1件: Sufentanil1件: Sufentanil 💬1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70 💬
1784Bupropion & Citalopram2件: Bupropion,
Citalopram		2件: Bupropion ,
Citalopram 💬		3件: SLC6A2,
SLC6A3,
SLC6A4 💬		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 18 💬
1785BUSILVEX - 6 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 10 ML 8 FLACONCINI1件: Busulfan1件: Busulfan 💬--2件: 19, 65 💬
1786Busulfan, Cyclophosphamide, Antithymocyte Globulin2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬		--2件: 19, 20 💬
1787Busulfan, Cyclophosphamide, ATG2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 19 💬
1788Busulfan, Cyclophosphamide, ATG, GCSF2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide ,
Cyclophosphamide 💬		--2件: 65, 284 💬
1789Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen)4件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Cyclophosphamide,
Fludarabine		4件: Busulfan ,
Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 326 💬
1790Busulfan, Fludarabine and ATG2件: Busulfan,
Fludarabine		2件: Busulfan ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
1791Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.4件: Busulfan,
Cyclophosphamide,
Cyclosporine,
Fludarabine		5件: Cyclosporine ,
Busulfan ,
Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		6件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
RRM1 💬		39件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 285 💬
1792Busulfan, Fludarabine, ATG, TLI2件: Busulfan,
Fludarabine		2件: Busulfan ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284 💬
1793Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF6件: Busulfan,
Filgrastim,
Fludarabine,
Methotrexate,
Phosphate ion,
Tacrolimus		6件: Tacrolimus ,
Methotrexate ,
Busulfan ,
Filgrastim ,
Fludarabine ,
Tacrolimus 💬		9件: CSF3R,
DHFR,
DHFR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
RRM1 💬		48件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
1794Butyrate enemas + routine management1件: Butyric Acid---1件: 291 💬
1795BUU 0.4mg/ml----1件: 98 💬
1796BV-101----1件: 8 💬
1797BX-1----1件: 13 💬
1798Bydureon 2 mg powder and solvent for prolonged-release suspension2件: Exenatide,
Manganese citrate		1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
1799Byetta 5 micrograms1件: Exenatide1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
1800BYM338 (Bimagrumab)1件: Bimagrumab1件: Bimagrumab 💬2件: ACVR2A,
ACVR2B 💬		4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 15 💬
1801BYM338/bimagrumab1件: Bimagrumab1件: Bimagrumab 💬2件: ACVR2A,
ACVR2B 💬		4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 15 💬
1802C (migalastat)1件: Migalastat1件: Migalastat 💬--1件: 19 💬
1803C-11 PiB1件: Pittsburgh Compound B---1件: 127 💬
1804C-82 Topical Gel, 1%----1件: 51 💬
1805C-kit+ cells----1件: 211 💬
1806C-Trelin OD Tab(5mg Taltirelin Hydrate)----1件: 18 💬
1807C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker1件: Polyethylene glycol1件: Polyethylene glycol 3350 💬--1件: 276 💬
1808C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER1件: Polyethylene glycol1件: Polyethylene glycol 3350 💬--1件: 276 💬
1809C. albicans----1件: 46 💬
1810C01CA04 - Dopamina1件: Dopamine1件: Dopamine 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 299 💬
1811C1-esterase inhibitor [recombinant] (C1-INH-R)1件: Human C1-esterase inhibitor---1件: 65 💬
1812C11-methionine1件: Methionine1件: Methionine 💬--1件: 84 💬
1813C326, IL-6 Inhibitory Avimer protein----1件: 96 💬
1814C5 inh MAb, SKY59, RO/CH7092230----2件: 62, 109 💬
1815Cabaletta for IV infusion once weekly during 24 weeks1件: Trehalose---1件: 18 💬
1816Cabaseril, 1,0 mg Tablette----1件: 6 💬
1817Cabaseril, 2,0 mg Tablette----1件: 6 💬
1818Cabotegravir (CAB) tablet1件: Cabotegravir1件: Cabotegravir 💬--1件: 256 💬
1819Cabotegravir - Injectable Suspension (CAB LA)1件: Cabotegravir1件: Cabotegravir 💬--1件: 256 💬
1820CAEL-101----1件: 28 💬
1821Caffeine 100-200 mg BID1件: Caffeine2件: Caffeine ,
Caffeine hydrate 💬		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
1822Calcineurin inhibitors maintenance----1件: 67 💬
1823Calcitriol & Calcium2件: Calcitriol,
Calcium		1件: Calcitriol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 235 💬
1824Calcium Channel Blockers1件: Calcium---1件: 51 💬
1825CALCIUM D3 SANDOZ - 1000 MG + 880 U.I. COMPRESSE EFFERVESCENTI 30 COMPRESSE DIVISIBILI2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬		--1件: 274 💬
1826Calcium, Dietary1件: Calcium---1件: 298 💬
1827CALD HR-D (High-Risk, Regimen C)----5件: 19, 20, 125, 234, 326 💬
1828CALD HR-D (High-Risk, Regimen D)----5件: 19, 20, 125, 234, 326 💬
1829CALD SR-A (Standard-Risk, Regimen A)----5件: 19, 20, 125, 234, 326 💬
1830CALD SR-B (Standard-Risk, Regimen B)----5件: 19, 20, 125, 234, 326 💬
1831Calvan (bevantolol hydrochloride)1件: Bevantolol---1件: 8 💬
1832Calvan® 100 mg----1件: 8 💬
1833Camoteskimab (CERC-007, AVTX-007, AEVI-007)----1件: 107 💬
1834Campath -1H1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 65 💬
1835Campath 1H1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-4件: 60, 65, 164, 285 💬
1836Campath, Busulfan, Clofarabine2件: Busulfan,
Clofarabine		2件: Busulfan ,
Clofarabine 💬		3件: POLA1,
POLA2,
RRM1 💬		7件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 326 💬
1837Campath, Chemo and/or TBI Allo SCT1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-3件: 60, 62, 283 💬
1838Campath, Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284 💬
1839Campath-1H1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-6件: 19, 20, 60, 234, 285, 326 💬
1840CAMPATH-1H (Alemtuzumab)1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 60 💬
1841Canakinumab (company code: ACZ885D)1件: Canakinumab1件: Canakinumab 💬1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
1842Cannabidiol , synthetic form1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 96 💬
1843Cannabidiol / Dronabinol capsule 5 mg+2,5 mg2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1844Cannabidiol Botanical Drug Substance (CBD BDS)1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1845Cannabidiol capsule 5 mg1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1846Cannabidiol Oral Solution1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬4件: 140, 144, 145, 193 💬
1847Cannabidiol Oral Solution, is known as Epidyolex 100 mg/mL oral solution and is the approved name in the EU. Epidiolex (cannabidiol) oral solution is the approved name in the US.1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 158 💬
1848Cannabidiol tablet 10 mg1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬2件: 46, 271 💬
1849Cannabis Based Medicine Extract (Sativex)1件: Medical Cannabis---1件: 13 💬
1850Cannabis Oil1件: Medical Cannabis---1件: 6 💬
1851Cannabis Sativa extract Oromucosal spray1件: Medical Cannabis---1件: 2 💬
1852Cannabis sativa L., folium cum flore1件: Medical Cannabis---1件: 19 💬
1853Cannabis, Medical1件: Medical Cannabis---5件: 2, 6, 13, 96, 97 💬
1854CAP-10021件: CAP-1002---1件: 113 💬
1855Capillary colchicine dosage in colchicine-resistant Familial Mediterranean Fever patients.1件: Colchicine1件: Colchicine 💬9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 266 💬
1856Capsule fecal microbiota material (cap-FMT)----1件: 96 💬
1857Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1858Capsules with 160 mg Teavigo (at least 94% EGCG)1件: Epigallocatechin gallate---1件: 13 💬
1859Carbidopa 20 mg1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1860Carbidopa 200mg oral dose1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
1861Carbidopa 27.5 mg1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1862Carbidopa 65 mg capsule1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1863Carbidopa and Levodopa 25mg/100mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1864Carbidopa and Levodopa Tablets, USP2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1865CARBIDOPA MONOHYDRATE1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1866Carbidopa, levodopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1867Carbidopa- Levodopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1868Carbidopa-4'-Monophosphate1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
1869Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1870Carbidopa/levodopa, as prescribed by treating physician2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1871Carbidopa/Levodopa, immediate release2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
1872CARBOLITHIUM*100CPS 150MG----1件: 2 💬
1873Carbon monoxide2件: Activated charcoal,
Carbon monoxide		1件: Carbon monoxide 💬--2件: 85, 86 💬
1874Carbon-14 BIA 28-61562件: Activated charcoal,
BIA		---1件: 6 💬
1875Cardicor (Merck brand)----1件: 113 💬
1876Carmustine, etoposide, cytarabine, and melphalan (BEAM)4件: Carmustine,
Cytarabine,
Etoposide,
Melphalan		4件: Etoposide ,
Cytarabine ,
Carmustine ,
Melphalan 💬		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
1877Carnosine, capsulle, 2 g/day, 8 weeks1件: Carnosine---1件: 13 💬
1878CAS # in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----1件: 254 💬
1879CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one----1件: 58 💬
1880CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one----1件: 58 💬
1881CAS No.: 7758-16-9----1件: 166 💬
1882CAS# in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid)----1件: 254 💬
1883CAT-1004----1件: 113 💬
1884Catapresan 75----1件: 78 💬
1885Catapresan 75, Tabletten----1件: 65 💬
1886Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03)----1件: 85 💬
1887Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
1888CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution1件: Aztreonam1件: Aztreonam 💬--1件: 299 💬
1889CB-01-05-MMX----1件: 97 💬
1890CBD - Oral Solution, is known as Epidiolex, and is the approved name in the USA.1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬2件: 140, 144 💬
1891CBD - Oral Solution, is known as Epidyolex 100 mg/ml oral solution,1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 158 💬
1892CBD - Oral Solution, is known as Epidyolex, and is the approved name1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
1893CBD - Solution Orale, conosciuto come Epidiolex, questo è il nome approvato negli Stati Uniti1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
1894CBD oil----1件: 51 💬
1895CBD Oral solution, is known as Epidyolex and is the approved name in the EU1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
1896CBD soluzione orale nota come Epidyolex e con tale nome è stato approvato in UE1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 156 💬
1897CBD-Oral Solution, is known as Epidiolex, and is the approved name in the USA.1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 158 💬
1898CC-100004----1件: 84 💬
1899CC-10004----5件: 46, 56, 97, 162, 271 💬
1900CC-220 0.3 mg Daily----1件: 84 💬
1901CC-5013----2件: 28, 96 💬
1902CCD 1042----1件: 152 💬
1903CCD 1042, MD 9150000, Mepalon 1042, SPT316----2件: 152, 206 💬
1904CCD 1042, MD 9150000, Mepalon 1042, SPT3162----1件: 152 💬
1905CCI-779----2件: 13, 46 💬
1906CCP-690-550-10----1件: 107 💬
1907CCX140-B----1件: 222 💬
1908CCX282-B----1件: 96 💬
1909CD19-directed humanised afucosylated monoclonal antibody----1件: 11 💬
1910CD19/BCMA CAR T-cells----2件: 16, 61 💬
1911CD3/CD19 neg allogeneic BMT----1件: 65 💬
1912CD34+ CELLS----1件: 285 💬
1913CD34+ cells transduced with ADA retrovir----1件: 65 💬
1914CD34+ enriched, T Cell Depleted donor stem cell product----1件: 326 💬
1915CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT----1件: 65 💬
1916CD34+ selected cells----1件: 285 💬
1917CD62L- Tem----1件: 60 💬
1918CDCA Weight-Based Dose TID1件: Chenodeoxycholic acid1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 263 💬
1919CDP6038 (olokizumab)1件: Olokizumab1件: Olokizumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
1920CDP870 100mg----1件: 46 💬
1921CDX-1135----1件: 222 💬
1922CE 224,535----1件: 46 💬
1923CE-224,535----1件: 46 💬
1924CEBION 500*20CPR MAST 500MG----1件: 10 💬
1925CEBION 500MG 20CPR MAST.ARAN----1件: 10 💬
1926Cediranib Maleate1件: Cediranib1件: Cediranib 💬3件: FLT1,
FLT4,
KDR 💬		15件: Breast cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 34 💬
1927CEFEPIME DIHYDROCHLORIDE MONOHYDRATE1件: Cefepime1件: Cefepime 💬--1件: 60 💬
1928Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬		--1件: 299 💬
1929Celebrex 200 mg----1件: 46 💬
1930Celebrex 200 mg capsule, hard1件: Celecoxib1件: Celecoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
1931Celebrex 200 mg Hartkapseln1件: Celecoxib1件: Celecoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
1932Celecoxib 200 milligrams1件: Celecoxib1件: Celecoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
1933Celecoxib 400 milligrams1件: Celecoxib1件: Celecoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
1934Celecoxib, Celebrex®1件: Celecoxib1件: Celecoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
1935Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in ALS patients----1件: 2 💬
1936CellCept (Mycophenolate Mofetil)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 42, 43 💬
1937CellCept 500 mg----1件: 11 💬
1938CellCept 500 mg comprimidos recubiertos----1件: 35 💬
1939CellCept 500 mg film-coated tablets1件: Mycophenolate mofetil1件: Mycophenolate mofetil 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 11 💬
1940CellCept 500 mg tablets1件: Mycophenolate mofetil1件: Mycophenolate mofetil 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 11 💬
1941Cellcept® in autoimmune bullous dermatoses----2件: 35, 162 💬
1942CellCept®500 mg comprimidos----1件: 35 💬
1943CellCept®500 mg tablets1件: Mycophenolate mofetil1件: Mycophenolate mofetil 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 11 💬
1944Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi----1件: 19 💬
1945Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida----1件: 274 💬
1946Cenerimod 0.5 mg1件: Cenerimod1件: Cenerimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
1947Cenerimod 1 mg1件: Cenerimod1件: Cenerimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
1948Cenerimod 2 mg1件: Cenerimod1件: Cenerimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
1949Cenerimod 4 mg1件: Cenerimod1件: Cenerimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 49 💬
1950Cenicriviroc 150 mg1件: Cenicriviroc1件: Cenicriviroc 💬2件: CCR2,
CCR5 💬		11件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 94 💬
1951CEP-13471件: CEP-1347---1件: 6 💬
1952CEP-1347 10mg1件: CEP-1347---1件: 6 💬
1953CEP-1347 50mg1件: CEP-1347---1件: 6 💬
1954Ceramic on Polyethylene articulation----1件: 46 💬
1955CERE-120----1件: 6 💬
1956CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])----1件: 6 💬
1957CERE-120: AAV2-NTN----1件: 6 💬
1958CERE-120: Adeno-Associated Virus Delivery of Neurturin----1件: 6 💬
1959CERETEC (TM) Estabilizado2件: Cobalt chloride,
Technetium Tc-99m exametazime		---1件: 6 💬
1960Cerezyme® / Imiglucerase1件: Imiglucerase1件: Imiglucerase 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
1961Certican 0,51件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 228 💬
1962Certican 0,5 mg Tabletten1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 228 💬
1963Certican 0,75mg1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 228 💬
1964Certican 0,75mg Tabletten1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 228 💬
1965Certican 1 mg tablets1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
1966Certolizumab pegol (CDP870, CZP)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1967Certolizumab pegol (CDP870, tradename Cimzia)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1968Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1969Certolizumab Pegol (CZP) 200 mg1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1970Certolizumab Pegol (CZP) 400 mg1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1971Certolizumab Pegol + Methotrexate (MTX)2件: Certolizumab pegol,
Methotrexate		2件: Methotrexate ,
Certolizumab pegol 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1972Certolizumab pegol / CIMZIA1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
1973Certolizumab Pegol 200 MG/ML [Cimzia]1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
1974Certolizumab pegol 400 mg1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
1975Cesamet™ (nabilone)1件: Nabilone1件: Nabilone 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1976Cetirizina Mylan Generics1件: Cetirizine1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
1977CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU1件: Cetirizine1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 300 💬
1978CF patients with a G551D mutation and treated with Ivacaftor1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
1979CF101 1 mg----1件: 46 💬
1980CF101 2 mg----1件: 46 💬
1981CFTR Modulators----1件: 299 💬
1982CFZ533 active - Cohort 1----1件: 53 💬
1983CFZ533 active - Cohort 2----1件: 53 💬
1984CFZ533 active - Cohort 3----1件: 53 💬
1985CGP 77116----1件: 13 💬
1986CH-1504----1件: 46 💬
1987Ch11-1F4 (NSC-711516)----1件: 28 💬
1988ChAdOx1 nCoV-191件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299 💬
1989Change in daily dosage of Growth Hormone1件: Somatotropin---1件: 78 💬
1990Chemical conjugate of recombinant human growth hormone (rhGH) and human immunoglobulin G4 fragment (HMC001)1件: Somatotropin---1件: 78 💬
1991CHEMICALLY MODIFIED RECOMBINANT HUMAN SULFAMIDASE----1件: 19 💬
1992CHF6333 (Part 1 - SAD)----1件: 299 💬
1993CHF6333 (Part 2 - MAD)----1件: 299 💬
1994CHIMERIC FIBRIL-REACTIVE IGG1K MONOCLONAL ANTIBODY 11-1F4----1件: 28 💬
1995Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4----1件: 28 💬
1996Chimeric Human-Murine IgG1 ----1件: 46 💬
1997Chimeric human/mouse anti-CD-20 monoclonal antibody----1件: 46 💬
1998Chimeric IgG1 monoclonal antibody----1件: 96 💬
1999Chimeric monoclonal antibody, IgG4 subtype----2件: 43, 44 💬
2000Chimeric murine human anti-IL-6 monoclonal antibody----1件: 331 💬
2001Chinese herbal concoction twice a day for 6 months----1件: 60 💬
2002Chinese herbal medicine treatment----1件: 6 💬
2003Chinese herbs based on syndrome differentiation----1件: 224 💬
2004Chlorhexidine gluconate oral rinse1件: Chlorhexidine1件: Chlorhexidine 💬--1件: 299 💬
2005Cholecalciferol 10,000 IU1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
2006Cholecalciferol and C. Xanthorrhiza1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
2007Cholecalciferol, Vitamin D31件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
2008CHR-1103 / GBR500----1件: 13 💬
2009Chromosomal microarray analysis (CMA) and whole exome sequencing (WES)----1件: 179 💬
2010Chronocort 10mg----1件: 81 💬
2011Chronocort 5mg----1件: 81 💬
2012Chronocort® 10 mg----1件: 81 💬
2013Chronocort® 20 mg----1件: 81 💬
2014Chronocort® 5 mg----1件: 81 💬
2015CI-984, 17AA70, PD 132301-2----1件: 81 💬
2016CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 75 💬
2017Cialis 10 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
2018Cialis 2.5 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
2019CIALIS 20 mg comprimidos recubiertos con película1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
2020Cialis 20 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
2021Cialis 5 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 86, 113 💬
2022Ciclosporina / Ciclosporin1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
2023Ciclosporina/ Ciclosporin1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
2024Ciclosporine, Ciclosporina1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
2025Ciliary Neurotrophic Factor Implant NT-5011件: Ciliary neurotrophic factor---1件: 90 💬
2026Cilostazol 100 MG1件: Cilostazol1件: Cilostazol 💬3件: PDE3A,
PDE3B,
TBXA2R 💬		14件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
2027CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2028CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI ALCOOL1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2029Cimzia 200 mg injeksjonsvæske, oppløsning1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2030Cimzia 200 mg solution for injection1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 271 💬
2031CIMZIA certolizumab pegol 200 mg/ml solution for injection1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2032CINRYZE® (C1 esterase inhibitor [human])1件: Human C1-esterase inhibitor---1件: 61 💬
2033Cipro (Ciprofloxacin, BAYQ3939)1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
2034Ciprofloxacin (BAYQ3939) dry powder for inhalation1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
2035Ciprofloxacin (Cipro Inhale, BAYQ3939)1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
2036Ciprofloxacin (Cipro, BAYQ3939)1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
2037Ciprofloxacin DPI (BAYQ3939)1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
2038CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE1件: Ciprofloxacin1件: Ciprofloxacin 💬--1件: 299 💬
2039CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE----1件: 299 💬
2040CIPROXIN*6CPR RIV 500MG----1件: 299 💬
2041Circadin ( INN= Melatonin)1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13 💬
2042Circadin 2 mg1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 90 💬
2043CIRCADIN 2 mg comprimidos de liberación prolongada1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 90 💬
2044CITICOLIN*1G/4ML IM IV 5 F----1件: 6 💬
2045Citicolina 1000 mg/die1件: Citicoline1件: Citicoline 💬--1件: 6 💬
2046Citric Acid based Mouthwash1件: Citric acid1件: Citric acid monohydrate 💬--1件: 53 💬
2047CJNJ-68150420-ZZZ-G001 (ACT- 064992D)----1件: 86 💬
2048CK-2017357 (Part B)----1件: 2 💬
2049CK-3773274 (10 - 30 mg)----1件: 58 💬
2050CK-3773274 (5 - 15 mg)----1件: 58 💬
2051CK-3773274 (5 - 20 mg)----1件: 58 💬
2052CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg)----1件: 58 💬
2053CK-3773274 - Granules in Capsule----1件: 58 💬
2054CK-3773274 - Tablets----1件: 58 💬
2055CKD-374 5mg Tab.----1件: 46 💬
2056CKD-504----1件: 8 💬
2057CKD-506----1件: 46 💬
2058CL20-i4-EF1a-h?c-OPT----1件: 65 💬
2059Cladribina oral1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2060Cladribine (MAVENCLAD®)1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2061Cladribine 3.5 mg/kg1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2062Cladribine 5.25 mg/kg1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2063Cladribine Oral Tablet1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2064Clarithromycin (Not used as of 4/2020)1件: Clarithromycin1件: Clarithromycin 💬--1件: 6 💬
2065Claritromycin 500mg film coated tablets----1件: 299 💬
2066Clarium 50 mg Retardtabletten----1件: 6 💬
2067Clartihromycin, amoxicillin, and omeprazole2件: Amoxicillin,
Omeprazole		3件: Amoxicillin ,
Omeprazole ,
Amoxicillin 💬		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 6 💬
2068Clemastine Milstein 1 mg, tabletten1件: Clemastine1件: Clemastine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
2069Clipper 30 cpr 5mg R.M.----1件: 97 💬
2070CLIPPER*30CPR 5MG R.M.----1件: 97 💬
2071Clobazam Medium Dose1件: Clobazam1件: Clobazam 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
2072Clobazam Tablets 10mg1件: Clobazam1件: Clobazam 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
2073Clobazam Tablets 5mg1件: Clobazam1件: Clobazam 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 144 💬
2074Clobetasol 0.05% ointment1件: Clobetasol1件: Clobetasol 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 39 💬
2075Clobetasol 0.05% Topical Ointment1件: Clobetasol1件: Clobetasol 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
2076Clobetasol propionate + Methotrexate3件: Clobetasol,
Clobetasol propionate,
Methotrexate		3件: Methotrexate ,
Clobetasol propionate ,
Clobetasol 💬		3件: DHFR,
DHFR2,
NR3C1 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬1件: 162 💬
2077Clonidine HCl CF 0,150 mg, tabletten1件: Clonidine1件: Clonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 78 💬
2078CLORFENAMINA MALEATO1件: Chlorpheniramine1件: Chlorphenamine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 14 💬
2079CLORURO SODICO 7%----1件: 299 💬
2080Clostridium botulinum1件: Clostridium botulinum---1件: 13 💬
2081CLOSTRIDIUM BOTULINUM TOXIN TYPE A2件: Botulinum toxin type A,
Clostridium botulinum		1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
2082CM-101----1件: 94 💬
2083CNP-104----1件: 93 💬
2084Cnp-MS-0601----1件: 13 💬
2085CNTO 1275----2件: 13, 96 💬
2086CNTO 136----2件: 41, 46 💬
2087CNTO 136 100 mg----1件: 46 💬
2088CNTO 136 25 mg----1件: 46 💬
2089CNTO 136 50 mg----1件: 46 💬
2090CNTO 136 IgG----1件: 46 💬
2091CNTO 148----4件: 46, 84, 97, 271 💬
2092CNTO 148 (Golimumab)1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
2093CNTO 1959----1件: 46 💬
2094CNTO 1959 + MTX (Group 4)----1件: 46 💬
2095CNTO 1959 + MTX (Group 5)----1件: 46 💬
2096CNTO 1959 IgG----1件: 46 💬
2097CNTO 6785 100 mg----1件: 46 💬
2098CNTO 6785 15 mg----1件: 46 💬
2099CNTO 6785 200 mg----1件: 46 💬
2100CNTO 6785 50 mg----1件: 46 💬
2101CNTO 888 1 mg/kg----1件: 85 💬
2102CNTO 888 15 mg/kg----1件: 85 💬
2103CNTO 888 5 mg/kg----1件: 85 💬
2104CNTO-148----1件: 97 💬
2105CO-14----1件: 13 💬
2106Co-medication: Synthetic DMARDs----1件: 46 💬
2107Coarse wheat bran2件: Wheat,
Wheat bran		1件: Wheat 💬--1件: 6 💬
2108Cobitolimod 250 mg1件: Cobitolimod1件: Cobitolimod 💬1件: TLR9 💬9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
2109Cobitolimod 500 mg1件: Cobitolimod1件: Cobitolimod 💬1件: TLR9 💬9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
2110Cobitolimod 500mg1件: Cobitolimod1件: Cobitolimod 💬1件: TLR9 💬9件: African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 97 💬
2111Coconut oil2件: Coconut,
Coconut oil		1件: Coconut oil 💬--1件: 13 💬
2112Coconut oil and epigallocatechin gallate4件: Coconut,
Coconut oil,
Epigallocatechin,
Epigallocatechin gallate		1件: Coconut oil 💬--1件: 13 💬
2113Cod liver oil1件: Cod liver oil1件: Cod liver oil 💬--1件: 46 💬
2114Coenzym Q10, Ubiquinon, Ubichinon----1件: 5 💬
2115Coenzyme Q-101件: Ubidecarenone1件: Ubidecarenone 💬--1件: 86 💬
2116Coenzyme Q-10 in Normal Control subjects1件: Ubidecarenone1件: Ubidecarenone 💬--1件: 86 💬
2117Coenzyme Q-10 in Pulmonary Hypertension subjects1件: Ubidecarenone1件: Ubidecarenone 💬--1件: 86 💬
2118Cofactor supplementation (thiamine, riboflavin, L-carnitine)3件: Levocarnitine,
Riboflavin,
Thiamine		3件: Riboflavin ,
Levocarnitine ,
Thiamine 💬		--1件: 265 💬
2119Cogane™ (PYM50028)----1件: 6 💬
2120Cohort 1 0.225g----1件: 240 💬
2121Cohort 1: 1.0 x 10^8 PolyTregs----1件: 35 💬
2122Cohort 1: hATG, CsA, EPAG Day 14 to Month 61件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
2123Cohort 1:Nilotinib Oral Capsules (150mg or 300mg)1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
2124Cohort 2 0.75g----1件: 240 💬
2125Cohort 2: 2.5x10^8 PolyTregs----1件: 35 💬
2126Cohort 2: hATG, CsA, EPAG Day 14 to Month 31件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
2127Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
2128Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 61件: Antilymphocyte immunoglobulin (horse)---1件: 60 💬
2129COLCHICINA LIRCA - 1 MG COMPRESSE 60 COMPRESSE1件: Colchicine1件: Colchicine 💬9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 2 💬
2130Colchicine 1 MG Oral Tablet1件: Colchicine1件: Colchicine 💬9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 2 💬
2131COLECALCIFEROL CONCENTRATE (OILY FORM)1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
2132Colecalciferol D3 (Vigantol Oil)1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
2133Colfinair 2 MIU Powder for Nebuliser Solution----1件: 299 💬
2134COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML----1件: 299 💬
2135Colistimethate 75 mg inhaled two times daily1件: Colistimethate---1件: 299 💬
2136Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate2件: Colistimethate,
Colistin		1件: Colistin 💬--1件: 299 💬
2137Colistin Forest - Trockenstechampullen mit Lösungsmittel1件: Colistin1件: Colistin 💬--1件: 299 💬
2138COLISTIN MESILATE SODIUM1件: Colistin1件: Colistin 💬--1件: 299 💬
2139Collect of 10 ml of peripheric blood for DNA extraction----1件: 46 💬
2140Collection of biological sample (blood and/or CSF)----2件: 2, 6 💬
2141Collection of blood and urine----1件: 25 💬
2142Collection of samples----4件: 49, 65, 95, 107 💬
2143Collection of samples of blood and urine----1件: 167 💬
2144Colonoscopic fecal microbiota material (colo-FMT)----1件: 96 💬
2145Colony-purified Bacteroides thetaiotaomicron (B.theta)----1件: 96 💬
2146Combination fish oil and borage seed oil1件: Fish oil---1件: 46 💬
2147Combination injection of EPO and G-CSF1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 6 💬
2148Combination of a single dose anti-CD20 antibody and bortezomib1件: Bortezomib1件: Bortezomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 61 💬
2149Combination of DMARDs----1件: 107 💬
2150Combination of fish oil and colesevelam2件: Colesevelam,
Fish oil		1件: Colesevelam 💬--1件: 260 💬
2151Combination of Minocycline and MTX or MTX alone1件: Minocycline1件: Minocycline 💬--1件: 46 💬
2152Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine3件: Azathioprine,
Dexamethasone,
Rituximab		3件: Azathioprine ,
Dexamethasone ,
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 35 💬
2153Combination of Rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 63 💬
2154Combination of Rituximab with subcutaneous belimumab2件: Belimumab,
Rituximab		2件: Rituximab ,
Belimumab 💬		2件: MS4A1,
TNFSF13B 💬		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 63 💬
2155Combination of thrombopoietin mimetic and cyclosporin A2件: Cyclosporine,
Thrombopoietin		1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
2156Combination Oral Budesonide and Rectal Hydrocortisone2件: Budesonide,
Hydrocortisone		2件: Hydrocortisone ,
Budesonide 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
2157Combination Product: Active treatment with dual therapy----1件: 2 💬
2158Combination Product: Beclomethasone dipropionate in addition to MC-EVOO1件: Beclomethasone dipropionate1件: Beclomethasone dipropionate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
2159Combination Product: Beclomethasone dipropionate in addition to refined oil1件: Beclomethasone dipropionate1件: Beclomethasone dipropionate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
2160Combination Product: Belimumab1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
2161Combination Product: EGCG 300 mg + Nintedanib2件: Epigallocatechin gallate,
Nintedanib		1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
2162Combination Product: EGCG 300 mg + Pirfenidone2件: Epigallocatechin gallate,
Pirfenidone		1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
2163Combination Product: EGCG 600 mg + Nintedanib2件: Epigallocatechin gallate,
Nintedanib		1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
2164Combination Product: EGCG 600 mg + Pirfenidone2件: Epigallocatechin gallate,
Pirfenidone		1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
2165Combination Product: Exercise, and methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
2166Combination Product: Goldic serum----1件: 70 💬
2167Combination Product: high MCT formula----1件: 296 💬
2168Combination Product: Humira (adalimumab)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
2169Combination Product: Implantable System for Remodulin (treprostinil)1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2170Combination Product: L-dopa 140 mg1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2171Combination Product: L-dopa 35 mg1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2172Combination Product: L-dopa 70mg1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2173Combination Product: L-dopa 70mg/carbidopa 7mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2174Combination Product: Laser, exercise, and methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
2175Combination Product: lipid injectable emulsion with Fish oil1件: Fish oil---1件: 294 💬
2176Combination Product: mavrilimumab1件: Mavrilimumab1件: Mavrilimumab 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 41 💬
2177Combination Product: Methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
2178Combination Product: ND0612 Solution for SC infusion----1件: 6 💬
2179Combination Product: ofatumumab with AI1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
2180Combination Product: ofatumumab with PRF1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
2181Combination Product: PRP combined Magnovision----1件: 90 💬
2182Combination Product: Ravulizumab OBDS1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
2183Combination Product: Sanacoach Parkinson (SCP)----1件: 6 💬
2184Combination Product: TransCon PTH----1件: 235 💬
2185Combination Product: Treprostinil via implanted pump1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2186Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 85 💬
2187Combivir (zidovudine [AZT] / lamivudine [3TC])2件: Lamivudine,
Zidovudine		2件: Lamivudine ,
Zidovudine 💬		--1件: 265 💬
2188Commercial Ventavis® (iloprost)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2189Common Name: Sialic Acid----1件: 30 💬
2190Comparator: carbidopa1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
2191Comparator: diclofenac1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
2192Comparator: Diclofenac sodium1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
2193Comparator: ezetimibe1件: Ezetimibe1件: Ezetimibe 💬1件: NPC1L1 💬1件: Fat digestion and absorption 💬2件: 79, 260 💬
2194Comparator: levodopa1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2195Comparator: naproxen tablet 500 mg1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
2196Compound 1a----2件: 246, 299 💬
2197Compound thrombosis capsule sig: 1.5g/tid----1件: 90 💬
2198Compressa effervescente 0,5 mg di budesonide per uso orodispersibile1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
2199Compressa effervescente 1 mg di budesonide per uso orodispersibile1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
2200COMTAN 200* 60 CPR 200 MG1件: Entacapone1件: Entacapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
2201Concentration unit: mg milligram(s)----1件: 254 💬
2202Conditioned Medium (CM)----1件: 90 💬
2203Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d1件: Conjugated estrogens1件: Estrogens, conjugated 💬--1件: 49 💬
2204Continuation of azathioprine1件: Azathioprine1件: Azathioprine 💬--1件: 49 💬
2205Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)----1件: 265 💬
2206Continue IS (B cell depletion therapy)----7件: 13, 35, 46, 49, 50, 51, 107 💬
2207Continue IS (MMF or MPA)----7件: 13, 35, 46, 49, 50, 51, 107 💬
2208Continue IS (MTX)----7件: 13, 35, 46, 49, 50, 51, 107 💬
2209Continued Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
2210Continuous infusion Meropenem1件: Meropenem2件: Meropenem ,
Meropenem 💬		--1件: 299 💬
2211Continuous intrajejunal infusion of levodopa-carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2212Continuous oxygen1件: Oxygen1件: Oxygen 💬--1件: 90 💬
2213Control Group 0.9% Isotonic Saline----1件: 299 💬
2214Control multivitamin----1件: 299 💬
2215Controlled-release levodopa / carbidopa2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2216Conventional drug therapy(expectorant,bronchodilator)----1件: 86 💬
2217Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)7件: Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		6件: Hydrocortisone ,
Dexamethasone ,
Prednisolone ,
Prednisone ,
Cortisone acetate ,
Cortisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
2218Conventional medication----1件: 6 💬
2219Conventional therapy users for the last 5 years----1件: 271 💬
2220Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)1件: Mesalazine1件: Mesalamine 💬--2件: 96, 97 💬
2221COP-11件: Glatiramer---1件: 13 💬
2222COP-1/Copolymer-11件: Glatiramer---1件: 13 💬
2223COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE1件: Glatiramer---1件: 13 💬
2224COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE1件: Glatiramer---1件: 13 💬
2225COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN1件: Glatiramer---1件: 13 💬
2226COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO1件: Glatiramer---1件: 13 💬
2227Copaxone 20 mg1件: Glatiramer---1件: 13 💬
2228Copaxone 20 mg/ml1件: Glatiramer---1件: 13 💬
2229COPAXONE 20 mg/ml solución inyectable en jeringa precargada1件: Glatiramer---1件: 13 💬
2230Copaxone 20 mg/ml solución para inyección en jeringa precargada1件: Glatiramer---1件: 13 💬
2231Copaxone 20 mg/ml Solution for Injection, pre-filled syringe1件: Glatiramer---1件: 13 💬
2232Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes1件: Glatiramer---1件: 13 💬
2233Copaxone 20mg/ml Solution for Injection, pre-filled syringe1件: Glatiramer---1件: 13 💬
2234Copaxone 40 mg/ml1件: Glatiramer---1件: 13 💬
2235Copaxone 40 mg/ml solution for injection, pre-filled syringe1件: Glatiramer---1件: 13 💬
2236COPAXONE*SC 28SIR 20MG/ML1件: Glatiramer---1件: 13 💬
2237Copolymer 1----1件: 13 💬
2238Copolymer-11件: Glatiramer---1件: 13 💬
2239COPPER (64CU) CHLORIDE2件: Chloride ion,
Copper		---1件: 171 💬
2240Cord blood----1件: 60 💬
2241Cord blood sampling----1件: 227 💬
2242Cord Blood Transplant----1件: 60 💬
2243Cord Blood Units----1件: 60 💬
2244Corn oil capsules1件: Corn---1件: 46 💬
2245Corn/soy oil1件: Corn---1件: 240 💬
2246CORTANCYL 20 mg1件: Prednisone acetate1件: Prednisone acetate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
2247Cortancyl ® 1 mg1件: Prednisone acetate1件: Prednisone acetate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
2248Cortancyl ® 20 mg1件: Prednisone acetate1件: Prednisone acetate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
2249Cortancyl ® 5 mg1件: Prednisone acetate1件: Prednisone acetate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
2250Cortef 5 mg1件: Hydrocortisone cypionate1件: Hydrocortisone cypionate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
2251Corticoids+ tocilizumab 8mg/Kg/4 weeks1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
2252Corticosteroid and non-biological agents.----1件: 46 💬
2253Corticosteroid or NSAID----1件: 46 💬
2254Corticosteroid treatment (Methylprednisolone or prednisolone)2件: Methylprednisolone,
Prednisolone		2件: Methylprednisolone ,
Prednisolone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 64 💬
2255Corticosteroids & tanCART19/20----1件: 13 💬
2256Corticosteroids (prednisone or prednisolone)2件: Prednisolone,
Prednisone		2件: Prednisolone ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
2257Corticosteroids only----1件: 97 💬
2258CortimentMMX 9 mg----1件: 97 💬
2259COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 1 SIRINGA PRERIEMPITA1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 107 💬
2260COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 2 SIRINGHE PRERIEMPITE1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 107 💬
2261Cosentyx 300 mg solution for injection in pre-filled syringe1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 41 💬
2262CosmoFer 50mg/ml solution for infusion or injection----2件: 96, 97 💬
2263Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin2件: Tetracosactide,
Vigabatrin		2件: Cosyntropin ,
Vigabatrin 💬		2件: ABAT,
MC2R 💬		12件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬1件: 145 💬
2264Cosyntropin Injectable Suspension, 1 mg/mL1件: Tetracosactide1件: Cosyntropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 145 💬
2265COVID-19 mRNA Vaccine (nucleoside modified)----3件: 13, 46, 51 💬
2266COVID-19 mRNA vaccine (nucleoside-modified)----4件: 13, 46, 51, 299 💬
2267COVID-19 mRNA vaccine Moderna (CX-024414)----4件: 13, 46, 51, 299 💬
2268COVID-19 vaccination----1件: 13 💬
2269COVID-19 vaccine----3件: 46, 49, 51 💬
2270COVID-19 vaccine (Ad26.COV2-S [recombinant])----1件: 299 💬
2271COVID-19 Vaccine (ChAdOx1-S [recombinant])----3件: 46, 51, 299 💬
2272COVID-19 Vaccine AstraZeneca1件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 53 💬
2273COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19)1件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299 💬
2274COVID-19 Vaccine AstraZeneca suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant])1件: AstraZeneca COVID-19 Vaccine---1件: 53 💬
2275Covid-19 Vaccine Janssen1件: Janssen COVID-19 Vaccine1件: COVID-19 vaccine 💬--2件: 53, 299 💬
2276COVID-19 Vaccine Janssen suspension for injection1件: Janssen COVID-19 Vaccine1件: COVID-19 vaccine 💬--1件: 299 💬
2277COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant])1件: Janssen COVID-19 Vaccine1件: COVID-19 vaccine 💬--2件: 53, 299 💬
2278COVID-19 Vaccine Moderna1件: Moderna COVID-19 Vaccine1件: Elasomeran 💬--4件: 46, 51, 65, 299 💬
2279COVID-19 Vaccine Moderna dispersion for injection1件: Moderna COVID-19 Vaccine1件: Elasomeran 💬--1件: 299 💬
2280Cozaar 501件: Losartan1件: Losartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167 💬
2281COZAAR 50 mg comprimidos recubierto con pelicula1件: Losartan1件: Losartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 179 💬
2282COZAAR INICIO 12,5 mg comprimidos recubiertos con pelicula1件: Losartan1件: Losartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167 💬
2283CP 690,550----1件: 46 💬
2284CP 690550 MR----1件: 46 💬
2285CP- 690 550----1件: 97 💬
2286CP-195,543----1件: 46 💬
2287CP-690, 550 - 10----1件: 46 💬
2288CP-690, 550-10----2件: 97, 107 💬
2289CP-690,500 5 mg----1件: 97 💬
2290CP-690,55-10----1件: 46 💬
2291CP-690,550----5件: 46, 96, 97, 107, 271 💬
2292CP-690,550 (tasocitinib)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
2293CP-690,550 (tofacitinib)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 107 💬
2294CP-690,550 + methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
2295CP-690,550 10 mg----1件: 97 💬
2296CP-690,550 – 10----1件: 46 💬
2297CP-690,550-10----5件: 46, 96, 97, 107, 271 💬
2298CP-690-550----1件: 46 💬
2299CP-690-550-10----1件: 107 💬
2300CP-690-550-10 (DMID D1600180)----1件: 107 💬
2301CP690,550----2件: 46, 97 💬
2302CPL500036 - high dose----1件: 6 💬
2303CPL500036 - low dose----1件: 6 💬
2304CR 1----1件: 46 💬
2305CR845 1.0 mg----1件: 93 💬
2306CRC3357, ZK-355322, Leukoton----1件: 299 💬
2307Creatine Monohydrate1件: Creatine---4件: 2, 8, 113, 156 💬
2308Creatine-13C1件: Creatine---1件: 113 💬
2309Crema de rapamicina al 1% y excipientes----1件: 157 💬
2310Creon 10.000, hårde enterokapsler----1件: 299 💬
2311Creon 10000----2件: 298, 299 💬
2312CREON 10000 Capsules----1件: 299 💬
2313Creon 25.000, hårde enterokapsler----1件: 299 💬
2314Creon 40.000, hårde enterokapsler----1件: 299 💬
2315Creon® (DR/GR)----1件: 299 💬
2316Creon® 25,000----1件: 299 💬
2317Crestor Tablets (calcium rosuvastatin) Film-Coated tablets2件: Calcium,
Rosuvastatin		1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 79 💬
2318Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 81 💬
2319Crohns Disease Exclusion Diet + PEN----1件: 96 💬
2320Cromolyn sodio (cromoglicato disodico, DSCG)1件: Cromoglicic acid1件: Cromoglicic acid 💬--1件: 85 💬
2321CRx-102----1件: 46 💬
2322CRx-102 (2.7/180)----1件: 46 💬
2323CRx-102 (2.7/360)----1件: 46 💬
2324CRX-1391件: CRx-139---1件: 46 💬
2325CRx-150----1件: 46 💬
2326CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE----1件: 19 💬
2327Cryopreserved EFS-ADA LV transduced patient CD34+ cells----1件: 65 💬
2328Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells----1件: 65 💬
2329Crystalline cholesterol oil-based suspension1件: Cholesterol1件: Cholesterol 💬--1件: 310 💬
2330Crysvita (burosumab-twza) Treatment1件: Burosumab1件: Burosumab 💬1件: FGF23 💬11件: Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬1件: 238 💬
2331CS (corticosteroids) Only----1件: 97 💬
2332CS20AT04 (allogenic bone marrow derived mesenchymal stem cell)----1件: 49 💬
2333CSM allogéniques issues de cordons ombilicaux ( MTI-PP)----1件: 49 💬
2334CST-103----1件: 6 💬
2335CST-107----1件: 6 💬
2336CST-139----1件: 6 💬
2337CSTI-500----1件: 193 💬
2338CT- P10----1件: 46 💬
2339CTI-16011件: CTI-1601---1件: 18 💬
2340CTNS-RD-04 or CTNS-RD-04-LB (where the suffix -LB stands for LentiBOOST)----1件: 19 💬
2341Cudetaxestat (BLD-0409)----1件: 85 💬
2342Cultivated oral mucosal epithelial sheet transplantation----2件: 38, 162 💬
2343Cuprior 150 mg1件: Triethylenetetramine---1件: 171 💬
2344Cuprior 150 mg film-coated tablets1件: Triethylenetetramine---1件: 171 💬
2345Cuprior 150mg film-coated tablets1件: Triethylenetetramine---1件: 171 💬
2346Cura-100----1件: 46 💬
2347Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg1件: Turmeric---1件: 299 💬
2348Current marketed FLOLAN (epoprostenol sodium)1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2349Current treatment of AL-CM----1件: 28 💬
2350Cutaneous iontophoresis of treprostinil1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51 💬
2351Cuvitru 200 mg/ml solution for subcutaneous injection1件: Human immunoglobulin G---1件: 65 💬
2352CV-MG011件: CV-MG01---1件: 11 💬
2353CVL-751----1件: 6 💬
2354CVT-301 (Dose Level 1)----1件: 6 💬
2355CVT-301 50mg----1件: 6 💬
2356CVT-301, LIP----1件: 6 💬
2357CX-4945 oral formulation----1件: 331 💬
2358CXA-101件: CXA-10---2件: 86, 222 💬
2359Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly di-aspartate----1件: 75 💬
2360Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) di-aspartate----1件: 75 💬
2361Cyclo(diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe)----1件: 75 💬
2362Cyclophosphamide (CY) (Plan 1)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--2件: 60, 285 💬
2363Cyclophosphamide (CY) (Plan 2)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--2件: 60, 285 💬
2364Cyclophosphamide + pred1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 283 💬
2365Cyclophosphamide 100mg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 60 💬
2366Cyclophosphamide 150mg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 60 💬
2367Cyclophosphamide 50mg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 60 💬
2368Cyclophosphamide 50Mg Oral Tablet1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 162 💬
2369Cyclophosphamide Dose Level 11件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--2件: 65, 284 💬
2370Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids3件: Azathioprine,
Cyclophosphamide,
Methotrexate		4件: Methotrexate ,
Azathioprine ,
Cyclophosphamide ,
Cyclophosphamide 💬		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44 💬
2371Cyclophosphamide Injection 1g1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--3件: 50, 51, 52 💬
2372CYCLOPHOSPHAMIDE MONOHYDRATE1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--4件: 13, 60, 96, 256 💬
2373Cyclophosphamide, Azathioprine,prednisone,methylprednisolone4件: Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		5件: Azathioprine ,
Cyclophosphamide ,
Methylprednisolone ,
Prednisone ,
Cyclophosphamide 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
2374Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
2375Cyclophosphamide, Bortezomib, dexamethasone3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
2376Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab4件: Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone		5件: Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide ,
Daratumumab 💬		3件: CD38,
NR3C1,
PSMB5 💬		16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28 💬
2377Cyclophosphamide, fludarabine , thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
2378Cyclophosphamide, Fludarabine, Rabbit ATG4件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine,
Rabbit		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
2379Cyclophosphamide, Fludarabine, Thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
2380Cyclophosphamidum 500 mg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 44 💬
2381Cyclosporin, low dose steroid1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
2382Cyclosporin, Methotrexate (GVHD prophylaxis)2件: Cyclosporine,
Methotrexate		2件: Methotrexate ,
Cyclosporine 💬		7件: DHFR,
DHFR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		38件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 326 💬
2383Cyclosporine 0.09% Ophthalmic Solution1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 53 💬
2384Cyclosporine 5 mg/kg bid days 0-141件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 38, 39 💬
2385Cyclosporine combine with mycophenolate mofetil3件: Cyclosporine,
Mycophenolate mofetil,
Mycophenolic acid		3件: Cyclosporine ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		7件: IMPDH1,
IMPDH2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 283 💬
2386Cyclosporine Oral Product1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
2387CYSTADROPS 0.55% eye drops, solution1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2388Cystagon (cysteamine bitartrate) immediate-release capsules1件: Cysteamine1件: Cysteamine 💬--1件: 299 💬
2389Cystagon 150mg1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2390Cystagon 50mg1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2391Cystagon® (Cysteamine Bitartrate)1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2392Cysteamine (mercaptamine) viscous solution1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2393Cysteamine Bitartrate1件: Cysteamine1件: Cysteamine 💬--4件: 8, 19, 21, 299 💬
2394Cysteamine bitartrate (Cystagon)1件: Cysteamine1件: Cysteamine 💬--1件: 299 💬
2395Cysteamine bitartrate (INN: mercaptamine bitartrate1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2396Cysteamine bitartrate (INN: mercaptamine bitartrate )1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2397Cysteamine bitartrate (INN: mercaptamine bitartrate)1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2398Cysteamine Bitartrate Delayed-release Capsules1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2399Cysteamine Bitartrate Delayed-release Capsules (RP103)1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
2400Cystoscopic injection of Botox into the urinary bladder1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
2401Cytochrome P450 (CYP) Substrates----2件: 96, 97 💬
2402Cytolytic CD4+ T cells----1件: 13 💬
2403Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant----1件: 62 💬
2404Cápsulas de Laquinimod 0.6 mg1件: Laquinimod---1件: 13 💬
2405Células madre mesenquimales----1件: 13 💬
2406Células madre mesenquimales de tejido adiposo autólogo----1件: 2 💬
2407Células madre mesenquimales haploidénticas derivadas de médula ósea----1件: 36 💬
2408Células Mesenquimales de tejido adiposo----1件: 2 💬
2409Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas----1件: 274 💬
2410Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada PEI nº 12-088)----1件: 274 💬
2411Células mesenquimales troncales adultas autólogas de medula ósea expandidas----1件: 117 💬
2412Células mesenquimales troncales adultas autólogas de médula ósea expandidas----1件: 117 💬
2413Células troncales hematopoyéticas autólogas adultas extraidas de médula ósea----1件: 2 💬
2414D (migalastat)1件: Migalastat1件: Migalastat 💬--1件: 19 💬
2415D Mannose1件: Mannose---1件: 13 💬
2416D-a-tocopheryl PEG 1000 succinate----1件: 299 💬
2417D-BIOTIN1件: Biotin1件: Biotin 💬--3件: 10, 13, 20 💬
2418D-BIOTINA1件: Biotin1件: Biotin 💬--1件: 13 💬
2419D-glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1)1件: Sorbitol1件: Sorbitol solution 💬--1件: 28 💬
2420D-glucitol, 1-deoxy-1-(methylamino)-,2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1)1件: Sorbitol1件: Sorbitol solution 💬--1件: 28 💬
2421D-methylphenidate1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84 💬
2422D-penicillamine 150mg1件: Penicillamine1件: Penicillamine 💬--1件: 171 💬
2423D-penicillamine 250 mg1件: Penicillamine1件: Penicillamine 💬--1件: 171 💬
2424D.3.6.2 - dose massima specificare: giornaliera----1件: 86 💬
2425D.3.6.2.1 - valore: 45 / 0.45 mg/ml----1件: 97 💬
2426D.3.6.2.1 - valore: 5 o 10 mg/kg----1件: 97 💬
2427D9421-C capsule 3 mg----1件: 96 💬
2428D9421-C, 15mg----1件: 96 💬
2429D9421-C, 9mg----1件: 96 💬
2430Dacepton 5 mg/ml----1件: 6 💬
2431Dacepton 5 mg/ml infuusioneste, liuos----1件: 6 💬
2432Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
2433Dacortín 2,5mg----1件: 222 💬
2434Dacortín 5mg----1件: 222 💬
2435Daily ingestion of Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 6 💬
2436Dalfampridine ER, 10 Mg Oral Tablet, Extended Release1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2437Dalfampridine-ER 10mg1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2438Dalfampridine-ER 5mg1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2439DAND (14-Deoxyandrographolide)----1件: 97 💬
2440Dapagliflozin 10 MG [Farxiga]1件: Dapagliflozin1件: Dapagliflozin 💬1件: SLC5A2 💬-2件: 86, 88 💬
2441Dapagliflozin 10mg Tab1件: Dapagliflozin1件: Dapagliflozin 💬1件: SLC5A2 💬-1件: 19 💬
2442Darifenacin (BAY79-4998)1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13 💬
2443Dark chocolate (85% cocoa)1件: Cocoa---1件: 6 💬
2444Dasatinib + Quercetin2件: Dasatinib,
Quercetin		2件: Dasatinib ,
Dasatinib 💬		8件: ABL1,
EPHA2,
FYN,
KIT,
LCK,
PDGFRB,
SRC,
YES1 💬		77件: Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 85 💬
2445DaTSCAN 74 MBq/ml solution for injection1件: Ioflupane I-123---1件: 6 💬
2446Davunetide (AL-108, NAP)1件: Davunetide1件: Davunetide 💬--3件: 5, 7, 127 💬
2447Dazucorilant 150 mg----1件: 2 💬
2448Dazucorilant 300 mg----1件: 2 💬
2449DB adalimumab 40 mg eow1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
2450DB adalimumab 40 mg ew1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
2451DCI 1020----1件: 299 💬
2452DCR-1171X----1件: 234 💬
2453DDAND (14-deoxy-11,12-didehydroandrographolide)----1件: 97 💬
2454Decadron Phosphate, Injectable1件: Phosphate ion---1件: 70 💬
2455DECORTIN (PREDNISONA) 5 MG COMPRIMIDOS1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
2456Decortin 20 mg----1件: 96 💬
2457Decortin 5 mg----1件: 96 💬
2458Decortin 5mg tablets----1件: 46 💬
2459Decortin H 1 mg----1件: 97 💬
2460Decortin H 10mg----1件: 97 💬
2461Decortin H 50 mg----1件: 97 💬
2462Decortin H 5mg----1件: 97 💬
2463Decrease Tocilizumab, Abatacept2件: Abatacept,
Tocilizumab		2件: Tocilizumab ,
Abatacept 💬		3件: CD80,
CD86,
IL6R 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
2464Defanyl 50 and 100 mg----1件: 46 💬
2465Deferiprone 600 mg delayed release tablet1件: Deferiprone1件: Deferiprone 💬--1件: 6 💬
2466Deferiprone 80 mg/mL oral solution1件: Deferiprone1件: Deferiprone 💬--1件: 120 💬
2467Deferiprone 80 mg/mL oral solution (Ferriprox)1件: Deferiprone1件: Deferiprone 💬--1件: 120 💬
2468Deferiprone oral solution1件: Deferiprone1件: Deferiprone 💬--1件: 120 💬
2469DEFEROXAMINE MESILATE1件: Deferoxamine1件: Deferoxamine 💬--1件: 286 💬
2470DEFLAN*10CPR 6MG----1件: 113 💬
2471Deflazacort 6 mg Tablets1件: Deflazacort1件: Deflazacort 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
2472Dehydrated Alcohol (Absolute Alcohol) BP for Injection1件: Ethanol1件: Ethanol 💬--1件: 279 💬
2473Dehydrated human amnion/chorion membrane----1件: 269 💬
2474Dehydroepiandrosterone 100 and 400 mg1件: Prasterone1件: Prasterone 💬3件: AR,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113 💬
2475Dekristol® 400-Tabletten----1件: 13 💬
2476Dekristol®-Tablette 1 (400 IE)----1件: 13 💬
2477Delayed and extended release mesalazine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
2478Delayed Release 6 mercaptopurine1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96 💬
2479Delayed Release 6MP or Calcitriol vs. Purinethol1件: Calcitriol1件: Calcitriol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
2480Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 8 💬
2481Deltacortene 10 cpr 25mg----1件: 97 💬
2482Deltacortene 20 cpr 5mg----1件: 97 💬
2483DELTACORTENE FORTE*10CPR 25MG----2件: 46, 97 💬
2484DELTACORTENE*10CPR 25MG----1件: 84 💬
2485DELTACORTENE*20CPR 5MG----3件: 49, 97, 113 💬
2486Demineralized Bone Matrix----1件: 70 💬
2487Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
2488Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
2489Denufosol Tetrasodium (INS37217) Inhalation Solution1件: Denufosol---1件: 299 💬
2490DEPAKINE CHRONO 500 mg----1件: 233 💬
2491DEPAKINE CHRONO® 500 mg----1件: 233 💬
2492Depletion of CD3/CD19 in an autologous stem cell transplant----2件: 49, 51 💬
2493Depo Medrol----1件: 46 💬
2494Depo-Medrol 40Mg/Ml Suspension for Injection----1件: 70 💬
2495Depo-Medrone----1件: 46 💬
2496Depot leuprolide acetate 3.75 mg2件: Acetate,
Leuprolide		---1件: 51 💬
2497Desloratadine given orally1件: Desloratadine1件: Desloratadine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
2498Desmopressin Oral Melt1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
2499Desmopressine nasal spray 10 mg/ml, flacon 60 doses1件: Desmopressin1件: Desmopressin 💬2件: AVPR2,
F8 💬		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 225 💬
2500Desmotabs® 0,2 mg Tabletten----1件: 6 💬
2501Desmotabs® 0,2mg Tabletten----1件: 6 💬
2502Determination of drug effects through amantadine cessation1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
2503Deutetrabenazine Oral Tablet [Austedo]1件: Deutetrabenazine1件: Deutetrabenazine 💬1件: SLC18A2 💬7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 8 💬
2504Dexamethasone (1 cycle)1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
2505Dexamethasone (50mg 1dd6, 3 consecutive days/month)1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 35 💬
2506Dexamethasone (or equivalent)1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 257 💬
2507Dexamethasone 0,1 mg Tablets1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
2508Dexamethasone 0,5mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
2509Dexamethasone 0.5mg Tablet1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
2510Dexamethasone 0.5mg/5ml solution1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
2511Dexamethasone 0.5mg/5ml solution in Mucolox™1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162 💬
2512Dexamethasone 1,5 mg Tablets1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
2513Dexamethasone 4 mg JENAPHARM1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
2514Dexamethasone given orally1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
2515Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 235 💬
2516Dexamethasone Oral, 10 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
2517Dexamethasone Oral, 20 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
2518Dexamethasone sodium phosphate (soluzione 25mg/ml)2件: Dexamethasone,
Phosphate ion		1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
2519Dexamethasone sodium phosphate 250 mg/ 10 ml2件: Dexamethasone,
Phosphate ion		1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
2520Dexamethasone sodium phosphate 250 mg/10 ml solution2件: Dexamethasone,
Phosphate ion		1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299 💬
2521DEXAMETHASONE SODIUM PHOSPHATE PH. EUR.2件: Dexamethasone,
Phosphate ion		1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
2522Dexamethasone, 40 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28 💬
2523Dexamethasone, procarbazine2件: Dexamethasone,
Procarbazine		2件: Dexamethasone ,
Procarbazine 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
2524Dexmedetomidine 11件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
2525Dexmedetomidine Hcl 100 Mcg/mL Inj1件: Dexmedetomidine1件: Dexmedetomidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
2526Dexpramipexole (dose 1)1件: Dexpramipexole1件: Dexpramipexole 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
2527Dexrazoxane (DRZ) plus Mitoxantrone (MX)2件: Dexrazoxane,
Mitoxantrone		2件: Dexrazoxane ,
Mitoxantrone 💬		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
2528DEXTRAN 1 FOR INJECTION1件: Dextran1件: Dextran 1 💬--1件: 97 💬
2529Dextran Sodium Sulfur Salt 5, Mw 5 kDa. a type of Low Molecular Weight Dextran Sulfate (LMW-DS)2件: Dextran,
Sulfate ion		1件: Dextran 1 💬--1件: 2 💬
2530Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
2531Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
2532Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg)2件: Dextromethorphan,
Quinidine		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 8 💬
2533Dextrose, 5% in Water2件: Dextrose, unspecified form,
Water		1件: Water 💬--1件: 65 💬
2534DI-17E6----1件: 51 💬
2535Diacerein 1% Ointment1件: Diacerein1件: Diacerein 💬--1件: 36 💬
2536Diagnosis of Fabry disease----1件: 19 💬
2537Diazepam, melatonin2件: Diazepam,
Melatonin		2件: Diazepam ,
Melatonin 💬		18件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
MTNR1A,
MTNR1B 💬		8件: Circadian entrainment, GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 46 💬
2538DIBASE*IM OS 2F 1ML 300000UI/M----1件: 46 💬
2539Diclofenac + Omeprazole2件: Diclofenac,
Omeprazole		2件: Omeprazole ,
Diclofenac 💬		4件: ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
2540Diclofenac 50 milligrams1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
2541Diet 1----1件: 96 💬
2542Diet B group----1件: 85 💬
2543Dietary supplement omega3 fatty acids aand vitamins----1件: 46 💬
2544Diethyl-[6-(4-hydroxycarbamoyl- phenyl carbamoyloxymethyl)-naphthalen-2-yl methyl]-ammonium chloride2件: Ammonium chloride,
Chloride ion		1件: Ammonium chloride 💬--1件: 107 💬
2545Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon2件: Ammonium chloride,
Chloride ion		1件: Ammonium chloride 💬--1件: 96 💬
2546Digoxin 0.25 mg1件: Digoxin1件: Digoxin 💬4件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4 💬		18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
2547Dihydroergotoxine Mesylate2件: Dihydroergotoxine,
Ergoloid mesylate		1件: Dihydroergotoxine 💬--1件: 6 💬
2548Dimebon + Dextromethorphan2件: Dextromethorphan,
Latrepirdine		2件: Dextromethorphan ,
Latrepirdine 💬		7件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2549Dimebon + Ketoconazole2件: Ketoconazole,
Latrepirdine		2件: Ketoconazole ,
Latrepirdine 💬		7件: ACHE,
CYP17A1,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		28件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Pathways of neurodegeneration - multiple diseases, Prion disease, Prolactin signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Steroid hormone biosynthesis, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2550Dimebon + Omeprazole2件: Latrepirdine,
Omeprazole		2件: Omeprazole ,
Latrepirdine 💬		8件: ACHE,
ATP4A,
ATP4B,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		26件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2551Dimebon MR11件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2552Dimebon MR21件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2553Dimebon MR31件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2554Dimebon MR41件: Latrepirdine1件: Latrepirdine 💬6件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
2555Dimethyl fumarate 240 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
2556Diosminex, 500 mg, tabletki powlekane----1件: 265 💬
2557Diovan 160 mg1件: Valsartan1件: Valsartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
2558Diovan 40 mg1件: Valsartan1件: Valsartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
2559Diovan 80 mg1件: Valsartan1件: Valsartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
2560Dipyridamole Tab 25 MG1件: Dipyridamole1件: Dipyridamole 💬2件: PDE4A,
PDE5A 💬		6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 224 💬
2561DISC-1459----1件: 254 💬
2562Discontinuation of disease modifying therapy----1件: 13 💬
2563Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics)1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 299 💬
2564Disease modified antirheumatic drugs or biological agents----1件: 46 💬
2565Disease Modifying therapy----1件: 13 💬
2566Disease modifying treatment (DMT)----1件: 13 💬
2567Disease modifying treatments----1件: 3 💬
2568Disease-modifying anti-rheumatic drugs----1件: 46 💬
2569Disease-modifying antirheumatic drug----1件: 46 💬
2570Disease-modifying antirheumatic drugs (DMARDs)----1件: 46 💬
2571Disodium Pamidronate 15mg (15mg strength)1件: Pamidronic acid1件: Pamidronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
2572Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias)1件: Amiodarone1件: Amiodarone 💬16件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
KCND3,
KCNJ11,
KCNJ12,
KCNJ3,
KCNJ5,
KCNJ8,
KCNQ1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		32件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 28 💬
2573Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus EGCG2件: Amiodarone,
Epigallocatechin gallate		1件: Amiodarone 💬16件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
KCND3,
KCNJ11,
KCNJ12,
KCNJ3,
KCNJ5,
KCNJ8,
KCNQ1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		32件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 28 💬
2574Dl-3-n-butylphthalide (NBP)1件: Butylphthalide---1件: 22 💬
2575DM-1992----1件: 6 💬
2576DMARD maintenance----1件: 46 💬
2577DMARDs (disease-modifying antirheumatic drugs)----1件: 46 💬
2578DMARDs (methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
2579DMARDs or Biologics----1件: 46 💬
2580DNL151, DN0001575, DN1575----1件: 6 💬
2581DNS-7801 (high dose)----1件: 6 💬
2582DNS-7801 (low-dose)----1件: 6 💬
2583Docosahexaenoic Acid (DHA) Dietary Supplement1件: Doconexent---1件: 301 💬
2584Docosahexaenoic acid administration: 50 mg/kg/day during 12 months1件: Doconexent---1件: 299 💬
2585Dolutegravir / Lamivudine Oral Tablet2件: Dolutegravir,
Lamivudine		2件: Lamivudine ,
Dolutegravir 💬		--1件: 265 💬
2586Dolutegravir 50 MG1件: Dolutegravir1件: Dolutegravir 💬--1件: 265 💬
2587Dolutegravir, Abacavir and Lamivudine3件: Abacavir,
Dolutegravir,
Lamivudine		3件: Lamivudine ,
Abacavir ,
Dolutegravir 💬		--1件: 2 💬
2588Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]2件: Dolutegravir,
Lamivudine		2件: Lamivudine ,
Dolutegravir 💬		--1件: 265 💬
2589Donor mesenchymal stem cell infusions----1件: 36 💬
2590Donor peripheral blood stem cells.----1件: 65 💬
2591Dopamine Agonists (pramipexole, ropirinole)2件: Dopamine,
Pramipexole		2件: Pramipexole ,
Dopamine 💬		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2592Dopaminergic Agonist + Apomorphine1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
2593Doptelet 20 mg film-coated tablets1件: Avatrombopag1件: Avatrombopag 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
2594Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]4件: Doravirine,
Lamivudine,
Tenofovir,
Tenofovir disoproxil		3件: Lamivudine ,
Tenofovir ,
Doravirine 💬		--1件: 265 💬
2595Dosage of cytokines----1件: 50 💬
2596Dose level 1----1件: 46 💬
2597Dose of 60 mg/kg alpha1-proteinase inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231 💬
2598Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---1件: 231 💬
2599Dose-Establishing Study 1 Niacin 250mg1件: Niacin1件: Niacin 💬--1件: 78 💬
2600Dose-Establishing Study 1 Niacin 500mg1件: Niacin1件: Niacin 💬--1件: 78 💬
2601Dose-Establishing Study 2 Niacin 500mg1件: Niacin1件: Niacin 💬--1件: 78 💬
2602Dosing Interruption of Natalizumab1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
2603Dotarem 0,5mmol/ml,1件: Gadoteric acid1件: Gadoteric acid 💬--1件: 13 💬
2604Double-blind Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
2605Double-blind adalimumab1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 107 💬
2606Double-Blind Rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 51 💬
2607Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase4件: Asparaginase Escherichia coli,
Cyclophosphamide,
Doxorubicin,
Methotrexate		4件: Methotrexate ,
Cyclophosphamide ,
Doxorubicin ,
Cyclophosphamide 💬		4件: DHFR,
DHFR2,
TOP2A,
TOP2B 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬1件: 65 💬
2608Doxycycline 100 mg Capsules1件: Doxycycline2件: Doxycycline ,
Doxycycline 💬		--1件: 89 💬
2609Doxycycline 100-200mg capsules daily for 6 months1件: Doxycycline2件: Doxycycline ,
Doxycycline 💬		--1件: 167 💬
2610DoxyHEXAL® tabs 100 mg Tabletten----1件: 28 💬
2611DP Mannitol1件: Mannitol1件: Mannitol 💬--1件: 299 💬
2612DPA-714 PET/MRI----1件: 13 💬
2613DPA-714-PET/MRI----1件: 6 💬
2614Dr. Reddy’s Rituximab (DRL_RI) 100mg1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
2615Dr. Reddy’s Rituximab (DRL_RI) 500mg1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
2616Dried blood spot (DBS) sampling----1件: 19 💬
2617Dronabinol 25 mg/ml, oral drops1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
2618Dronabinol capsule 2,5 mg1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
2619Dronabinol capsule 2.5. mg1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬2件: 46, 271 💬
2620Droxidopa 100 MG [Northera]1件: Droxidopa1件: Droxidopa 💬9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
2621Drug - SHR1459----1件: 13 💬
2622Drug free, IS monotherapy and GC combined with IS----1件: 300 💬
2623Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom----2件: 46, 49 💬
2624DS-1211b----1件: 166 💬
2625DS-5141b----1件: 113 💬
2626DS-7011a----1件: 49 💬
2627DTR Melatonin (NIH CC PDS)1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬
2628Dulaglutide 0.75Mg/0.5Ml Inj Pen1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 299 💬
2629Duo-Therapy with Sildenafil + Bosentan2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
2630Duodopa LD/CD 20/5 mg/mL2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2631Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2632Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
2633Dupilumab (blinded)1件: Dupilumab1件: Dupilumab 💬1件: IL4R 💬8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 98 💬
2634Dupilumab (open-label)1件: Dupilumab1件: Dupilumab 💬1件: IL4R 💬8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 98 💬
2635Duramycin, 2622U901件: Lancovutide---1件: 299 💬
2636DW1809-1----1件: 46 💬
2637DYNE-101----1件: 113 💬
2638DYSPORT*SC IM 2FL 500U1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
2639Dysport® (Botulinumtoxin A (Btx A))1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 36 💬
2640E (migalastat)1件: Migalastat1件: Migalastat 💬--1件: 19 💬
2641E. coli Nissle----1件: 97 💬
2642E. coli Nissle 1917 (Mutaflor®)----1件: 97 💬
2643E0302 (mecobalamin)1件: Mecobalamin1件: Mecobalamin 💬--1件: 2 💬
2644E5501 40 mg 2 x 20-mg tablets, orally, fasted----1件: 63 💬
2645E5501 40 mg 2 x 20-mg tablets, orally, with food----1件: 63 💬
2646E5501 40mg 2 x 20-mg tablets, orally, fasted----1件: 63 💬
2647E6011 10 mg/kg----1件: 96 💬
2648E6011 15 mg/kg----1件: 96 💬
2649E6011 2 mg/kg----1件: 96 💬
2650E6011 5 mg/kg----1件: 96 💬
2651Early Harvest Extra Virgin Olive Oil2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬--1件: 13 💬
2652Early immunosuppressants (azathioprine, methotrexate)2件: Azathioprine,
Methotrexate		2件: Methotrexate ,
Azathioprine 💬		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 96 💬
2653EB-101----1件: 36 💬
2654EB-101 Surgical application of RDEB wounds----1件: 36 💬
2655EB8018 (First-in-class FimH blocker)----1件: 96 💬
2656Ebetrex 15 mg = 0,75 ml, oplossing voor injectie in voorgevulde injectiespuit 20 mg/ml----1件: 96 💬
2657EC 3.1.3.1----1件: 46 💬
2658Echo and myocardial contrast echocardiography perfusion imaging----1件: 58 💬
2659Edaravone (Radicava®/Radicava ORS®)1件: Edaravone1件: Edaravone 💬--1件: 2 💬
2660EDG-5506----1件: 113 💬
2661EDG-5506 Dose 1----1件: 113 💬
2662EDG-5506 Dose 2----1件: 113 💬
2663EDG-5506 Dose 3----1件: 113 💬
2664EDG-5506 Dose 4----1件: 113 💬
2665EDG-5506 Dose 5----1件: 113 💬
2666EDP-305 Dose 1----1件: 93 💬
2667EDS-EP dose range of ~14-22 mg DSP/infusion----1件: 65 💬
2668EDS-EP dose range of ~5-10 mg DSP/infusion----1件: 65 💬
2669EEN (Nestle Modulen®)----1件: 96 💬
2670EF1aS-ADA lentiviral vector gene modified autologous CD34+ cells----1件: 65 💬
2671EF1aS-ADA lentiviral vector transduced patient CD34+ cells----1件: 65 💬
2672Efexor XL 75 mg----1件: 46 💬
2673Efexor XL 75 mg (venlafaxine)1件: Venlafaxine1件: Venlafaxine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
2674Efficacy of Gammagard subcutaneously at Week 12----1件: 65 💬
2675Efficacy of Gammagard subcutaneously at Week 24----1件: 65 💬
2676Efficacy of Gammagard subcutaneously at Week 36----1件: 65 💬
2677Efficacy of Gammagard subdermally at Week 12----1件: 65 💬
2678Efficacy of Gammagard subdermally at Week 24----1件: 65 💬
2679Efficacy of Gammagard subdermally at Week 36----1件: 65 💬
2680Efgartigimod concentrate for solution for infusion 20 mg/mL----1件: 11 💬
2681Efgartigimod PH20 SC in stage B----1件: 14 💬
2682Efmody 10 mg modified release hard capsules2件: Hydrocortisone,
Manganese citrate		1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
2683Efmody 5 mg modified release hard capsules2件: Hydrocortisone,
Manganese citrate		1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
2684Efzofitimod 3 mg/kg----1件: 84 💬
2685Efzofitimod 5 mg/kg----1件: 84 💬
2686EGB 761 (r) 120 mg----1件: 18 💬
2687EGb 761 120 mg----1件: 18 💬
2688EGb 761® (Tanakan®)1件: Ginkgo biloba---1件: 13 💬
2689EGCG + Tocotrienol2件: Epigallocatechin gallate,
Tocotrienol		---1件: 299 💬
2690Egg substitute, without cholesterol2件: Cholesterol,
Egg		1件: Cholesterol 💬--1件: 310 💬
2691EHP-101 25 mg BID----1件: 13 💬
2692EHP-101 25 mg OD----1件: 13 💬
2693EHP-101 50 mg BID----1件: 13 💬
2694EHP-101 50 mg OD----1件: 13 💬
2695EK-12----1件: 13 💬
2696Elafibranor 120 mg1件: Elafibranor1件: Elafibranor 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
2697Elafibranor 80 mg1件: Elafibranor1件: Elafibranor 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
2698Elaprase 2mg/ml1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2699Elaprase for intravenous (IV) infusion1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2700Elaprase_0.5mg/kg----1件: 19 💬
2701Elexacaftor / Ivacaftor / Tezacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: Ivacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
2702Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: Ivacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
2703Eliglustat Tartrate – Powder for Oral Suspension1件: Eliglustat1件: Eliglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2704Elosulfase Alfa 1 MG/ML Intravenous Solution [VIMIZIM]1件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2705Eltrombopag 12.5 mg1件: Eltrombopag---1件: 60 💬
2706Eltrombopag 25 mg1件: Eltrombopag---1件: 60 💬
2707ELTROMBOPAG OLAMINE1件: Eltrombopag---2件: 60, 63 💬
2708Eltrombopag olamine (SB-497115-GR)1件: Eltrombopag---1件: 63 💬
2709Eltrombopag olamine, Revolade, Promacta1件: Eltrombopag---1件: 63 💬
2710Eltrombopag oral tablets1件: Eltrombopag---1件: 63 💬
2711ELX (VX-445)/TEZ (VX-661)/IVA (VX-770)----1件: 299 💬
2712EMD 128130----2件: 6, 156 💬
2713EMD 525797----1件: 51 💬
2714EMFLAZA® (DEFLAZACORT)1件: Deflazacort1件: Deflazacort 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
2715Emicizumab (ACE910, RO5534262)1件: Emicizumab1件: Emicizumab 💬2件: F10,
F9 💬		1件: Complement and coagulation cascades 💬1件: 288 💬
2716Empagliflozin 10 MG1件: Empagliflozin1件: Empagliflozin 💬1件: SLC5A2 💬-2件: 58, 97 💬
2717Empagliflozin 25 MG1件: Empagliflozin1件: Empagliflozin 💬1件: SLC5A2 💬-1件: 72 💬
2718EMSELEX 15 mg Retardtabletten1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13 💬
2719EMSELEX 7,5 mg Retardtabletten1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13 💬
2720EnaHexal®, 10mg----1件: 113 💬
2721Enalapril and other angiotensin converting enzyme inhibitors2件: Angiotensin II,
Enalapril		3件: Angiotensin II ,
Angiotensin II ,
Enalapril 💬		3件: ACE,
AGTR1,
AGTR2 💬		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 19 💬
2722Enalapril Maleate1件: Enalapril1件: Enalapril 💬1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 46 💬
2723ENALAPRIL VALSARTAN METHYLPREDNISONE3件: Enalapril,
Methylprednisone,
Valsartan		2件: Valsartan ,
Enalapril 💬		2件: ACE,
AGTR1 💬		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
2724EnalHexal®, 5 mg----1件: 113 💬
2725ENBREL - 50 MG POLV SOLUZ INIET SOTTOC. POLV. FLAC VETRO SOLV. SIRI. VET. SOLV 1 ML (50 MG/ML) 12 FLAC+12 SIRI. PRE+12 AGHI+12 ADAT PER FLAC+24 TAMP. PRE INIEZ1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2726ENBREL - 50 MG SOLUZIONE INIETTABILE IN SIRINGA (VETRO DA 1 ML) PRERIEMPITA - USO SOTTOCUTANEO 12 SIRINGHE PRERIEMPITE + 24 TAMPONI IMBEVUTI DI ALCOL1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2727Enbrel 25 mg1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2728ENBREL 25 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte.1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2729Enbrel 25 mg powder and solvent for solution for injection1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2730ENBREL 25 mg/ml polvo y disolvente para solución inyectable para uso pediátrico1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
2731Enbrel 50 mg1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2732Enbrel 50 mg powder and solvent for solution for injection1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2733ENBREL 50 mg solución inyectable en jeringas precargadas1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
2734Enbrel 50 mg solution for injection in pre-filled syringe1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2735Enbrel 50mg PFS1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2736Enbrel 50mg pre-filled pen1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2737Enbrel 50mg pre-filled syringe1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2738ENBREL*BB SC 4FL 25MG 1ML+4SIR1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
2739ENBREL*SC 4FL 25MG+4SIR 1ML1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 60, 285 💬
2740ENBREL*SC 4FL 50MG+4SIR+4AGHI+1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2741ENBREL*SC 4SIR 25MG 0,5ML+8TAM1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2742ENBREL*SC 4SIR 50MG 1ML+8TAMP1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2743Enbrel, Benepali, Erelzi1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2744Enbrel® 50 mg Solution for Injection in Pre-filled Syringe1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2745Encapsulated Baclofen 20 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
2746Encapsulated faecal microbiota----1件: 97 💬
2747Encapsulated faecal microbiota filtrate----1件: 97 💬
2748Encapsulated Mesalamine Granules (eMG)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
2749Encorton, 5 mg, tablets----1件: 46 💬
2750End-of-life nursing education consortium-pediatric palliative care as web based-training plus usual care----2件: 113, 299 💬
2751Endobronchial infusion of adult mesenchymal stem cells----1件: 85 💬
2752ENDOPROST - 0.05 MG/0.5 ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FIALA----1件: 51 💬
2753ENDOPROST 0,05MG/0,5ML 1F----1件: 51 💬
2754ENDOPROST 50*INFUS 1F 0,050MG/----1件: 51 💬
2755Endothelin receptor blocker----1件: 51 💬
2756Endoxan - ciclofosfamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
2757ENDOXAN BAXTER----3件: 13, 43, 96 💬
2758ENDOXAN BAXTER*50CPR RIV 50MG----1件: 222 💬
2759Endoxan® 500 mg----1件: 44 💬
2760Engineerd Protein Inhibitor of human Neutrophil Elastase----1件: 299 💬
2761Engineered humanized monoclonal anti-human CD19 antibody.----1件: 46 💬
2762Engineered humanized monoclonal anti-human CD19 antibody. Lot Numbers: 1-FIN-1588 (9.6mg/ml)----1件: 46 💬
2763Engineered Protein Inhibitor of human Neutrophil Elastase----1件: 299 💬
2764ENOS transfected EPCs will be delivered via a PA line----1件: 86 💬
2765Enpatoran medium dose----1件: 49 💬
2766Entacapone 400mg oral dose1件: Entacapone1件: Entacapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬2件: 6, 17 💬
2767EnteraBio's Oral Parathyroid Hormone (1-34)1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
2768Enteric coated mycophenolate sodium1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 228 💬
2769Enteric-Coated Mycophenolate Sodium1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49 💬
2770Entocort EC® 3 mg1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
2771Entocort® CR1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
2772Entocort® Kapseln1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
2773ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFU1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
2774ENTYVIO - 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
2775ENTYVIO - 300 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) (20ML) - 1 FLACONCINO1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
2776Entyvio 300 mg1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
2777Eosinophilic Esophagitis (E0E) food introduction-2nd----1件: 98 💬
2778Eosinophilic Esophagitis (EoE) food introduction-1st----1件: 98 💬
2779Eosinophilic Esophagitis (EoE) Food introduction-3rd dose----1件: 98 💬
2780EP-104IAR----1件: 98 💬
2781Epanova™ (Omega-3 Free Fatty Acids)1件: Omega-3 fatty acids---1件: 96 💬
2782EPARMEFOLIN 30 CPR 0,1/0,5MG----1件: 13 💬
2783EPAX 6000 EE 1000mg (0.6 gr DHA+EPA)----1件: 46 💬
2784Epaxal Berna (virosomal hepatitis A vaccine)1件: Hepatitis A Vaccine---2件: 96, 97 💬
2785EPI-5891件: EPI-589---2件: 2, 6 💬
2786EPI-743----3件: 21, 156, 337 💬
2787EPI-743 200mg----1件: 6 💬
2788EPI-743 400mg----1件: 6 💬
2789Epidiolex 100 mg/mL Oral Solution1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬2件: 140, 144 💬
2790Epilim Chrono 500 Controlled Released tablets----1件: 256 💬
2791Epoeitin beta----1件: 18 💬
2792Epoetin beta1件: Erythropoietin---1件: 13 💬
2793Epratuzumab 100 mg1件: Epratuzumab1件: Epratuzumab 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
2794Epratuzumab 1200 mg1件: Epratuzumab1件: Epratuzumab 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
2795Epratuzumab 400 mg1件: Epratuzumab1件: Epratuzumab 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
2796Epratuzumab 600 mg1件: Epratuzumab1件: Epratuzumab 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
2797EPREX IV SC 1FL 1ML 40000 UI----1件: 2 💬
2798EPREX*1FL 40000UI/ML 1ML----1件: 18 💬
2799EPREX*1SIR 10000UI 1ML----1件: 18 💬
2800EPREX*1SIR 40000UI/ML 1ML----2件: 2, 18 💬
2801EPX-100----1件: 140 💬
2802EPX-100 (Clemizole HCl)1件: Clemizole---1件: 140 💬
2803EPX-100 (Clemizole Hydrochloride)1件: Clemizole---1件: 140 💬
2804Equfina 50 mg----1件: 6 💬
2805ER tablet 100 mg AZD3241----1件: 6 💬
2806ER tablet 25 mg AZD3241----1件: 6 💬
2807ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)4件: Bosentan,
Macitentan,
Sildenafil,
Tadalafil		5件: Bosentan ,
Tadalafil ,
Bosentan ,
Sildenafil ,
Macitentan 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
2808Eradication of Helcobacter Pylori----1件: 6 💬
2809ERCP with Bupivacaine infusion1件: Bupivacaine1件: Bupivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 298 💬
2810Erector spinae plane block (Group E)----1件: 70 💬
2811Ergocalciferol 1.25 mg tablet1件: Ergocalciferol1件: Ergocalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 46 💬
2812Ergoloid Mesylate1件: Ergoloid mesylate---1件: 206 💬
2813ERMM-1----1件: 46 💬
2814Erythrocine oral----1件: 36 💬
2815ESBRIET - 267 MG - CAPSULA RIGIDA - USO ORALE - FLACONE (HDPE) 270 CAPSULE1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
2816Esbriet 267 MG Oral Capsule1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
2817Esbriet® (Pirfenidon)1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
2818Escitalopram 10mg1件: Escitalopram1件: Escitalopram 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
2819Escitalopram oxalate1件: Escitalopram1件: Escitalopram 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
2820Escitalopram oxalate antidepressant1件: Escitalopram1件: Escitalopram 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
2821ESIDREX-R 25 mg----1件: 235 💬
2822ESO-101----1件: 98 💬
2823Esomeprazole 20 mg1件: Esomeprazole1件: Esomeprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 46 💬
2824Essential amino acid intake + Leucine vs total AA supplement1件: Leucine1件: Leucine 💬--1件: 299 💬
2825Estimation of P.Gingivalis levels----1件: 46 💬
2826Estradiol 2 mg1件: Estradiol1件: Estradiol 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299 💬
2827Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab4件: Abatacept,
Rituximab,
Sarilumab,
Tocilizumab		4件: Tocilizumab ,
Rituximab ,
Abatacept ,
Sarilumab 💬		4件: CD80,
CD86,
IL6R,
MS4A1 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
2828Etanercept (50mg per week)1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2829Etanercept (50mg per week, for 2 weeks)1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2830Etanercept (50mg per week, for 4 weeks)1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2831Etanercept + Methotrexate2件: Etanercept,
Methotrexate		2件: Methotrexate ,
Etanercept 💬		4件: DHFR,
DHFR2,
LTA,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2832Etanercept , Methotrexate2件: Etanercept,
Methotrexate		2件: Methotrexate ,
Etanercept 💬		4件: DHFR,
DHFR2,
LTA,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2833Etanercept / Autoinjector A1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2834Etanercept 50 mg sc day 0 and day 31件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 38, 39 💬
2835Etanercept 50mg1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2836Etanercept and its biosimilars1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
2837Etanercept biosimilar1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2838Etanercept biosimilare1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
2839Etanercept Optimal dosing1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 107 💬
2840Etanercept or adalimumab2件: Adalimumab,
Etanercept		2件: Etanercept ,
Adalimumab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2841Etanercept via Autoinjector B1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2842Etanercept, methotrexate and depomedrone2件: Etanercept,
Methotrexate		2件: Methotrexate ,
Etanercept 💬		4件: DHFR,
DHFR2,
LTA,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2843Etanercept, Methotrexate, Prednisolone3件: Etanercept,
Methotrexate,
Prednisolone		3件: Methotrexate ,
Prednisolone ,
Etanercept 💬		5件: DHFR,
DHFR2,
LTA,
NR3C1,
TNF 💬		72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 56 💬
2844Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
2845ETD001 multiple once daily doses----1件: 299 💬
2846ETD001 multiple twice daily doses----1件: 299 💬
2847Ethanol 96% Gel1件: Ethanol1件: Ethanol 💬--1件: 279 💬
2848Ethanol 98% Solution1件: Ethanol1件: Ethanol 💬--1件: 279 💬
2849ETHANOL BP1件: Ethanol1件: Ethanol 💬--1件: 279 💬
2850Ethanol-amine Oleate Sclerotherapy Injection1件: Ethanol1件: Ethanol 💬--1件: 279 💬
2851Ethanolamine oleate2件: Ethanolamine,
Ethanolamine oleate		1件: Ethanolamine oleate 💬--1件: 279 💬
2852Ethyl-EPA (Miraxion™)1件: Icosapent ethyl1件: Icosapent ethyl 💬--1件: 8 💬
2853Ethylhydrogenfumarat, Calciumsalz----1件: 49 💬
2854Ethylhydrogenfumarat, Magnesiumsalz----1件: 49 💬
2855Ethylhydrogenfumarat, Zinksalz----1件: 49 💬
2856Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester (**See other 2 names below)----1件: 6 💬
2857ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients)1件: Myelin basic protein---1件: 13 💬
2858ETN+MTX----1件: 46 💬
2859Etoposide, cytarabine, mercaptopurine3件: Cytarabine,
Etoposide,
Mercaptopurine		4件: Etoposide ,
Mercaptopurine ,
Cytarabine ,
Mercaptopurine 💬		3件: HPRT1,
TOP2A,
TOP2B 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Platinum drug resistance, Purine metabolism 💬1件: 65 💬
2860Etoricoxib 60 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
2861Etoricoxib 90 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
2862EU Orphan Designation Number EU/3/02/120----1件: 299 💬
2863EU/1/03/256/001----1件: 107 💬
2864EU/1/03/268/002----1件: 96 💬
2865EU/1/06/362/003: 5µg (1 pen)----1件: 193 💬
2866EU/1/07/389/001----1件: 107 💬
2867EU/1/08/454/001-002, EU/1/08/454/005-007----1件: 13 💬
2868EU/1/14/980/002----1件: 269 💬
2869EU/1/14/980/003----1件: 269 💬
2870EU/1/95/003/005-010----1件: 13 💬
2871EU/1/97/033/002----1件: 13 💬
2872EU/1/98/063/001-003----1件: 13 💬
2873EU/1/98/063/004-006----1件: 13 💬
2874EU/1/99/116/003----1件: 96 💬
2875EU/1/99/126/001----1件: 107 💬
2876EU/1/99/126/017----1件: 46 💬
2877EU/1/99/126/020----1件: 46 💬
2878EU/3/13/1208 orphan----1件: 301 💬
2879EUR-1008----1件: 299 💬
2880EUR-1008 (APT-1008)----1件: 299 💬
2881EUR-1008 (APT-1008) High Dose----1件: 298 💬
2882EUR-1008 (APT-1008) Low Dose----1件: 298 💬
2883EUR-1008 25,000 Units----1件: 299 💬
2884EUR-1066-A----1件: 298 💬
2885EUR-1066-B----1件: 298 💬
2886EUR-1100----1件: 98 💬
2887EV substance code: SUB188638----1件: 113 💬
2888Evenity 105mg1件: Romosozumab1件: Romosozumab 💬1件: SOST 💬2件: Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬1件: 274 💬
2889Everolimus (RAD001) , Afinitor®1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 34 💬
2890Everolimus Oral Product1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 89, 158 💬
2891Evobrutinib 10mg1件: Evobrutinib1件: Evobrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
2892Evolocumab (AMG 145)1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
2893Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4i-EF1alpha-hgammac-OPT vector----1件: 65 💬
2894EX VIVO CULTURED HUMAN MESENCHYMAL STEM CELLS----2件: 51, 107 💬
2895Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length LAMB3 cDNA.----1件: 36 💬
2896EXCL-100, 600 MG Oral Tablet----1件: 85 💬
2897Exelon 1,5 mg Hartkapseln1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 5 💬
2898Exelon 3,0 mg Hartkapseln1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 5 💬
2899Exelon 4.6 mg/24 h transdermal patch1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
2900Exelon 6,0 mg Hartkapseln1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 5 💬
2901Exelon 9.5 mg/24 h transdermal patch1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
2902Exenatide 10 micrograms1件: Exenatide1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
2903Exenatide 5 micrograms1件: Exenatide1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
2904Exenatide extended release 2mg (Bydureon)1件: Exenatide1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
2905Exenatide Pen Injector [Bydureon]1件: Exenatide1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 17 💬
2906Exondys 511件: Eteplirsen1件: Eteplirsen 💬1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
2907EXONDYS 51™1件: Eteplirsen1件: Eteplirsen 💬1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
2908Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eASCs)----1件: 96 💬
2909Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eASCs)----1件: 96 💬
2910Expanded human allogenic mesenchymal adult stem cells extracted from adipose----1件: 96 💬
2911Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue----1件: 96 💬
2912Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs----1件: 96 💬
2913Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs)----1件: 96 💬
2914Expanded human first trimester fetal liver-derived mesenchymal stem cells----1件: 274 💬
2915Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
2916Experimental: Arm A: DRL_RI----1件: 46 💬
2917Experimental: CRH administration----2件: 72, 78 💬
2918Experimental: GLP1-RA (exenatide) administration1件: Exenatide1件: Exenatide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 72, 78 💬
2919Experimental: Seladelpar / MBX-8025 200 mg1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
2920Experimental: Seladelpar / MBX-8025 50 mg1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
2921Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS----1件: 13 💬
2922Extavia (interferon beta-1b), Novartis Pharma AG2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2923Extavia 250 microgram/ml1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2924Extavia 250 micrograms/ml1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2925EXTAVIA*SC 15FL 250MCG/ML+15SI1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
2926Extended Release Melatonin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
2927Extended-release oxycodone1件: Oxycodone1件: Oxycodone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
2928Extra blood draw samples----1件: 300 💬
2929Extra Virgin Olive Oil (EVOO)2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬--1件: 49 💬
2930EZ-2053 5mg/kg----2件: 85, 299 💬
2931Ezetimibe + other lipid-lowering medication(s)1件: Ezetimibe1件: Ezetimibe 💬1件: NPC1L1 💬1件: Fat digestion and absorption 💬1件: 260 💬
2932EZOGABINE (US ONLY)1件: Ezogabine1件: Ezogabine 💬5件: KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬		6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬1件: 144 💬
2933F 18 T807----2件: 2, 127 💬
2934F-18----2件: 5, 127 💬
2935F-18 3F4AP----1件: 13 💬
2936F-18 AV 1451----2件: 5, 127 💬
2937F-18 FDG----1件: 127 💬
2938F-18 FEDAA1106 (BAY85-8101)----1件: 13 💬
2939F-18 FPCIT----1件: 6 💬
2940Fabrazyme (agalsidase beta)1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2941Fabrazyme (agalsidase beta) 1 mg/kg1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2942FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2943Fabrazyme 35 mg1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2944Fabrazyme 5 mg1件: Agalsidase beta1件: Agalsidase beta 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2945FACTANE 200 IU/ml----1件: 288 💬
2946Factor XIIa antagonist monoclonal antibody----1件: 85 💬
2947Factor XIII Concentrate (Human), Pasteurized1件: Factor XIII (human)---1件: 288 💬
2948Faecal matter----1件: 97 💬
2949Faecal Microbiota Transplant----1件: 97 💬
2950Faecal microbiota transplantation----5件: 46, 84, 96, 97, 271 💬
2951FamC-1----1件: 2 💬
2952Famotidine 20 MG1件: Famotidine1件: Famotidine 💬1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬1件: 86 💬
2953Fampridine-SR b.i.d. (Twice Daily)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2954FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2955Fampyra 10 mg prolonged-release tablets2件: Dalfampridine,
Manganese citrate		1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2956Fampyra 10mg prolonged release tablets2件: Dalfampridine,
Manganese citrate		1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
2957FANHDI 100 UI----1件: 288 💬
2958Fanhdi 100 UI FVIII-120 UI FVW----1件: 288 💬
2959FANHDI 250UI*1F 250UI+F 10ML----1件: 288 💬
2960FANHDI 50 UI----1件: 288 💬
2961Fanhdi 50 UI FVIII-60 UI FVW----1件: 288 💬
2962FANHDI*INF FL 500UI+SIR SOLV+S----1件: 288 💬
2963FB-101----1件: 6 💬
2964FBL-MTX----1件: 46 💬
2965FBX-101----1件: 19 💬
2966Fc- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109 💬
2967FDC macitentan/tadalafil2件: Macitentan,
Tadalafil		2件: Tadalafil ,
Macitentan 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
2968FDL176 & FDL169 coadministration1件: FDL169---1件: 299 💬
2969Fecal Microbial transplant----2件: 96, 97 💬
2970Fecal microbial transplant (FMT)----1件: 13 💬
2971Fecal Microbial Transplantation----2件: 96, 97 💬
2972Fecal Microbial Transplants----1件: 13 💬
2973Fecal microbiota----3件: 13, 96, 97 💬
2974Fecal microbiota capsule----1件: 97 💬
2975Fecal Microbiota Enema----1件: 97 💬
2976Fecal Microbiota Transplant----2件: 96, 97 💬
2977Fecal Microbiota Transplant (FMT)----2件: 96, 97 💬
2978Fecal microbiota transplantation----5件: 2, 66, 94, 96, 97 💬
2979Fecal Microbiota Transplantation (FMT)----2件: 96, 97 💬
2980Fecal Microbiota Transplantation (FMT), OpenBiome----1件: 97 💬
2981Fecal Microbiota Transplantation by Intra-rectal enemas----1件: 97 💬
2982Fecal Microbiota Transplantation by Stool capsules----1件: 97 💬
2983Femoston 1/10----1件: 13 💬
2984Femoston 2/10----1件: 13 💬
2985Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed).1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
2986Fenfluramine HCl, DL-Fenfluramine, (±)-Fenfluramine1件: Fenfluramine1件: Fenfluramine 💬5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬1件: 144 💬
2987Fenofibrate 160mg1件: Fenofibrate1件: Fenofibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 97 💬
2988Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)1件: Fenofibrate1件: Fenofibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
2989Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		2件: Fentanyl ,
Dexmedetomidine 💬		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
2990Ferinject or CosmoFer----1件: 86 💬
2991Fermented oyster extract1件: Oyster---1件: 84 💬
2992Ferric Carboxy Maltose1件: Maltose1件: Maltose 💬--1件: 96 💬
2993Ferric Maltol1件: Ferric maltol1件: Ferric maltol 💬--1件: 96 💬
2994Ferriprox 500 mg1件: Deferiprone1件: Deferiprone 💬--1件: 6 💬
2995FERRIPROX*100CPR RIV 500MG1件: Deferiprone1件: Deferiprone 💬--1件: 120 💬
2996Ferrous sulphate 200mg oral tablet----1件: 227 💬
2997Fetal porcine cells, Neurocell-PD----1件: 6 💬
2998FG-3019 10mg/mL in 10 mL vials----1件: 85 💬
2999Fibrogammin® 1250----1件: 51 💬
3000Fibrogammin® P----1件: 288 💬
3001Fibrogammin®P, coagulation factor XIII concentrate (Human)1件: Factor XIII (human)---1件: 51 💬
3002Filgrastim, Alemtuzumab2件: Alemtuzumab,
Filgrastim		2件: Alemtuzumab ,
Filgrastim 💬		2件: CD52,
CSF3R 💬		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
3003Fingolimod 0.5 mg1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3004Fingolimod 0.5mg1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3005Fingolimod 1.25 mg1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3006Fipamezole hydrochloride 30 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
3007Fipamezole hydrochloride 60 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
3008Fipamezole hydrochloride 90 mg oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
3009Fipamezole ODT1件: Fipamezole---1件: 6 💬
3010Fipamezole ODT Cohort 21件: Fipamezole---1件: 6 💬
3011Firategrast 150 mg1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
3012Firategrast 300 mg1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
3013Firategrast modified release tablet1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
3014FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE1件: Amifampridine1件: Amifampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 11 💬
3015Fish Oil1件: Fish oil---8件: 13, 46, 49, 66, 96, 260, 294, 299 💬
3016Fish oil concentrate1件: Fish oil---1件: 13 💬
3017Fish oil supplement1件: Fish oil---1件: 46 💬
3018Fish oil, gamma-linolenic acid3件: Fish oil,
Gamolenic acid,
alpha-Linolenic acid		1件: Gamolenic acid 💬--1件: 46 💬
3019FISH OIL, RICH IN OMEGA-3-ACIDS2件: Fish oil,
Omega-3 fatty acids		---1件: 13 💬
3020FISH OIL,RICH IN OMEGA 3 ACIDS1件: Fish oil---1件: 13 💬
3021FK-506----1件: 60 💬
3022FK506 level 2-3 ng/ml----1件: 86 💬
3023FK506 level 3-5 ng/ml----1件: 86 💬
3024FK506 level < 2 ng/ml----1件: 86 💬
3025FLEBOGAMMA 5%----1件: 15 💬
3026Flebogamma 5% DIF----1件: 65 💬
3027FLOLAN injection with currently marketed diluent1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3028FLOLAN™ and Glycine Diluent2件: Epoprostenol,
Glycine		2件: Glycine ,
Epoprostenol 💬		1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3029FLORBETABEN (18F)----1件: 6 💬
3030Florbetapir (18F)----1件: 127 💬
3031Florbetapir 18F----1件: 127 💬
3032Florbetapir 18F Injection----1件: 127 💬
3033Florbetapir F 18----1件: 6 💬
3034Florence 30 µg/mL----1件: 98 💬
3035Florence 60 µg/mL----1件: 98 💬
3036Florence 90 µg/mL----1件: 98 💬
3037Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution1件: Flucloxacillin1件: Floxacillin 💬--1件: 299 💬
3038FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19 💬
3039FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
3040Fludarabine monophosphate1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 65, 284, 326 💬
3041Fludarabine phosphate 30 mg2件: Fludarabine,
Phosphate ion		1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
3042Fludarabine phosphate 40 mg2件: Fludarabine,
Phosphate ion		1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
3043Fludarabine, Busulfan, Thymoglobulin3件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Fludarabine		2件: Busulfan ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
3044Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
3045Fludarabine, Melphalan, Thiotepa3件: Fludarabine,
Melphalan,
Thiotepa		3件: Melphalan ,
Thiotepa ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
3046Fludarabine/ melphalan2件: Fludarabine,
Melphalan		2件: Melphalan ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
3047Fludarabine/busulfan2件: Busulfan,
Fludarabine		2件: Busulfan ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
3048Fluimucil® 600 mg effervescent tablets----1件: 85 💬
3049FLUORINE (18F) FLUDEOXYGLUCOSE1件: Fludeoxyglucose1件: Fludeoxyglucose F 18 💬--2件: 84, 85 💬
3050FLUORINE-181件: Fluorine F-181件: Sodium fluoride F 18 💬--1件: 41 💬
3051Fluticasone MDI1件: Fluticasone1件: Fluticasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
3052Fluticasone Propionate, USP2件: Fluticasone,
Fluticasone propionate		2件: Fluticasone propionate ,
Fluticasone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
3053FLX-787-ODT----1件: 2 💬
3054FLX-787-ODT (orally disintegrating tablet)----1件: 10 💬
3055FLX-787-ODT (orally disintigrating tablet)----1件: 2 💬
3056FMT oral----1件: 97 💬
3057Focetria (Monovalent MF59-Adjuvanted vaccine)----3件: 46, 49, 271 💬
3058Folic (or folinic) acid----1件: 46 💬
3059Folic acid or folate1件: Folic acid1件: Folic acid 💬--1件: 46 💬
3060Folic Acid, Vitamin B6, Vitamin B123件: Cyanocobalamin,
Folic acid,
Pyridoxine		6件: Folic acid ,
Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 ,
Pyridoxine 💬		--1件: 6 💬
3061Foliglurax 10 mg (treatment A)1件: Foliglurax---1件: 6 💬
3062Foliglurax 30 mg (treatment B)1件: Foliglurax---1件: 6 💬
3063Follow-up study of the treated cohort----1件: 193 💬
3064Fordadistrogene movaparvovec1件: Fordadistrogene movaparvovec---1件: 113 💬
3065FORLAX 4 g, poudre pour solution buvable en sachet----1件: 299 💬
3066FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE----1件: 13 💬
3067Formistin 10 mg----1件: 13 💬
3068Formoterol/Budesonide2件: Budesonide,
Formoterol		2件: Budesonide ,
Formoterol 💬		2件: ADRB2,
NR3C1 💬		9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
3069Formulation B----1件: 13 💬
3070Fortecortin Inject 40 mg Amp.----1件: 65 💬
3071Fospropofol (Lusedra®) 101件: Fospropofol---1件: 226 💬
3072Fospropofol (Lusedra®) 121件: Fospropofol---1件: 226 💬
3073Fospropofol (Lusedra®) 6.51件: Fospropofol---1件: 226 💬
3074Fostamatinib 100 mg1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
3075Fostamatinib 100 mg tablet1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
3076Fostamatinib 150 mg1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
3077Fostamatinib 150 mg bid1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 61 💬
3078Fostamatinib 150 mg tablet1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
3079Fostamatinib 50 mg blue film-coated tablet1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
3080Fostamatinib Disodium tablet 100 mg1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
3081Fostamatinib Disodium tablet 150 mg1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
3082FP-110----1件: 97 💬
3083FPFS-1169----1件: 6 💬
3084Frameshift Array blood sample test----1件: 34 💬
3085Freeze-dried black raspberry powder1件: Raspberry1件: Raspberry 💬--1件: 97 💬
3086FRISIUM*30CPS 10MG----1件: 140 💬
3087Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the a-L-iduronidase cDNA, in their final formulation medium.----1件: 19 💬
3088FT011 100 mg----1件: 51 💬
3089FT011 200 mg----1件: 51 💬
3090FTI, AZLI----1件: 299 💬
3091FTX-1821----1件: 113 💬
3092Fully human anti-interferon gamma monoclonal antibody1件: Interferon Gamma---1件: 107 💬
3093Fully human IgG1 monoclonal antibody specific for TL1A----2件: 96, 97 💬
3094Fully human IgG2 lambda monoclonal antibody----1件: 172 💬
3095Fully human monoclonal antibody directed against CXCL10----1件: 93 💬
3096Fully humanised, recombinant monoclonal antibody (IgG1)----1件: 96 💬
3097Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----1件: 13 💬
3098Fumaderm® initial----1件: 49 💬
3099Fx-1006A1件: Fx-1006A---1件: 28 💬
3100FXIIa inhibitor monoclonal antibody----1件: 85 💬
3101FXIII Concentrate (Human) (FXIII)----1件: 288 💬
3102G-CSF for Conditioning before HSCT.1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
3103G04BE03- Sildenafil - sildenafil (citrato)1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
3104G1XCGD transduced CD34+ cells----1件: 65 💬
3105G2-SFM (IFN-beta-1a from clone 484-39,FBS-free process)----1件: 13 💬
3106GA 20 mg/mL----1件: 13 💬
3107GA 40 mg/mL----1件: 13 💬
3108GA Depot 25mg once monthly----1件: 13 💬
3109GA Depot 40 mg----1件: 13 💬
3110GA Depot 40mg once monthly----1件: 13 💬
3111GA Depot 80 mg----1件: 13 💬
3112Gabapentin (neurontin® capsule 300mg) treatment1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 70 💬
3113GABOXADOL MONOHYDRATE1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
3114Gaboxadol monohydrate 0.5 mg1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
3115Gaboxadol monohydrate 0.5 mg (intended commercial formulation)1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
3116Gaboxadol monohydrate 0.5 mg capsule1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
3117Gaboxadol monohydrate 2 mg1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
3118Gaboxadol monohydrate 2 mg (intended commercial formulation)1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
3119Gaboxadol monohydrate 2 mg capsule1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
3120Gaboxadol monohydrate 5 mg1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
3121Gaboxadol monohydrate 5 mg (intended commercial formulation)1件: Gaboxadol1件: Gaboxadol 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
3122Gadolinium For lower back1件: Gadolinium---1件: 65 💬
3123Gadolinium-based contrast1件: Gadolinium---1件: 13 💬
3124GADOVIST 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado----1件: 13 💬
3125Gadovist 1.0 mmol/ml Injektionslösung1件: Gadobutrol1件: Gadobutrol 💬--1件: 13 💬
3126GALEN® tablet----2件: 43, 44 💬
3127Gallium-68-DOTA-N-Octreotide1件: Octreotide1件: Octreotide 💬1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84 💬
3128Gammanorm 165 mg/mL----1件: 65 💬
3129Gammaplex (5%)----1件: 65 💬
3130Gammaplex 101件: Human immunoglobulin G---1件: 65 💬
3131Gammaplex, intravenous immunoglobulin----1件: 63 💬
3132GAMUNEX 10%1件: Human immunoglobulin G---1件: 11 💬
3133Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one)1件: Ganaxolone1件: Ganaxolone 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 152 💬
3134Ganaxolone, SPT3162, MD 9150000, CCD-1042, Mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one)1件: Ganaxolone1件: Ganaxolone 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 152 💬
3135GAZYVARO - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 1000MG/40ML - 1 FLACONCINO1件: Obinutuzumab1件: Obinutuzumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
3136GB224 10mg----1件: 46 💬
3137GB224 15mg----1件: 46 💬
3138GB224 5mg----1件: 46 💬
3139GBT440 300 mg capsule----1件: 85 💬
3140GBT440 300 mg tablet----1件: 85 💬
3141GC1111_0.5mg/kg----1件: 19 💬
3142GCK 100 mg----1件: 46 💬
3143GCK 200 mg----1件: 46 💬
3144GCK 300 mg----1件: 46 💬
3145GDNF & Synchro Med Infusion System----1件: 5 💬
3146GED-0507-34-Levo 160 mg1件: GED-0507-34-Levo---1件: 97 💬
3147GED-0507-34-Levo 80 mg1件: GED-0507-34-Levo---1件: 97 💬
3148Gene activated human glucocerebrosidase, velaglucerase alfa1件: Velaglucerase alfa1件: Velaglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
3149Gene Therapy Method for CGD----1件: 65 💬
3150Gene transduced PBL and/or gene transduced HSC----1件: 65 💬
3151Gene-modified autologous fibroblasts----1件: 36 💬
3152Gene-modified autologous stem cells----1件: 285 💬
3153Gene-Transduced Autologous CD34+ Stem Cells----1件: 65 💬
3154Genetic analysis by SANGER and WHOLE EXOME NEXT GENERATION SEQUENCING----1件: 84 💬
3155Genetically modified autologous blood stem cells----1件: 65 💬
3156Genicular nerve block----1件: 107 💬
3157Genistein (Unconjugated Isoflavones 100)1件: Genistein1件: Genistein 💬--1件: 299 💬
3158Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg----1件: 299 💬
3159Genome-wide DNA methylation----1件: 96 💬
3160Genotonorm Kabipen 5.3 mg polvo y disolvente para sol. inyectable (Marca internacional Genotropin)1件: Somatotropin---1件: 78 💬
3161Genotonorm Kabipen 5.3 mg polvo y disolvente para solución inyectable (Marca internacional Genotropin)1件: Somatotropin---1件: 78 💬
3162Genotonorm Miniquick 0,2 mg----1件: 193 💬
3163Genotropin (PN-180,307) Somatropin1件: Somatotropin---1件: 78 💬
3164GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made.1件: Somatotropin---1件: 193 💬
3165Genotropin 12 mg1件: Somatotropin---1件: 78 💬
3166GENOTROPIN 12 mg powder and solvent for solution for injection.1件: Somatotropin---1件: 78 💬
3167Genotropin 12 mg/ml1件: Somatotropin---1件: 78 💬
3168Genotropin 12mg1件: Somatotropin---3件: 74, 75, 78 💬
3169Genotropin 5 mg/ml1件: Somatotropin---1件: 78 💬
3170Genotropin 5.3 mg in injection system Genotropin pen1件: Somatotropin---1件: 78 💬
3171Genotropin 5.3mg1件: Somatotropin---3件: 74, 75, 78 💬
3172Genotropin Mark VII pen1件: Somatotropin---1件: 78 💬
3173Genotropin Miniqu1件: Somatotropin---3件: 74, 75, 78 💬
3174Genotropin MiniQuick----1件: 78 💬
3175Genotropin Miniquick 0.2mg1件: Somatotropin---3件: 74, 75, 78 💬
3176Genotropin Miniquick 0.4mg1件: Somatotropin---3件: 74, 75, 78 💬
3177Genotropin miniquick 0.5 mg, injection----1件: 78 💬
3178Genotropin Miniquick 0.6mg1件: Somatotropin---3件: 74, 75, 78 💬
3179Genotropin Miniquick 0.8mg1件: Somatotropin---3件: 74, 75, 78 💬
3180Genotropin Miniquick 1.0mg1件: Somatotropin---3件: 74, 75, 78 💬
3181Genotropin Miniquick 1.2mg1件: Somatotropin---3件: 74, 75, 78 💬
3182GENOTROPIN*1TBF 5,3MG (16UI)1件: Somatotropin---1件: 274 💬
3183Genotropin, Genotropin MiniQuick1件: Somatotropin---1件: 78 💬
3184Genotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms----1件: 11 💬
3185Gentamicin infusions twice a week for six months1件: Gentamicin1件: Gentamicin 💬--1件: 113 💬
3186Gentamicin sulfate 0.1% ointment2件: Gentamicin,
Sulfate ion		1件: Gentamicin 💬--1件: 36 💬
3187Gentamicin Sulfate, Injectable2件: Gentamicin,
Sulfate ion		1件: Gentamicin 💬--1件: 36 💬
3188Genz-112638----1件: 19 💬
3189Gernebcin 80 mg----1件: 299 💬
3190Gevokizumab open-label1件: Gevokizumab1件: Gevokizumab 💬1件: IL1B 💬44件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 269 💬
3191GFI 38518168-AEK-B-007----1件: 46 💬
3192GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3193GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3194GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3195GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3196Gilenya / Imusera1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3197GILENYA 0,5 mg cápsulas duras1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 14 💬
3198Gilenya 0,5 mg Hartkapseln1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3199Ginkgo biloba1件: Ginkgo biloba---4件: 13, 18, 47, 90 💬
3200Ginkgo biloba pills sig: 300mg/tid1件: Ginkgo biloba---1件: 90 💬
3201Givinostat (hydrochloride monohydrate)1件: Givinostat---1件: 113 💬
3202Givinostat (hydrochloride-monohydrate)1件: Givinostat---1件: 107 💬
3203GIVINOSTAT (hyrochloride monohydrate)1件: Givinostat---1件: 113 💬
3204Givinostat (idrocloruro monoidrato)1件: Givinostat---1件: 113 💬
3205Glatiramer Acetate (GA) 40 mg2件: Acetate,
Glatiramer		---1件: 13 💬
3206Glatiramer Acetate (OL)2件: Acetate,
Glatiramer		---1件: 13 💬
3207Glatiramer acetate 150mg enteric coated tablets2件: Acetate,
Glatiramer		---1件: 13 💬
3208Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets2件: Acetate,
Glatiramer		---1件: 13 💬
3209Glatiramer acetate 20 mg2件: Acetate,
Glatiramer		---1件: 13 💬
3210Glatiramer acetate 20 mg, with mitoxantrone3件: Acetate,
Glatiramer,
Mitoxantrone		1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
3211Glatiramer Acetate 20 mg/0.5 mL2件: Acetate,
Glatiramer		---1件: 13 💬
3212Glatiramer acetate 40 mg2件: Acetate,
Glatiramer		---1件: 13 💬
3213Glatiramer acetate injection with oral cetirizine hydrochloride3件: Acetate,
Cetirizine,
Glatiramer		1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
3214Glatiramer acetate with minocycline3件: Acetate,
Glatiramer,
Minocycline		1件: Minocycline 💬--1件: 13 💬
3215Glatiramer acetate, (Copaxone®)2件: Acetate,
Glatiramer		---1件: 13 💬
3216Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b2件: Acetate,
Glatiramer		---1件: 13 💬
3217Glatiramer Acetate, N-Acetylcysteine3件: Acetate,
Acetylcysteine,
Glatiramer		1件: Acetylcysteine 💬--1件: 13 💬
3218Glentek 50 mg compresse rivestite con film----1件: 18 💬
3219Glentek 50 mg film-coated tablets----1件: 18 💬
3220Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato----1件: 13 💬
3221GLIVEC 100 mg comprimidos recubiertos con película1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 34, 86 💬
3222Glivec 100 mg Filmtabletten1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 51, 86 💬
3223Glivec 100 mg Hartkapsel1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
3224GLIVEC 400 mg comprimidos recubiertos con película1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
3225Glivec® 100 mg Filmtabletten1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
3226Global DNA methylation will be quantified in the DNA samples by colorimetry----1件: 63 💬
3227GLP-1----1件: 299 💬
3228GLPG0259 (Part B)----1件: 46 💬
3229GLPG0259 oral capsule----1件: 46 💬
3230GLPG1690 600 mg QD----1件: 85 💬
3231GLPG1837 dose 1----1件: 299 💬
3232GLPG2222 100 mg----1件: 299 💬
3233GLPG2222 150 mg q.d.----1件: 299 💬
3234GLPG2222 200 mg----1件: 299 💬
3235GLPG2222 300 mg q.d.----1件: 299 💬
3236GLPG2222 400 mg----1件: 299 💬
3237GLPG2222 50 mg----1件: 299 💬
3238GLPG2451 dose regimen B----1件: 299 💬
3239Glucocorticoid (prednisone or prednisolone)2件: Prednisolone,
Prednisone		2件: Prednisolone ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
3240Glucocorticoid + cytoxan----1件: 222 💬
3241Glucocorticoid + tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
3242Glucocorticoid combined with cyclophosphamide induction + maintenance1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 222 💬
3243Glucocorticoids - Reduced Dose----2件: 43, 44 💬
3244Glucocorticoids - Standard Dose----2件: 43, 44 💬
3245Glucophage (metformin)1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬2件: 46, 75 💬
3246Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate1件: Glycerin1件: Glycerin 💬--1件: 13 💬
3247Glycine Buffer1件: Glycine1件: Glycine 💬--1件: 299 💬
3248Glycomacropeptide-based protein substitute----1件: 240 💬
3249Glycosides Of Tripterygium Wilfordii Hook(GTW)1件: Tripterygium wilfordii whole---1件: 224 💬
3250GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.)----1件: 299 💬
3251GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)1件: Sargramostim1件: Sargramostim 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
3252GM-CSF, fosfomycin and metronidazole2件: Fosfomycin,
Metronidazole		2件: Metronidazole ,
Fosfomycin 💬		--1件: 97 💬
3253GNbAC1 Monoclonal Antibody----1件: 13 💬
3254GNR-055 1.0-2.0-3.0 mg/kg----1件: 19 💬
3255GNR-055 2.0 mg/kg----1件: 19 💬
3256GNR-055 3.0 mg/kg----1件: 19 💬
3257Golimumab (CNTO 148)1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
3258Golimumab (Optimization)1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3259Golimumab 1 mg per kg1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3260Golimumab 100 mg1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 97 💬
3261Golimumab 100 mg injections1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3262Golimumab 2 mg per kg1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3263Golimumab 2 mg/kg IV1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3264Golimumab 200 mg1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3265Golimumab 4 mg per kg1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3266Golimumab 400 mg1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3267Golimumab 50 mg1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 97 💬
3268Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3269Golimumab 50 mg injections1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3270Golimumab 50 mg SC1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3271Golimumab Dose 11件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3272Golimumab liquid in prefilled pen or Prefilled Syringe1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3273Golimumab prefilled pen or prefilled syringe1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3274Golimumab treatment optimization.1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3275Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]1件: Golodirsen1件: Golodirsen 💬1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
3276GP2013 - A Proposed biosimilar rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
3277GP2017 (adalimumab biosimilar)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
3278GPI 1485----1件: 6 💬
3279Graft intracerebral of foetal neurons----1件: 8 💬
3280GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF)1件: Lenograstim1件: Lenograstim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 57 💬
3281Granulated mesalamine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
3282Granulocyte - colony stimulating factor (G-CSF)1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 2 💬
3283Granulocyte-colony stimulating factor (G-CSF) and prednisone2件: Filgrastim,
Prednisone		2件: Prednisone ,
Filgrastim 💬		2件: CSF3R,
NR3C1 💬		6件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 13 💬
3284Granulocyte-macrophage colony stimulating factor (GM-CSF)----1件: 229 💬
3285Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)----1件: 11 💬
3286Group 1 or Orencia treated group1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
3287Group 1- Control Diet----1件: 97 💬
3288Group 2 ustekinumab 130 mg1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
3289Group 2- UCD Diet----1件: 97 💬
3290Group 3: ustekinumab approximately 6 mg/kg1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
3291Group AD Anti-PD + Antidepressant----1件: 6 💬
3292Group C meningococcal conjugate vaccine----1件: 14 💬
3293Group R+AD Rasagiline + Antidepressant1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
3294Growth hormone (Genotonorm® or Omnitrope®)1件: Somatotropin---2件: 78, 193 💬
3295Growth hormone - LB030021件: Somatotropin---1件: 78 💬
3296Growth hormone administration for 6 months1件: Somatotropin---1件: 78 💬
3297Growth hormone releasing hormone (GHRH) 1-442件: Somatorelin,
Somatotropin		1件: Somatorelin 💬1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬1件: 78 💬
3298Growth hormone releasing hormone (GHRH) and arginine3件: Arginine,
Somatorelin,
Somatotropin		2件: Arginine ,
Somatorelin 💬		1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬1件: 78 💬
3299Growth hormone replacement therapy in growth hormone deficient patients only.1件: Somatotropin---1件: 78 💬
3300Growth Hormone, GH1件: Somatotropin---1件: 78 💬
3301GS-4997 18 mg----1件: 86 💬
3302GS-4997 2 mg----1件: 86 💬
3303GS-4997 6 mg----1件: 86 💬
3304GS-5718----1件: 46 💬
3305GS-5737----1件: 299 💬
3306GS-57451件: GS-5745---4件: 46, 96, 97, 299 💬
3307GS-5745 IV1件: GS-5745---1件: 97 💬
3308GS-5745 SC1件: GS-5745---1件: 97 💬
3309GS-6615 3 mg----1件: 58 💬
3310GS-6615 3 mg Pink----1件: 58 💬
3311GS-6615 3 mg White----1件: 58 💬
3312GS-6615 6 mg----1件: 58 💬
3313GS-6615 6 mg White----1件: 58 💬
3314GS-9674 100 mg----1件: 93 💬
3315GS-9674 30 mg----1件: 93 💬
3316GSK1265744B (sodium salt) containing 14C-GSK1265744B----1件: 265 💬
3317GSK1550188 (Belimumab)1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 222 💬
3318GSK1550188 1mg/kg or 10mg/kg----1件: 49 💬
3319GSK1605786 500 mg----1件: 96 💬
3320GSK1605786 ChemoCentryx: formulation A----1件: 96 💬
3321GSK1605786 GSK direct-fill: formulation C----1件: 96 💬
3322GSK1605786 GSK modified-process: formulation D----1件: 96 💬
3323GSK1605786 GSK tablet: formulation E----1件: 96 💬
3324GSK1605786 GSK: formulation B----1件: 96 💬
3325GSK2018682 CD3 micronised Tablet----1件: 13 💬
3326GSK2018682 CD3 non-micronised Tablet----1件: 13 💬
3327GSK2018682 CD3 non-micronised Tablet in fed state----1件: 13 💬
3328GSK2330672/linerixibat 40 mg----1件: 93 💬
3329GSK2330811 Solution for Injection, 100mg/ml----1件: 51 💬
3330GSK2402968 6 mg/kg/week----1件: 113 💬
3331GSK2586184 100 mg----1件: 49 💬
3332GSK2586184 200 mg----1件: 49 💬
3333GSK2586184 400 mg----1件: 49 💬
3334GSK2586184 50 mg----1件: 49 💬
3335GSK2618960 2 mg/kg----1件: 53 💬
3336GSK2831781 - Double Blind Phase----1件: 97 💬
3337GSK2831781 - Open Label phase----1件: 97 💬
3338GSK2982772 60 mg----1件: 46 💬
3339GSK2982772A, where A denotes the free base----2件: 46, 97 💬
3340GSK315234 Injection 100mg/mL----1件: 46 💬
3341GSK3196165 (Otilimab)1件: Otilimab1件: Otilimab 💬1件: CSF2 💬16件: Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬1件: 46 💬
3342GSK3196165 Dose 1----1件: 46 💬
3343GSK962040 (25 mg tablet)----1件: 6 💬
3344GTA: Glyceryltriacetate----1件: 307 💬
3345GTX-1021件: GTX-102---2件: 65, 201 💬
3346GTX-102 high dose fast Period 1 and Period 21件: GTX-102---1件: 65 💬
3347GTX-102 low dose fast Period 1 and Period 21件: GTX-102---1件: 65 💬
3348GTX-102 medium dose fast Period 1 and Period 21件: GTX-102---1件: 65 💬
3349GTX-102 medium dose slow Period 1 and Period 21件: GTX-102---1件: 65 💬
3350Guna-Anti Interleukin 1----1件: 46 💬
3351Guna-Antiinterleukin 1 alfa----1件: 46 💬
3352Guna-Antiinterleukin 1 beta----1件: 46 💬
3353Guna-Interleukin 10----1件: 46 💬
3354Guselkumab 100 mg1件: Guselkumab1件: Guselkumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 37 💬
3355Guselkumab Dose 11件: Guselkumab1件: Guselkumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬3件: 51, 96, 97 💬
3356Guselkumab Dose 51件: Guselkumab1件: Guselkumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
3357Gusperimus + glucocorticoids1件: Gusperimus1件: Gusperimus 💬--1件: 44 💬
3358Gutron 2,5mg----1件: 58 💬
3359Gutron 5mg----1件: 58 💬
3360GW-1000-02----1件: 13 💬
3361GWP42003-P 10 mg/kg/day Dose----1件: 140 💬
3362GWP42003-P 20 mg/kg/day Dose----2件: 140, 144 💬
3363GWP42003-P 5 mg/kg/day Dose----1件: 140 💬
3364GYLENIA 0,5 mg----1件: 13 💬
3365GYPP-06 (GKT137831 free base), C10071301-D----1件: 93 💬
3366GZ402671 / SAR402671----1件: 19 💬
3367H-116PI-DE.pdf----1件: 18 💬
3368H.P. Acthar Gel1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 46, 49, 50, 84, 222 💬
3369H.P. Acthar Gel (repository corticotropin injection)1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
3370H.P. Acthar® Gel1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 14 💬
3371H02 - Corticosteroidi Sistemici----1件: 299 💬
3372H1 Blocker----1件: 257 💬
3373H2 Blocker----1件: 257 💬
3374H5G1.1-mAb----3件: 13, 50, 62 💬
3375HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM----2件: 6, 49 💬
3376HA20 (IMMU-106)----1件: 46 💬
3377Haemate P® (Human Coagulation Factor VIII)2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288 💬
3378Haemate-P, Wilate1件: Von Willebrand factor human---1件: 288 💬
3379Haemate® P 250----1件: 288 💬
3380Haemocomplettan(R) P----1件: 65 💬
3381Haemocomplettan(R) P 1g/2g----1件: 65 💬
3382HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---2件: 13, 14 💬
3383Haemophilus type b vaccine (conjugated)----1件: 14 💬
3384Haplo BM with T cell depletion----1件: 65 💬
3385Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 60 💬
3386HBM9161 Dose B----1件: 63 💬
3387HBM9161 Injection (340 mg)----1件: 11 💬
3388HBM9161 Injection (680mg and 340 mg)----1件: 11 💬
3389HBVAXPRO 5 micrograms/0.5 ml1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
3390HBVAXPRO 5 micrograms/0.5 ml Suspension for injection Hepatitis B vaccine (rDNA)1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
3391HBVAXPRO® 40 micrograms1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
3392HC-58----1件: 149 💬
3393Helium / oxygen mixed gas inhalation therapy2件: Helium,
Oxygen		2件: Oxygen ,
Helium 💬		--1件: 330 💬
3394Helminth ova----1件: 13 💬
3395Helopanflat Mono®----1件: 298 💬
3396Hematide, peginesatide1件: Peginesatide1件: Peginesatide 💬1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283 💬
3397Hemay007 1200 mg QD group----1件: 46 💬
3398Hemay007 600 mg QD group----1件: 46 💬
3399Hemay007 800 mg QD group----1件: 46 💬
3400Heparin & Alkalinized Lidocaine Bladder Instillation2件: Heparin,
Lidocaine		3件: Lidocaine ,
Adomiparin ,
Lidocaine hydrochloride monohydrate 💬		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬		4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬1件: 226 💬
3401Heparin 25mg inhalation powder, hard capsule1件: Heparin1件: Adomiparin 💬1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 299 💬
3402Hepatitis A vaccine ( HAVRIX or EPAXAL)1件: Hepatitis A Vaccine---1件: 46 💬
3403Hepatitis B Vaccine1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
3404HEPATITIS B VACCINE (RDNA)1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
3405HEPATITIS B VIRUS SURFACE ANTIGEN RECOMBINANT (S PROTEIN)----1件: 46 💬
3406Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)1件: Reynoutria multiflora root---1件: 6 💬
3407Herbal medicine----1件: 70 💬
3408Hericium erinaceus mycelium----1件: 6 💬
3409Herpes Zoster Subunit (HZ/su) Vaccine----1件: 49 💬
3410Heterologous booster----1件: 13 💬
3411Hetrombopag Olamine1件: Hetrombopag---2件: 60, 63 💬
3412Hetrombopag Olamine Tablet1件: Hetrombopag---1件: 60 💬
3413HGH-hyFc, recombinant human growth hormone1件: Somatotropin---1件: 78 💬
3414HGH-ViaDerm™ System (hGH or somatropin)1件: Somatotropin---1件: 78 💬
3415HGS1006, LymphoStat-B----1件: 53 💬
3416HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 49, 53 💬
3417HGT-1110----1件: 19 💬
3418HGT-1111----1件: 19 💬
3419HGT-1410----1件: 19 💬
3420HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML1件: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen---3件: 61, 62, 66 💬
3421HIDONAC*EV 1FL 5G 25ML----1件: 51 💬
3422High dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
3423High dose ANAVEX2-73----1件: 6 💬
3424High Dose Aspirin (1300 mg/day)1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
3425High dose BIBF 1120 twice daily----1件: 85 💬
3426High Dose Budesonide1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
3427High dose budesonide suspension1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
3428High dose budesonide tablet1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
3429High Dose Mesenchymal Stem Cells (MSCs)----1件: 49 💬
3430High Dose MT-1303----1件: 97 💬
3431High Dose MYOBLOC1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
3432High dose of BIIL 284 BS tablets----1件: 46 💬
3433High dose of budesonide1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299 💬
3434High dose ORTD-1----1件: 46 💬
3435High doses of Thiamine y Biotin2件: Biotin,
Thiamine		2件: Biotin ,
Thiamine 💬		--1件: 8 💬
3436High milk intake.----1件: 238 💬
3437High Oligosaccharide Group----1件: 96 💬
3438High Phenolic Extra Virgin Olive Oil2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬--1件: 13 💬
3439High Protein. T-Diet plus Range----1件: 6 💬
3440High-carbohdyrate breakfast----1件: 265 💬
3441Hiomega-3 supplement of Naturalis® company -----1件: 49 💬
3442HIV Anti-retroviral Background Therapy----1件: 265 💬
3443HLA-B*5801 test----1件: 38 💬
3444HLA-identical allogeneic mesoangioblasts----1件: 113 💬
3445HLL2 (trivial name or chemical description)----1件: 49 💬
3446HLL2,IMMU-103----1件: 49 💬
3447HM71224 Multiple ascending dose----1件: 46 💬
3448HMI-102----1件: 240 💬
3449HMI-103----1件: 240 💬
3450HMPL-004 1800 mg/day----1件: 97 💬
3451HMPL-004 2400 mg/day----1件: 97 💬
3452HMPL-523----2件: 46, 63 💬
3453HMPL-523(300mg PO QD)----1件: 61 💬
3454HMR 1726D----1件: 13 💬
3455Hologene 5----1件: 36 💬
3456Hologene 5 DS----1件: 36 💬
3457Homeostasis Model Assessment of insulin resistance (HOMA)----1件: 17 💬
3458Homologous booster----1件: 13 💬
3459HORA-PDE6B (AAV2/5.hPDE6B)----1件: 90 💬
3460Hormonal balance measurements1件: Isoxaflutole---1件: 81 💬
3461Hourly dosing of the nychtemeral secretion of melatonin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬
3462HOV-12020 (Palm tocotrienols complex)----1件: 124 💬
3463HP 129Xe----1件: 299 💬
3464Hp 129Xenon----1件: 228 💬
3465HPN-100----1件: 251 💬
3466HRA052015 (mifepristone)1件: Mifepristone1件: Mifepristone 💬2件: NR3C1,
PGR 💬		6件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 75 💬
3467HT-100----1件: 113 💬
3468Hu Leptin (A-100)1件: Leptin---1件: 265 💬
3469Hu MiK-Beta-1----1件: 26 💬
3470HUC-MSC + DMARDs----1件: 46 💬
3471Humalog Mix50 100 U/ml sospensione iniettabile----1件: 78 💬
3472HUMAN ALBUMIN AS MACROAGGREGATES1件: Albumin human1件: Albumin human 💬--1件: 96 💬
3473Human allogeneic adipose tissue-derived mesenchymal stem cells expanded----1件: 36 💬
3474Human Allogeneic WJ-MSCs1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36 💬
3475Human anti TNF-alpha monoclonal----1件: 46 💬
3476Human anti TNF-alpha monoclonal antibody----2件: 46, 84 💬
3477Human anti-IL 12/23 monoclonal antibody----1件: 84 💬
3478Human Anti-IL-12 Antibody----1件: 96 💬
3479Human anti-IL-12 IgG1 Mab----1件: 13 💬
3480Human anti-IL-12 Mab----1件: 13 💬
3481Human anti-IL6 monoclonal antibody----1件: 46 💬
3482Human anti-IP10 monoclonal antibody----2件: 96, 97 💬
3483Human anti-LINGO-1 monoclonal antibody----1件: 13 💬
3484HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY----1件: 3 💬
3485Human Anti-TNF IgG1 Monoclonal Antibody----3件: 46, 97, 271 💬
3486Human anti-TNF-alpha monoclonal antibody----3件: 46, 97, 107 💬
3487Human anti-TNFa monoclonal antibody----1件: 271 💬
3488Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody----1件: 51 💬
3489Human autologous mesenchymal stem cells----2件: 2, 13 💬
3490Human coagulation Factor VIII / von Willebrand Factor3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
3491Human Coagulation Factor VIII, Von Willebrand Factor3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
3492HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
3493HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND HUMAN COAGULATION FACTOR2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288 💬
3494Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh----1件: 36 💬
3495Human fibroblast-derived dermal substitute, Dermagraft----1件: 36 💬
3496Human glucocerebrosidase gene into autologous peripheral blood stem cells----1件: 19 💬
3497Human Growth Hormone (1-134)1件: Somatotropin---1件: 78 💬
3498Human IgG1 monoclonal antibody against alpha-synuclein----1件: 17 💬
3499HUMAN IGG4 ISOTYPE MONOCLONAL (IL2-RG) ANTIBODY----1件: 60 💬
3500Human IgG4 monoclonal antibody against CD40----1件: 46 💬
3501Human interferon beta1件: Human interferon beta---2件: 13, 26 💬
3502Human interferon beta 1a (Rebif)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3503Human interferon beta-1a and glatiramer acetate4件: Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3504Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40----1件: 96 💬
3505Human monoclonal antibody (CNTO 1275) to interleukin-12p40----1件: 13 💬
3506Human monoclonal antibody directed against CD20 on B-cells----1件: 46 💬
3507Human monoclonal antibody directed against complement 5 protein----1件: 62 💬
3508Human normal 10% immunoglobulin for intravenous administration----1件: 14 💬
3509Human normal 10% immunoglobulin for intravenous administrationn----1件: 14 💬
3510Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)1件: Human immunoglobulin G---1件: 65 💬
3511Human normal immunoglobulin for intravenous (IV) administration1件: Human immunoglobulin G---1件: 51 💬
3512Human normal immunoglobulin G (IgG > 98% purity)1件: Human immunoglobulin G---3件: 14, 63, 65 💬
3513Human primary Retinal Pigment Epithelial (HuRPE) cells----1件: 90 💬
3514Human Recombinant IgG1, lambda----1件: 46 💬
3515Human recombinant leptin (metreleptin)2件: Leptin,
Metreleptin		1件: Metreleptin 💬1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
3516HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH)2件: Albumin human,
Somatotropin		1件: Albumin human 💬--1件: 78 💬
3517Human Serum Albumin (HSA) fused to somatropin2件: Albumin human,
Somatotropin		1件: Albumin human 💬--1件: 78 💬
3518Human T Lymphoid Progenitor (HTLP) injection----1件: 65 💬
3519Human Transthyretin Antisense Oligonucleotide----1件: 28 💬
3520Human Umbilical Cord Blood-derived Mesenchymal Stem Cells----1件: 36 💬
3521Human umbilical cord derived MSC transplantation for SLE----1件: 49 💬
3522Human umbilical cord mesenchymal stem cell injection----1件: 85 💬
3523Human Umbilical Cord Mesenchymal Stem Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---3件: 13, 96, 113 💬
3524Human umbilical cord mesenchymal stem cells (UC-MSCs)1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 96 💬
3525Human umbilical cord-derived MSCs----1件: 271 💬
3526Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII)2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
3527Humanised anti-CD4 IgG1 monoclonal----1件: 46 💬
3528Humanised IgG1 monoclonal antibody against blood dendritic cell antigen 2----1件: 49 💬
3529Humanised IgG1 monoclonal antibody against human eotaxin-2----1件: 94 💬
3530Humanised IgG1K monoclonal antibody against interferon beta1件: Human interferon beta---1件: 50 💬
3531Humanized anti-alpha v beta 6 mAb----1件: 85 💬
3532Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody----1件: 28 💬
3533Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody----1件: 46 💬
3534Humanized recombinant IgG4 monoclonal antibody against CD-127----1件: 97 💬
3535Humanized TNFa monoclonal antibody----1件: 46 💬
3536Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten1件: Somatotropin---1件: 193 💬
3537Humatrope® 6 mg, powder and solvent for solution for injection1件: Somatotropin---1件: 78 💬
3538HuMax-CD38, 3003-005----1件: 28 💬
3539Humira (adalimumab original)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3540Humira (adalimumab) 40 mg in 0.4 ml s.c. injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3541Humira (adalimumab) 40 mg s.c. injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3542Humira (adalimumab) 40mg in 0.4 ml s.c. injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3543Humira (adalimumab) 40mg in 0.4ml s.c.injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3544HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 56, 97 💬
3545HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 2 SIRINGHE PRERIEMPITE 0.8 ML + 2 TAMPONI IMBEVUTI DI ALCOL IN 1 BLISTER1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3546HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
3547Humira 20 mg solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3548Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3549Humira 40 mg injekcní roztok v predplnené injekcní stríkacce1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3550Humira 40 mg injeksjonsvæske, oppløsning, i ferdigfylt sprøyte----1件: 46 💬
3551HUMIRA 40 mg solución inyectable en jeringa precargada1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
3552Humira 40 mg solution for injection in pre-filled pen1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3553Humira 40 mg solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 97 💬
3554Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3555Humira 40 mg solution for injection in pre-filled syringes----1件: 97 💬
3556Humira 40 mg/0.8 ml solution for injection1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271 💬
3557Humira 40 mg/0.8 ml solution for injection for paediatric use1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3558Humira 40mg/0.8 ml solution for injection for paediatric use1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3559Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3560Humira ® (Adalimumab) 40mg/0.8mL Pre-filled Syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3561Humira, 40 mg solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3562Humira, Hulio, Amgevita, Hyrimoz, Idacio, Imraldi1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3563Humira® (adalimumab)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3564Humira® 40 mg Injektionslösung in Fertigspritze1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3565Humira® 40 mg solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3566Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3567Hydrochlorothiazide 25 mg1件: Hydrochlorothiazide1件: Hydrochlorothiazide 💬1件: SLC12A3 💬-1件: 67 💬
3568Hydrocortison 100 mg (Pfizer®) in 2 ml solvent----1件: 83 💬
3569Hydrocortisone 100mg/ml1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
3570Hydrocortisone 10mg1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
3571Hydrocortisone 10mg Tablet1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
3572Hydrocortisone 10mg Tablets1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
3573Hydrocortisone cream 1%1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
3574Hydrocortisone cream 10mg/g FNA Fagron1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
3575HYDROCORTISONE MICRONIZED1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
3576Hydrocortisone Modified Release Capsules1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
3577Hydrocortisone tablet 2.5 mg1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
3578Hydrocortisone TAKEDA, tabletter1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 78 💬
3579HYDROCORTISONE- hydrocortisone tablet1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
3580Hydrokortison APL kapsel 2,5 mg----1件: 83 💬
3581Hydrokortison Glostrup 5 mg----1件: 78 💬
3582Hydrokortison orion----1件: 41 💬
3583Hydroxocobalamin with Butyrate2件: Butyric Acid,
Hydroxocobalamin		1件: Hydroxocobalamin 💬--1件: 97 💬
3584Hydroxychloroquine + low-dose prednisone2件: Hydroxychloroquine,
Prednisone		2件: Prednisone ,
Hydroxychloroquine 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
3585Hydroxychloroquine + Prednisone2件: Hydroxychloroquine,
Prednisone		2件: Prednisone ,
Hydroxychloroquine 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
3586Hydroxychloroquine or Chloroquine2件: Chloroquine,
Hydroxychloroquine		2件: Chloroquine ,
Hydroxychloroquine 💬		--1件: 49 💬
3587Hydroxychloroquine Sulfate 100 milligram (mg) Tab2件: Hydroxychloroquine,
Sulfate ion		1件: Hydroxychloroquine 💬--1件: 218 💬
3588Hydroxypropyl-beta-cyclodextrin1件: Betadex1件: Betadex 💬--1件: 19 💬
3589Hyperglycemic clamp with concurrent GLP-1 infusion----1件: 299 💬
3590Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment1件: Xenon2件: Xenon ,
Xenon Xe 133 💬		--1件: 85 💬
3591Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment1件: Xenon2件: Xenon ,
Xenon Xe 133 💬		--1件: 85 💬
3592Hyperpolarized 129-Xenon gas1件: Xenon2件: Xenon ,
Xenon Xe 133 💬		--1件: 85 💬
3593Hyperpolarized 129Xe----1件: 86 💬
3594Hyperpolarized 13C-Pyruvate----1件: 58 💬
3595Hyperpolarized [1-13C]pyruvate----2件: 2, 67 💬
3596Hyperpolarized Helium-3 MRI2件: Helium,
Helium He-3		1件: Helium 💬--1件: 228 💬
3597Hyperpolarized Helium-3 MRI of the chest2件: Helium,
Helium He-3		1件: Helium 💬--1件: 299 💬
3598Hyperpolarized Xenon 1291件: Xenon2件: Xenon ,
Xenon Xe 133 💬		--1件: 299 💬
3599Hyperpolarized xenon-1291件: Xenon2件: Xenon ,
Xenon Xe 133 💬		--1件: 299 💬
3600Hypertonic bicarbonate----1件: 299 💬
3601Hypertonic saline (7 %) and isotonic saline (0.9%)----1件: 299 💬
3602Hypertonic saline (7%)----1件: 299 💬
3603Hypertonic saline 6% -----1件: 299 💬
3604Hypertonic Saline 7%1件: Sodium chloride1件: Sodium chloride 💬--1件: 299 💬
3605Hypoxic Gas Mixture----1件: 6 💬
3606HyQvia 100 mg/ml solution for infusion for subcutaneous use2件: Human immunoglobulin G,
Hyaluronidase (human recombinant)		---1件: 65 💬
3607HZN-825 BID----1件: 51 💬
3608HZT-5011件: HZT-501---1件: 46 💬
3609I 1231件: Iodide I-123---1件: 6 💬
3610I-1231件: Iodide I-123---2件: 2, 6 💬
3611I-123-5-IA853801件: Iodide I-123---1件: 6 💬
3612I-123] ADAM1件: Iodide I-123---1件: 2 💬
3613I.v. immunoglobulins----1件: 151 💬
3614I.v. selexipag1件: Selexipag1件: Selexipag 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3615I124-AT01 only----1件: 28 💬
3616IA-14069----1件: 46 💬
3617IB 1001----1件: 65 💬
3618IB-MECA----1件: 46 💬
3619IBD98-M----1件: 97 💬
3620IBD98-M Delayed-release Capsules1件: Manganese citrate---1件: 97 💬
3621Ibuprofen Sandoz 400 mg Filmtabletten1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
3622IBUTAMOREN MESILATE----1件: 78 💬
3623ICG-guided bowel perfusion assessment----1件: 96 💬
3624ICI 182,780 (Faslodex)1件: Fulvestrant1件: Fulvestrant 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49 💬
3625Idebenone 150 mg film-coated tablets1件: Idebenone1件: Idebenone 💬--1件: 113 💬
3626IDEC-C2B8, Ro 45-2294----1件: 64 💬
3627Identification of COMT HH, COMT HL or COMT LL genes----1件: 6 💬
3628IdeS (0.25 mg/kg)1件: Imlifidase1件: Imlifidase 💬--1件: 64 💬
3629IdeS (0.50 mg/kg)1件: Imlifidase1件: Imlifidase 💬--1件: 64 💬
3630IDL-2965 Oral Capsule----1件: 85 💬
3631IDPM: Inhaled Dry Powder Mannitol1件: Mannitol1件: Mannitol 💬--1件: 299 💬
3632IDROCORTISONE ACETATO DYNACREN - 1 % CREMA 1 TUBO DA 30 G----1件: 272 💬
3633IDROCORTISONE ACETATO DYNACREN 1% CREMA----1件: 272 💬
3634IDURONATE-2-SULFATASE FUSED TO A FC POLYPEPTIDE THAT BINDS TO THE HUMAN TRANSFERRIN RECEPTOR----1件: 19 💬
3635Idursulfase beta2件: Idursulfase,
Idursulfase beta		2件: Idursulfase ,
Idursulfase beta 💬		1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
3636Idursulfase IT (1 mg)1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
3637Idursulfase IT (10 mg)1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
3638Idursulfase IT (30 mg)1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
3639Idursulfase(12S)-IT1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
3640IFB-088 50mg/day----1件: 2 💬
3641IFN beta 1a 44 mcg TIW----1件: 13 💬
3642IFN beta-1a----1件: 13 💬
3643IFN ß-1a----1件: 13 💬
3644IFN-beta-1a (Rebif®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3645IFN-beta-1a, (Avonex®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3646IFN-ß-1a (Rebif®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3647IFN-ß-1a, (Avonex®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3648IFX-11件: Vilobelimab1件: Vilobelimab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 43, 44, 269 💬
3649Ig VENA (10g/200mL)----1件: 50 💬
3650Ig VENA 100 ml vial----1件: 63 💬
3651Ig VENA 50 g/l solution for infusion 100 ml vial + infusion set----2件: 63, 65 💬
3652IGF-1----1件: 113 💬
3653IgG Next Generation (BT595)----1件: 65 💬
3654IGIV, 10%----2件: 14, 65 💬
3655IGIV-C 10%----1件: 65 💬
3656IGIV3I Grifols 10%----1件: 63 💬
3657IgNextGen 10%----1件: 63 💬
3658IgNextGen 16%----1件: 65 💬
3659IGSC 20% 150 mg/kg----1件: 65 💬
3660IGSC 20% daily push versus 2 times per week pump----1件: 65 💬
3661IGSC 20% daily push versus every 2 weeks pump----1件: 65 💬
3662IGSC 20% daily push versus once a week pump----1件: 65 💬
3663IGSC 20% infusion----1件: 65 💬
3664IGSC, 16%----1件: 65 💬
3665IGSC, 20%----1件: 65 💬
3666IGVENA*FL 200ML 10G+SET----2件: 14, 50 💬
3667IkT-148009----1件: 6 💬
3668IL-1 Trap----1件: 266 💬
3669IL-111件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
3670IL-6 receptor inhibitor, humanized monoclonal antibody----1件: 46 💬
3671IL-6 receptor inhibitor, recombinant humanized monoclonal antibody----2件: 46, 107 💬
3672IL-6R Monoclonal Antibody Injection 4mg/kg----1件: 46 💬
3673IL-6R Monoclonal Antibody Injection 6mg/kg----1件: 46 💬
3674IL-6R Monoclonal Antibody Injection 8mg/kg----1件: 46 💬
3675ILB: 100mg/ml solution for injection and infusion----1件: 2 💬
3676Ilomedin 20 [20 µg / ml]----1件: 86 💬
3677Iloprost (5 µg)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3678Iloprost (Ventavis BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3679Iloprost (Ventavis inhaled, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3680Iloprost (Ventavis, BAYQ 6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3681Iloprost (Ventavis, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3682Iloprost Injection, for intravenous use1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51 💬
3683Iloprost PD-151件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3684Iloprost therapy up to 2 ng/kg x min1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51 💬
3685Iloprost,(Ventavis, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3686ILT-1011件: Aldesleukin1件: Aldesleukin 💬3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 49 💬
3687IMATINIB MESILATE1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬3件: 13, 86, 88 💬
3688IMATINIB MESILATO1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 51 💬
3689Imatinib Mesylate1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬5件: 13, 28, 34, 51, 86 💬
3690Imatinib Mesylate (Gleevec)1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 85 💬
3691Imatinib Mesylate 400Mg Capsule1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 89 💬
3692IMB-1018972----1件: 58 💬
3693Imiglucérase (drug) pharmacokinetics----1件: 19 💬
3694Imipenem / cilastatine2件: Cilastatin,
Imipenem		3件: Imipenem ,
Imipenem ,
Cilastatin 💬		1件: DPEP1 💬-1件: 60 💬
3695Imiquimod 5% Cream1件: Imiquimod1件: Imiquimod 💬1件: TLR7 💬5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬2件: 34, 51 💬
3696Immediate post operative bioassay of Parathyroid Hormone1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
3697Immediate Release carbidopa/levodopa 10/100 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3698Immediate Release carbidopa/levodopa 25/100 mg2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
3699Immediate Release Melatonin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6 💬
3700IMMU-103----1件: 49 💬
3701Immune Globulin (Human), 10% Caprylate/Chromatography Purified----1件: 11 💬
3702Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C)----1件: 11 💬
3703Immune Globulin 10% Intravenous Solution----1件: 14 💬
3704Immune Globulin Infusion (Human), 10%----1件: 65 💬
3705Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SN™----1件: 65 💬
3706Immune Globulin Intravenous (human), 10%----2件: 14, 65 💬
3707Immune Globulin Intravenous (Human), 10% Solution----1件: 65 💬
3708Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution----1件: 63 💬
3709Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution----1件: 65 💬
3710Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified----1件: 65 💬
3711Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified----1件: 14 💬
3712Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified----1件: 13 💬
3713Immune Globulin Subcutaneos, 20%----1件: 65 💬
3714Immune Globulin Subcutaneous (Human) (SCIG)----1件: 65 💬
3715Immune Globulin Subcutaneous (Human), 20%----1件: 65 💬
3716Immune Globulin Subcutaneous (Human), 20% Caprylate/Chromatography Purified (IGSC 20%)----1件: 65 💬
3717Immune Globulin Subcutaneous (Human), 20% Solution----1件: 65 💬
3718Immune Globulin Subcutaneous (Human), 20%, Caprylate/Chromatography Purified----1件: 65 💬
3719Immune Globulin Subcutaneous, 20%----1件: 65 💬
3720Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)----1件: 65 💬
3721Immunoglobulin G (Ig NextGen 16%)----1件: 65 💬
3722Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy----1件: 2 💬
3723Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy chain), disulfide with human Mus musculus monoclonal light chain, dimer----1件: 2 💬
3724Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer----1件: 49 💬
3725Immunoglobulins, normal human----1件: 65 💬
3726Immunoglobulins, normal human, for extravascular adm.----1件: 14 💬
3727Immunoglobulins, normal human, for intravascular adm.----2件: 14, 15 💬
3728Immunosuppression Only Conditioning----1件: 65 💬
3729Immunosuppression Only Conditioning -Closed with amendment L----1件: 65 💬
3730Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate)4件: Azathioprine,
Methotrexate,
Mycophenolate mofetil,
Mycophenolic acid		4件: Methotrexate ,
Azathioprine ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		4件: DHFR,
DHFR2,
IMPDH1,
IMPDH2 💬		8件: Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, Nucleotide metabolism, One carbon pool by folate, Purine metabolism 💬1件: 49 💬
3731Immunosuppressive treatment (eg, rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 64 💬
3732Imnovid 1 mg hard capsules1件: Pomalidomide1件: Pomalidomide 💬2件: IL6,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 51 💬
3733IMO-8400 Dose Group 1----1件: 50 💬
3734IMod.Fc, H-Fcv3-N4----1件: 84 💬
3735IMP will be labeled as ''PF-04236921 106mg/vial, Clonal SC lyophilized form''.----1件: 96 💬
3736IMP will be labeled as PF-04236921 106mg/vial, Clonal SC lyophilized form----1件: 96 💬
3737IMU-838 (30 mg/day)----1件: 13 💬
3738IMU-838 (45 mg/day)----1件: 13 💬
3739IMUKIN - 6 FLACONI 0.5 ML 100 MCG----2件: 18, 58 💬
3740IMUKIN*SC 6F 0,5ML 100MCG----1件: 18 💬
3741Imurek 50mg Filmtabletten----1件: 97 💬
3742Imurel 25 mg----1件: 96 💬
3743In double-blind phase: treatment with tofacitinib1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 107 💬
3744In open-label phase: treatment with tofacitinib1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 107 💬
3745Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus----1件: 53 💬
3746INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI----1件: 294 💬
3747INALOSSIN 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO----1件: 294 💬
3748INBRX-101/rhAAT-Fc----1件: 231 💬
3749INCB050465 0.3 mg1件: Parsaclisib1件: Parsaclisib 💬1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 35 💬
3750INCB050465 1 mg1件: Parsaclisib1件: Parsaclisib 💬1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 61 💬
3751INCB050465 1.0 mg1件: Parsaclisib1件: Parsaclisib 💬1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 35 💬
3752INCB050465 1.0mg1件: Parsaclisib1件: Parsaclisib 💬1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 35 💬
3753INCB050465 2.5 mg1件: Parsaclisib1件: Parsaclisib 💬1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 61 💬
3754INCB050465 2.5mg1件: Parsaclisib1件: Parsaclisib 💬1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 35 💬
3755IncobotulinumtoxinA (100 Units)1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
3756IncobotulinumtoxinA (75 Units)1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
3757INCRELEX 10 mg/ml1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 78 💬
3758INCRELEX 10 mg/ml, solución inyectable1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 78 💬
3759Increlex 10mg/ml solution for injection1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 96 💬
3760INCRELEX*SC 1FL 4ML 10MG/ML1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 299 💬
3761IND 127861----2件: 51, 53 💬
3762Indium 111-radiolabelled anti-CD661件: Indium---1件: 28 💬
3763Indium-111 Pentreotide1件: Indium---1件: 84 💬
3764Indium­ 111 ­labelled Anti­-CD661件: Indium---1件: 28 💬
3765Individualized dose of rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 49 💬
3766INDUSIL*OS GTT FL 30MG+FL 15ML----1件: 299 💬
3767INF beta-1a----1件: 13 💬
3768Infigratinib 0.016 mg/kg1件: Infigratinib1件: Infigratinib 💬3件: FGFR1,
FGFR2,
FGFR3 💬		21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
3769Infigratinib 0.032 mg/kg1件: Infigratinib1件: Infigratinib 💬3件: FGFR1,
FGFR2,
FGFR3 💬		21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
3770Infigratinib 0.064 mg/kg1件: Infigratinib1件: Infigratinib 💬3件: FGFR1,
FGFR2,
FGFR3 💬		21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
3771Infigratinib 0.128 mg/kg1件: Infigratinib1件: Infigratinib 💬3件: FGFR1,
FGFR2,
FGFR3 💬		21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
3772Infigratinib 0.25 mg/kg1件: Infigratinib1件: Infigratinib 💬3件: FGFR1,
FGFR2,
FGFR3 💬		21件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬1件: 276 💬
3773INFLECTRA - 100 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 1 FLACONCINO1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 56 💬
3774Inflectra 100 mg1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3775Inflectra 100 mg powder for concentrate for solution for infusion1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3776Infliximab (BCD-055)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
3777Infliximab (INF) + MTX, DB1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3778Infliximab (Remicade): 100 mg of lyophilized infliximab1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3779Infliximab + methotrexate (MTX)2件: Infliximab,
Methotrexate		2件: Methotrexate ,
Infliximab 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3780Infliximab 10 mg/kg1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 97 💬
3781Infliximab 20 mg/kg1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3782Infliximab 3 mg/kg1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3783Infliximab 5 mg/kg1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3784Infliximab 5 mg/kg body weight infused over 2 hours1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3785Infliximab 5 mg/kg every 6 weeks1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3786Infliximab 7 mg/kg every 8 weeks1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3787Infliximab [infliximab biosimilar 3]1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 37, 46, 96, 97 💬
3788Infliximab and azathioprine combination at week 142件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3789Infliximab and MTX1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
3790Infliximab biosimilar1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
3791Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab5件: Adalimumab,
Golimumab,
Infliximab,
Ustekinumab,
Vedolizumab		5件: Adalimumab ,
Infliximab ,
Golimumab ,
Vedolizumab ,
Ustekinumab 💬		6件: IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
TNF 💬		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3792Infliximab plus methotrexate2件: Infliximab,
Methotrexate		2件: Methotrexate ,
Infliximab 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
3793Infliximab therapeutic drug monitoring1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3794Infliximab with azathioprine (IIFX + AZA)2件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3795Infliximab, adalimumab, certolizumab pegol3件: Adalimumab,
Certolizumab pegol,
Infliximab		3件: Adalimumab ,
Infliximab ,
Certolizumab pegol 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
3796Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab5件: Adalimumab,
Golimumab,
Infliximab,
Ustekinumab,
Vedolizumab		5件: Adalimumab ,
Infliximab ,
Golimumab ,
Vedolizumab ,
Ustekinumab 💬		6件: IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
TNF 💬		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
3797Infliximab, azathioprine2件: Azathioprine,
Infliximab		2件: Azathioprine ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3798Infliximab, etanercept2件: Etanercept,
Infliximab		2件: Etanercept ,
Infliximab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3799Infliximab, etanercept, adalimumab3件: Adalimumab,
Etanercept,
Infliximab		3件: Etanercept ,
Adalimumab ,
Infliximab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3800Infliximab, methylprednisolone, methotrexate3件: Infliximab,
Methotrexate,
Methylprednisolone		3件: Methotrexate ,
Methylprednisolone ,
Infliximab 💬		4件: DHFR,
DHFR2,
NR3C1,
TNF 💬		72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
3801Infliximab-Biosimilar1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
3802Infliximab: Adalimumab2件: Adalimumab,
Infliximab		2件: Adalimumab ,
Infliximab 💬		1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
3803INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED)----1件: 49 💬
3804Influenza vaccine, Immune function----1件: 107 💬
3805Infusion of ADR-001 (Mesenchymal stem cell)----1件: 66 💬
3806Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)----1件: 65 💬
3807Infusion of autologous EFS-ADA LV CD34+ cells----1件: 65 💬
3808Infusion of autologous mononuclear bone marrow cells----1件: 57 💬
3809Infusion of lentiviral TYF-CGD-modified autologous stem cells----1件: 65 💬
3810Infusions of young plasma----1件: 6 💬
3811Inhaled 7% hypertonic saline (HS)----1件: 299 💬
3812Inhaled AR-501----1件: 299 💬
3813Inhaled carbon monoxide2件: Activated charcoal,
Carbon monoxide		1件: Carbon monoxide 💬--1件: 85 💬
3814Inhaled Dry Powder Mannitol1件: Mannitol1件: Mannitol 💬--1件: 299 💬
3815Inhaled hypertonic saline (7%)----1件: 299 💬
3816Inhaled Iloprost (5 µg)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3817Inhaled iloprost (Ventavis, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3818Inhaled Mannitol1件: Mannitol1件: Mannitol 💬--1件: 299 💬
3819Inhaled Nitric Oxide1件: Nitric Oxide1件: Nitric oxide 💬--2件: 85, 86 💬
3820Inhaled nitric oxide & INOpulse delivery1件: Nitric Oxide1件: Nitric oxide 💬--1件: 86 💬
3821Inhaled Nitric Oxide (iNO) use1件: Nitric Oxide1件: Nitric oxide 💬--1件: 294 💬
3822Inhaled Nitric Oxide - 30 mcg/kg IBW/hr1件: Nitric Oxide1件: Nitric oxide 💬--1件: 85 💬
3823Inhaled Nitric Oxide 5,10,15 mcg/Kg IBW/hr1件: Nitric Oxide1件: Nitric oxide 💬--1件: 85 💬
3824Inhaled nitric oxide 75 mcg/kg IBW/hr1件: Nitric Oxide1件: Nitric oxide 💬--2件: 85, 86 💬
3825Inhaled/swallowed budesonide1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
3826Initiation of CFTR Modulator----1件: 299 💬
3827Injectable MS DMT----1件: 13 💬
3828INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS----1件: 51 💬
3829Injection of apomorphine1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
3830Injection of autologous bone marrow derived mesenchymal stem cells----1件: 13 💬
3831Injection of autologous stromal vascular fraction----1件: 51 💬
3832Injection of cell free media----1件: 13 💬
3833Injection of iron----1件: 96 💬
3834Injection of normal saline----1件: 6 💬
3835Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa----1件: 90 💬
3836Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa----1件: 90 💬
3837Injection of Umbilical cord derived MSCs----1件: 6 💬
3838INM-755----1件: 36 💬
3839INM-755 (cannabinol) cream1件: Cannabinol---1件: 36 💬
3840INN - FILGOTINIB1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
3841INN Parathyroid Hormone (1-84) human1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
3842INN: aceneuramic acid1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
3843INOmax 400ppm mol/mol inhalation gas1件: Nitric Oxide1件: Nitric oxide 💬--2件: 85, 299 💬
3844INOmax 800ppm mol/mol inhalatiegas1件: Nitric Oxide1件: Nitric oxide 💬--1件: 294 💬
3845INS1007 10 mg oral tablet----1件: 299 💬
3846INS1007 25 mg oral tablet----1件: 299 💬
3847Insulin detemir [rDNA origin] injection1件: Insulin detemir1件: Insulin detemir 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299 💬
3848Insulin like growth factor, type 1----1件: 2 💬
3849INT-747----1件: 93 💬
3850INT-747, OCA----2件: 93, 94 💬
3851Inteferone Beta-1A----1件: 13 💬
3852Integrative Medicine----1件: 46 💬
3853INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE1件: Etravirine1件: Etravirine 💬--1件: 18 💬
3854Interferon alpha oral lozenge----1件: 85 💬
3855Interferon Beta1件: Human interferon beta---6件: 13, 20, 26, 50, 96, 97 💬
3856INTERFERON BETA - 1A1件: Human interferon beta---1件: 13 💬
3857Interferon beta - 1a (IFN)1件: Human interferon beta---1件: 13 💬
3858Interferon beta -1b1件: Human interferon beta---1件: 13 💬
3859Interferon Beta 11件: Human interferon beta---1件: 13 💬
3860Interferon Beta 1-A2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3861Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)1件: Human interferon beta---1件: 13 💬
3862Interferon Beta 1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3863Interferon beta 1a 30 ug IM once weekly2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3864Interferon Beta 1a pegilado2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3865Interferon beta 1a, oral doxycycline3件: Doxycycline,
Human interferon beta,
Interferon beta-1a		3件: Doxycycline ,
Interferon beta-1a ,
Doxycycline 💬		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3866Interferon beta 1B1件: Human interferon beta---1件: 13 💬
3867Interferon beta 1b (Betaseron, BAY86-5046)1件: Human interferon beta---1件: 13 💬
3868Interferon Beta Therapy1件: Human interferon beta---1件: 13 💬
3869Interferon beta treatment to add-on atorvastatin treatment2件: Atorvastatin,
Human interferon beta		1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
3870Interferon beta-1 a1件: Human interferon beta---1件: 13 💬
3871INTERFERON BETA-1A2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬4件: 13, 26, 96, 97 💬
3872Interferon beta-1a (Avonex)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3873INTERFERON BETA-1A (Avonex®)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3874Interferon beta-1a (current approved manufacturing process invloving FBS)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3875Interferon beta-1a (new process, manufactured without FBS)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3876Interferon beta-1a (Rebif)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3877Interferon beta-1a (Rebif®) alone2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3878Interferon beta-1a 30 µg2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3879Interferon beta-1a FBS-free/HSA free, RNF2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3880Interferon beta-1a FBS-free/HSA-free2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3881Interferon beta-1a FBS-free/HSA-free, RNF2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3882Interferon beta-1a HSA+ biosimilar2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3883Interferon beta-1a HSA-free biosimilar2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3884Interferon beta-1a original2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3885Interferon Beta-1A Prefilled Syringe2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3886Interferon beta-1a, 30 µg/0.5 ml2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3887INTERFERON BETA-1B2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3888Interferon beta-1b (Betaferon, BAY 86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3889Interferon beta-1b (Betaferon, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3890Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3891Interferon beta-1b (Betaferon®, BAY 86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3892Interferon beta-1b (Betaseron, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3893Interferon beta-1b (Betaseron, Betaferon, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3894Interferon beta-1b (PF530, Betaferon)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3895Interferon beta-1b and Tacrolimus3件: Human interferon beta,
Interferon beta-1b,
Tacrolimus		3件: Tacrolimus ,
Interferon beta-1b ,
Tacrolimus 💬		7件: IFNAR1,
IFNAR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		48件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
3896Interferon beta-1b group2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3897Interferon beta-1b, (Betaseron BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3898Interferon beta-1b, FRP about 6 weeks after randomization2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3899Interferon beta-1b, FRP within 15 days after randomization2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3900Interferon beta-1b/Atorvastatin group3件: Atorvastatin,
Human interferon beta,
Interferon beta-1b		2件: Interferon beta-1b ,
Atorvastatin 💬		3件: HMGCR,
IFNAR1,
IFNAR2 💬		22件: AMPK signaling pathway, Bile secretion, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Terpenoid backbone biosynthesis, Toll-like receptor signaling pathway 💬1件: 13 💬
3901INTERFERON BETA1A----1件: 13 💬
3902Interferon gamma 1b1件: Interferon Gamma---1件: 228 💬
3903INTERFERON GAMMA-1B2件: Interferon Gamma,
Interferon gamma-1b		1件: Interferon gamma-1b 💬2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326 💬
3904Interferon gamma-1b (Actimmune)2件: Interferon Gamma,
Interferon gamma-1b		1件: Interferon gamma-1b 💬2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬1件: 85 💬
3905Interferon ß-1a----1件: 13 💬
3906Interferon ß-1a 30 µg----1件: 13 💬
3907Interferon ß-1b----1件: 13 💬
3908Interferon-1beta (Betaseron, BAY86-5046)1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3909Interferon-Beta1件: Human interferon beta---2件: 13, 97 💬
3910Interferon-beta (IFN-beta)1件: Human interferon beta---1件: 13 💬
3911Interferon-beta 1a1件: Human interferon beta---1件: 13 💬
3912Interferon-beta 1a FBS-free/HSA free, RNF1件: Human interferon beta---1件: 13 💬
3913Interferon-beta 1a FBS-free/HSA-free, RNF1件: Human interferon beta---1件: 13 💬
3914Interferon-beta 1b1件: Human interferon beta---1件: 13 💬
3915Interferon-beta 1b (Betaseron)1件: Human interferon beta---1件: 13 💬
3916Interferon-beta [IFN-beta]1件: Human interferon beta---1件: 13 💬
3917Interferon-beta and human leukocyte Interferon-a1件: Human interferon beta---1件: 13 💬
3918Interferon-beta-11件: Human interferon beta---1件: 13 💬
3919Interferon-beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97 💬
3920Interferon-beta-1a (Avonex) plus methylprednisolone3件: Human interferon beta,
Interferon beta-1a,
Methylprednisolone		2件: Methylprednisolone ,
Interferon beta-1a 💬		3件: IFNAR1,
IFNAR2,
NR3C1 💬		19件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3921Interferon-beta-1a FBS-free/HSA free, RNF2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3922Interferon-beta-1a FBS-free/HSA-free2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3923Interferon-beta-1a, 44 microgram2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 97 💬
3924Interferon-beta-1a, 66 microgram2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 97 💬
3925Interferon-beta-1b2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3926Interferon-beta-1b (BETASERON, BAY 86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3927Interferon-beta1----1件: 13 💬
3928Interferon-gamma 1b----1件: 85 💬
3929Interferon-ß [IFN-ß]----1件: 13 💬
3930Interferon-ß-1----1件: 13 💬
3931Interferon-ß-1a----1件: 13 💬
3932Interferon-ß-1b----1件: 13 💬
3933Interferone beta 1a----1件: 13 💬
3934INTERFERONE BETA 1B----1件: 13 💬
3935Interferone beta-1a----1件: 13 💬
3936Interferone Beta-1B----1件: 13 💬
3937Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		10件: Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod 💬		7件: CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬		30件: Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬1件: 13 💬
3938Interferón beta 1a----1件: 13 💬
3939Interferón beta 1a pegilado----1件: 13 💬
3940Interferón Beta-1a pegilado----1件: 13 💬
3941Interleukin 10----1件: 46 💬
3942Interleukin 111件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
3943Interleukin-111件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬2件: 96, 288 💬
3944Interleukin-71件: Interleukin-7---1件: 25 💬
3945Intermediate dose BIBF 1120 twice daily----1件: 85 💬
3946Intermittent, short infusion Cefepime1件: Cefepime1件: Cefepime 💬--1件: 299 💬
3947Intermittent, short infusion Ceftazidime1件: Ceftazidime2件: Ceftazidime ,
Ceftazidime 💬		--1件: 299 💬
3948Intermittent, short infusion Meropenem1件: Meropenem2件: Meropenem ,
Meropenem 💬		--1件: 299 💬
3949Intermittent, short infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		3件: Tazobactam ,
Piperacillin ,
Piperacillin 💬		--1件: 299 💬
3950Intermittent, short infusion Ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: Clavulanic acid ,
Ticarcillin 💬		--1件: 299 💬
3951Intervention for incipient patients at low risk of disease progression----1件: 66 💬
3952Intervention for patients at high risk of disease progression----1件: 66 💬
3953Intervention on primary cultured cells----1件: 187 💬
3954Intestinal microbiota transplant (IMT)----1件: 86 💬
3955Intra venous injection of stem cell----1件: 2 💬
3956Intra-articular Compound Betamethasone1件: Betamethasone1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
3957Intra-striatal rAAV5-miHTT1件: AMT-130---1件: 8 💬
3958Intraarticular betamethasone1件: Betamethasone1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
3959Intraarticular morphine1件: Morphine1件: Morphine 💬1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 46 💬
3960Intracerebral administration of AAVrh.10cuARSA----1件: 19 💬
3961Intracerebral microinjections----1件: 6 💬
3962Intradetrusor injection of Botulinum Toxin-A----1件: 13 💬
3963Intralipid 10%----1件: 96 💬
3964Intranasal glutathione - (in)GSH1件: Glutathione2件: Glutathione ,
Oxiglutatione 💬		--1件: 6 💬
3965Intranasal oxytocin1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬2件: 127, 193 💬
3966Intranasal Oxytocin (IN-OXT)1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
3967Intraparenchymal rAAV1 - (mi)RNA HTT----1件: 8 💬
3968Intratect 5%----1件: 35 💬
3969Intrathecal administration of autologous MSC-NP----1件: 13 💬
3970Intrathecal methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 13 💬
3971Intrathecal MSC-NP injection----1件: 13 💬
3972Intravenous (i.v.) methylprednisolone 1000 mg, total 91件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
3973Intravenous (IV) Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
3974Intravenous (IV) infusions----2件: 13, 97 💬
3975Intravenous administration of 1 million of MSC----1件: 2 💬
3976Intravenous administration of 2 million of MSC----1件: 2 💬
3977Intravenous administration of 4 million of MSC----1件: 2 💬
3978Intravenous administration of ferric carboxymaltose1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬--1件: 86 💬
3979Intravenous bone marrow mesenchymal stem cells infusion----1件: 60 💬
3980Intravenous Dexamethasone 1 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
3981Intravenous immunoglobulin (IVIG), 10% solution for infusion----1件: 63 💬
3982Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)----1件: 11 💬
3983Intravenous Infusion of Diclofenac Sodium1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 78 💬
3984Intravenous infusion of MSCs----1件: 271 💬
3985Intravenous infusion of transduced cells----1件: 65 💬
3986Intravenous injection autologous mesenchymal stem cells----1件: 67 💬
3987Intravenous injection of mesenchymal stem cells----1件: 13 💬
3988Intravenous methyl prednisolone1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 43 💬
3989Intravenous Methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 13, 145 💬
3990Intravesical injection of Botulinum A toxin----2件: 6, 17 💬
3991Intravesical onabotulinumtoxinA injection1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 226 💬
3992Intravitreal autologous CD34+ cells----1件: 90 💬
3993Intravitreal injection of Autologous bone marrow Stem Cell----1件: 90 💬
3994Intravitreal injection of autologous bone marrow stem cells----1件: 90 💬
3995Investigators Choice of Approved AED----1件: 144 💬
3996Investigators choice of approved AEDs----1件: 144 💬
3997INZ-701----1件: 166 💬
3998IODIO IOFLUPANO-123I----1件: 6 💬
3999IOFLUPANE (123I)----1件: 6 💬
4000Ioflupane 123I----1件: 2 💬
4001Ioflupane 123I (DATSCAN®)1件: Ioflupane I-123---1件: 6 💬
4002Ioflupane [123 I]----1件: 6 💬
4003Ioflupane [123I]----1件: 6 💬
4004Ioflupane I 1232件: Iodide I-123,
Ioflupane I-123		---1件: 6 💬
4005Iohexol Inj 300 milligrams per milliliter (MG/ML)1件: Iohexol1件: Iohexol 💬--1件: 67 💬
4006Iontophoresis of treprostinil1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 51 💬
4007IPD® (Japanese tradename)----1件: 226 💬
4008IPD® (suplatast tosilate)----1件: 226 💬
4009IPI 145----1件: 46 💬
4010IPI-145----1件: 46 💬
4011IPN60130 10 mg capsules----1件: 272 💬
4012IPN60130 50 mg capsules----1件: 272 💬
4013IPP - 201101----1件: 49 💬
4014IPP-201101, P140----1件: 49 💬
4015Ipratropium bromide (drug)1件: Ipratropium---1件: 6 💬
4016IPX054 100 mg----1件: 6 💬
4017IPX054 150 mg----1件: 6 💬
4018IPX054 200 mg----1件: 6 💬
4019IPX054 250 mg----1件: 6 💬
4020IPX054 300 mg----1件: 6 💬
4021IPX056 10 mg----1件: 13 💬
4022IPX056 20 mg----1件: 13 💬
4023IPX056 30 mg----1件: 13 💬
4024IPX056 35 mg----1件: 13 💬
4025IPX056 40 mg----1件: 13 💬
4026IPX056-10 mg----1件: 13 💬
4027IPX056-20 mg----1件: 13 💬
4028IPX056-25 mg----1件: 13 💬
4029IPX056-30 mg----1件: 13 💬
4030IPX056-35 mg----1件: 13 💬
4031IPX056-40 mg----1件: 13 💬
4032IPX066 145 mg----1件: 6 💬
4033IPX066 145 mg LD----1件: 6 💬
4034IPX066 195 mg----1件: 6 💬
4035IPX066 195 mg LD----1件: 6 💬
4036IPX066 245 mg----1件: 6 💬
4037IPX066 245 mg LD----1件: 6 💬
4038IPX066 95 mg----1件: 6 💬
4039IPX066 95 mg LD----1件: 6 💬
4040IPX066-145----1件: 6 💬
4041IPX066-195----1件: 6 💬
4042IPX203 140 mg----1件: 6 💬
4043IPX203 180 mg----1件: 6 💬
4044IPX203 210 mg----1件: 6 💬
4045IPX203 270 mg----1件: 6 💬
4046IPX203 280 mg----1件: 6 💬
4047IPX203 350 mg----1件: 6 💬
4048IR CD-LD (carbidopa-levodopa) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4049IR LD / CD----1件: 6 💬
4050Irbesartan 150-300mg capsules daily for 6 months1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 167 💬
4051Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-031件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
4052Irbesartan tablets (NDA 020 757)1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
4053Irbesartan tablets (NDC# 31722-729-30 approved in the United states)1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
4054Irbesartan tablets (NDC# 43547-0374-03 and NDC 43547-374-09, approved in the USA) Generic tablets distributed by Solco Healthcare US, LLC1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
4055Iron oxide1件: Ferric oxide1件: Ferric oxide 💬--1件: 13 💬
4056Iron supplement 300-600 mg/day1件: Iron---2件: 96, 97 💬
4057Iron(III)- hydroxide dextran complex3件: Dextran,
Hydroxide ion,
Iron		1件: Dextran 1 💬--2件: 96, 97 💬
4058ISIS 1048381件: ISIS 104838---1件: 46 💬
4059ISIS 301012 phosphorothioate oligonucleotide----1件: 79 💬
4060ISIS 396443 (BIIB058)----1件: 3 💬
4061ISIS 396443, BIIB058----1件: 3 💬
4062ISIS 443139 10 mg----1件: 8 💬
4063ISIS 443139 120 mg----1件: 8 💬
4064ISIS 443139 30 mg----1件: 8 💬
4065ISIS 443139 60 mg----1件: 8 💬
4066ISIS 443139 90 mg----1件: 8 💬
4067ISIS 703802----1件: 79 💬
4068Isosorbide Dinitrate 20 mg2件: Isosorbide,
Isosorbide dinitrate		2件: Isosorbide ,
Isosorbide dinitrate 💬		--1件: 113 💬
4069Isosorbide Dinitrate 40 mg2件: Isosorbide,
Isosorbide dinitrate		2件: Isosorbide ,
Isosorbide dinitrate 💬		--1件: 113 💬
4070Isosorbide Dinitrate 60 mg2件: Isosorbide,
Isosorbide dinitrate		2件: Isosorbide ,
Isosorbide dinitrate 💬		--1件: 113 💬
4071Isosorbide Dinitrate 80 mg2件: Isosorbide,
Isosorbide dinitrate		2件: Isosorbide ,
Isosorbide dinitrate 💬		--1件: 113 💬
4072Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung----1件: 50 💬
4073Isotopic Intravenous [13C]-Urea1件: Urea2件: Urea ,
Urea C13 💬		--1件: 251 💬
4074Isradipine CR 10mg1件: Isradipine1件: Isradipine 💬4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
4075Isradipine CR 5mg1件: Isradipine1件: Isradipine 💬4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
4076IST (ATG + CsA)----1件: 60 💬
4077Istradefylline ( KW-6002)1件: Istradefylline1件: Istradefylline 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
4078Istradefylline 20 mg1件: Istradefylline1件: Istradefylline 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
4079Istradefylline 20 mg or 40 mg1件: Istradefylline1件: Istradefylline 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
4080Istradefylline 40 mg1件: Istradefylline1件: Istradefylline 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
4081ITF2357 10 mg/mL----1件: 113 💬
4082Itolizumab [Bmab 600]1件: Itolizumab1件: Itolizumab 💬1件: CD6 💬1件: Cell adhesion molecules 💬1件: 49 💬
4083Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally.2件: Itraconazole,
Terbinafine		2件: Itraconazole ,
Terbinafine 💬		--1件: 96 💬
4084Itraconazole? SHR0302 tablets1件: Itraconazole1件: Itraconazole 💬--1件: 46 💬
4085IUPAC name: 1-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one----1件: 17 💬
4086IUPAC name: 2-[4-[(2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylam ino]benzoyl]amino----1件: 337 💬
4087IV meropenem1件: Meropenem2件: Meropenem ,
Meropenem 💬		--1件: 299 💬
4088IV methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
4089IV methylprednisolone (steroids)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
4090IV migalastat HCl1件: Migalastat1件: Migalastat 💬--1件: 19 💬
4091IV treatment with IGSC, 10%----1件: 65 💬
4092Ivacaftor 125mg tablet1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4093Ivacaftor 150 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4094Ivacaftor 150 mg or 250 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4095Ivacaftor 25 mg/75 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4096IVACAFTOR 59,5mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4097IVACAFTOR 59.5mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4098Ivacaftor 75 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4099Ivacaftor 75 mg/150 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4100IVACAFTOR 75mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4101Ivacaftor or elexacaftor/tezacaftor/ivacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: Ivacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4102Ixazomib (NINLARO®) capsules1件: Ixazomib1件: Ixazomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 13 💬
4103J695, BSF 415977 (formerly LU415977), WAY-165772, A-796874.0----1件: 96 💬
4104JAK1 / JAK2 Inhibitor----1件: 46 💬
4105JAK1 / JAK2 Inhibtor----1件: 46 💬
4106Jaktinib Dihydrochloride Monohydrate 50mg BID and Mimic tablets of jakitinib hydrochloride 75mg BID and Acetylcysteine Effervescent Tablets1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 85 💬
4107Jaktinib Dihydrochloride Monohydrate 75mg BID and Mimic tablets of jakitinib hydrochloride 50mg BID and Acetylcysteine Effervescent Tablets1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 85 💬
4108JBT-101----4件: 49, 50, 51, 299 💬
4109JBT-101 (lenabasum)----1件: 299 💬
4110Jevity 1.0----1件: 2 💬
4111Jevity 1.5----1件: 2 💬
4112JINARC - 15 MG +45 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28X15 MG + 28 X 45 MG)1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4113JINARC - 15 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4114JINARC - 30 MG + 60 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 60 MG)1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4115JINARC - 30 MG +90 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 90 MG)1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4116JINARC - 30 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4117Jinarc - Tolvaptan tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4118Jinarc 15 mg tablets, Jinarc 45 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4119Jinarc 30 mg Tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4120Jinarc 30 mg tablets, 90 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4121Jinarc 30 mg tablets, Jinarc 60 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4122Jinarc® 15mg Tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4123Jinarc® 30 Tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
4124JKB-122----1件: 95 💬
4125JKB-122 in capsule or tablet form----1件: 95 💬
4126JnJ 54767414----1件: 28 💬
4127JNJ-16240159-AAC----1件: 46 💬
4128JNJ-38518168 (10 mg)----1件: 46 💬
4129JNJ-38518168 (3 mg)----1件: 46 💬
4130JNJ-38518168 (30 mg)----1件: 46 💬
4131JNJ-38518168 / MTX----1件: 46 💬
4132JNJ-38518168 50-mg Over Encapsulated Tablet----1件: 46 💬
4133JNJ-38518168-AEK - Over Encapsulated Tablet - 50 mg----1件: 46 💬
4134JNJ-38518168-ZBQ - film-coated tablet - 10 mg----1件: 46 💬
4135JNJ-38518168-ZBQ - film-coated tablet - 10mg----1件: 46 💬
4136JNJ-38518168-ZBQ - film-coated tablet - 3 mg----1件: 46 💬
4137JNJ-38518168-ZBQ - film-coated tablet - 30 mg----1件: 46 💬
4138JNJ-38518168-ZBQ - film-coated tablet - 30mg----1件: 46 💬
4139JNJ-38518168-ZBQ - film-coated tablet - 3mg----1件: 46 💬
4140JNJ-39758979 (10 mg)----1件: 46 💬
4141JNJ-39758979 (100 mg)----1件: 46 💬
4142JNJ-39758979 (30 mg)----1件: 46 💬
4143JNJ-39758979 (300 mg)----1件: 46 💬
4144JNJ-39758979 / MTX----1件: 46 💬
4145JNJ-39758979-AAC - enteric coated tablet - 10 mg----1件: 46 💬
4146JNJ-39758979-AAC - enteric coated tablet - 100 mg----1件: 46 💬
4147JNJ-39758979-AAC - enteric coated tablet - 30 mg----1件: 46 💬
4148JNJ-40346527-AAC - capsule - 50 mg1件: JNJ-40346527---1件: 46 💬
4149JNJ-54767414----2件: 28, 49 💬
4150JNJ-54781532 150 mg once daily----1件: 97 💬
4151JNJ-54781532 25 mg once daily----1件: 97 💬
4152JNJ-54781532 75 mg once daily----1件: 97 💬
4153JNJ-54781532 75 mg twice daily----1件: 97 💬
4154JNJ-54781532-AAD-10 mg----1件: 97 💬
4155JNJ-54781532-AAD-30 mg----1件: 97 💬
4156JNJ-54781532-AAD-5 mg----1件: 97 💬
4157JNJ-55920839----1件: 49 💬
4158JNJ-56022473----1件: 49 💬
4159JNJ-67896062 / ACT-064992----2件: 86, 88 💬
4160JNJ-67896062/ ACT-064992----2件: 86, 88 💬
4161JNJ-67896153/ACT-128800----1件: 13 💬
4162JNJ-72537634----1件: 97 💬
4163JNJ-78934804----2件: 96, 97 💬
4164Jojoba oil1件: Jojoba oil---1件: 36 💬
4165Jojoba oil with broccoli sprout extract2件: Broccoli,
Jojoba oil		---1件: 36 💬
4166Jorveza 0.5 mg compresse orodispersibili1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
4167Jorveza 0.5 mg orodispersible tablets1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
4168Jorveza 1 mg compresse orodispersibili1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
4169Jorveza 1 mg orodispersible tablets1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
4170JP 1730----1件: 6 💬
4171JP-1730/F01----2件: 6, 17 💬
4172JP-1730/F02----2件: 6, 17 💬
4173JP-1730/F03----2件: 6, 17 💬
4174JR-141----1件: 19 💬
4175JR-141 or Idursulfase1件: Idursulfase1件: Idursulfase 💬1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
4176JR-171 (lepunafusp alfa)----1件: 19 💬
4177Jyseleca 100 mg film-coated tablets1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
4178Jyseleca 200 mg film-coated tablets1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
4179JZP-110----1件: 6 💬
4180Kalydeco 150 mg film-c1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4181Kalydeco 150 mg film-coated tablets1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4182Kalydeco 150mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4183Kamada -AAT for Inhalation or inhaled AAT (AAT)----1件: 231 💬
4184Kamada-AAT for Inhalation, 160mg----1件: 231 💬
4185Kamada-AAT for Inhalation, 80mg----1件: 231 💬
4186Kamillenblüten 3ml/10ml----1件: 97 💬
4187KCT-0809 ophthalmic solution----1件: 53 💬
4188Kedrion IVIG 10%----1件: 65 💬
4189Keppra 500mg1件: Levetiracetam1件: Levetiracetam 💬1件: SV2A 💬1件: ECM-receptor interaction 💬1件: 13 💬
4190Kesimpta 20 mg Injektionslösung im Fertigpen1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4191Kesimpta 20 mg solution for injection in pre-filled pen1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4192Ketocal 4:1 liquid Nutricia (intervention)----1件: 256 💬
4193Ketone Monoester----1件: 299 💬
4194Keyhole limpet hemocyanin (KLH) neo-antigen1件: Keyhole limpet hemocyanin---1件: 13 💬
4195KHK4827 140mg SC----1件: 37 💬
4196KIN-1901----1件: 271 💬
4197KIN-1902----1件: 84 💬
4198KINERET*SC 7SIR 100MG 0,67ML1件: Anakinra1件: Anakinra 💬2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬3件: 28, 46, 107 💬
4199Kineret® (Anakinra)1件: Anakinra1件: Anakinra 💬2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 46 💬
4200Kineret® or anakinra1件: Anakinra1件: Anakinra 💬2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 107 💬
4201KIOVIG 100 mg/ml solution for infusion1件: Human immunoglobulin G---2件: 14, 65 💬
4202Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14 💬
4203KN019, 10 mg/kg----1件: 46 💬
4204KN019, 5mg/kg----1件: 46 💬
4205KNS-760704----1件: 2 💬
4206Koselugo 10mg1件: Selumetinib1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
4207KPS-0373, High dose----1件: 18 💬
4208KPS-0373, Low dose----1件: 18 💬
4209Kremezin®, Spherical Adsorptive Carbon1件: Activated charcoal---2件: 96, 97 💬
4210Kreon® 25,000----1件: 299 💬
4211KRP-116D----1件: 226 💬
4212Kuvan 100mg soluble tablet1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
4213Kuvan® (sapropterin dihydrochloride)1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
4214KVD824 300 mg Compresse a rilascio modificato----1件: 65 💬
4215KVD824 300 mg Modified Release Tablets1件: Manganese citrate---1件: 65 💬
4216KVD900 100 mg Film Coated Tablet----1件: 65 💬
4217KVD900 300 mg----1件: 65 💬
4218KVD900 300 mg Film Coated Tablet----1件: 65 💬
4219KVD900 600 mg----1件: 65 💬
4220KW-0761 0.3 mg/kg IV----1件: 26 💬
4221KW-6356 Middle Dose1件: KW-6356---1件: 6 💬
4222KZR-616 maleate1件: KZR-616---1件: 50 💬
4223Kümmel 2ml/10ml----1件: 97 💬
4224L - Antineoplastic and immunomodulating agents----1件: 85 💬
4225L-123 Ioflupane----1件: 6 💬
4226L-Citrulline and Metformin & L-Citrulline2件: Citrulline,
Metformin		1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
4227L-Citrulline Malate1件: Citrulline---1件: 86 💬
4228L-Dopa/ MODOPAR1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4229L-Lysine- N-acetylcysteinate1件: Lysine1件: Lysine 💬--1件: 299 💬
4230L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate1件: Acetate---1件: 97 💬
4231L-methionine1件: Methionine1件: Methionine 💬--1件: 84 💬
4232L-METHIONINE ([11C]METHYL)1件: Methionine1件: Methionine 💬--1件: 84 💬
4233L-methylfolate1件: Levomefolic acid1件: Levomefolic acid 💬--1件: 6 💬
4234L01 - Antineoplastic agents----1件: 85 💬
4235L01X - Other antineoplastic agents----1件: 85 💬
4236L01XE - Protein kinase inhibitors----1件: 85 💬
4237L01XE31 - Nintedanib1件: Nintedanib1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
4238L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE1件: Antithymocyte immunoglobulin (rabbit)---1件: 13 💬
4239L606 (Liposomal Treprostinil) Inhalation Solution 51ug1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4240LABP-104 250mg----1件: 49 💬
4241Lactic acid producing organisms1件: Lactic acid1件: Lactic acid 💬--1件: 299 💬
4242Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers1件: Lactobacillus acidophilus1件: Lactomin 💬--1件: 6 💬
4243Lactobacillus rhamnosus GG ATCC 531031件: Lactobacillus delbrueckii bulgaricus---1件: 97 💬
4244Lactobacilus acidophilus & bifidobacterium animalis/lactis1件: Lactobacillus acidophilus1件: Lactomin 💬--1件: 97 💬
4245Lactose monohydrate1件: Lactose2件: Anhydrous lactose ,
Lactose 💬		--1件: 13 💬
4246Lamotrigin beta----2件: 34, 195 💬
4247Lamotrigin ”Nordic Prime 100 mg----1件: 114 💬
4248Lamotrigin ”Nordic Prime 25 mg----1件: 114 💬
4249Lamotrigin ”Nordic Prime 50 mg----1件: 114 💬
4250Lamotrigine - generic product1件: Lamotrigine1件: Lamotrigine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 38 💬
4251Lamotrigine 25Mg Oral Tablet, Extended Release1件: Lamotrigine1件: Lamotrigine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114 💬
4252Lansoprazole, amoxicillin, clarithromycin3件: Amoxicillin,
Clarithromycin,
Lansoprazole		4件: Amoxicillin ,
Clarithromycin ,
Lansoprazole ,
Amoxicillin 💬		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 222 💬
4253Lansoprazole, clarithromycin, amoxycillin3件: Amoxicillin,
Clarithromycin,
Lansoprazole		4件: Amoxicillin ,
Clarithromycin ,
Lansoprazole ,
Amoxicillin 💬		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 63 💬
4254Lantus 100 units/ml solution for injection in a cartridge----1件: 299 💬
4255LANTUS*SC 5CAR3ML100UI/ML1件: Insulin glargine1件: Insulin glargine 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299 💬
4256Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen----1件: 299 💬
4257Lap TAP Bupivacaine/Epinephrine2件: Bupivacaine,
Epinephrine		2件: Epinephrine ,
Bupivacaine 💬		14件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 96 💬
4258Laquinimod 1.21件: Laquinimod---1件: 13 💬
4259Laquinimod Capsulas 0.6 mg1件: Laquinimod---1件: 13 💬
4260Laquinimod Capsules 0.3 mg1件: Laquinimod---1件: 13 💬
4261Laquinimod capsules 0.5 mg1件: Laquinimod---2件: 8, 96 💬
4262Laquinimod Capsules 0.6 mg1件: Laquinimod---1件: 13 💬
4263Laquinimod Cápsulas 0.5 mg1件: Laquinimod---1件: 96 💬
4264Laquinimod Tablets 0.3 mg1件: Laquinimod---1件: 13 💬
4265Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP5件: Dapsone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone,
Triamcinolone		5件: Triamcinolone ,
Prednisolone ,
Dapsone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 162 💬
4266Large protein molecule----1件: 46 💬
4267LAU-7b----1件: 299 💬
4268LAX-1011件: LAX-101---1件: 8 💬
4269LCI699, 1 mg----1件: 75 💬
4270LCI699, 10 mg----1件: 75 💬
4271LCI699, 20 mg----1件: 75 💬
4272LCI699, 5 mg----1件: 75 💬
4273LCZ696 100 mg----1件: 58 💬
4274LCZ696 200 mg----1件: 58 💬
4275LCZ696 50 mg----1件: 58 💬
4276LD / BE----1件: 6 💬
4277Leflunomide (permitted, not necessary)1件: Leflunomide1件: Leflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 46 💬
4278Leflunomide 20 mg Tablets (Geneva Pharmaceutical)1件: Leflunomide1件: Leflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 46 💬
4279Leflunomide 20 mg+prednisone 0.5mg/kg/d2件: Leflunomide,
Prednisone		2件: Prednisone ,
Leflunomide 💬		2件: DHODH,
NR3C1 💬		4件: Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬1件: 66 💬
4280Leflunomide Mylan1件: Leflunomide1件: Leflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 53 💬
4281LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
4282Lenabasum 20 mg----2件: 51, 299 💬
4283Lenabasum 20 mg Powder in Capsule----1件: 51 💬
4284Lenabasum 5 mg----2件: 51, 299 💬
4285Lenabasum 5 mg Powder in Capsule----1件: 51 💬
4286Lenabasum 5mg Powder in Capsule----1件: 51 💬
4287Lenalidomide, Dexamethasone2件: Dexamethasone,
Lenalidomide		2件: Dexamethasone ,
Lenalidomide 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16 💬
4288Lenalidomide, Dexamethasone and Cyclophosphamide3件: Cyclophosphamide,
Dexamethasone,
Lenalidomide		4件: Cyclophosphamide ,
Dexamethasone ,
Lenalidomide ,
Cyclophosphamide 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
4289Lentiviral vector containing MYO7A gene----2件: 90, 303 💬
4290Lentiviral vector containing the human MY07A gene----2件: 90, 303 💬
4291Lentiviral Vector Trans-Skip gene modified Autologous Mesoangioblasts----1件: 113 💬
4292Lentiviral vector transduced CD34+ cells----1件: 65 💬
4293Lentivirus-mediated delivery of ARSA to the CNS.----1件: 19 💬
4294Leqvio 284 mg solution for injection in pre-filled syringe1件: Inclisiran1件: Inclisiran 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
4295Letairis 10 mg1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
4296Letairis 5 mg1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
4297Leuco-methylthioninium bis(hydromethanesulfonate)1件: Methylthioninium---1件: 127 💬
4298Leuplin DPS 11.25mg----1件: 76 💬
4299Leuprolide acetate 11.25 mg2件: Acetate,
Leuprolide		---1件: 76 💬
4300Leuprolide Acetate 3 Month Depot2件: Acetate,
Leuprolide		---1件: 76 💬
4301Leuprolide acetate 30 mg2件: Acetate,
Leuprolide		---1件: 76 💬
4302Leuprolide Acetate 45 mg2件: Acetate,
Leuprolide		---1件: 76 💬
4303Leuprorelin Acetate 3.75mg Injection2件: Acetate,
Leuprolide		---1件: 76 💬
4304Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen1件: Insulin detemir1件: Insulin detemir 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299 💬
4305LEVODOPA (DC.IT) (FU)1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4306Levodopa (drug), intraduodenal administration1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4307Levodopa (L-DOPA) + Standard care1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4308Levodopa / Benserazid1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4309LEVODOPA / BENSERAZIDE 200 + 50 MG2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4310Levodopa / carbidopa solution2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4311Levodopa 100 mg / benserazide 25 mg2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4312Levodopa 100 mg A CAP1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4313Levodopa 125 mg A CAP1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4314Levodopa 150 mg A CAP1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4315Levodopa 25mg/100mg1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4316Levodopa 75 mg A CAP1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4317Levodopa Benserazide Madopar2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4318Levodopa Benserazide Teva Italia2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4319Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4320Levodopa MR1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4321Levodopa, carbidopa, entacapone3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4322Levodopa, carbidopa, ODM-1042件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4323Levodopa, decarboxylase inhibitor and COMT inhibitor1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4324Levodopa-4'-Monophosphate2件: Foslevodopa,
Levodopa		2件: Levodopa ,
Foslevodopa 💬		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4325Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4326Levodopa-carbidopa Immediate Release (LC-IR) Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4327Levodopa-Carbidopa Multilayer Extended Release Tablet2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4328Levodopa-Carbidopa XL tablet (M)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4329Levodopa/benserazide2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4330Levodopa/benserazide 100/25 mg2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4331LEVODOPA/BENZERASIDE1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4332Levodopa/Benzerazide1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4333Levodopa/Carbidopa (4:1)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 201 💬
4334Levodopa/carbidopa 100/252件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4335Levodopa/Carbidopa(200mg/50mg)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4336LEVOFOLENE 4 MG 30 CPR1件: Levoleucovorin---1件: 13 💬
4337Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 11件: Aminolevulinic acid1件: Aminolevulinic acid 💬--1件: 34 💬
4338Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 21件: Aminolevulinic acid1件: Aminolevulinic acid 💬--1件: 34 💬
4339Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 31件: Aminolevulinic acid1件: Aminolevulinic acid 💬--1件: 34 💬
4340LFB-R603, TGTX1101----1件: 13 💬
4341Liatermin (r-metHuGDNF)1件: Liatermin1件: Liatermin 💬--1件: 6 💬
4342Lidocaine 1% Injectable Solution1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 34 💬
4343Lidocaine 2% without vessel constrictor1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 51 💬
4344Lidocaine Hydrochloride, Injectable1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
4345Lidocaine patch 5%1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
4346Lidocaine Releasing Intravesical System - LiRIS®1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 226 💬
4347LimphoStat-B----1件: 53 💬
4348Linerixibat (GSK2330672) 40 mg----1件: 93 💬
4349Linerixibat (GSK2330672) 45 mg----1件: 93 💬
4350Linerixibat (GSK2330672) 45mg----1件: 93 💬
4351Lingzhi and Sen Miao San----1件: 46 💬
4352Linoleic Acid/Oleic Acid2件: Linoleic acid,
Oleic Acid		1件: Oleic acid 💬--1件: 13 💬
4353LION-101 dose level 1----1件: 113 💬
4354LION-101 dose level 2----1件: 113 💬
4355LIORESAL*50CPR 10MG1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 2 💬
4356Liothyronine I 1312件: Liothyronine,
Liothyronine I-131		1件: Liothyronine 💬2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬2件: 210, 212 💬
4357Lipasa ácida lisosómica, esterasa, colesterol (gen humano LIPA), lipasa ácida lisosómica (gen humano LIPA)----1件: 19 💬
4358Lipiodol® Ultra Fluid with surgical glues1件: Ethiodized oil2件: Ethiodized oil ,
Ethiodized oil I 131 💬		--1件: 280 💬
4359Lipoic acid (LA) with fish oil and LA without fish oil2件: Fish oil,
Lipoic acid		---1件: 13 💬
4360Lipoic acid and omega-3 fatty acids2件: Lipoic acid,
Omega-3 fatty acids		---1件: 13 💬
4361Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.1件: Amikacin1件: Amikacin 💬--1件: 299 💬
4362Liposomal amphotericin B (Ambisome®)1件: Amphotericin B1件: Amphotericin B 💬--1件: 299 💬
4363Liposomal bupivacaine1件: Bupivacaine1件: Bupivacaine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 51, 70, 96 💬
4364Liposomal Cyclosporine A 10 mg1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
4365Liposomal Cyclosporine A 5 mg1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
4366Liposome encapsulated BoNT-A----1件: 226 💬
4367Liprotamase Powder for Oral Solution----1件: 299 💬
4368LIQ861 100 µg----1件: 86 💬
4369LIQ861 106 µg----1件: 86 💬
4370LIQ861 26.5 µg----1件: 86 💬
4371LIQ861 50 µg----1件: 86 💬
4372LIQ861 53 µg----1件: 86 💬
4373LIQ861 75 µg----1件: 86 💬
4374LIQ861 79.5 µg----1件: 86 💬
4375Liquigen MCT oil----1件: 6 💬
4376LiRIS 400 mg----1件: 226 💬
4377LiRIS® 400 mg----1件: 226 💬
4378Lisinopril, losartan, and atorvastatin3件: Atorvastatin,
Lisinopril,
Losartan		4件: Lisinopril ,
Atorvastatin ,
Lisinopril ,
Losartan 💬		3件: ACE,
AGTR1,
HMGCR 💬		22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
4379Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field----1件: 13 💬
4380Lisuride TTS 10cm²1件: Lisuride1件: Lisuride 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4381Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)1件: Triacetin1件: Triacetin 💬--1件: 307 💬
4382LIV-GAMMA SN Inj.10%----1件: 63 💬
4383Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules1件: Lactobacillus delbrueckii bulgaricus---1件: 6 💬
4384LJN452, 0,01 mg----1件: 93 💬
4385LJN452, 0,03 mg----1件: 93 💬
4386LJN452, 0,1 mg----1件: 93 💬
4387Lloprost(Ventavis,BAYQ6252, 10 µg/mL)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4388Lloprost(Ventavis,BAYQ6252, 20 µg/mL)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4389Lo-Ovral Oral Contraceptive Pills----1件: 60 💬
4390LOBIVON*28CPR 5MG----1件: 167 💬
4391Local Trade Name, 2mg----1件: 6 💬
4392Local Trade Name, 4mg----1件: 6 💬
4393Local Trade Name, 8mg----1件: 6 💬
4394Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI)----1件: 13 💬
4395Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)4件: Acetate,
Estradiol,
Ethinylestradiol,
Norethisterone		3件: Estradiol ,
Norethindrone ,
Ethinyl estradiol 💬		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 46, 49 💬
4396Lojuxta 10 mg hard capsules1件: Lomitapide1件: Lomitapide 💬1件: MTTP 💬1件: Fat digestion and absorption 💬1件: 79 💬
4397Lojuxta 20 mg hard capsules1件: Lomitapide1件: Lomitapide 💬1件: MTTP 💬1件: Fat digestion and absorption 💬1件: 79 💬
4398Lojuxta 5 mg hard capsules1件: Lomitapide1件: Lomitapide 💬1件: MTTP 💬1件: Fat digestion and absorption 💬1件: 79 💬
4399Lomecel-B medicinal signaling cells----1件: 211 💬
4400Lonafarnib, Zoledronic Acid, and Pravastatin3件: Lonafarnib,
Pravastatin,
Zoledronic acid		4件: Zoledronic acid ,
Lonafarnib ,
Pravastatin ,
Zoledronic acid 💬		4件: FDPS,
FNTA,
FNTB,
HMGCR 💬		6件: AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 333 💬
4401Longeveron Mesenchymal Stem Cells----1件: 211 💬
4402Lopinavir/ritonavir + nevirapine3件: Lopinavir,
Nevirapine,
Ritonavir		3件: Ritonavir ,
Nevirapine ,
Lopinavir 💬		--1件: 265 💬
4403Lopinavir/ritonavir + zidovudine + lamivudine4件: Lamivudine,
Lopinavir,
Ritonavir,
Zidovudine		4件: Lamivudine ,
Zidovudine ,
Ritonavir ,
Lopinavir 💬		--1件: 265 💬
4404Loratadina STADA 10 mg1件: Loratadine1件: Loratadine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 89 💬
4405Lorenzo's Oil----1件: 20 💬
4406LORTAAN*28CPR RIV DIV 50MG----1件: 167 💬
4407Losartan and Atenolol or Propranolol3件: Atenolol,
Losartan,
Propranolol		3件: Atenolol ,
Losartan ,
Propranolol 💬		4件: ADRB1,
ADRB2,
ADRB3,
AGTR1 💬		23件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 167 💬
4408Losartan and other angiotensin receptor blockers2件: Angiotensin II,
Losartan		3件: Angiotensin II ,
Angiotensin II ,
Losartan 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 19 💬
4409Losartan Bluefish 50 mg2件: Bluefish,
Losartan		1件: Losartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58 💬
4410Losartan Tablets & QingReMoShen Granule1件: Losartan1件: Losartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
4411Losec Capsules 20 mg1件: Omeprazole1件: Omeprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 46 💬
4412Lovastatin 60 MG1件: Lovastatin1件: Lovastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 34 💬
4413Lovastatin, then Minocycline/Lovastatin2件: Lovastatin,
Minocycline		2件: Lovastatin ,
Minocycline 💬		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 206 💬
4414Low dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
4415Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day1件: Vitamin D---1件: 13 💬
4416Low Dose Aspirin (162 mg/day)1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
4417Low dose BIBF 1120 twice daily----1件: 85 💬
4418Low dose BIBF1120 once daily----1件: 85 💬
4419Low Dose Budesonide1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
4420Low dose budesonide tablet1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
4421Low Dose Mesenchymal Stem Cells (MSCs)----1件: 49 💬
4422Low Dose MT-1303----1件: 97 💬
4423Low Dose MYOBLOC1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
4424Low dose of BIIL 284 BS tablets----1件: 46 💬
4425Low dose ORTD-1----1件: 46 💬
4426Low immunogenic interferon-beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4427Low Molecular Weight Heparin Calcium Injection2件: Calcium,
Heparin		1件: Adomiparin 💬1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 224 💬
4428LP-168 tablet----1件: 13 💬
4429LT-02 (modified-release PC pellets)1件: Manganese citrate---1件: 97 💬
4430LTS 0.5mg----1件: 46 💬
4431LTS 1.0mg----1件: 46 💬
4432LU 70274----1件: 299 💬
4433LUM001 (Maralixibat)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 297 💬
4434Lumacaftor / ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4435Lumacaftor, Ivacaftor Drug Combination2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4436Lumacaftor/ivacaftor 100mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4437Lumacaftor/ivacaftor 200mg/125mg2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4438Lumacaftor/ivacaftor 200mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
4439Lung Spheroid Stem Cells 100 million----1件: 85 💬
4440Lung Spheroid Stem Cells 200 million----1件: 85 💬
4441Luphere depot 3.75mg(Leuprolide acetate 3.75mg)2件: Acetate,
Leuprolide		---1件: 76 💬
4442Lutein (10 or 30 mg/day) capsules1件: Lutein---1件: 90 💬
4443LX3305 250 mg capsule----1件: 161 💬
4444LX3305 mid dose----1件: 46 💬
4445LY03003 ( Rotigotine, extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4446LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4447LY03003( the name of rotigotine)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4448LY03003(Rotigotine,extended-release microspheres)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4449LY3090106 - IV----1件: 46 💬
4450LY3090106 - SQ----1件: 46 💬
4451LY3337641 20 mg----1件: 46 💬
4452LY3337641 5 mg----1件: 46 💬
4453Lycium Barbarum----1件: 90 💬
4454LymphoStat-B----1件: 49 💬
4455LymphoStat-B TM----1件: 49 💬
4456LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA®1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
4457Lysomucil 10 %----1件: 299 💬
4458Lysosomal acid lipase, Esterase cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬--1件: 19 💬
4459Lysosomal acid lipase, Esterase, cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬--1件: 19 💬
4460LYT-100----1件: 85 💬
4461M-M-RVAXPRO3件: Measles virus vaccine live attenuated,
Mumps virus strain B level jeryl lynn live antigen,
Rubella virus vaccine		---1件: 107 💬
4462M2591 25 mg QD----1件: 46 💬
4463M2951 (Other Name: Evobrutinib)1件: Evobrutinib1件: Evobrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 49 💬
4464M2951 50 mg BID----1件: 46 💬
4465M2951 75 mg QD----1件: 46 💬
4466M5049 medium dose----1件: 49 💬
4467MABCAMPATH 10 mg/ml concentrado para solución para perfusión1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
4468MabCampath-1h1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
4469MabionCD20 (candidate biosimilar to rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4470MABp1 (Bermekimab)1件: Bermekimab1件: Bermekimab 💬1件: IL1A 💬21件: AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬1件: 51 💬
4471MABTHERA - 1 FIALA 500 MG 50 ML1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 14, 53 💬
4472MABTHERA - 2 FIALE 100 MG 10 ML1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 19, 65 💬
4473MabThera 100 mg concentrate for solution for infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
4474MabThera 100mg1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4475MabThera 5001件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 271 💬
4476MabThera 500 mg1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4477MabThera 500 mg (10 mg/ml) concentrate for solution for infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4478MabThera 500 mg (10mg/ml)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4479MABTHERA 500 mg concentrado para solución para perfusión1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4480MabThera 500 mg concentrate for solution for infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 46, 222 💬
4481MabThera 500 mg Konzentrat zur Herstellung einer Infusionslösung1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4482MabThera 500mg1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4483Mabthera or biosimilar Rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 61 💬
4484Mabthera or biosimilar rituximab product1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
4485MABTHERA*EV 1FL 50ML 500MG1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 46, 222 💬
4486MabThera® (rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4487MabThera® 100MG1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 43 💬
4488MabThera® 500MG1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 43 💬
4489MabThera®, 100 mg Concentrado para solución para perfusión1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4490MabThera®, 100 mg concentrate for solution for infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
4491Macitentan 10 mg1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 86, 88 💬
4492Macitentan 10 mg tablet, once daily.1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
4493Macitentan 10mg1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 51, 88 💬
4494Macitentan 3 mg1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51 💬
4495Macitentan 37.5 mg1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
4496Macitentan 75 mg1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
4497Madopar 125 mg T, tablets----1件: 6 💬
4498Madopar 125 mg, orodispersible tablet----1件: 6 💬
4499Madopar 200+50 mg----1件: 6 💬
4500Madopar monotherapy----1件: 6 💬
4501Madopar Tab. 125 or Perkin Tab. 25-100mg----1件: 6 💬
4502Madopar® 125----1件: 6 💬
4503Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride)2件: Benserazide,
Levodopa		2件: Levodopa ,
Benserazide 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
4504Madopar® 250----1件: 6 💬
4505Madopar® HBS----1件: 6 💬
4506Madopar® HBS 125----1件: 6 💬
4507Magnesiocard 2.5mmol----1件: 298 💬
4508Magnesium oxide2件: Magnesium,
Magnesium oxide		1件: Magnesium oxide 💬--3件: 6, 166, 291 💬
4509Mannitol + pulmozyme2件: Dornase alfa,
Mannitol		2件: Mannitol ,
Dornase alfa 💬		--1件: 299 💬
4510MANNITOLO 18%----1件: 2 💬
4511MANNITOLO 18% LDB----1件: 2 💬
4512MANTADAN*20CPR 100MG----1件: 13 💬
4513Manufacturerd by Cambridge Therapeutic Antibody Centre, Burroughs Wellcome, Glaxo Wellcome)----1件: 46 💬
4514Maralixibat (formely SHP625 or LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338 💬
4515Maralixibat (formerly SHP625 or LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338 💬
4516Maralixibat (in precedenza SHP625 o LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338 💬
4517Mare´s milk----2件: 96, 97 💬
4518Masitinb mesylate----1件: 13 💬
4519Masitinib (4.5)1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 2, 13 💬
4520Masitinib 100 mg Tablets1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 2 💬
4521Masitinib 100mg1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 2, 5 💬
4522Masitinib 200 mg Tablets1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 2 💬
4523Masitinib 3 mg1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 46 💬
4524Masitinib 6.0 mg1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 46 💬
4525Masitinib mesilate1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 2, 13 💬
4526MASITINIB MESYLATE1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96 💬
4527MASP-2 Antibody, OMS00620646, OMS6206461件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬1件: 66 💬
4528MATRICARIA RECUTITA L. FLOS----1件: 97 💬
4529MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
4530MAVENCLAD 10 mg tablets1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
4531Mavenclad tabletter 10 mg1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
4532Mavrilimumab 10 mg1件: Mavrilimumab1件: Mavrilimumab 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
4533Mavrilimumab 100 mg1件: Mavrilimumab1件: Mavrilimumab 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
4534Mavrilimumab 150 mg1件: Mavrilimumab1件: Mavrilimumab 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
4535Mavrilimumab 30 mg1件: Mavrilimumab1件: Mavrilimumab 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
4536Mavrilimumab 50 mg1件: Mavrilimumab1件: Mavrilimumab 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46 💬
4537Maximal oral 5ASA----1件: 97 💬
4538MAXOMAT ®, biosynthetic growth hormone1件: Somatotropin---1件: 195 💬
4539Mayzent 0,25 mg Filmtabletten1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
4540Mayzent 0.25 mg fi1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
4541Mayzent 2 mg film-coated tablets1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
4542Mayzent 2 mg Filmtabletten1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
4543MB-102----1件: 96 💬
4544MBS2320 20 mg----1件: 46 💬
4545MBS2320 40 mg----1件: 46 💬
4546MBS2320 5 mg----1件: 46 💬
4547MBX-8025 50 mg (Dose Escalation Period 1)----1件: 79 💬
4548MBX-8025 50 mg or 100 mg (Dose Escalation Period 2)----1件: 79 💬
4549MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3)----1件: 79 💬
4550MBX-8025, DSIC----1件: 93 💬
4551MBX-8025, Formulation 2----1件: 93 💬
4552MCI-186----1件: 2 💬
4553MCI-186 in open label phase----1件: 2 💬
4554MD-711----1件: 86 💬
4555MD1003 100 mg capsule----1件: 20 💬
4556MD1003 100mg capsule----1件: 13 💬
4557MDX-1100----3件: 46, 96, 97 💬
4558MDX-1100 (anti-CXCL10 human monoclonal antibody)----1件: 97 💬
4559MDX-1342----1件: 46 💬
4560ME2125 (safinamide mesilate)1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
4561Measles, Mumps, Rubella vaccination----1件: 107 💬
4562Mecasermin [rDNA Origin] 10mg/ml solution1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 96 💬
4563MEDI 545----1件: 49 💬
4564MEDI-522----1件: 46 💬
4565MEDI-545----2件: 49, 50 💬
4566MEDI-545 600----1件: 49 💬
4567MEDI-546----2件: 49, 51 💬
4568MEDI-551----2件: 13, 51 💬
4569MEDI-551 100 MG-IV----1件: 13 💬
4570MEDI-551 30 MG-IV----1件: 13 💬
4571MEDI-551 300 MG-SC----1件: 13 💬
4572MEDI-551 60 MG-SC----1件: 13 💬
4573MEDI-551 600 MG-IV----1件: 13 💬
4574MEDI-563----5件: 44, 45, 98, 162, 299 💬
4575MEDI-570 0.03 MG----1件: 49 💬
4576MEDI-570 0.1 MG----1件: 49 💬
4577MEDI-570 0.3 MG----1件: 49 💬
4578MEDI-570 1 MG----1件: 49 💬
4579MEDI7183 medium dose----1件: 97 💬
4580MEDI9929 anti-TSLP mAb (AMG157)1件: Tezepelumab1件: Tezepelumab 💬1件: TSLP 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 98 💬
4581MediCabilis CBD Oil----1件: 2 💬
4582Medical air (sham O2)2件: Medical air,
Oxygen		1件: Oxygen 💬--1件: 85 💬
4583Medical Air vs Oxygen2件: Medical air,
Oxygen		1件: Oxygen 💬--1件: 193 💬
4584Medical Grade Oxygen1件: Oxygen1件: Oxygen 💬--1件: 299 💬
4585Medical Marijuana1件: Medical Cannabis---1件: 13 💬
4586Medical Standard of Care for ITP----1件: 63 💬
4587Mediterranean diet supplemented with medium-chain triglyceride oil----1件: 6 💬
4588Medium THC/medium CBD----1件: 46 💬
4589MEDROL - 4 MG COMPRESSE 30 COMPRESSE----1件: 56 💬
4590Medrol 4 mg tablets1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
4591Medrol A 16 mg tablets1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
4592MEDROL*10CPR DIV 4MG1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
4593Megadose oral methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
4594Melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d2件: Eflornithine,
Melarsoprol		2件: Melarsoprol ,
Eflornithine 💬		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65 💬
4595Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d2件: Melarsoprol,
Nifurtimox		2件: Melarsoprol ,
Nifurtimox 💬		--1件: 65 💬
4596Melissenblätter 15ml/10ml----1件: 97 💬
4597Meloxicam 0.125 mg/kg1件: Meloxicam1件: Meloxicam 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4598Meloxicam 0.25 mg/kg1件: Meloxicam1件: Meloxicam 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4599Meloxicam oral suspension1件: Meloxicam1件: Meloxicam 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4600Melphalan, thalidomide and dexamethasone3件: Dexamethasone,
Melphalan,
Thalidomide		3件: Dexamethasone ,
Melphalan ,
Thalidomide 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
4601Melphalan-Flufenamide (Melflufen)2件: Melphalan,
Melphalan flufenamide		2件: Melphalan ,
Melphalan flufenamide 💬		--1件: 28 💬
4602Memantin Orion----1件: 6 💬
4603Memantine Hydrochloride Oral Solution1件: Memantine1件: Memantine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 2 💬
4604MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
4605MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
4606MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
4607MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
4608MENINGOCOCCAL GROUP Y OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (Â197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11 💬
4609MENTHA × PIPERITA L. FOLIUM----1件: 97 💬
4610MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC9件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine,
Meningococcal polysaccharide vaccine group A,
Meningococcal polysaccharide vaccine group C,
Meningococcal polysaccharide vaccine group W-135,
Meningococcal polysaccharide vaccine group Y,
Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen		2件: Meningococcal polysaccharide vaccine group A ,
Meningococcal polysaccharide vaccine group C 💬		--2件: 62, 66 💬
4611MENVEO – Polvere e soluzione per soluzione iniettabile9件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine,
Meningococcal polysaccharide vaccine group A,
Meningococcal polysaccharide vaccine group C,
Meningococcal polysaccharide vaccine group W-135,
Meningococcal polysaccharide vaccine group Y,
Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen		2件: Meningococcal polysaccharide vaccine group A ,
Meningococcal polysaccharide vaccine group C 💬		--2件: 61, 62 💬
4612Mepolizumab (a-IL-5 antibody)1件: Mepolizumab1件: Mepolizumab 💬1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 162 💬
4613Mepolizumab 100 mg1件: Mepolizumab1件: Mepolizumab 💬1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 98 💬
4614Mepolizumab 300 mg1件: Mepolizumab1件: Mepolizumab 💬1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 98 💬
4615MERCAPTAMINE BITARTRATE1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
4616Mercaptamine, mercamine, 2-aminoethanethiol1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
4617Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie1件: Meropenem2件: Meropenem ,
Meropenem 💬		--1件: 299 💬
4618Mesalamine Once-Daily1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4619Mesalamine Oral Product1件: Mesalazine1件: Mesalamine 💬--1件: 98 💬
4620Mesalamine, 5-aminosalicylic acid2件: Aminosalicylic acid,
Mesalazine		2件: Aminosalicylic acid ,
Mesalamine 💬		--1件: 96 💬
4621Mesalamine, 5-aminosalicylic acid [5-ASA]2件: Aminosalicylic acid,
Mesalazine		2件: Aminosalicylic acid ,
Mesalamine 💬		--1件: 97 💬
4622Mesalamine, 5-ASA1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4623Mesalazine (3,600 mg)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4624Mesalazine (Mesalamine)1件: Mesalazine1件: Mesalamine 💬--1件: 96 💬
4625Mesalazine - TID 1000 mg1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4626Mesalazine - TID 2x 500 mg1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4627Mesalazine 1000 mg gastro-resistant tablets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4628Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet2件: Mesalazine,
Nitazoxanide		2件: Mesalamine ,
Nitazoxanide 💬		--1件: 97 💬
4629Mesalazine 500 mg gastro-resistant tablets (Salofa1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4630Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4631Mesalazine EC 500 mg1件: Mesalazine1件: Mesalamine 💬--1件: 96 💬
4632Mesalazine, Tripterygium glycosides2件: Mesalazine,
Tripterygium wilfordii whole		1件: Mesalamine 💬--1件: 96 💬
4633Mesenchymal stem cell 0.5----1件: 228 💬
4634Mesenchymal stem cell 1.0----1件: 228 💬
4635Mesenchymal stem cells (MSC)----3件: 2, 13, 96 💬
4636Mesenchymal stem cells (MSCs)----4件: 13, 36, 96, 97 💬
4637Mesenchymal stem cells derived from bone marrow (BM-MSCs)----1件: 36 💬
4638Mesenchymal Stem Cells extracted from bone marrow----1件: 36 💬
4639Mesenchymal Stem Cells from Wharton ´s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ´s jelly----1件: 51 💬
4640Mesenchymal stromal cells (MSC) for infusion1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 96 💬
4641Metabolic balance measurements1件: Isoxaflutole---1件: 81 💬
4642Metalcaptase® 150 mg gastro-resistant tablet----1件: 171 💬
4643Metalcaptase® 300 mg gastro-resistant tablet----1件: 171 💬
4644Metex 10 mg/ml Injektionslösung, Fertigspritze----1件: 46 💬
4645Metex 10mg Tabletten----1件: 46 💬
4646Metex 2,5 mg Tabletten----1件: 44 💬
4647Metex 2,5mg Tabletten----1件: 46 💬
4648Metex 50 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte----1件: 46 💬
4649Metex 7,5mg Tabletten----1件: 46 💬
4650Metex® 50 mg/ml Injektionslösung, Fertigspritze----1件: 46 💬
4651MetFORMIN 1000 Mg Oral Tablet1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
4652Metformin 500 Mg Oral Tablet, up to 4 tablets a day1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
4653Metformin 500 mg TID Oral Tablet1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 97 💬
4654Metformin 500mg1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
4655Metformin and Metformin & L-Citrulline2件: Citrulline,
Metformin		1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
4656Metformin/CP-690,5501件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 46 💬
4657METFORMINA - 500 30 COMPRESSE 500 MG1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113 💬
4658METFORMINE ARROW 500mg1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 46 💬
4659Metformine HCL 500 PCH1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 299 💬
4660Metformine Sandoz 850 mg filmomhulde tabletten1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 81 💬
4661Methotrexat 2,5 mg Tabletten medac1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4662Methotrexat HEXAL® 2,5 mg Tabletten1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4663Methotrexat Lachema 2,5mg1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50 💬
4664Methotrexat Lachema 2,5mg tbl.1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50 💬
4665Methotrexat Lachema 5 inj. sol1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50 💬
4666METHOTREXAT Lederle - Tabletten1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4667Methotrexat Lederle 2.5mg tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4668Methotrexate 'Lederle' 2,5mg tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4669Methotrexate 'Lederle' 2.5mg Tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4670Methotrexate 'Lederle' Tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4671Methotrexate (Metoject® prefilled pen)1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4672Methotrexate (MTX)1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4673Methotrexate + Infliximab2件: Infliximab,
Methotrexate		2件: Methotrexate ,
Infliximab 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
4674Methotrexate + Methylprednisolone2件: Methotrexate,
Methylprednisolone		2件: Methotrexate ,
Methylprednisolone 💬		3件: DHFR,
DHFR2,
NR3C1 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬1件: 46 💬
4675METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 96 💬
4676Methotrexate - Amneal1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4677Methotrexate - DAVA1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4678Methotrexate - Delay1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4679Methotrexate - etanercept - prednisolone arm3件: Etanercept,
Methotrexate,
Prednisolone		3件: Methotrexate ,
Prednisolone ,
Etanercept 💬		5件: DHFR,
DHFR2,
LTA,
NR3C1,
TNF 💬		72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 107 💬
4680Methotrexate - Immediate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4681Methotrexate 10 mg1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4682Methotrexate 10 mg tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4683Methotrexate 2.5 mg1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44 💬
4684METHOTREXATE 2.5 mg tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4685Methotrexate 2.5mg Tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4686Methotrexate 2.5mg Tablets BP1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4687Methotrexate 25 mg1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44 💬
4688Methotrexate 50mg/ml solution for injection, pre-filled syringe1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4689Methotrexate ``Lederle`` 2.5mg tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4690Methotrexate as methotrexate disodium1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4691Methotrexate bellon1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 97 💬
4692Methotrexate bellon 25mg/ml1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 97 💬
4693METHOTREXATE HOSPIRA 2,5 mg tablety1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4694METHOTREXATE HOSPIRA 2.5 mg tablety1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4695Methotrexate Lachema 5inj. sol1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50 💬
4696Methotrexate Lederle 2.5 mg Tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4697Methotrexate Pfizer 2,5 mg tabletter1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4698Methotrexate plus ENBREL or ENBREL alone1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4699Methotrexate plus ERB-041 for 12 weeks1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4700Methotrexate Sodium 2.5mg Tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4701Methotrexate Sodium Tablets 2.5 mg1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4702Methotrexate Sodium Tablets 2.5mg1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4703Methotrexate tablets 2.5 mg1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4704Methotrexate Wyeth 2,5mg1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50 💬
4705Methotrexate Wyeth 2,5mg tbl.1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50 💬
4706Methotrexate ® 2.5mg Tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4707Methotrexate(MTX)1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4708Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4709Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4710METHOTREXATE*100CPR 2,5MG1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4711METHOTREXATE*10MG/1,33ML 4S1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4712METHOTREXATE*15MG/2ML 4SIR1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4713METHOTREXATE*2,5MG 25CPR1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4714METHOTREXATE*25CPR 2,5MG1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬2件: 46, 107 💬
4715METHOTREXATE*7,5MG/ML 4SIR.1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4716Methotrexate, Leucovorin and BMS-9861423件: BMS-986142,
Leucovorin,
Methotrexate		3件: Methotrexate ,
Folinic acid ,
Folinic acid calcium salt pentahydrate 💬		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4717Methotrexate® 2.5 mg tablets1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4718Methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-beta-Dribofuronamide1件: Adenine1件: Adenine 💬--1件: 46 💬
4719Methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-ß-Dribofuronamide1件: Adenine1件: Adenine 💬--1件: 46 💬
4720Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo----1件: 86 💬
4721Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb----2件: 86, 88 💬
4722Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth----2件: 86, 88 💬
4723METHYLENE BLUE1件: Methylene blue2件: Methylene blue ,
Methylthioninium chloride hydrate 💬		--1件: 97 💬
4724Methylene blue 25mg tablets1件: Methylene blue2件: Methylene blue ,
Methylthioninium chloride hydrate 💬		--1件: 97 💬
4725Methylenetetrahydrofolate reductase (MTHFR) deficiency----1件: 337 💬
4726Methylphenidate (MPD)1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 6 💬
4727Methylphenidate (overencapsulated)1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84 💬
4728Methylphenidate 10mg tablets1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84 💬
4729Methylphenidate modified release1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
4730Methylphenidate modified release 20 mg1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
4731Methylphenidate modified release 30 mg1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
4732Methylphenidate modified release 40 mg1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
4733Methylphenidate Oral Solution1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 206 💬
4734Methylphenidate, fluoxetin, risperidone3件: Fluoxetine,
Methylphenidate,
Risperidone		3件: Fluoxetine ,
Risperidone ,
Methylphenidate 💬		5件: DRD2,
HTR2A,
SLC6A2,
SLC6A3,
SLC6A4 💬		14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬2件: 179, 206 💬
4735Methylprednisolon (Solu-Medrol)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14 💬
4736Methylprednisolon-21-hydrogensuccinat, Natriumsalz1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
4737Methylprednisolone (MP)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 60, 285 💬
4738Methylprednisolone (MP) or prednisone (pred)2件: Methylprednisolone,
Prednisone		2件: Methylprednisolone ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
4739Methylprednisolone (or other glucocorticoid)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 43 💬
4740Methylprednisolone (Solu-Medrol)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14 💬
4741Methylprednisolone 1250 mg/24h x3 days1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
4742Methylprednisolone and Mycophenolate mofetil3件: Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid		3件: Methylprednisolone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬2件: 93, 95 💬
4743Methylprednisolone bolus IV 15 mg/kg/d for 3 days.1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
4744METHYLPREDNISOLONE MYLAN Générique1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
4745Methylprednisolone or budesonide2件: Budesonide,
Methylprednisolone		2件: Budesonide ,
Methylprednisolone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
4746Methylprednisolone or Prednisolone2件: Methylprednisolone,
Prednisolone		2件: Methylprednisolone ,
Prednisolone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65 💬
4747Methylprednisolone(intravenously in the 1st-2nd-3rd month )1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
4748Methylprednisolone(intravenously in the 1st-3rd-5th month)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
4749METILPREDNISOLONE HIKMA - 1000 MG POLVERE PER SOLUZIONE INIETTABILE 10 FLACONCINI IN VETRO----1件: 300 💬
4750METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL1件: Metoclopramide1件: Metoclopramide 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 51 💬
4751MetoHEXAL® Succ ® 23,75 mg Retardtabletten----1件: 113 💬
4752MetoHEXAL® Succ ® 47,5 mg Retardtabletten----1件: 113 💬
4753MetoHEXAL® Succ ® 95 mg Retardtabletten----1件: 113 💬
4754Metoject 10 mg/ml1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50 💬
4755METOJECT 10 mg/ml, solution injectable en seringue pré-remplie1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44 💬
4756Metopirone 250 mg capsules1件: Metyrapone1件: Metyrapone 💬1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75 💬
4757Metopirone 250 mg capsules/ Cormeto1件: Metyrapone1件: Metyrapone 💬1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75 💬
4758Metopirone 250 mg capsules/Cormeto1件: Metyrapone1件: Metyrapone 💬1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75 💬
4759METOPROLOL SUCCINATE (PH. EUR.)1件: Metoprolol1件: Metoprolol 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 193 💬
4760Metoprolol succinate + doxazosin2件: Doxazosin,
Metoprolol		2件: Metoprolol ,
Doxazosin 💬		4件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1 💬		13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 57 💬
4761Metoprolol tartrate 50 mg1件: Metoprolol1件: Metoprolol 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
4762Metoprolol Tartrate Oral Tablet1件: Metoprolol1件: Metoprolol 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
4763Metoprololsuccinat Orion 25mg----1件: 193 💬
4764Metoprololsuccinat ”Orion” 25mg----1件: 193 💬
4765Metotrexat Orion----1件: 46 💬
4766METOTREXATO SANDOZ - 2.5 MG COMPRESSE 50 COMPRESSE IN FLACONE PP1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4767METOTREXATO-LEDERLE 2,5 MG COMPRIMIDOS1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4768Metronidazole capsule 50 mg1件: Metronidazole1件: Metronidazole 💬--1件: 97 💬
4769Metronidazole Oral1件: Metronidazole1件: Metronidazole 💬--1件: 96 💬
4770Mexiletine 167 mg1件: Mexiletine1件: Mexiletine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 113 💬
4771Mezavant 1200 mg magensaftresistente Retardtabletten1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4772Mezavant Gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
4773Mezavant XL 1200 mg gastro-resistant prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
4774Mezavant XL 1200 mg gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
4775Mezavant XL 1200 mg gastro-resistant, prolonged release tablets.2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
4776Mezavant XL 1200mg gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
4777Mezavant XL Gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
4778MG-O-1002----1件: 11 💬
4779MH004 Ia(0.1%)----1件: 46 💬
4780MH004 Ia(1%)----1件: 46 💬
4781MH004 Ib-1(0.1%)----1件: 46 💬
4782MH004 Ib-1(0.3%)----1件: 46 💬
4783MH004 Ib-1(1%)----1件: 46 💬
4784MH004 Ib-2(1%)----1件: 46 💬
4785MICOFENOLATO MOFETILE----1件: 53 💬
4786Micofenolato mofetilo----1件: 35 💬
4787Microgynon® 30 (Oral contraceptive)----1件: 46 💬
4788Mid dose ANAVEX2-73----1件: 6 💬
4789Midazolam 3 mg1件: Midazolam1件: Midazolam 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 96 💬
4790Midazolam Maleate Tablets1件: Midazolam1件: Midazolam 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 46 💬
4791Midodrine or atomoxetine pill2件: Atomoxetine,
Midodrine		2件: Atomoxetine ,
Midodrine 💬		4件: ADRA1A,
ADRA1B,
ADRA1D,
SLC6A2 💬		8件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Synaptic vesicle cycle, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 17 💬
4792Migalastat HCl 150 mg1件: Migalastat1件: Migalastat 💬--1件: 19 💬
4793MIN-102----2件: 18, 20 💬
4794Mind-body therapy----1件: 168 💬
4795Minocycline 100 mg Film-coated Tablets1件: Minocycline1件: Minocycline 💬--1件: 13 💬
4796Minocycline 100mg1件: Minocycline1件: Minocycline 💬--1件: 13 💬
4797Minocycline, then Minocycline/Lovastatin2件: Lovastatin,
Minocycline		2件: Lovastatin ,
Minocycline 💬		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 206 💬
4798Mirapexin / Sifrol1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4799MIRAPEXIN*30CPR 0,7MG1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
4800Mirdametinib (MEK Inhibitor)1件: Mirdametinib1件: Mirdametinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
4801Mirdametinib (PD-0325901) oral capsule or dispersible tablet1件: Mirdametinib1件: Mirdametinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
4802MK-5475----1件: 86 💬
4803MK-7962----1件: 86 💬
4804MK-8457 100 mg----1件: 46 💬
4805MK0653, ezetimibe1件: Ezetimibe1件: Ezetimibe 💬1件: NPC1L1 💬1件: Fat digestion and absorption 💬1件: 260 💬
4806MK0663, etoricoxib1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4807MK0812 / Duration of Treatment: 12 Weeks----1件: 46 💬
4808MMX Mesalamine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4809MMX mesalamine/ mesalazine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4810MMX Mesalamine/Mesalazine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4811MMX Mesalamine/Mesalazine (High Dose)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4812MMX Mesalamine/Mesalazine (Low Dose)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
4813MN-001 BID----1件: 226 💬
4814MN-08 24 mg/day----1件: 86 💬
4815MN-08 60 mg/day----1件: 86 💬
4816MN-166----1件: 2 💬
4817MNC (Mononuclear cells)----1件: 2 💬
4818MNK-1411----1件: 113 💬
4819Mobilization of stem cells to prepare for Leukapheresis----1件: 96 💬
4820Modafinil 50mg1件: Modafinil1件: Modafinil 💬--1件: 6 💬
4821Moderate doses of Thiamine y Biotin2件: Biotin,
Thiamine		2件: Biotin ,
Thiamine 💬		--1件: 8 💬
4822Moderate Oligosaccharide Group----1件: 96 💬
4823Moderna COVID-19 Vaccine1件: Moderna COVID-19 Vaccine1件: Elasomeran 💬--1件: 46 💬
4824Moderna mRNA-1273----7件: 13, 35, 46, 49, 50, 51, 107 💬
4825Moderna mRNA-1273, Bivalent----7件: 13, 35, 46, 49, 50, 51, 107 💬
4826Modified BiP----1件: 46 💬
4827Modified mRNA encoding human methylmalonyl-coenzyme A mutase2件: (R)-methylmalonyl-CoA,
Coenzyme A		---1件: 246 💬
4828Modified Oral Glucose Tolerance Test (50g 4-hours)1件: Dextrose, unspecified form---1件: 299 💬
4829Modified-thoracolumbar interfascial plane block----1件: 70 💬
4830Modopar 125----1件: 6 💬
4831Modopar 62,5----1件: 6 💬
4832MODULEN IBD (R) (specific Enteral Nutrition)----1件: 96 💬
4833Molgramostim 300 mcg nebuliser solution1件: Molgramostim1件: Molgramostim 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
4834Molgramostim Nebuliser solution 300 mcg1件: Molgramostim1件: Molgramostim 💬1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
4835MOLI 1901----1件: 299 💬
4836Moli 1901 (2622U90, duramycin)1件: Lancovutide---1件: 299 💬
4837Moli1901 (2622U90, duramycin)1件: Lancovutide---1件: 299 💬
4838Mono Nuclear Cell (MNC) transplantation----1件: 57 💬
4839Monoamine oxidase B inhibitors----1件: 6 💬
4840Monoclonal Antibody (MAb)----1件: 271 💬
4841Monoclonal antibody (Mab) sB24M----1件: 269 💬
4842Monoclonal antibody M-T412----1件: 13 💬
4843Monocytes and megacaryocytes culture and RNA extraction----1件: 113 💬
4844Monomethyl fumarate 190 mg1件: Monomethyl fumarate1件: Monomethyl fumarate 💬--1件: 13 💬
4845Monotherapy (Lopinavir/ritonavir) + ABC/3TC2件: Lopinavir,
Ritonavir		2件: Ritonavir ,
Lopinavir 💬		--1件: 265 💬
4846Monovalent [B.1.351] CoV2 preS dTM-AS03----7件: 13, 35, 46, 49, 50, 51, 107 💬
4847Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-9861426件: BMS-986142,
Digoxin,
Flurbiprofen,
Midazolam,
Montelukast,
Pravastatin		5件: Digoxin ,
Flurbiprofen ,
Midazolam ,
Montelukast ,
Pravastatin 💬		24件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4,
CYSLTR1,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
HMGCR,
PTGS1,
PTGS2 💬		49件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
4848Montelukast/ Singulair1件: Montelukast1件: Montelukast 💬1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 98 💬
4849Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections1件: Human interleukin-2---1件: 2 💬
4850Moringa Oleifera----1件: 46 💬
4851Moss-aGal (recombinant human alpha-galactosidase A produced in moss)1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
4852Moxifloxacin 400 mg1件: Moxifloxacin1件: Moxifloxacin 💬--1件: 86 💬
4853MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - F1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 19 💬
4854MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 24 MG/1.2 ML 1 FLACONCINO1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65 💬
4855Mozobil 20mg/mL vial (injectable solution for subcutaneous use)1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65 💬
4856Mozobil 20mg/mL vial (injectable solution, subcutaneous use)1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65 💬
4857MP-435(dose1) + Methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
4858MQX-503----1件: 51 💬
4859MR-MC-01----1件: 226 💬
4860MRA, Actemra1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
4861MRC375 150mg----1件: 46 💬
4862MRNA encoding modified Ornithine transcarbamylase1件: Ornithine1件: Ornithine 💬--1件: 251 💬
4863MRX Drug Substance (formerly Maralixibat , SHP625 or LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338 💬
4864MRX Drug Substance (formerly Maralixibat, SHP625 or LUM001)1件: Maralixibat1件: Maralixibat 💬2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338 💬
4865MS-20 oral solution----1件: 97 💬
4866MSC2430913A or ONO-4641 (to be used as synonyms)----1件: 13 💬
4867MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF----1件: 2 💬
4868MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
4869MSI-1995----1件: 299 💬
4870MSTC-001 (MS-STAT)----1件: 13 💬
4871MT-1186----1件: 2 💬
4872MT-1303----3件: 13, 96, 97 💬
4873MT-1303 [0.1]----1件: 13 💬
4874MT-1303 [0.2]----1件: 13 💬
4875MT-1303 [0.4]----1件: 13 💬
4876MT-1303 High dose----1件: 49 💬
4877MT-1303 Low dose----1件: 49 💬
4878MT-1303-FormA----1件: 13 💬
4879MT-1303-FormB----1件: 13 💬
4880MT-1303-High----1件: 13 💬
4881MT-1303-Low----1件: 13 💬
4882MT-1303-Middle----1件: 13 💬
4883MT-7117----2件: 51, 254 💬
4884MT-7117 High Dose----1件: 254 💬
4885MT-7117 Low Dose----1件: 254 💬
4886MTP-131----1件: 21 💬
4887MTX 12.5----1件: 97 💬
4888MTX HEXAL 2,5 mg Tabletten----1件: 46 💬
4889MTX HEXAL 2,5mg Tabletten----1件: 46 💬
4890Mucoid exopolysaccharide P. aeruginosa immune globulin IV----1件: 299 💬
4891Multi-glycoside of Tripterygium Wilfordii HOOK. f. (TWH)1件: Tripterygium wilfordii whole---1件: 66 💬
4892Multi-modal pain management [Acetaminophen + Gabapentin]2件: Acetaminophen,
Gabapentin		2件: Acetaminophen ,
Gabapentin 💬		7件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
PTGS1,
PTGS2,
SLC6A1 💬		31件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway 💬1件: 70 💬
4893Multi-modal pain management [Fentanyl]1件: Fentanyl1件: Fentanyl 💬1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70 💬
4894Multi-modal pain management [Intravenous Ketamine]1件: Ketamine1件: Ketamine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 70 💬
4895Multi-modal pain management [Valium + Gabapentin]1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 70 💬
4896Multienzymes (lipase, protease etc.)----2件: 298, 299 💬
4897Multimodal Bundle Drugs----1件: 226 💬
4898Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)1件: Myelin basic protein---1件: 13 💬
4899Multiple dose- Group B----1件: 97 💬
4900Multiple dose-Group B----1件: 97 💬
4901Mussel oil capsules----1件: 46 💬
4902Mycofenolate Mofetil (MMF)----1件: 226 💬
4903Mycophenolate mofeti1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 95 💬
4904Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
4905Mycophenolate mofetil (CellCept)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 11, 13 💬
4906Mycophenolate mofetil (MMF)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬7件: 13, 49, 51, 60, 65, 66, 222 💬
4907Mycophenolate Mofetil (MMF) 3 g/Day2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 35 💬
4908Mycophenolate Mofetil 2 g/Day2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 35 💬
4909Mycophenolate mofetil 2000mg/d2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 53 💬
4910Mycophenolate Mofetil 500mg2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬3件: 49, 51, 61 💬
4911Mycophenolate mofetil [CellCept]2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 11 💬
4912Mycophenolate mofetil orally 1000 mg twice a day (BID)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222 💬
4913Mycophenolate mofetil plus lower dose of Prednisone3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		3件: Prednisone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 66 💬
4914Mycophenolate mofetil TEVA2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 53 💬
4915Mycophenolate mofetil(MMF)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 224 💬
4916Mycophenolate mofetil, low dose steroid2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222 💬
4917Mycophenolate mofetil,methotrexate3件: Methotrexate,
Mycophenolate mofetil,
Mycophenolic acid		3件: Methotrexate ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		4件: DHFR,
DHFR2,
IMPDH1,
IMPDH2 💬		8件: Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, Nucleotide metabolism, One carbon pool by folate, Purine metabolism 💬3件: 42, 43, 45 💬
4918Mycophenolate motetil1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49 💬
4919Mycophenolic acid mofetil1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 60 💬
4920Mycophenylate mofetil----2件: 19, 20 💬
4921Mycophénolate mofétil----1件: 44 💬
4922MYELOSTIM - 34 1 FLACONCINO LIOFILIZZATO 33.6 MIU + SIRINGA PRERIEMPITA SOLVENTE 1 ML----2件: 19, 65 💬
4923MYELOSTIM 34 milions UI/ml - powder and solvent for solution for injection/infusion----1件: 65 💬
4924MYELOSTIM 34 milions UI/ml, powder and solvent for solution for injection or infusion----1件: 65 💬
4925MYELOSTIM 34*1FL 263MCG+1SIR----1件: 2 💬
4926Myfortic 180 mg1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 162 💬
4927Myfortic 180 mg Filmtabletten1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 162 💬
4928Myfortic 180mg Tablets1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 66, 222 💬
4929MYFORTIC*50CPR RIV 360MG1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49 💬
4930MYONAL*30CPR RIV 100MG----1件: 2 💬
4931Myozyme 50 mg powder for concentrate for solution for infusion1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
4932Myozyme® (alglucosidase alfa)1件: Alglucosidase alfa1件: Alglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
4933Mémantine----1件: 6 💬
4934Méthotrexate Bellon Comprimé1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 271 💬
4935Méthylprednisolone Mylan----1件: 13 💬
4936N(4,5Bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate1件: Guanidine---1件: 113 💬
4937N,N,N',N'-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: Phenothiazine 💬--1件: 127 💬
4938N,N,N?,N?-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: Phenothiazine 💬--1件: 127 💬
4939N,N,N’,N’-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: Phenothiazine 💬--1件: 127 💬
4940N-(4,5-Bis methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate1件: Guanidine---1件: 113 💬
4941N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide----1件: 299 💬
4942N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide----1件: 299 💬
4943N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide----1件: 49 💬
4944N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide----1件: 299 💬
4945N-[1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide2件: Acetamide,
Pyrazole		---1件: 154 💬
4946N-Acetylcysteine, (NAC)1件: Acetylcysteine1件: Acetylcysteine 💬--1件: 85 💬
4947N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium----1件: 28 💬
4948N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine----1件: 13 💬
4949N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate2件: Acetate,
Somatotropin		---1件: 265 💬
4950N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium----1件: 96 💬
4951N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium----1件: 96 💬
4952N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO----1件: 11 💬
4953N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE5件: Aluminium,
Aluminum hydroxide,
Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein,
Hydroxide ion		1件: Aluminum hydroxide 💬--1件: 11 💬
4954N. MENINGITIDIS GROUP C POLYSACCHARIDE----1件: 14 💬
4955N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM1971件: Corynebacterium diphtheriae CRM197 protein---1件: 13 💬
4956N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE----2件: 5, 17 💬
4957Nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin)1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 86 💬
4958Nabilone 0.25 mg1件: Nabilone1件: Nabilone 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
4959Nabiximols - Sativex3件: Cannabidiol,
Dronabinol,
Nabiximols		3件: Dronabinol ,
Nabiximols ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
4960NACOM 100----1件: 6 💬
4961Nalbuphine Extended-Realease (ER) Tablets1件: Nalbuphine1件: Nalbuphine 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
4962Nalbuphine Extended-Release (ER) Tablets1件: Nalbuphine1件: Nalbuphine 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
4963Namilumab (MT203)1件: Namilumab---1件: 46 💬
4964Nanobody directed towards the human A1 domain of von Willebrand factor1件: Von Willebrand factor human---1件: 64 💬
4965Nanogam 100 mg/ml----1件: 65 💬
4966Nanogam® 50 mg/ml----1件: 65 💬
4967Naprosyn 500 mg1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4968Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.)1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4969Naproxen 10 mg/kg1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4970Naproxen 500 mg tablets (PN 200 minus omeprazole)2件: Naproxen,
Omeprazole		2件: Naproxen ,
Omeprazole 💬		4件: ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271 💬
4971Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.)1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4972Naproxen oral suspension1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4973Naproxen sodium 550mg tablet1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
4974Natalizumab (BG00002)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
4975Natalizumab 300 MG in 15 ML Injection1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
4976National Drug Code: 59762-0074----1件: 81 💬
4977Natriumklorid 9mg/ml----1件: 46 💬
4978NBI-5788----1件: 13 💬
4979NBI-74788----1件: 81 💬
4980NBI-77860----1件: 81 💬
4981NC 1 cell therapy----1件: 117 💬
4982NC-503 (Anti-amyloidotic (AA) Agent)----1件: 46 💬
4983NCA 500mg----1件: 93 💬
4984Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection3件: Testosterone,
Testosterone undecanoate,
Undecanoic acid		2件: Testosterone ,
Testosterone undecanoate 💬		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13 💬
4985Nebivolol 5 mg1件: Nebivolol1件: Nebivolol 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
4986Nebulization of Amikacin during NIV (RR: 15 cycles/minute)1件: Amikacin1件: Amikacin 💬--1件: 299 💬
4987Nebulization of Amikacin during NIV (RR: 25 cycles/minute)1件: Amikacin1件: Amikacin 💬--1件: 299 💬
4988Nebulized combination ipratropium bromide with salbutamol2件: Ipratropium,
Salbutamol		1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
4989Nebulized ipratropium bromide1件: Ipratropium---1件: 86 💬
4990Needle biopsy of the vastus lateralis muscle----1件: 113 💬
4991NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 50 💬
4992NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETA1件: Triethylenetetramine---1件: 50 💬
4993NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 50 💬
4994Nelfinavir mesylate1件: Nelfinavir1件: Nelfinavir 💬--1件: 265 💬
4995NeoGAA or avalglucosidase alfa1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
4996Neophyr 1000ppm mol/mol----1件: 294 💬
4997Neoral Oral Solution1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 269 💬
4998Neramexane mesylate1件: Neramexane---1件: 13 💬
4999NERIXIA*IM EV 1F 25MG----1件: 6 💬
5000NERIXIA*INFUS IV CONC 2F 100MG----1件: 274 💬
5001Nerve block----1件: 46 💬
5002Nerve Growt Factor - 2.5S----1件: 90 💬
5003Neu-120----1件: 6 💬
5004Neumega (Oprelvekin, Interleukin 11, IL-11)1件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
5005NEUPRO 2 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5006Neupro 2 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5007NEUPRO 4 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5008Neupro 4 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5009NEUPRO 6 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5010Neupro 6 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5011NEUPRO 8 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5012Neupro 8 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5013NEUPRO*7CER 4MG/24H1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5014NEUPRO*7CER 6MG/24H1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5015NEUPRO*7CER 8MG/24H1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5016Neupro® 8 mg/24 h1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5017Neurontin 300 mg hard capsule1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
5018NeuroVax 300ug/mL Dose for IM Injection1件: NeuroVax---1件: 13 💬
5019New Formulation of rebif - human interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5020New thermo stable formulation of epoprostenol sodium1件: Epoprostenol1件: Epoprostenol 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5021Nexavar (BAY 43-9006) (Sorafenib)1件: Sorafenib1件: Sorafenib 💬8件: BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
5022Nexium (esomeprazole magnesium)2件: Esomeprazole,
Magnesium		1件: Esomeprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 298 💬
5023NFC-1----1件: 203 💬
5024NFX-179 Gel----1件: 34 💬
5025NG-Monomethyl-L-arginine3件: Arginine,
L-arginine,
Tilarginine		1件: Arginine 💬--1件: 67 💬
5026Ng-monomethyl-L-arginine (drug)3件: Arginine,
L-arginine,
Tilarginine		1件: Arginine 💬--1件: 67 💬
5027NGN-101----1件: 19 💬
5028NI-0401 (anti-CD3 mAB)1件: Muromonab---1件: 96 💬
5029Nicorette 10mg/ 16 h1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
5030Nicorette 15 mg/ 16 h1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
5031Nicorette 5 mg/ 16 h1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
5032Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
5033Nicotinell 17,5 mg/24-Stunden-Pflaster----1件: 6 💬
5034Nicotinell 35 mg/24-Stunden-Pflaster----1件: 6 💬
5035Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d2件: Eflornithine,
Nifurtimox		2件: Nifurtimox ,
Eflornithine 💬		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65 💬
5036Nilotinib 150 MG1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 8 💬
5037Nilotinib 150mg oral capsule [Tasigna]1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
5038Nilotinib 300mg oral capsule [Tasigna]1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
5039Nilotinib 50 mg1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
5040NILOTINIB HYDROCHLORIDE MONOHYDRATE1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
5041Nintedanib 150 mg and 100 mg soft capsules1件: Nintedanib1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 227 💬
5042Nitazoxanide 500Mg Oral Tablet1件: Nitazoxanide1件: Nitazoxanide 💬--2件: 46, 97 💬
5043Nitisinone 10 mg Tablet High Compritol1件: Nitisinone1件: Nitisinone 💬1件: HPD 💬5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241 💬
5044Nitisinone Baked Tablet1件: Nitisinone1件: Nitisinone 💬1件: HPD 💬5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241 💬
5045Nitrate-depleted beetroot juice1件: Nitrate1件: Nitric acid 💬--1件: 67 💬
5046NITRIC OXIDE1件: Nitric Oxide1件: Nitric oxide 💬--7件: 85, 86, 88, 210, 251, 294, 299 💬
5047Nitric Oxide 160 ppm1件: Nitric Oxide1件: Nitric oxide 💬--1件: 299 💬
5048Nitric Oxide for inhalation1件: Nitric Oxide1件: Nitric oxide 💬--2件: 86, 299 💬
5049Nitric Oxide generated by the GeNO nitrosyl delivery system1件: Nitric Oxide1件: Nitric oxide 💬--1件: 86 💬
5050Nitric Oxide plus Oxygen2件: Nitric Oxide,
Oxygen		2件: Oxygen ,
Nitric oxide 💬		--1件: 86 💬
5051Nitric oxide supplement1件: Nitric Oxide1件: Nitric oxide 💬--1件: 251 💬
5052Nitroglycerin Ointment 2%1件: Nitroglycerin1件: Nitroglycerin 💬--1件: 51 💬
5053Nitrous Oxide1件: Nitrous oxide1件: Nitrous oxide 💬--1件: 34 💬
5054Nle4,D-Phe7]-a-melanocyte stimulating hormone or NDP-a-MSH----1件: 254 💬
5055Nle4-D-Phe7-alpha-MSH----1件: 254 💬
5056NLX-112----1件: 6 💬
5057NN 1841----1件: 288 💬
5058NNC 126-0083----1件: 78 💬
5059NNC 142-0002----1件: 46 💬
5060NNC0195-0092 10 mg/1.5 ml PDS290-10----1件: 78 💬
5061NNC0195-0092 15 mg/1.5 ml PDS290-15----1件: 78 💬
5062NNC0195-0092 5 mg/1.5 ml PDS290-10----1件: 78 💬
5063NNC0195-0092 DP 6.7 mg ml 3 ml cartridge----1件: 78 💬
5064NNC0195-0092 PDS290 10 mg-1.5 ml----1件: 78 💬
5065NNC0195-0092 PDS290 10 mg/1.5 ml----1件: 78 💬
5066Nolpitantium Besylate----1件: 97 💬
5067Non as of yet----1件: 97 💬
5068NON PROPIETRY, THEREFORE N/A----1件: 51 💬
5069Non-anti-TNF biologics----2件: 46, 271 💬
5070Non-biologic anti-rheumatic drugs----1件: 46 💬
5071Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)----1件: 46 💬
5072Non-Biologic DMARDs----3件: 46, 86, 107 💬
5073Non-biological DMARDs----1件: 46 💬
5074Non-myeloablative Hematopoietic Stem Cell Transplantation----1件: 93 💬
5075Non-TNFi-biologic class----1件: 46 💬
5076Nonbiologic DMARDs of investigator's choice----1件: 46 💬
5077None as of yet1件: Interleukin-1 alpha, human recombinant---1件: 46 💬
5078Norditropin FlexPro 10 mg1件: Somatotropin---1件: 78 💬
5079Norditropin FlexPro 10 mg/1.5 ml1件: Somatotropin---1件: 78 💬
5080Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen1件: Somatotropin---1件: 195 💬
5081Norditropin FlexPro 5 mg/1.5 mL1件: Somatotropin---1件: 78 💬
5082Norditropin FlexPro 5mg/1.5 ml1件: Somatotropin---1件: 78 💬
5083Norditropin NordiFlex® 10 mg/1.5 ml1件: Somatotropin---1件: 78 💬
5084Norditropin NordiFlex® 10mg/1.5 ml1件: Somatotropin---1件: 78 💬
5085Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)1件: Somatotropin---1件: 78 💬
5086Norditropin SimpleXx 10 mg1件: Somatotropin---1件: 78 💬
5087Norditropin SimpleXx 15 mg/1.5 ml1件: Somatotropin---1件: 3 💬
5088Norditropin SimpleXx 5mg/1.5ml1件: Somatotropin---2件: 78, 107 💬
5089Norditropin® FlexPro®----1件: 78 💬
5090Norditropin® FlexPro® pen----1件: 78 💬
5091Norditropin® SimpleXx® 5 mg/1.5ml1件: Somatotropin---1件: 78 💬
5092Norepinephrine Bitartrate1件: Norepinephrine1件: Noradrenaline 💬9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 296 💬
5093Normal Saline 0.9% Infusion Solution----1件: 22 💬
5094Normal saline IV, salt tablets----1件: 299 💬
5095NORMIX*AD 12CPR RIV 200MG----1件: 96 💬
5096Norovirus -specific T-cell (NST) therapy----1件: 65 💬
5097Norucholic acid (NCA) 500 mg1件: norUrsodeoxycholic acid---1件: 93 💬
5098Norursodeoxycholic acid, NCA1件: norUrsodeoxycholic acid---1件: 94 💬
5099Norvir 100 mg film-coated tablets----1件: 299 💬
5100NOVANTRONE*INF 2MG/ML 5ML1件: Mitoxantrone1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
5101NovoNorm 0.5 mg----1件: 299 💬
5102NovoNorm 1 mg----1件: 299 💬
5103NovoNorm 2 mg----1件: 299 💬
5104Novorapid / humalog short acting insulin----1件: 299 💬
5105NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen.----1件: 299 💬
5106NOXAFIL - 40 mg/ml oral suspension1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
5107NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
5108NOXAFIL - oral suspension 40 mg/ml1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
5109Noxafil 100 mg1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
5110Noxafil 100 mg Tablets Gastro-Resistant1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
5111Noxafil 40 mg/ml oral solution1件: Posaconazole1件: Posaconazole 💬--1件: 65 💬
5112NPC-12G gel----2件: 34, 158 💬
5113NPC-12Y gel----1件: 158 💬
5114NPC-14----1件: 113 💬
5115NPLATE 500 microgramos polvo para solución inyectable1件: Romiplostim1件: Romiplostim 💬1件: MPL 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
5116NPSP 558----1件: 235 💬
5117NR2B NMDA Antagonist CP-101,606 (traxoprodil)1件: Ketamine1件: Ketamine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
5118NRTX-1001----1件: 141 💬
5119NT 101----4件: 5, 6, 7, 17 💬
5120NT-501----2件: 90, 303 💬
5121Nucala 100 mg powder for solution for injection1件: Mepolizumab1件: Mepolizumab 💬1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 45 💬
5122NurOwn (MSC-NTF cells)----2件: 2, 13 💬
5123NurOwn® (MSC-NTF cells)----1件: 2 💬
5124Nutropin AQ [somatropin (DNA origin) injection]1件: Somatotropin---1件: 299 💬
5125NutropinAq 10 mg/2 ml1件: Somatotropin---1件: 78 💬
5126NutropinAq 10 mg/2 ml (30 UI)1件: Somatotropin---1件: 78 💬
5127NUTROPINAq 10 mg/2 ml (30 UI), solución inyectable1件: Somatotropin---1件: 78 💬
5128NutropinAq 10mg/2ml (30 I.E.) Injektionsllösung1件: Somatotropin---1件: 65 💬
5129NutropinAq 10mg/2ml solution for injection1件: Somatotropin---1件: 96 💬
5130NW-1015----1件: 6 💬
5131NW-1015E, EMD 1195686, MSC2191632B----1件: 6 💬
5132NX-13 250 mg----1件: 97 💬
5133NX-13 250mg IR----1件: 97 💬
5134NX-13 500mg IR----1件: 97 💬
5135NX-13 500mg MR----1件: 97 💬
5136Nébivolol----1件: 113 💬
5137O-15 Water1件: Water1件: Water 💬--1件: 6 💬
5138Obatoclax mesylate (GX15-070MS)1件: Obatoclax---1件: 60 💬
5139Obeticholic Acid (OCA)1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
5140Obeticholic Acid 10 MG1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
5141Obeticholic Acid 5 MG1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
5142OBI-1----1件: 288 💬
5143OBINUTUZUMAB/ GA1011件: Obinutuzumab1件: Obinutuzumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
5144Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi4件: Epoprostenol,
Iloprost,
Macitentan,
Selexipag		4件: Epoprostenol ,
Iloprost ,
Selexipag ,
Macitentan 💬		3件: EDNRA,
EDNRB,
PTGIR 💬		10件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Platelet activation, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
5145OC oral solution treatment A----1件: 6 💬
5146OC oral solution treatment B----1件: 6 💬
5147OC oral solution treatment C----1件: 6 💬
5148OC oral solution treatment D----1件: 6 💬
5149OCA (INT-747)----1件: 93 💬
5150OCA 0.1 mg----1件: 296 💬
5151OCA 0.1mg----1件: 296 💬
5152OCA 1,5 mg----1件: 94 💬
5153OCA 1.5mg----1件: 296 💬
5154OCA 5 mg----1件: 94 💬
5155OCA 5mg----1件: 296 💬
5156OCA, INT-747----1件: 93 💬
5157Ocaliva 10mg1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
5158Ocaliva 5mg1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
5159Ocrelizumab (CinnaGen, Iran)1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5160Ocrelizumab (Roche, Switzerland)1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5161Ocrelizumab / rhuMAb 2H71件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5162Ocrelizumab 300 mg1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5163Ocrelizumab 300mg /10ml1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5164Ocrelizumab 300mg/10 ml1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5165Ocrelizumab 300mg/10ml1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5166Ocrelizumab 500mg1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5167Ocrelizumab 600 mg1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5168Ocrelizumab Dose 11件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5169Ocrelizumabu 50mg----1件: 46 💬
5170Ocrevus 300 mg, solution à diluer pour perfusion1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5171Ocrrelizumab 300 mg----1件: 13 💬
5172Octagam 10%1件: Human immunoglobulin G---3件: 50, 63, 65 💬
5173Octagam 5%----2件: 13, 65 💬
5174Octagam 50 mg/ml1件: Human immunoglobulin G---1件: 13 💬
5175OCTAGAM 50 mg/ml oldatos infúzió----1件: 65 💬
5176Octagam® 10%1件: Human immunoglobulin G---1件: 63 💬
5177OCTANATE 100 UI/ml, poudre et solvant pour solution injectable1件: Beroctocog alfa---1件: 288 💬
5178OCTANATE 50 UI/ml, poudre et solvant pour solution injectable1件: Beroctocog alfa---1件: 288 💬
5179Octanorm 16.5%----2件: 50, 65 💬
5180Octreotide a azione pronta 0,1 mg1件: Octreotide1件: Octreotide 💬1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 227 💬
5181Octreotide LAR / Sandostatin LAR (LAR=long acting release)1件: Octreotide1件: Octreotide 💬1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 84 💬
5182OCU400 Mid Dose----1件: 90 💬
5183ODM-101----1件: 6 💬
5184ODM-101 105mg Carbidopa1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5185ODM-101 65mg Carbidopa1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5186ODM-104----1件: 6 💬
5187ODM-109----1件: 2 💬
5188ODM-109 capsule 1 mg----1件: 2 💬
5189ODSH at 0.125 mg/kg/h----1件: 210 💬
5190ODSH at 0.250 mg/kg/h----1件: 210 💬
5191ODSH at 0.375 mg/kg/h----1件: 210 💬
5192Ofatumumab 1001件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5193Ofatumumab 7001件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5194Ofev 100 mg capsule1件: Nintedanib1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
5195Ofev 150 mg capsule1件: Nintedanib1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
5196Okrido 6mg/mL oral solution----1件: 3 💬
5197OL adalimumab 40 mg1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
5198OLE BSA Adalimumab +/- MTX1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
5199OLE FD Adalimumab +/- MTX1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 107 💬
5200Oleovit D3 14.400 IU/ml oral drops, solution----1件: 13 💬
5201OligoG (60 mg/ml)----1件: 299 💬
5202OLIGOG CF-5/20----1件: 299 💬
5203OligoG CF-5/20 - 17.5 mg----1件: 299 💬
5204OligoG CF-5/20, 17,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299 💬
5205OligoG CF/20 - 27.5 mg----1件: 299 💬
5206OligoG CF/20 - 37.5 mg----1件: 299 💬
5207OligoG CF/20, 27,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299 💬
5208OligoG CF/20, 37,5 mg, Hartkapsel mit Pulver zur Inhalation----1件: 299 💬
5209OligoG-CF5/20, Alginate oligosaccharide (G-block) fragment1件: Alginic acid1件: Alginic acid 💬--1件: 299 💬
5210Oligomer of Sodium Alginate1件: Alginic acid1件: Alginic acid 💬--1件: 299 💬
5211Oligomero morfolino fosforodiamidato per skipping dell’esone 45----1件: 113 💬
5212Oligomero morfolino fosforodiamidato per skipping dell’esone 53----1件: 113 💬
5213Olive oil2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬--5件: 13, 35, 49, 53, 162 💬
5214Olokizumab (OKZ)1件: Olokizumab1件: Olokizumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 96 💬
5215Olokizumab 120 mg1件: Olokizumab1件: Olokizumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
5216Olokizumab 240 mg1件: Olokizumab1件: Olokizumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
5217Olokizumab 60 mg1件: Olokizumab1件: Olokizumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
5218Olokizumab 64 mg SC q2w1件: Olokizumab1件: Olokizumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
5219Olokizumab 64 mg SC q4w1件: Olokizumab1件: Olokizumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
5220Olumiant - EU/1/16/1170/001-0081件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
5221Olumiant - EU/1/16/1170/009-0161件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
5222OLUMIANT 4 mg1件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5223Omadacycline Oral Tablet [Nuzyra]1件: Omadacycline1件: Omadacycline 💬--1件: 299 💬
5224Omaveloxolone Capsules, 10 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
5225Omaveloxolone Capsules, 150 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
5226Omaveloxolone Capsules, 160 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
5227Omaveloxolone Capsules, 2.5 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
5228Omaveloxolone Capsules, 20 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
5229Omaveloxolone Capsules, 300 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
5230Omaveloxolone Capsules, 40 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
5231Omaveloxolone Capsules, 5 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
5232Omaveloxolone Capsules, 80 mg1件: Omaveloxolone1件: Omaveloxolone 💬1件: NFE2L2 💬7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
5233OMB 157----1件: 13 💬
5234Omega-3 Fatty Acid Fish Oil Supplement2件: Fish oil,
Omega-3 fatty acids		---1件: 66 💬
5235Omegaven (10% fish-oil emulsion----1件: 46 💬
5236Omegaven 10%----1件: 96 💬
5237Omeprazole 40 mg1件: Omeprazole1件: Omeprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 96 💬
5238OMEPRAZOLE MAGNESIUM2件: Magnesium,
Omeprazole		1件: Omeprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 225 💬
5239Omeprazole rectally 1mg/kg1件: Omeprazole1件: Omeprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 294 💬
5240OMNIPAQUE - 300 MG I/ML SOLUZIONE INIETTABILE FLACONE IN POLIPROPILENE DA 50 ML1件: Iohexol1件: Iohexol 💬--1件: 222 💬
5241OMS00620646, OMS620646, MASP-2 Antibody1件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬1件: 109 💬
5242OMS721 100 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody1件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬2件: 64, 109 💬
5243OMS721 185 mg/ml Injection solution, OMS00620646, OMS620646, MASP-2 Antibody1件: Narsoplimab1件: Narsoplimab 💬1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬2件: 64, 109 💬
5244OMS721 Drug Product 185 mg/mL----1件: 109 💬
5245Once daily subcutaneous injection of Genotropin1件: Somatotropin---1件: 78 💬
5246Once weekly subcutaneous injection of TransCon hGH----1件: 78 💬
5247Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter2件: Iodide,
Sodium iodide		3件: Sodium iodide ,
Sodium iodide I 123 ,
Sodium iodide I 125 💬		--1件: 34 💬
5248Oncoxin + Viusid----1件: 46 💬
5249Ondansetron 8 mg film-coated tablets1件: Ondansetron1件: Ondansetron 💬5件: HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬		2件: Serotonergic synapse, Taste transduction 💬1件: 6 💬
5250One 20cm2/10cm2 autologous skin sheet graft----1件: 160 💬
5251One additional blood sample during a planned blood test----1件: 266 💬
5252Ongentys 50 mg capsule rigide1件: Opicapone1件: Opicapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
5253Ongentys 50 mg hard capsules1件: Opicapone1件: Opicapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
5254Ongentys 50mg1件: Opicapone1件: Opicapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
5255Only 1 arm: treatment with MSC-AFP----1件: 96 💬
5256Only medicinal products registered in Austria will be used in this clinical trial.----1件: 78 💬
5257Only medicinal products registered in Germany will be used in this clinical trial----1件: 78 💬
5258ONO-4641/ MSC2430913A----1件: 13 💬
5259ONO-4641/MSC2430913A----1件: 13 💬
5260Open label - AL0011件: Latozinemab1件: Latozinemab 💬1件: SORT1 💬3件: Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬1件: 127 💬
5261Open label RAD001 (only used for post-extension phase)----1件: 158 💬
5262Open Label Topical Beremagene Geperpavec (B-VEC)----1件: 36 💬
5263Open-Label CDCA 250 mg TID1件: Chenodeoxycholic acid1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 263 💬
5264Open-label PTH(1-84)----1件: 235 💬
5265Opicapone (OPC)1件: Opicapone1件: Opicapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
5266Opicapone 50 mg1件: Opicapone1件: Opicapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
5267Opicapone 50 mg hard capsules1件: Opicapone1件: Opicapone 💬1件: COMT 💬4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬1件: 6 💬
5268Oprelvekin, Interleukin 11, IL-111件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
5269OPRX-106----1件: 97 💬
5270OPRX-106 (plant cells expressing TNFR-Fc) 2mg----1件: 97 💬
5271OPRX-106 (plant cells expressing TNFR-Fc) 8mg----1件: 97 💬
5272OPS-2071 150 mg----1件: 96 💬
5273OPS-2071 300 mg----1件: 96 💬
5274OPS-2071 600 mg----1件: 96 💬
5275Opsumit (macitentan)1件: Macitentan1件: Macitentan 💬2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
5276Opsumit 10 Mg Tablet----1件: 51 💬
5277Optimized Medical Treatment----1件: 6 💬
5278Optimized oral treatment----1件: 6 💬
5279Optinate 5 mg filmcoated tablets----1件: 274 💬
5280Optivate® (Human Coagulation Factor VIII)2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288 💬
5281Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone2件: Mesalazine,
Methylprednisolone		2件: Mesalamine ,
Methylprednisolone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
5282Oral bovine type I collagen1件: Bovine type I collagen---1件: 51 💬
5283Oral bovine type II collagen----1件: 46 💬
5284Oral Budesonide1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
5285Oral Budesonide Suspension (MB-9)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
5286Oral Budesonide Suspension (OBS)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
5287Oral corticosteroids (OCS)----1件: 162 💬
5288Oral Glucose Tolerance test (75g 2-hour)1件: Dextrose, unspecified form---1件: 299 💬
5289Oral methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
5290Oral Methylprednisolone 625 mg/24h x3 days1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
5291Oral migalastat HCl1件: Migalastat1件: Migalastat 💬--1件: 19 💬
5292Oral OKT3----1件: 97 💬
5293Oral Prednisone 5mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
5294Oral treprostinil (UT-15C) Sustained Release Tablets1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5295Oral Viscous Budesonide1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
5296Oral Viscous Budesonide (OVB)1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
5297Orelabrutinib( higher dose)1件: Orelabrutinib1件: Orelabrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
5298Orelabrutinib( lower dose)1件: Orelabrutinib1件: Orelabrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
5299Orencia 125 mg1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
5300ORENCIA 125 mg solution for injection1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
5301ORENCIA 125 mg solution for injection in pre-filled syringe1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬3件: 46, 49, 53 💬
5302ORENCIA 125 mg, solution injectable en seringue préremplie1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
5303ORENCIA 250 mg polvo para concentrado para sol. para perfusión1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
5304Orencia® (Abatacept)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 95 💬
5305ORENCIA® 125 mg solution for injection in pre-filled syringe1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 65 💬
5306Orfadin oral suspension 4mg/ml1件: Nitisinone1件: Nitisinone 💬1件: HPD 💬5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241 💬
5307Originator (legacy) drug----4件: 46, 96, 97, 271 💬
5308Originator rituximab - Rituxan ® or MabThera ®1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
5309Orkambi 100 mg/125 mg film-coated tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
5310Orkambi 200 mg/125 mg film-coated tablets2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
5311Orkambi: contains lumacaftor and ivacaftor2件: Ivacaftor,
Lumacaftor		2件: Ivacaftor ,
Lumacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
5312ORL-1B----1件: 255 💬
5313ORM-12471----1件: 51 💬
5314ORM-12471 30mg----1件: 51 💬
5315ORM-127411件: ORM-12741---1件: 51 💬
5316Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg3件: Estradiol,
Ethinylestradiol,
Norgestimate		3件: Estradiol ,
Ethinyl estradiol ,
Norgestimate 💬		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299 💬
5317Ortho-Novum 7771件: Mestranol1件: Mestranol 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49 💬
5318Ortho-Novum® 1/351件: Mestranol1件: Mestranol 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 46 💬
5319Orvepitant Maleate1件: Orvepitant1件: Orvepitant 💬1件: TACR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 85 💬
5320OSE-127----2件: 53, 97 💬
5321Osilodrostat 10mg1件: Osilodrostat1件: Osilodrostat 💬1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75 💬
5322Osilodrostat 1mg1件: Osilodrostat1件: Osilodrostat 💬1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75 💬
5323Osilodrostat 5mg1件: Osilodrostat1件: Osilodrostat 💬1件: CYP11B2 💬3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75 💬
5324OsrhAAT 1 mg/kg IV----1件: 231 💬
5325OsrhAAT 10 mg/kg IV----1件: 231 💬
5326OsrhAAT 20 mg/kg IV----1件: 231 💬
5327OsrhAAT 3 mg/kg IV----1件: 231 💬
5328OsrhAAT 40 mg/kg IV----1件: 231 💬
5329OsrhAAT 60 mg/kg IV----1件: 231 💬
5330Ossium vBM-MSC----1件: 96 💬
5331OST-122----1件: 97 💬
5332Osteoblast biology study----1件: 238 💬
5333Osteopetrosis Haploidentical Only Preparative Regimen----5件: 19, 20, 125, 234, 326 💬
5334Osteopetrosis Only Preparative Regimen----5件: 19, 20, 125, 234, 326 💬
5335OSU 6162 similar to (-)-OSU 6162----1件: 6 💬
5336OSU6162 similar to (-)-OSU 6162----2件: 6, 8 💬
5337OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 56, 107 💬
5338OTEZLA - 30 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/ALU) - 56 COMPRESSE1件: Apremilast1件: Apremilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 107 💬
5339Other Biologic Therapies----2件: 96, 97 💬
5340Other biological agent----2件: 46, 96 💬
5341Other Biologics----1件: 46 💬
5342Other disease-modifying therapy----1件: 13 💬
5343Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac1件: Etodolac1件: Etodolac 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
5344OTL-101----1件: 65 💬
5345OTL-103----1件: 65 💬
5346OTL-103 Dispersion for Infusion----1件: 65 💬
5347Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254measured as amount of total protein containing the PorA P1.4----1件: 11 💬
5348OV101 Regimen 1----1件: 201 💬
5349Ovastat 10001件: Treosulfan1件: Treosulfan 💬--2件: 13, 65 💬
5350Ovastat 1000 (Treosulfan injection)1件: Treosulfan1件: Treosulfan 💬--1件: 65 💬
5351Ovastat 1000 mg, powder for solution for infusion1件: Treosulfan1件: Treosulfan 💬--1件: 65 💬
5352Ovastat 50001件: Treosulfan1件: Treosulfan 💬--2件: 13, 65 💬
5353Ovastat 5000 (Treosulfan injection)1件: Treosulfan1件: Treosulfan 💬--1件: 65 💬
5354Ovastat 5000 mg, powder for solution for infusion1件: Treosulfan1件: Treosulfan 💬--1件: 65 💬
5355Over-encapsulated 150 mg Irbesartan Tablets1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
5356Over-encapsulated 75 mg Irbesartan Tablets1件: Irbesartan1件: Irbesartan 💬1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
5357Over-encapsulated Modafinil1件: Modafinil1件: Modafinil 💬--1件: 6 💬
5358Overencapsulated Azathioprine (Imuran) 50 mg Tablet1件: Azathioprine1件: Azathioprine 💬--1件: 97 💬
5359Overencapsulated mesalazine tablets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
5360Ovine Corticotropin-Releasing Hormone (oCRH)2件: Corticorelin,
Corticotropin		2件: Corticotropin ,
Corticorelin 💬		3件: CRHR1,
CRHR2,
MC2R 💬		6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
5361Oxaloacetate (OAA)1件: Oxaloacetic acid---1件: 6 💬
5362OXB-102----1件: 6 💬
5363OXN 10 mg / 5 mg PR----1件: 6 💬
5364OXN 10/5 mg PR----1件: 226 💬
5365OXN 20 mg / 10 mg PR----1件: 6 💬
5366OXN 20/10 mg PR----1件: 226 💬
5367OXN 5 mg/2.5 mg PR----1件: 6 💬
5368OXN 5/2.5 mg PR----1件: 226 💬
5369Oxybutynin, tolterodine, solifenacin3件: Oxybutynin,
Solifenacin,
Tolterodine		3件: Oxybutynin ,
Tolterodine ,
Solifenacin 💬		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 53 💬
5370Oxycodone Depot ”Sandoz”, depot tablets1件: Oxycodone1件: Oxycodone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 298 💬
5371Oxycodone Orion1件: Oxycodone1件: Oxycodone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 70 💬
5372Oxycodone/naloxone prolonged release tablets 10 mg /5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
5373Oxycodone/naloxone prolonged release tablets 10/5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
5374Oxycodone/naloxone prolonged release tablets 20 mg /10 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
5375Oxycodone/naloxone prolonged release tablets 20/10 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
5376Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
5377Oxycodone/naloxone prolonged release tablets 5/2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		2件: Oxycodone ,
Naloxone 💬		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
5378Oxycodonhydrochlorid ”Lannacher”, depot tablets----1件: 298 💬
5379Oxycontin LP 10mg1件: Oxycodone1件: Oxycodone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
5380Oxycontin LP 5mg1件: Oxycodone1件: Oxycodone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
5381Oxygen, liquid1件: Oxygen1件: Oxygen 💬--2件: 86, 88 💬
5382Oxygen-15 Water2件: Oxygen,
Water		2件: Water ,
Oxygen 💬		--1件: 6 💬
5383Oxytocin (OXT) continuous1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
5384Ozanimod 0.5 mg1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
5385Ozanimod 1 mg1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
5386Ozonated olive oil2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬--2件: 35, 162 💬
5387P 140----1件: 49 💬
5388P-1037----1件: 299 💬
5389P-188 NF----1件: 113 💬
5390P-552----1件: 53 💬
5391P144. Cytokines Inhibitors----1件: 51 💬
5392P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline		3件: Pramipexole ,
Rasagiline ,
Rasagiline tartrate 💬		4件: DRD2,
DRD3,
DRD4,
MAOB 💬		18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5393P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline		3件: Pramipexole ,
Rasagiline ,
Rasagiline tartrate 💬		4件: DRD2,
DRD3,
DRD4,
MAOB 💬		18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5394P38 (4) Map Kinase Inhibitor----1件: 46 💬
5395P38 Inhibitor (4) 150mg----1件: 46 💬
5396P38 Inhibitor (4) 25mg----1件: 46 💬
5397P38 Inhibitor (4) 300mg----1件: 46 💬
5398P38 Inhibitor (4) 50mg----1件: 46 💬
5399P38 Inhibitor (4) 75mg----1件: 46 💬
5400P38 Map Kinase Inhibitor----1件: 46 💬
5401P38(4) Map Kinase Inhibitor----1件: 46 💬
5402PAH medication----1件: 86 💬
5403PALOVAROTENE - 1.5mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5404PALOVAROTENE - 10 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5405PALOVAROTENE - 1mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5406PALOVAROTENE - 2 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5407PALOVAROTENE - 2.5 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5408PALOVAROTENE - 3 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5409PALOVAROTENE - 4 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5410PALOVAROTENE - 5 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5411PALOVAROTENE 1.5 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5412Palovarotene dose level 11件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5413PALOVAROTENE-2 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5414PALOVAROTENE-3 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5415PALOVAROTENE-4 mg1件: Palovarotene1件: Palovarotene 💬1件: RARG 💬-1件: 272 💬
5416PANCREASE MT----1件: 299 💬
5417Pancrease MT 10.5, or MT 21----1件: 299 💬
5418Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)2件: Acarbose,
Pancrelipase		2件: Acarbose ,
Pancrelipase 💬		5件: AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬		7件: Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬1件: 298 💬
5419PANCRECARB® (pancrelipase)1件: Pancrelipase1件: Pancrelipase 💬--1件: 299 💬
5420Pancrelipase Microtablets1件: Pancrelipase1件: Pancrelipase 💬--1件: 299 💬
5421Pancrelipase with bicarbonate1件: Pancrelipase1件: Pancrelipase 💬--1件: 299 💬
5422Pantoprazolo 20 mg gastro-resistant tablets----1件: 65 💬
5423Panzytrat 25.000 FIP-E units of Lipase----1件: 298 💬
5424Panzytrat® 25,000----1件: 299 💬
5425Panzytrat® ok----1件: 299 💬
5426Paracetamol 120Mg/5mL Oral Suspension1件: Acetaminophen1件: Acetaminophen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 3 💬
5427Paracetamolo 500 mg----1件: 13 💬
5428PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE----1件: 19 💬
5429PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE----1件: 300 💬
5430Paraffin Oil1件: Mineral oil1件: Mineral oil 💬--1件: 291 💬
5431PARALEN 500----1件: 46 💬
5432Parathyroid hormon 1-84----1件: 235 💬
5433Parathyroid Hormone (1-84) Human Recombinant1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
5434Parenteral Remodulin (treprostinil) injection1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5435Paroxetine & Prednisolone2件: Paroxetine,
Prednisolone		2件: Prednisolone ,
Paroxetine 💬		2件: NR3C1,
SLC6A4 💬		3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
5436Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP2件: Paroxetine,
Prednisolone		2件: Prednisolone ,
Paroxetine 💬		2件: NR3C1,
SLC6A4 💬		3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
5437Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP2件: Paroxetine,
Prednisolone		2件: Prednisolone ,
Paroxetine 💬		2件: NR3C1,
SLC6A4 💬		3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
5438Parsaclisib (1 mg)1件: Parsaclisib1件: Parsaclisib 💬1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 61 💬
5439Parsaclisib (2.5 mg)1件: Parsaclisib1件: Parsaclisib 💬1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 61 💬
5440Part 1 Levulan injection----1件: 34 💬
5441Part 1 Levulan surface application----1件: 34 💬
5442Part 1 Levulan surface application twice----1件: 34 💬
5443Part 1 Levulan surface application twice with microneedling----1件: 34 💬
5444Part 1, JM-010 component Group A----1件: 6 💬
5445Part 1, JM-010 component Group B----1件: 6 💬
5446Part 1, JM-010 component Group C----1件: 6 💬
5447Part 1: LJN452----1件: 93 💬
5448Part 2 Adult Alogabat High Dose (aged 15-17)----1件: 201 💬
5449Part 2, JM-010 combination Group A----1件: 6 💬
5450Part 2, JM-010 combination Group B----1件: 6 💬
5451Part 2, JM-010 component Group C----1件: 6 💬
5452Part 2: LJN452 Dose level 1----1件: 93 💬
5453Part 2: LJN452 Dose level 2----1件: 93 💬
5454Part A: 100 mg/mL GSK2618960----1件: 13 💬
5455Part B----1件: 46 💬
5456Part B Open-Label Extension----1件: 51 💬
5457Part B: Dose of GSK2618960 decided from Part A----1件: 13 💬
5458Part C: Dose of GSK2618960 decided from Part A and B----1件: 13 💬
5459Part I - etoricoxib 60 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
5460Part I - etoricoxib 90 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
5461Part I- naproxen 1000 mg1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
5462Part II- etoricoxib 60 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
5463Part II- etoricoxib 90 mg1件: Etoricoxib1件: Etoricoxib 💬1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
5464Part II- naproxen 1000 mg1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
5465Pasireotide 0.6 MG/ML1件: Pasireotide1件: Pasireotide 💬4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
5466Pasireotide 0.9 mg1件: Pasireotide1件: Pasireotide 💬4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
5467Pasireotide with or without cabergoline2件: Cabergoline,
Pasireotide		2件: Cabergoline ,
Pasireotide 💬		6件: DRD2,
PRL,
SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 75 💬
5468PAT-001, 0.1%----1件: 160 💬
5469PAT-001, 0.2%----1件: 160 💬
5470Patients will be randomized to receive EHP-101----1件: 51 💬
5471Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses----1件: 46 💬
5472PB1046, VIP-ELP1-120, Vasomera----1件: 86 💬
5473PBF-509----1件: 6 💬
5474PBF-999 / 160 mg----1件: 8 💬
5475PBF-999 / 320 mg----1件: 8 💬
5476PCCLchimGp91s lentiviral vector transduced CD34+ cells infusion----1件: 65 💬
5477PD 0299685 at 15mg BID----1件: 226 💬
5478PD 0299685 at 30mg BID----1件: 226 💬
5479PD patients H&Y=1.5-2 Medications OFF----1件: 6 💬
5480PD patients H&Y=1.5-2 Medications ON----1件: 6 💬
5481PD patients H&Y=3 Medications OFF----1件: 6 💬
5482PD patients H&Y=3 Medications ON----1件: 6 💬
5483PEGINTERFERON BETA-1A1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5484Peginterferone beta 1a----1件: 13 💬
5485PEGINTERFERONE BETA-1A----1件: 13 💬
5486PEGINTERFERONE LAMBDA-1A----1件: 13 💬
5487PEGylated Intereron Beta-1a----1件: 13 💬
5488PEGylated Interferon Beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5489Pegylated polypeptide hormone of human recombinant origin PEG-hGH----1件: 78 💬
5490Pelubiprofen 30 mg1件: Pelubiprofen1件: Pelubiprofen 💬--1件: 46 💬
5491PEMINE - 150 MG CAPSULE RIGIDE 50 CAPSULE----1件: 171 💬
5492Pemziviptadil (PB1046) Injection----1件: 86 💬
5493Pentasa 500 mg Retardtabletten1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
5494Pentasa Compact 2g, granulate with prolonged release2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
5495Pentasa Compact 4g, granulate with prolonged release2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 97 💬
5496Pentasa Sachet 1 g1件: Mesalazine1件: Mesalamine 💬--2件: 96, 97 💬
5497Pentasa Sachet 1 g prolonged release granules2件: Manganese citrate,
Mesalazine		1件: Mesalamine 💬--1件: 96 💬
5498Pentasa Sachet 1g1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
5499Pentosan Polysulfat SP 54® injection solution----1件: 19 💬
5500Pentosan polysulfate sodium 100 mg1件: Pentosan polysulfate---1件: 226 💬
5501Pentoxifylline 400 MG1件: Pentoxifylline1件: Pentoxifylline 💬--1件: 97 💬
5502Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping----1件: 113 💬
5503Perfluorinated gas/oxygen mixture1件: Oxygen1件: Oxygen 💬--1件: 299 💬
5504Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----1件: 265 💬
5505Perfusion of treatment Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5506Perfusion of treatment Rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
5507Peri-neural Dexamethasone 1 mg1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5508Peripheral blood stem cell----1件: 285 💬
5509Peripheral Blood Stem Cells----2件: 51, 65 💬
5510Persantin 100 mg----1件: 46 💬
5511Persantin 100 mg and----1件: 46 💬
5512Personalized extended interval dosing of natalizumab1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
5513PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE4件: Aluminium,
Aluminum hydroxide,
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated),
Hydroxide ion		1件: Aluminum hydroxide 💬--1件: 46 💬
5514PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE4件: Aluminium,
Aluminum hydroxide,
Bordetella pertussis pertactin antigen,
Hydroxide ion		1件: Aluminum hydroxide 💬--1件: 46 💬
5515PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE4件: Aluminium,
Aluminum hydroxide,
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated),
Hydroxide ion		1件: Aluminum hydroxide 💬--1件: 46 💬
5516PET with 11C-Flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13 💬
5517PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----1件: 85 💬
5518PF-04171327 10 mg----1件: 46 💬
5519PF-04171327 25 mg----1件: 46 💬
5520PF-06291826-83/Fx-1006A1件: Fx-1006A---1件: 28 💬
5521PF-06342674 0.25 mg/kg----1件: 13 💬
5522PF-06342674 1.5 mg/kg----1件: 13 💬
5523PF-06342674 6.0 mg/kg----1件: 13 💬
5524PF-06480605 100 mg/ml----1件: 97 💬
5525PF-06649751 - 15mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5526PF-06649751 - 1mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5527PF-06649751 - 5mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5528PF-06649751 high dose (15 mg QD)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5529PF-06649751 low dose (1 mg QD)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5530PF-06649751 middle dose 1 (3 mg QD)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5531PF-06649751 middle dose 2 (7 mg QD)1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5532PF-06650833 100 mg1件: PF-06650833---1件: 46 💬
5533PF-06650833 20 mg1件: PF-06650833---1件: 46 💬
5534PF-06651600 10 mg1件: PF-06651600---1件: 97 💬
5535PF-06651600 50 mg1件: PF-06651600---2件: 96, 97 💬
5536PF-06651600 50mg1件: PF-06651600---1件: 96 💬
5537PF-06651600-151件: PF-06651600---2件: 96, 97 💬
5538PF-06700841 15 mg1件: PF-06700841---1件: 49 💬
5539PF-06700841 25 mg1件: PF-06700841---2件: 96, 97 💬
5540PF-06700841 30 mg1件: PF-06700841---1件: 49 💬
5541PF-06700841 45 mg1件: PF-06700841---1件: 49 💬
5542PF-06700841 5 mg1件: PF-06700841---3件: 49, 96, 97 💬
5543PF-06700841 5mg1件: PF-06700841---1件: 49 💬
5544PF-06700841-151件: PF-06700841---3件: 49, 96, 97 💬
5545PF-06826647 100 mg QD----1件: 97 💬
5546PF-06826647 300 mg QD----1件: 97 💬
5547PF-06826647 600 mg QD----1件: 97 💬
5548PF-6826647 400 mg QD----1件: 97 💬
5549Pfefferminzblätter 1ml/10ml----1件: 97 💬
5550PG-760564----1件: 46 💬
5551PGT-1 gene lipid complex----1件: 299 💬
5552PGx-guided post-operative pain management----2件: 96, 97 💬
5553PH-7978041件: PH-797804---1件: 46 💬
5554Ph. Eur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid1件: Propanoic acid---1件: 6 💬
5555Ph. Eur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid----1件: 6 💬
5556PHA-022121 medium dose----1件: 65 💬
5557PHA-794,428----1件: 78 💬
5558PHA-794428----1件: 78 💬
5559Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells----1件: 65 💬
5560Pharmacokinetics of certolizumab pegol1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
5561Phase 1, SQY51----1件: 113 💬
5562Phase 1: Conventiaonal DMARD----1件: 46 💬
5563Phase 1: Etanercept1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
5564Phase 1: Methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
5565Phase 2: Optional ETN, SSZ, HCQ, MTX----1件: 46 💬
5566Phase 2a, SQY51 (cohort 1)----1件: 113 💬
5567Phase 2a, SQY51 (cohort 2)----1件: 113 💬
5568Phase 2a, SQY51 (cohort 3)----1件: 113 💬
5569Phase1 : CDED/Modulen™IBD® + Maintenance therapy----1件: 96 💬
5570Phenylalanine-free protein substitute in tablet form (XPhe minis)1件: Phenylalanine1件: Phenylalanine 💬--1件: 240 💬
5571Phenylbutyrate Oral Tablet1件: Phenylbutyric acid---1件: 15 💬
5572PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR1件: Lysine1件: Lysine 💬--1件: 13 💬
5573Pheripheral blood stem cells----1件: 65 💬
5574PhEur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid1件: Propanoic acid---1件: 6 💬
5575PhEur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid----1件: 6 💬
5576Phosphate and betamethasone acetate, 2 mL.3件: Acetate,
Betamethasone,
Phosphate ion		1件: Betamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 235 💬
5577Phosphate-buffered saline1件: Phosphate ion---1件: 49 💬
5578Phosphorodiamidate Morpholino Oligomer----1件: 113 💬
5579Phosphorodiamidate morpholino oligomer for exon 45 skipping----1件: 113 💬
5580Phosphorodiamidate morpholino oligomer for exon 53 skipping----1件: 113 💬
5581Physician standard-of-care----1件: 96 💬
5582PHYSIOLOGISCHE Kochsalzloesung Fresenius - Infusionsloesung----1件: 227 💬
5583Physiologische Kochsalzlösung Fresenius - Infusionslösung----1件: 288 💬
5584Pilocarpine Nitrate 5%2件: Nitrate,
Pilocarpine		2件: Pilocarpine ,
Nitric acid 💬		2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299 💬
5585Pimavanserin (ACP-103)1件: Pimavanserin---1件: 6 💬
5586Pimavanserin tartrate (ACP-103)1件: Pimavanserin---1件: 6 💬
5587Pimecrolimus 1% Cream1件: Pimecrolimus1件: Pimecrolimus 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 160 💬
5588Pimozide 2 mg per day1件: Pimozide1件: Pimozide 💬2件: ADRA2A,
DRD2 💬		9件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
5589Pimozide 2mg/day (current) or 4 mg/day (study initiation)1件: Pimozide1件: Pimozide 💬2件: ADRA2A,
DRD2 💬		9件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
5590Pimozide 4 mg per day1件: Pimozide1件: Pimozide 💬2件: ADRA2A,
DRD2 💬		9件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
5591Pioglitazone 15 mg1件: Pioglitazone1件: Pioglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 96 💬
5592Pioglitazone or metformin2件: Metformin,
Pioglitazone		2件: Metformin ,
Pioglitazone 💬		3件: PPARG,
PRKAA1,
PRKAA2 💬		27件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 265 💬
5593Piperacillin sodium , tazobactam sodium2件: Piperacillin,
Tazobactam		3件: Tazobactam ,
Piperacillin ,
Piperacillin 💬		--1件: 299 💬
5594Piperacillin/Tazobactam Kabi - Fresenius Kabi Austria2件: Piperacillin,
Tazobactam		3件: Tazobactam ,
Piperacillin ,
Piperacillin 💬		--1件: 299 💬
5595Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie1件: Tazobactam1件: Tazobactam 💬--1件: 299 💬
5596Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie1件: Tazobactam1件: Tazobactam 💬--1件: 299 💬
5597PIR, S-7701----1件: 85 💬
5598Pirepemat, 100 mg----1件: 6 💬
5599Pirepemat, 50 mg----1件: 6 💬
5600Pirfenidone 267 MG [Esbriet]1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 228 💬
5601Pirfenidone or nintedanib2件: Nintedanib,
Pirfenidone		2件: Pirfenidone ,
Nintedanib 💬		14件: CCL2,
FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
IL10,
IL1A,
IL1B,
IL6,
KDR,
PDGFRA,
PDGFRB,
TNF 💬		106件: AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
5602Pirfenidone, deuterated1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
5603Pitolisant Oral Tablet1件: Pitolisant1件: Pitolisant 💬1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
5604Pitolisant oral tablets1件: Pitolisant1件: Pitolisant 💬1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬1件: 193 💬
5605Pittsburgh Compound B1件: Pittsburgh Compound B---1件: 127 💬
5606Pittsburgh Compound B (C-11 PiB)1件: Pittsburgh Compound B---1件: 127 💬
5607PK-Merz----1件: 6 💬
5608PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
5609PL 00095/5079R----1件: 46 💬
5610PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION)1件: Water1件: Water 💬--1件: 57 💬
5611PL 12762/0049----1件: 13 💬
5612PL 17901/0122----1件: 96 💬
5613PLA + MTX switched to ABA+ MTX, DB----1件: 46 💬
5614Placental Mesenchymal Stem Cells1件: Placental Mesenchymal Stem Cells---1件: 118 💬
5615Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix1件: Placental Mesenchymal Stem Cells---1件: 118 💬
5616PLACENTEX ® Polydeoxyribonucleotide----1件: 51 💬
5617PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml----1件: 51 💬
5618PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿----1件: 51 💬
5619Plantago ovata husk----1件: 6 💬
5620Plaquenil - Hydroxychloroquine 200mg Film coated tablets1件: Hydroxychloroquine1件: Hydroxychloroquine 💬--3件: 43, 44, 45 💬
5621Plaquenil 200 mg filmdrasjerte tabletter----1件: 46 💬
5622Plasma analysis for bacterial translocation----1件: 46 💬
5623Plasma from healthy young people treatment + Riluzole1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
5624Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI)----1件: 96 💬
5625PLASMASAFE - SOLUZIONE PER INFUSIONE 1 SACCA DA 200 ML----1件: 274 💬
5626Plegridy (peginterferon beta-1a), Biogen Idec Ltd1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5627PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5628Plegridy 125 micrograms1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5629Plegridy 63 micrograms1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5630Plenadren 20 mg modified-release tablets2件: Hydrocortisone,
Manganese citrate		1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 78 💬
5631Plenadren 5 mg modified-release tablets2件: Hydrocortisone,
Manganese citrate		1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 78 💬
5632Pleneva TM BGC20-0134----1件: 13 💬
5633Plerixafor for Conditioning before HSCT.1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65 💬
5634Plerixafor mobilization of autologous CD117 stem cells1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 299 💬
5635PLN-748091件: PLN-74809---2件: 85, 94 💬
5636PLN-74809-0001件: PLN-74809---1件: 85 💬
5637PLN-74809-0201件: PLN-74809---1件: 85 💬
5638Plovamer acetate 0.5 milligram (mg)1件: Acetate---1件: 13 💬
5639Plovamer acetate 10 mg1件: Acetate---1件: 13 💬
5640Plovamer acetate 20 mg1件: Acetate---1件: 13 💬
5641Plovamer acetate 3 mg1件: Acetate---1件: 13 💬
5642PMG1015 Dose 1----1件: 85 💬
5643PMG1015 Dose 5----1件: 85 💬
5644PMG1015 Dose 7----1件: 85 💬
5645PN 200 tablets (500 mg naproxen and 20 mg omeprazole)2件: Naproxen,
Omeprazole		2件: Naproxen ,
Omeprazole 💬		4件: ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271 💬
5646PN-101----1件: 50 💬
5647PN-10884A----1件: 97 💬
5648PN-180307----1件: 78 💬
5649Pneumo23 / Pneumovax----1件: 46 💬
5650PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----2件: 13, 14 💬
5651PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE4件: Aluminium,
Aluminium phosphate,
Corynebacterium diphtheriae CRM197 protein,
Phosphate ion		---1件: 46 💬
5652Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F----1件: 46 💬
5653Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F----1件: 46 💬
5654Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F----1件: 222 💬
5655Pneumococcal polysaccharide serotype 11 2.2 µg----1件: 222 💬
5656PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml----2件: 62, 66 💬
5657Pneumovax® (pneumococcal polysaccharide vaccine)----1件: 65 💬
5658PNEUMOVAX® 23----1件: 46 💬
5659POLY(OXY-1,2-ETHANEDIYL), A----1件: 235 💬
5660POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-1件: Diethyl ether1件: Ether 💬--1件: 235 💬
5661POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DI1件: Diethyl ether1件: Ether 💬--1件: 235 💬
5662POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL]-2-METHYLALANYL-TERIPARATIDE (2:1)2件: Diethyl ether,
Teriparatide		2件: Ether ,
Teriparatide 💬		1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
5663Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.----1件: 13 💬
5664Pomalidomide Oral Product1件: Pomalidomide1件: Pomalidomide 💬2件: IL6,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 227 💬
5665Ponesimod 10 mg1件: Ponesimod1件: Ponesimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
5666Ponesimod 20 mg1件: Ponesimod1件: Ponesimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
5667Ponesimod 40 mg1件: Ponesimod1件: Ponesimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
5668Pooled mesenchymal stem cell----1件: 49 💬
5669Pooled Plasma (Human), Solvent/Detergent Treated----1件: 64 💬
5670Porcine (pig) PERT----1件: 299 💬
5671Posaconazole 100 MG [Noxafil]1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
5672Posaconazole 40 MG/ML1件: Posaconazole1件: Posaconazole 💬--1件: 299 💬
5673Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin)1件: Activated charcoal---1件: 6 💬
5674Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin)----1件: 6 💬
5675Post-CPB Drug: Dobutamine Hydrochloride1件: Dobutamine1件: Dobutamine 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58 💬
5676Postoperative 3-month exclusive enteral nutrition----1件: 96 💬
5677Powder for Oral Suspension)----1件: 113 💬
5678Pozelimab + Cemdisiran2件: Cemdisiran,
Pozelimab		1件: Pozelimab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
5679PR Oxycodone1件: Oxycodone1件: Oxycodone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
5680PRALIA 60 mg Subcutaneous Injection Syringe(denosumab)1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 46 💬
5681Pramipexole 0.125 mg tablets1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5682Pramipexole 0.5 mg tablets1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5683PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5684Pramipexole dihydrochloride monohydrate extended release2件: Manganese citrate,
Pramipexole		1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5685Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole)1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5686Pramipexole or ropinirole2件: Pramipexole,
Ropinirole		2件: Pramipexole ,
Ropinirole 💬		3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5687Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride)1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5688Pre and post-CPB Drug: Dobutamine Hydrochloride1件: Dobutamine1件: Dobutamine 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58 💬
5689Precedentemente denominato MEDI2070 e AMG 139----1件: 96 💬
5690Pred + Meth----1件: 46 💬
5691Predinose oral----1件: 70 💬
5692PredniHEXAL® 10mg Tabletten----1件: 46 💬
5693PredniHEXAL® 20mg Tabletten----1件: 46 💬
5694PredniHEXAL® 5mg Tabletten----1件: 46 💬
5695PredniHEXAL® 5mg Tabletten, PredniHEXAL® 10mg Tabletten----1件: 46 💬
5696PredniHEXAL® 5mg Tabletten, PredniHEXAL® 20mg Tabletten----1件: 46 💬
5697Prednisolene tablets BP 1 mg----1件: 46 💬
5698Prednisolon 1 mg JENAPHARM----1件: 41 💬
5699Prednisolon 10 mg JENAPHARM----1件: 41 💬
5700Prednisolon 20 mg JENAPHARM----1件: 41 💬
5701Prednisolon 5 mg JENAPHARM----1件: 41 💬
5702Prednisolone & dipyridamole2件: Dipyridamole,
Prednisolone		2件: Dipyridamole ,
Prednisolone 💬		3件: NR3C1,
PDE4A,
PDE5A 💬		7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
5703Prednisolone + mabthera2件: Prednisolone,
Rituximab		2件: Prednisolone ,
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61 💬
5704Prednisolone 1mg Tablets1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
5705Prednisolone 2,5 mg Tablets1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
5706Prednisolone 20 mg1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5707Prednisolone 40 mg1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5708Prednisolone 5 mg1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 46, 51 💬
5709Prednisolone 5 mg JENAPHARM1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5710Prednisolone 5 mg Tablets1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
5711Prednisolone 5mg Gastro-resistant Tablets1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 51 💬
5712Prednisolone 5mg Tablet1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
5713Prednisolone and mycophenolate mofetil3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone		3件: Prednisolone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 222 💬
5714Prednisolone sodium metasulphobenzoate1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
5715Prednisolone Tablets B.P. 5mg1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
5716Prednisolone Tablets BP1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5717Prednisolone Tablets BP 1 mg1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5718Prednisolone Tablets USP 5 mg1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5719Prednison 10 mg GALEN----1件: 35 💬
5720Prednison 5 mg GALEN----1件: 35 💬
5721PREDNISON 5, 20 Léciva por. tablet nob----1件: 50 💬
5722Prednison 5, 20 Léciva por. tablet nob.----1件: 50 💬
5723Prednison 50 mg GALEN----1件: 35 💬
5724Prednison acis® 20 mg----2件: 43, 44 💬
5725Prednison acis® 5 mg----2件: 43, 44 💬
5726Prednison acis¿ 20 mg----2件: 43, 44 💬
5727Prednison acis¿ 5 mg----2件: 43, 44 💬
5728Prednison20 mg GALEN----1件: 35 💬
5729Prednisone (and methylprednisolone)2件: Methylprednisolone,
Prednisone		2件: Methylprednisolone ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 43 💬
5730Prednisone + Inhibace/Cozaar1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
5731Prednisone - Azathioprine2件: Azathioprine,
Prednisone		2件: Azathioprine ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 11 💬
5732Prednisone 0,5 mg/kg orally on alternate days1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
5733Prednisone 1 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5734Prednisone 15 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5735Prednisone 2 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5736Prednisone 3 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5737Prednisone 4 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5738Prednisone 5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 46, 66 💬
5739Prednisone 5 mg tablets1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
5740Prednisone 7.5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
5741Prednisone and Belimumab2件: Belimumab,
Prednisone		2件: Prednisone ,
Belimumab 💬		2件: NR3C1,
TNFSF13B 💬		5件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬1件: 300 💬
5742Prednisone and Mycophenolate mofetil3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		3件: Prednisone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 300 💬
5743PREDNISONE ARROW 5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
5744PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 19 💬
5745PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 300 💬
5746Prednisone or Prednisolone2件: Prednisolone,
Prednisone		2件: Prednisolone ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 66, 84 💬
5747PredniSONE Tablets USP, 1 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46 💬
5748PredniSONE Tablets USP, 10 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5749PredniSONE Tablets USP, 1mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5750PredniSONE Tablets USP, 2.5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5751PredniSONE Tablets USP, 2.5mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5752PredniSONE Tablets USP, 20mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5753PredniSONE Tablets USP, 5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46 💬
5754PredniSONE Tablets USP, 5mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5755PredniSONE Tablets, USP1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 41, 43, 44 💬
5756PredniSONE Tablets, USP 10 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5757PredniSONE Tablets, USP 2.5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5758PredniSONE Tablets, USP 5 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5759PredniSONE Tablets, USP, 1 mg1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41 💬
5760Prednisone, ciclosporin and mycophenolate mofetil4件: Cyclosporine,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		4件: Cyclosporine ,
Prednisone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬		8件: IMPDH1,
IMPDH2,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		38件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
5761Prednisone, cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: Cyclophosphamide ,
Prednisone ,
Cyclophosphamide 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 40 💬
5762Prednisone, FK506, MMF1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
5763Prednisone, low dose rituximab2件: Prednisone,
Rituximab		2件: Prednisone ,
Rituximab 💬		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61 💬
5764Prednisone, methylprednisolone,cyclophosphamides2件: Methylprednisolone,
Prednisone		2件: Methylprednisolone ,
Prednisone 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
5765Prefilled Syringe delivery of Golimumab1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
5766PREFOLIC 15*30CPR GASTROR 15MG----1件: 337 💬
5767PREFOLIC*30CPR GASTROR 15MG----1件: 299 💬
5768Pregabalin 75mg1件: Pregabalin1件: Pregabalin 💬4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 70 💬
5769Preladenant 10 mg tablet1件: Preladenant1件: Preladenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
5770Preladenant 2 mg tablet1件: Preladenant1件: Preladenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
5771Preladenant 5 mg tablet1件: Preladenant1件: Preladenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
5772Prevenar 1312件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---5件: 13, 14, 46, 96, 222 💬
5773PREVENAR 13 - 0.5 ML SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - FLACONCINO MONODOSE (0,5 ML VETRO TIPO I) - 1 FLACONCINO MONODOSE12件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---1件: 222 💬
5774Prevenar 13 sospensione per iniezione12件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---1件: 14 💬
5775Prevenar 13 suspension for injection12件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---1件: 222 💬
5776Prevenar® (7-valent pneumococcal conjugate vaccine)----1件: 65 💬
5777Prevenar® and Pneumo23®----1件: 49 💬
5778Previously referred to as MEDI2070 and AMG 139----2件: 96, 97 💬
5779Previously referred to as MEDI2070 and AMG 139, AGN-151-598----1件: 96 💬
5780Previously termed sc.AAV9.CB.SMN and AVXS-101----1件: 3 💬
5781Pridia (Donepezil Hydrochloride) 5mg1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
5782Pridia 10mg----1件: 6 💬
5783Pridia 5mg----1件: 6 💬
5784Pridopidine (90 mg)1件: Pridopidine1件: Pridopidine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8 💬
5785Prior Donepezil 5mg1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
5786Prior Donzepezil 10mg----1件: 6 💬
5787PRIVIGEN - 100 MG/ML - SOLUZIONE PER INFUSIONE USO ENDOVENOSO FLACONCINO(VETRO) 1 FLACONCINO DA 100 ML----1件: 51 💬
5788Privigen 100 mg/ml, solution pour perfusion----1件: 53 💬
5789PRIVIGEN 100mg/ml----1件: 85 💬
5790PRM-1511件: PRM-151---1件: 85 💬
5791PRM-151 (Zinpentraxin Alfa)1件: PRM-151---1件: 85 💬
5792PRO044 IV 6 mg/kg----1件: 113 💬
5793PRO044 IV 9 mg/kg----1件: 113 💬
5794PRO044 SC 6 mg/kg----1件: 113 💬
5795PRO045, 0.15 mg/kg/week1件: BMN-045---1件: 113 💬
5796PRO045, 1.0 mg/kg/week1件: BMN-045---1件: 113 💬
5797PRO045, 3.0 mg/kg/week1件: BMN-045---1件: 113 💬
5798PRO045, 6.0 mg/kg/week1件: BMN-045---1件: 113 💬
5799PRO045, 9.0 mg/kg/week1件: BMN-045---1件: 113 💬
5800PRO045, selected dose1件: BMN-045---1件: 113 💬
5801Probiotic - VSL#3----1件: 96 💬
5802Probiotic capsules containing Lactobacillus rhamnosus GR-1 and L. reuteri RC-141件: Lactobacillus delbrueckii bulgaricus---1件: 46 💬
5803Probiotic Mixture----2件: 96, 97 💬
5804Probiotic Product - Cap----1件: 53 💬
5805PROCAPTAN - 10 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE IN CONTENITORE PER COMPRESSE PP----1件: 58 💬
5806PROCAPTAN - 5 MG COMPRESSE RIVESTITE CON FILM 10 COMPRESSE IN CONTENITORE PER COMPRESSE PP----1件: 58 💬
5807PROCHYMAL adult human mesenchymal stem cells1件: Remestemcel-L1件: Remestemcel-L 💬--1件: 96 💬
5808Prochymal™ adult human mesenchymal stem cells1件: Remestemcel-L1件: Remestemcel-L 💬--1件: 96 💬
5809Products containing azathioprine or 6-mercaptopurine2件: Azathioprine,
Mercaptopurine		3件: Mercaptopurine ,
Azathioprine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 97 💬
5810Progressive spacing of TNF-blocker injections----1件: 46 💬
5811Progynova 21 mite----1件: 65 💬
5812Prolastin-C, 120 mg/kg1件: Alpha-1-proteinase inhibitor---1件: 231 💬
5813Prolastin-C, 60 mg/kg1件: Alpha-1-proteinase inhibitor---1件: 231 💬
5814Proleukin 18 MUI1件: Aldesleukin1件: Aldesleukin 💬3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 2 💬
5815PROLEUKIN® S1件: Aldesleukin1件: Aldesleukin 💬3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 65 💬
5816Prolotherapy solution of 20% dextrose1件: Dextrose, unspecified form---1件: 70 💬
5817Prometic's Immune Globulin Intravenous 10%----1件: 65 💬
5818Promixin 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299 💬
5819PROMIXIN*NEBUL 30MONOD 1MUI----1件: 299 💬
5820Promixin, 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299 💬
5821Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador----1件: 299 💬
5822Propantheline Bromide1件: Propantheline---1件: 26 💬
5823Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal)----1件: 13 💬
5824Proposed INN - FILGOTINIB1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5825Propranolol HCl CF 40 mg tablet1件: Propranolol1件: Propranolol 💬3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
5826Propsoed INN - FILGOTINIB1件: Filgotinib1件: Filgotinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
5827PROSCAR*30CPR RIV 5MG1件: Finasteride1件: Finasteride 💬1件: SRD5A2 💬3件: Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬1件: 6 💬
5828Proteína recombinante estimulante de la megacariopoyesis----1件: 63 💬
5829Provigil (modafinil)1件: Modafinil1件: Modafinil 💬--1件: 13 💬
5830PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE1件: Modafinil1件: Modafinil 💬--1件: 113 💬
5831PRTX-100----1件: 46 💬
5832PRTX-100 (Staphylococcal protein A)1件: Bevifimod---1件: 63 💬
5833PRTX-100 at 1.5 mcg/kg----1件: 46 💬
5834PRTX-100 at 12.0 mcg/kg----1件: 46 💬
5835PRTX-100 at 240 mcg----1件: 46 💬
5836PRTX-100 at 3.0 mcg/kg----1件: 46 💬
5837PRTX-100 at 420 mcg----1件: 46 💬
5838PRTX-100 at 6.0 mcg/kg----1件: 46 💬
5839PRX-102----1件: 19 💬
5840PRX-102 (pegunigalsidase alfa)1件: Pegunigalsidase alfa1件: Pegunigalsidase alfa 💬--1件: 19 💬
5841PRX-102 1 mg/kg every 2 weeks----1件: 19 💬
5842PRX-102 2 mg/kg every 4 weeks----1件: 19 💬
5843PRX-112----1件: 19 💬
5844PRX002, ELT2, anti-alpha-synuclein monoclonal antibody----1件: 6 💬
5845Pseudoephedrine + 480 ml water2件: Pseudoephedrine,
Water		2件: Water ,
Pseudoephedrine 💬		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
5846Pseudoephedrine + 50 ml water2件: Pseudoephedrine,
Water		2件: Water ,
Pseudoephedrine 💬		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
5847Psorcutan-Ointment----1件: 36 💬
5848PSRS11.EFS.IL2RG.pre* retroviral vector----1件: 65 💬
5849PSRS11.EFS.IL2RG.pre* retroviral vector transduce----1件: 65 💬
5850PSRS11.EFS.IL2RG.pre* retroviral vector transduced cells----1件: 65 💬
5851PT320 2.0 mg----1件: 6 💬
5852PT320 2.5 mg----1件: 6 💬
5853PTC-124----2件: 246, 299 💬
5854PTC0161480, PTC124 Compound 1a, RPS2505, PTC-C124, 291844----1件: 113 💬
5855PTC518 tablet 20 mg----1件: 8 💬
5856PTC518 tablet 5 mg----1件: 8 💬
5857PTC857 oral solution----1件: 2 💬
5858PTG-100----1件: 97 💬
5859PTH 1-341件: Teriparatide1件: Teriparatide 💬1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬2件: 65, 235 💬
5860PTW-002 10 mg/g gel----1件: 36 💬
5861Puerarin injection 400 mg1件: Puerarin---1件: 46 💬
5862Puerarin tablet 50 mg1件: Puerarin---1件: 46 💬
5863PUR 0110 Rectal Enema 1000 mg----1件: 97 💬
5864PUR 0110 Rectal Enema 250 mg----1件: 97 💬
5865PUR 0110 Rectal Enema 500 mg----1件: 97 💬
5866Puri-Nethol 50 mg----1件: 96 💬
5867Purified form of the lysosomal enzyme iduronate-2-sulfatase----1件: 19 💬
5868PURINETHOL - 50 MG COMPRESSE25 COMPRESSE1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96 💬
5869PXT002331 - 20mg----1件: 6 💬
5870PXT002331 - dose 1----1件: 6 💬
5871PXT002331 - dose 2----1件: 6 💬
5872PXT3003 Dose 1----1件: 10 💬
5873PXT3003 Dose 2 (equivalent to twice Dose 1)----1件: 10 💬
5874Pyridostigmine Bromide1件: Pyridostigmine---3件: 3, 6, 256 💬
5875Pyridostigmine, Prednisone, Tacrolimus3件: Prednisone,
Pyridostigmine,
Tacrolimus		3件: Tacrolimus ,
Prednisone ,
Tacrolimus 💬		6件: NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
5876Pyridostigmine, Tacrolimus2件: Pyridostigmine,
Tacrolimus		2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
5877Pyridoxine 10mg1件: Pyridoxine1件: Pyridoxine 💬--1件: 93 💬
5878Pyridoxine 10mg BP1件: Pyridoxine1件: Pyridoxine 💬--1件: 93 💬
5879Pyruvate, creatine, niacinamide2件: Creatine,
Nicotinamide		1件: Niacinamide 💬--1件: 5 💬
5880Q4W GMA301 IV injections (1000 mg)----1件: 86 💬
5881Q4W GMA301 IV injections (300 mg)----1件: 86 💬
5882Q4W GMA301 IV injections (600 mg)----1件: 86 💬
5883QBW276 1500mcg----1件: 299 💬
5884QCC374 0.015 mg----1件: 86 💬
5885QCC374 0.06 mg----1件: 86 💬
5886Qingkailing injection 40 ml----1件: 46 💬
5887QLS-101 ophthalmic solution, 2.0 %----1件: 157 💬
5888QOL assessment, Neuropsychological----1件: 34 💬
5889QR-1123----1件: 90 💬
5890QR-313 Gel for Topical (Cutaneous) Administration----1件: 36 💬
5891QRL-201 - Dose 1----1件: 2 💬
5892QRL-201 - Dose 2----1件: 2 💬
5893QRL-201 - Dose 3----1件: 2 💬
5894QRL-201 - Dose 4----1件: 2 💬
5895QRL-201 - Dose 5----1件: 2 💬
5896QRL-201 - Dose 6----1件: 2 💬
5897QRL-201 - Dose 7----1件: 2 💬
5898QRL-201- Dose 8----1件: 2 💬
5899QTXEW2-04-AF, EW2, GC-1, QRX-431----1件: 20 💬
5900Quality of life----1件: 13 💬
5901Qutenza (8% capsaicin)1件: Capsaicin1件: Capsaicin 💬1件: TRPV1 💬2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 86 💬
5902R(+) pramipexole dihydrochloride monohydrate1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 2 💬
5903R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride1件: Benzofuran---1件: 6 💬
5904R-Gene 101件: Arginine1件: Arginine 💬--1件: 78 💬
5905R-hIL-18BP----1件: 65 💬
5906R-metHuGDNF1件: Liatermin1件: Liatermin 💬--1件: 6 💬
5907R-metHuLeptin1件: Metreleptin1件: Metreleptin 💬1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
5908R05C B01----1件: 299 💬
5909R788 sodium hexahydrate, RIG2-01, RIG-G----1件: 46 💬
5910R788 Sodium, R788 Na, R788----1件: 46 💬
5911R788, fostamatinib disodium hexahydrate (in USPI/FPI)1件: Fostamatinib1件: Fostamatinib 💬1件: SYK 💬17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 61 💬
5912RA15804589, C19061501-F, DNL788, DN2489, DN0002489----2件: 2, 13 💬
5913RAAV-Olig001-ASPA1件: MYR-101---1件: 307 💬
5914RAAV1-CMV-GAA (study agent) Administration----1件: 256 💬
5915RAAV1.tMCK.human-alpha-sarcoglycan- First cohort----1件: 113 💬
5916RAAV1.tMCK.human-alpha-sarcoglycan- Second cohort----1件: 113 💬
5917RAAV2.5-CMV-minidystrophin (d3990)----1件: 113 💬
5918RAAV2/5-hNAGLU----1件: 19 💬
5919RAAV2/5-PBGD vector dosage 1----1件: 254 💬
5920RAAV2/5-PBGD vector dosage 2----1件: 254 💬
5921RAAV2/5-PBGD vector dosage 3----1件: 254 💬
5922RAAV2/5-PBGD vector dosage 4----1件: 254 💬
5923RAAV5-miHTT1件: AMT-130---1件: 8 💬
5924RAAVrh74.MCK.GALGT2----1件: 113 💬
5925RAAVrh74.MCK.micro-Dystrophin----1件: 113 💬
5926Rabbit ATG, (Genzyme)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---1件: 60 💬
5927Rabbit ATG, Cyclosporine, Levamisole4件: Antithymocyte immunoglobulin (rabbit),
Cyclosporine,
Levamisole,
Rabbit		2件: Cyclosporine ,
Levamisole 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
5928Rabbit ATG, Thymoglobuline (Genzyme)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---1件: 60 💬
5929RAD001 1mg----1件: 158 💬
5930RAD001 2,5 mg----1件: 158 💬
5931RAD001 5mg----2件: 89, 158 💬
5932RAD001, everolimus1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 34 💬
5933RAD001: Everolimus1件: Everolimus1件: Everolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 34 💬
5934RADAMTS-13----1件: 64 💬
5935Radiolabelled OligoG CF-5/20 6% Solution----1件: 299 💬
5936Radiolabelled OligoG CF-5/20 6% Solution for Nebulisation----1件: 299 💬
5937Radiolabelled OligoG CF-5/20 DPI----1件: 299 💬
5938Radiolabelled OligoG CF-5/20 Dry Powder for Inhalation (DPI)----1件: 299 💬
5939Radotinib HCl 50 mg1件: Radotinib---1件: 6 💬
5940RAG1 LV CD34+ cells----1件: 65 💬
5941RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE1件: Ranolazine1件: Ranolazine 💬--1件: 58 💬
5942RANEXA*60CPR 500MG R.P.1件: Ranolazine1件: Ranolazine 💬--1件: 58 💬
5943RANEXA*60CPR 750MG R.P.1件: Ranolazine1件: Ranolazine 💬--1件: 58 💬
5944Ranibizumab injection (0.5 mg)1件: Ranibizumab1件: Ranibizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬2件: 166, 301 💬
5945RANKL/OPG ratio----1件: 49 💬
5946Ranolazine 1000 MG1件: Ranolazine1件: Ranolazine 💬--1件: 2 💬
5947Ranolazine 1000 mg PR tablets1件: Ranolazine1件: Ranolazine 💬--1件: 58 💬
5948Ranolazine 500 MG1件: Ranolazine1件: Ranolazine 💬--1件: 2 💬
5949Ranolazine 500 mg PR tablets1件: Ranolazine1件: Ranolazine 💬--1件: 58 💬
5950Ranolazine 750 mg PR tablets1件: Ranolazine1件: Ranolazine 💬--1件: 58 💬
5951Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die1件: Ranolazine1件: Ranolazine 💬--1件: 58 💬
5952RAPA-501 Autologous T cells----1件: 2 💬
5953Rapamicina tópica al 1% y excipiente----1件: 157 💬
5954RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 2 💬
5955RAPAMUNE 1 mg/ml oral solution1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
5956Rapamune 1 mg/ml solución oral1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
5957Rapamune 1mg tablets1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 67 💬
5958RAPAMUNE*100CPR RIV 1MG1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 67 💬
5959RAPAMUNE*30CPR RIV 1MG1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 67 💬
5960Rapamycin cream, topical, 0.5%, 1.0% w/w1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
5961Rapamycin, sirolimus1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 89, 158 💬
5962Rapid Dose Titration Group of Subcutaneous Treprostinil1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5963Raptiva 100 mg/ml powder and solvent for solution for injection1件: Efalizumab1件: Efalizumab 💬1件: ITGAL 💬12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬7件: 11, 13, 46, 53, 61, 95, 96 💬
5964RASAGILINA MESILATO1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
5965Rasagilina mesilato (12 weeks)1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5966Rasagiline 1 mg capsule1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5967Rasagiline 1mg tablet1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5968Rasagiline 2 mg tablet1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5969RASAGILINE MESILATE1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬3件: 2, 5, 6 💬
5970RASAGILINE MESYLATE1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
5971Rasagiline mesylate 1.0 mg1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5972Rasagiline mesylate plus Mirapex1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5973Rasagiline mesylate with Levodopa2件: Levodopa,
Rasagiline		3件: Levodopa ,
Rasagiline ,
Rasagiline tartrate 💬		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
MAOB 💬		20件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
5974Rasagiline mesylate with Requip1件: Rasagiline2件: Rasagiline ,
Rasagiline tartrate 💬		1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
5975RAvPAL-PEG 0.001 mg/kg1件: Pegvaliase1件: Pegvaliase 💬1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
5976RAvPAL-PEG 0.003 mg/kg1件: Pegvaliase1件: Pegvaliase 💬1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
5977RAvPAL-PEG 0.01 mg/kg1件: Pegvaliase1件: Pegvaliase 💬1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
5978RAvPAL-PEG 0.03 mg/kg1件: Pegvaliase1件: Pegvaliase 💬1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
5979RAvPAL-PEG 0.1 mg/kg1件: Pegvaliase1件: Pegvaliase 💬1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
5980RAXONE - 150 MG- COMPRESSE RIVESTITE CON FILM- USO ORALE- FLACONE (HDPE)- 180 COMPRESSE1件: Idebenone1件: Idebenone 💬--1件: 113 💬
5981RC18 160 mg----2件: 13, 53 💬
5982RC18 160 mg plus MTX----1件: 46 💬
5983RC18 160 mg plus standard therapy----1件: 49 💬
5984RC18 160mg----3件: 11, 13, 66 💬
5985RC18 240 mg----2件: 11, 53 💬
5986RC18 240 mg plus standard therapy----1件: 49 💬
5987RC18 80 mg plus standard therapy----1件: 49 💬
5988Rcombinant Human Parathyroid Hormone [rhPTH(1-84)]1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
5989Rebif (IFN beta-1a subcutaneous three times per week)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5990Rebif (IFN ß-1a subcutaneous three times per week)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5991Rebif (interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5992Rebif (Interferon beta-1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5993Rebif (interferon beta-1a), Merck Serono Europe Ltd2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5994REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5995Rebif 22 micrograms1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5996Rebif 22 y 44 mcg1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5997Rebif 44 microgrammi/0.5ml soluzione iniettabile in cartuccia1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5998REBIF 44 microgramos solución inyectable1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
5999REBIF 44 microgramos solución inyectable en jeringa precargada1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6000Rebif 44 micrograms1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6001Rebif 44 micrograms solution for injection1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6002Rebif 44 micrograms solution for injection in pre-filled syringe1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6003Rebif 8,8 µg, Rebif 22µg1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6004Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6005Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack.1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6006Rebif New Formulation + ibuprofen PRN1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
6007Rebif New Formulation + prophylactic Ibuprofen1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
6008Rebif New Formulation 44mcg multidose cartridge1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6009REBIF SC 12SIR 12000000UI44MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6010REBIF SC 12SIR 6000000UI 22MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6011REBIF*SC 12SIR 12000000UI44MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6012REBIF*SC 12SIR 6000000UI 22MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6013Rebif® (clone 484-39)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6014Rebif® New Formulation1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6015Rebif® New Formulation (IFN-beta-1a, RNF)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6016Rebif® new formulation (RNF)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6017Rebif® New Formulation (RNF) using RebiSmartTM1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6018Received hormone maintenance therapy----1件: 96 💬
6019Recombiant human Desoxyribonuclease ( rhDNase)1件: Desoxyribonuclease---1件: 299 💬
6020Recombinant A Disintegrin and Metalloproteinase Thrombospondin Type-1 Motifs 13----1件: 64 💬
6021Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1----1件: 64 💬
6022Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs----1件: 64 💬
6023Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs 13----1件: 64 💬
6024Recombinant A Disintegrin And Metalloproteinase with Thrombospondin Type-1 Motifs 13 (rADAMTS13)----1件: 64 💬
6025Recombinant AAV vector serotype 2 containing the human wild type mitochondrial ND4 gene----1件: 302 💬
6026RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR EXPRESSING THE HUMAN ALPHA-1-ANTITRYPSIN GENE1件: Alpha-1-proteinase inhibitor---1件: 231 💬
6027Recombinant adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene----1件: 90 💬
6028Recombinant Adeno-Associated Viral vector, serotype 2 (rAAV2/2) containing the human wild-type mitochondrial NADH Dehydrogenase 4 gene (ND4)1件: NADH---1件: 302 💬
6029Recombinant adenovirus containing the ornithine transcarbamylase gene1件: Ornithine1件: Ornithine 💬--1件: 251 💬
6030Recombinant antihumanized anti-human monoclonal antibody directed against the IL-6R----1件: 107 💬
6031Recombinant coagulation FVIII Fc – von Willebrand factor – XTEN fusion protein1件: Von Willebrand factor human---1件: 288 💬
6032Recombinant coagulation FVIII Fc –von Willebrand factor – XTEN fusion protein1件: Von Willebrand factor human---1件: 288 💬
6033Recombinant form of human nerve growth factor produced in Escherichia Coli.2件: Escherichia coli,
Nerve Growth Factor		---1件: 53 💬
6034Recombinant granulocyte - colony stimulating factor----1件: 39 💬
6035Recombinant Growth Hormone, Genotropin (Pfizer)1件: Somatotropin---1件: 78 💬
6036RECOMBINANT HUMAN ?-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN1件: Phosphate ion---1件: 256 💬
6037Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (NEOGAA)3件: Avalglucosidase alfa,
Mannose,
Phosphate ion		1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
6038Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan Avalglucosidase Alfa (NeoGAA)3件: Avalglucosidase alfa,
Mannose,
Phosphate ion		1件: Avalglucosidase alfa 💬1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
6039RECOMBINANT HUMAN ALFA-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN1件: Phosphate ion---1件: 256 💬
6040Recombinant human alpha B-crystallin----1件: 13 💬
6041Recombinant human alpha-mannosidase----1件: 19 💬
6042Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN012件: Alunacedase alfa,
Angiotensin II		2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
6043Recombinant human anti IL-22 monoclonal antibody IgG1----1件: 46 💬
6044Recombinant human Arysulfatase B, recombinant human N-acetylgalactosamine 4-sulfatase----1件: 19 💬
6045RECOMBINANT HUMAN BETA GLUCURONIDASE----1件: 19 💬
6046Recombinant human beta-glucuronidase1件: Vestronidase alfa1件: Vestronidase alfa 💬1件: GUSB 💬8件: Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬1件: 19 💬
6047Recombinant human beta-glucuronidase (rhGUS)1件: Vestronidase alfa1件: Vestronidase alfa 💬1件: GUSB 💬8件: Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬1件: 19 💬
6048Recombinant human betaglucuronidase----1件: 19 💬
6049Recombinant human brain natriuretic peptide (rhBNP)----1件: 215 💬
6050RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTO2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288 💬
6051RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
6052RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - XTEN FUSION PROTEIN3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
6053RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -XTEN FUSION PROTEIN3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288 💬
6054Recombinant human derived macrophage-targeted beta-Glucocerebrosidase----1件: 19 💬
6055Recombinant human derived macrophage-targeted ß-Glucocerebrosidase----1件: 19 💬
6056RECOMBINANT HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 FUSED TO THE FC FRAGMENT OF IGG1----1件: 166 💬
6057Recombinant human Growth Hormone (Genotropin® )1件: Somatotropin---1件: 78 💬
6058Recombinant Human Growth Hormone (rhGH) Injection1件: Somatotropin---1件: 193 💬
6059Recombinant human growth hormone + rosiglitazone2件: Rosiglitazone,
Somatotropin		1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 265 💬
6060Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV)2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬		--1件: 65 💬
6061Recombinant human hyaluronidase + immune globulin intravenous2件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬		--1件: 65 💬
6062Recombinant human IFN beta----1件: 13 💬
6063Recombinant human IGF-1----2件: 78, 299 💬
6064Recombinant Human Insulin Growth Factor 1 (rhIGF-1)1件: Insulin human1件: Insulin human 💬1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 156 💬
6065Recombinant human interferon beta1件: Human interferon beta---1件: 13 💬
6066Recombinant human interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 26 💬
6067Recombinant Human Interleukin-11 (rhIL-11)1件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 96 💬
6068Recombinant human interleukin-71件: Interleukin-7---1件: 25 💬
6069Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬--1件: 19 💬
6070Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA), lysosomal acid lipase (human gene LIPA)1件: Cholesterol1件: Cholesterol 💬--1件: 19 💬
6071Recombinant human lysosomal alpha-mannosidase----1件: 19 💬
6072Recombinant human Mab of IgG4 subtype----1件: 46 💬
6073Recombinant human monoclonal antibody----1件: 46 💬
6074Recombinant human monoclonal antibody to human IL-1Beta of the IgG1/K class----3件: 106, 107, 108 💬
6075Recombinant human monoclonal antibody to Il-17 of the IgG1-k-class----1件: 271 💬
6076Recombinant human monoclonal antibody to inerleukin-1beta of the IgG1-K-class----1件: 46 💬
6077Recombinant human monoclonal antibody to interleukin-1beta of the IgG1-Kappa-class----1件: 46 💬
6078Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110----1件: 19 💬
6079Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 drug substance----1件: 19 💬
6080Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 1101件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
6081Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance1件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
6082RECOMBINANT HUMAN PARATHYROID HORMONE (1-84)1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
6083Recombinant Human Parathyroid Hormone [rhPTH(1-84)]1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
6084Recombinant human Pentraxin-2 (PRM-151)1件: PRM-151---1件: 85 💬
6085RECOMBINANT HUMAN SERUM ALBUMIN (HSA) FUSED TO HUMAN GROWTH HORMONE (HGH)2件: Albumin human,
Somatotropin		1件: Albumin human 💬--1件: 78 💬
6086Recombinant human tripeptidyl peptidase-1----1件: 19 💬
6087RECOMBINANT HUMAN TRIPEPTIDYL PEPTIDASE-1 (RHTPP1)----1件: 19 💬
6088Recombinant humanised anti-human monoclonal antibody directed against the IL-6R----1件: 46 💬
6089Recombinant humanized anti-CD20 monoclonal antibody----1件: 13 💬
6090Recombinant humanized anti-human Interleukin 6-Receptor (IL-6R) monoclonal----1件: 46 💬
6091Recombinant humanized anti-human Interleukin 6-Receptor (IL-6R) monoclonal antibody----1件: 46 💬
6092Recombinant humanized anti-human Interleukin-6 Receptor (IL-6R) monoclonal antibody----1件: 46 💬
6093Recombinant humanized anti-human monoclonal antibody directed against the IL-6R----3件: 46, 51, 107 💬
6094Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg----1件: 331 💬
6095Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 6mg/kg----1件: 331 💬
6096Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 8mg/kg----1件: 331 💬
6097Recombinant humanized IgG4 monoclonal antibody----1件: 61 💬
6098Recombinant humanized monoclonal antibody omalizumab to IgE1件: Omalizumab1件: Omalizumab 💬1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬
6099Recombinant humanized monoclonal antibody specific for human IL-5----1件: 44 💬
6100Recombinant humanized monoclonal antibody: IgG4 (heavy chain)----1件: 61 💬
6101RECOMBINANT INTERFERON BE----1件: 13 💬
6102RECOMBINANT INTERFERON BETA-1B2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6103Recombinant interleukin-111件: Oprelvekin1件: Oprelvekin 💬1件: IL11RA 💬3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
6104Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)----1件: 60 💬
6105Recombinant microbial lipase----1件: 298 💬
6106Recombinant Microbial Lipase SLV339----1件: 298 💬
6107RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E.COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE5件: Aluminium,
Aluminum hydroxide,
Hydroxide ion,
Iron polymaltose,
Lactobacillus casei		2件: Aluminum hydroxide ,
Lactobacillus casei 💬		--1件: 11 💬
6108RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN----1件: 11 💬
6109RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬--2件: 11, 13 💬
6110Recombinant porcine coagulation factor VIII (B domain deleted)1件: Beroctocog alfa---1件: 288 💬
6111Recombinant porcine coagulation factor VIII (B-domain deleted)1件: Beroctocog alfa---1件: 288 💬
6112Recombinant TNF-a receptor: IgG Fc fusion protein2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬--2件: 46, 271 💬
6113Recombinant von Willebrand Factor 1300IU1件: Von Willebrand factor human---1件: 288 💬
6114Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII)1件: Von Willebrand factor human---1件: 288 💬
6115Recombinant-methionyl human glial cell line-derived neurotrophic factor----1件: 6 💬
6116Red Blood Cell Zn----1件: 299 💬
6117Reduced Glutathione 100mg1件: Glutathione2件: Glutathione ,
Oxiglutatione 💬		--1件: 6 💬
6118REF CRUZADA PEI Nº 12-088----1件: 274 💬
6119Regimen Selection Phase Group 1 (COMPLETED)----1件: 113 💬
6120REGN1500 250 mg SC/15 mg/kg IV/450 mg SC----1件: 79 💬
6121Reldesemtiv 150 mg1件: Reldesemtiv1件: Reldesemtiv 💬1件: TNNC2 💬1件: Calcium signaling pathway 💬1件: 3 💬
6122Reldesemtiv 450 mg1件: Reldesemtiv1件: Reldesemtiv 💬1件: TNNC2 💬1件: Calcium signaling pathway 💬1件: 3 💬
6123REMICADE - 100 MG POLVERE PER CONCENTRATO PER INFUSIONE ENDOVENOSA 1 FLACONE VETRO 20 ML USO EV1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6124Remicade 100 mg1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 56, 96 💬
6125Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
6126REMICADE 100 mg polvo para concentrado para solución para perfusión1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
6127Remicade 100 mg powder for concentrate for solution for infusion.1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
6128Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271 💬
6129Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning.1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6130REMICADE*EV F 100MG+F 2ML1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6131REMICADE® (Infliximab)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6132Remodulin 10mg/ml 20ml1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 88 💬
6133Remodulin 1mg/ml 20ml1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 88 💬
6134Remodulin 2.5mg/ml 20ml1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 88 💬
6135Remodulin 5mg/ml 20ml1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 88 💬
6136Remodulin® (treprostinil) 1 mg/ml solution for infusion1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6137Remodulin® (treprostinil) 10 mg/ml solution for infusion1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6138Remodulin® (treprostinil) 2.5 mg/ml solution for infusion1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6139Remodulin® (treprostinil) 5 mg/ml solution for infusion1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6140REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271 💬
6141Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271 💬
6142Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i)2件: Angiotensin II,
Dextrose, unspecified form		2件: Angiotensin II ,
Angiotensin II 💬		2件: AGTR1,
AGTR2 💬		16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
6143Repatha 140 mg Solution for Injection in Pre-filled Pen1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
6144Repatha 140 mg soluzione per iniezione in penna preriempita.1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
6145Repatha 420 mg solution for injection in cartridge1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
6146Repatha 420 mg soluzione per iniezione in cartuccia1件: Evolocumab1件: Evolocumab 💬1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79 💬
6147REQUIP 21 CPR 0,25 MG1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6148REQUIP 21 CPR 0,5 MG1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6149REQUIP 21 CPR 1 MG1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6150REQUIP 21 CPR 2 MG1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6151Requip Modutab, 2mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6152Requip Modutab, 4mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6153Requip Modutab, 8mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6154REQUIP*21CPR 0,5MG1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6155REQUIP*21CPR 1MG1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6156REQUIP*21CPR 5MG1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6157Requip-Modutab1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6158REQUIP-MODUTAB , 2mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6159REQUIP-MODUTAB , 4mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6160REQUIP-MODUTAB , 8mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6161REQUIP-MODUTAB, 2mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6162REQUIP-MODUTAB, 4mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6163REQUIP-MODUTAB, 8mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6164Rescue Medication CDCA 250 mg TID1件: Chenodeoxycholic acid1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 263 💬
6165Resistant maltodextrin1件: Maltodextrin1件: Maltodextrin 💬--1件: 6 💬
6166Response to anakinra associated with methotrexate2件: Anakinra,
Methotrexate		2件: Methotrexate ,
Anakinra 💬		4件: DHFR,
DHFR2,
IL1R1,
IL1R2 💬		20件: Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 46 💬
6167Response to infliximab associated with methotrexate2件: Infliximab,
Methotrexate		2件: Methotrexate ,
Infliximab 💬		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6168Resunab, ajulemic acid, anabasum1件: Ajulemic acid1件: Lenabasum 💬1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299 💬
6169Retrospective Case Only----1件: 172 💬
6170Retroviral SF71-gp91phox transduced CD34+ cells----1件: 65 💬
6171REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294 💬
6172Revatio 0.8mg/ml solution for injection1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294 💬
6173Revatio 10 mg/ml powder for oral suspension1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6174Revatio 20 mg1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 85 💬
6175Revatio 20 mg film coated tablets1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6176Revatio 20 mg film-coated tablets----1件: 86 💬
6177Revatio 20 mg Filmtabletten1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6178REVATIO 20 mg, comprimidos recubiertos con película1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6179Revatio oral1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6180Revatio ® 20 mg film-coated tablets1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6181Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir3件: Abacavir,
Lamivudine,
Zidovudine		3件: Lamivudine ,
Zidovudine ,
Abacavir 💬		--1件: 325 💬
6182REVOLADE - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU) 28 COMPRESSE1件: Eltrombopag---1件: 60 💬
6183REVOLADE - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU1件: Eltrombopag---1件: 60 💬
6184Revolade 25 mg film-coated tablets1件: Eltrombopag---1件: 63 💬
6185Revolade 50 mg film-coated tablets1件: Eltrombopag---1件: 63 💬
6186Revolade 75 mg1件: Eltrombopag---1件: 60 💬
6187REVOLADE, PROMACTA1件: Eltrombopag---1件: 63 💬
6188REYATAZ 150MG 60 CPS BL1件: Atazanavir1件: Atazanavir 💬--1件: 265 💬
6189RFB002, rhuFab V21件: Ranibizumab1件: Ranibizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 166 💬
6190RFVIIa, rFVIIa + TXA1件: Coagulation factor VIIa Recombinant Human---1件: 288 💬
6191RG2133 (2',3',5'-tri-O-acetyluridine)1件: Uridine triacetate1件: Uridine triacetate 💬--1件: 21 💬
6192RG6042, formerly ISIS 443139, IONIS-HTTRx----1件: 8 💬
6193RGH-706----1件: 193 💬
6194RGX-111----1件: 19 💬
6195RGX-121----1件: 19 💬
6196RhASA - Dose Level 1----1件: 19 💬
6197RhASA - Dose Level 2----1件: 19 💬
6198RhASA - Dose Level 3----1件: 19 💬
6199RHB-104----2件: 13, 96 💬
6200Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)----1件: 46 💬
6201RhGAA, acid alpha glucosidase----1件: 256 💬
6202RhGH Norditropin® pen (34 µg/kg)1件: Somatotropin---1件: 78 💬
6203RhHNS-10 mg----1件: 19 💬
6204RhHNS-45 mg----1件: 19 💬
6205RhHNS-90 mg----1件: 19 💬
6206RhIFN beta-1b----1件: 13 💬
6207RhIGF-1----1件: 156 💬
6208RhIGF-1 (CEP-151)----1件: 13 💬
6209RhIGF-1/rhIGFBP-31件: rhIGFBP-3---1件: 195 💬
6210RhIL-11----1件: 97 💬
6211RhNGF 180 µg/ml eye drops solution1件: Cenegermin1件: Cenegermin 💬1件: NGFR 💬9件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Lyssavirus 💬1件: 90 💬
6212RhNGF 60 µg/ml eye drops solution1件: Cenegermin1件: Cenegermin 💬1件: NGFR 💬9件: Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Lyssavirus 💬1件: 90 💬
6213RhPTH (1-34)1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 70 💬
6214RhPTH (1-84)1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
6215RhPTH(1-84)1件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
6216RhuDex 100 mg (127 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬--1件: 93 💬
6217RhuDex 25 mg (31.75 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬--1件: 93 💬
6218RhuDex 50 mg (63.5 mg RhuDex choline salt) granules1件: Choline1件: Choline 💬--1件: 93 💬
6219RhuMAb Beta7----1件: 97 💬
6220RhuMAb Beta7, Anti Beta 7, PRO145223----1件: 97 💬
6221RhuMAb Beta7, Anti Beta7, PRO145223----1件: 97 💬
6222RhumAb to Il-17A (IgG1-k-class)----4件: 13, 46, 56, 96 💬
6223RhumAb to Il-17A (IgG1-k-class) rhumAb to Il-17A (IgG1-k-class)----1件: 96 💬
6224RhumAb to IL-17A igG1-k-class----1件: 13 💬
6225Rice/turkey free diet (R/TFD) group2件: Rice,
Turkey		---1件: 53 💬
6226Rifabutin, Clarithromycin, and Clofazimine3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: Clarithromycin ,
Clofazimine ,
Rifabutin 💬		--1件: 96 💬
6227Rifampin 300mg BID + istradefylline 40mg Day 8 only2件: Istradefylline,
Rifampicin		2件: Rifampin ,
Istradefylline 💬		1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
6228Rifaximin 550 MG1件: Rifaximin1件: Rifaximin 💬--1件: 6 💬
6229Rifaximin 550 MG Oral Tablet [XIFAXAN]1件: Rifaximin1件: Rifaximin 💬--1件: 299 💬
6230Rifaximin delayed release 400 mg film coated tablet1件: Rifaximin1件: Rifaximin 💬--1件: 96 💬
6231Rifaximin oral tablet1件: Rifaximin1件: Rifaximin 💬--1件: 99 💬
6232Rifaximin+omeprazole+miralax2件: Omeprazole,
Rifaximin		2件: Omeprazole ,
Rifaximin 💬		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 96 💬
6233Rigosertib Oral Capsules / Rigosertib Intravenous1件: Rigosertib1件: Rigosertib 💬1件: PLK1 💬4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 36 💬
6234RIL-1RA----1件: 107 💬
6235Rilonacept (IL-1 Trap)1件: Rilonacept1件: Rilonacept 💬2件: IL1A,
IL1B 💬		45件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 107 💬
6236Rilonacept 160 mg1件: Rilonacept1件: Rilonacept 💬2件: IL1A,
IL1B 💬		45件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 106 💬
6237Rilpivirine (RPV) tablet1件: Rilpivirine1件: Rilpivirine 💬--1件: 256 💬
6238Rilpivirine - Injectable Suspension (RPV LA)1件: Rilpivirine1件: Rilpivirine 💬--1件: 256 💬
6239Rilutek 50 mg film-coated tablets1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
6240RILUTEK 50 mg, film-coated tablets1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
6241Riluzole (100 mg)1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
6242Riluzole 100mg/day1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
6243Riluzole 50 MG1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
6244Riluzole 50 MG (Part B)1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
6245Riluzole Oral Soluble Film1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
6246Riluzole Oral Soluble film (ROSF) 50 mg1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2 💬
6247RILUZOLO TEVA - 50 MG COMPRESSE RIVESTITE CON FILM 90 COMPRESSE IN BLISTER AL/PVC----1件: 114 💬
6248Rilzabrutinib Oral Tablet----1件: 35 💬
6249RIMSO 50----1件: 226 💬
6250Riociguat (Adempas, BAY63-2521)1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬4件: 51, 86, 88, 299 💬
6251Riociguat (BAY63-2521)1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
6252Riociguat coated tablet 0.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
6253Riociguat coated tablet 1.0 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
6254Riociguat coated tablet 1.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
6255Riociguat coated tablet 2.0 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
6256Riociguat coated tablet 2.5 m1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
6257Riociguat coated tablet 2.5 mg1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 51 💬
6258Riociguat granules 0.3% for oral application1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
6259Riociguat Oral Product1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 86 💬
6260Riociguat Oral Tablet1件: Riociguat1件: Riociguat 💬3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 51, 86, 88 💬
6261Risankizumab 10 mg/ml1件: Risankizumab1件: Risankizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
6262Risankizumab 180 mg SC1件: Risankizumab1件: Risankizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
6263Risankizumab 600 mg IV1件: Risankizumab1件: Risankizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
6264Risankizumab 90 mg/ml1件: Risankizumab1件: Risankizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
6265Risankizumab On-Body Injector (OBI)1件: Risankizumab1件: Risankizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
6266Risedronate Oral Tablet1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
6267Risedronate sodium 2.5mg1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
6268Risedronate sodium 5mg1件: Risedronic acid1件: Risedronic acid 💬1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
6269Risedronato sódico 2.5mg----1件: 274 💬
6270Risedronato sódico 5mg----1件: 274 💬
6271Risperidone 1Mg Tab1件: Risperidone1件: Risperidone 💬2件: DRD2,
HTR2A 💬		11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬1件: 8 💬
6272Ritlecitinib 10 mg----1件: 97 💬
6273Ritlecitinib 5 mg----1件: 97 💬
6274Ritlecitinib 50 mg----2件: 96, 97 💬
6275Ritlecitinib 50mg----1件: 96 💬
6276Rituxan (INN: Rituximab), brand name in the United States1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6277Rituxan (INN: Rituximab), brand name in the US1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6278Rituxan (US, Canada, Japan), MabThera (rest of the world)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6279Rituxan (US, Canada, Japan), MabThera (rest of world)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 53 💬
6280Rituxan® (rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6281Rituximab (Arm B)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 43, 44 💬
6282Rituximab (MABTHERA® or RITUXAN®).1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 35, 61 💬
6283Rituximab (Mabthera®)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 61 💬
6284Rituximab (RTX) and Azathioprine (AZA)2件: Azathioprine,
Rituximab		2件: Azathioprine ,
Rituximab 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 65 💬
6285Rituximab - MabThera1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6286Rituximab 1g IV1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 162 💬
6287Rituximab [MabThera/Rituxan]1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 46, 63 💬
6288Rituximab [MabThera]1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6289Rituximab combined with Omalizumab2件: Omalizumab,
Rituximab		2件: Rituximab ,
Omalizumab 💬		2件: FCER1A,
MS4A1 💬		5件: Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 162 💬
6290Rituximab combined with tacrolimus induction + rituximab maintenance2件: Rituximab,
Tacrolimus		3件: Tacrolimus ,
Rituximab ,
Tacrolimus 💬		6件: MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
6291Rituximab combined with tacrolimus induction + tacrolimus maintenance2件: Rituximab,
Tacrolimus		3件: Tacrolimus ,
Rituximab ,
Tacrolimus 💬		6件: MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
6292Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
6293Rituximab MabThera1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6294Rituximab, Cyclophosphamide, and Corticosteroids2件: Cyclophosphamide,
Rituximab		3件: Cyclophosphamide ,
Rituximab ,
Cyclophosphamide 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222 💬
6295Rituximab, Mabthera1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 53 💬
6296Rituximab, MTX, folic acid2件: Folic acid,
Rituximab		2件: Folic acid ,
Rituximab 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6297Rituximab, observational study amon patients with active RA1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6298Rituximab-EU+ Rituximab-Pfizer x 2 Courses1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6299Rituximab-Pfizer (PF-05280586) x 3 courses1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6300Rituximab-US + Rituximab-Pfizer x 2 Courses1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6301Rituximab/ Mabthera1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 271 💬
6302RIV-TDS 13.3 mg/24 h----1件: 6 💬
6303Rivaroxaban 20 mg1件: Rivaroxaban1件: Rivaroxaban 💬1件: F10 💬1件: Complement and coagulation cascades 💬1件: 91 💬
6304Rivastigmin Luye Transdermal Patches - 4.6mg/24h----1件: 6 💬
6305Rivastigmine Luye Transdermal Patch- 9.5mg/24h1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
6306Rivastigmine Patch 9.5 cm21件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
6307Rivastigmine transdermal system 13.3 mg/24 h1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6 💬
6308RIXATHON 500 mg----1件: 85 💬
6309RIXATHON 500mg----1件: 43 💬
6310RM-131----1件: 6 💬
6311RN624, RI624----1件: 226 💬
6312RNA antisense oligonucleotide for intravitreal injection----2件: 90, 303 💬
6313RNS60 125 ml----1件: 13 💬
6314RNS60 250 ml----1件: 13 💬
6315Ro 106-1443----1件: 49 💬
6316Ro 47-0203 / ACT-050088----1件: 86 💬
6317Ro 48-77533----1件: 46 💬
6318Ro 487-533/F01----1件: 271 💬
6319Ro 487-5733/F01----1件: 271 💬
6320RO 487-7533----1件: 46 💬
6321Ro 487-7533/F01----3件: 46, 107, 271 💬
6322Ro 487-7533/F10----2件: 46, 107 💬
6323Ro 487-7533/F10-02----1件: 46 💬
6324Ro 487-7533/F10-04----4件: 41, 46, 51, 107 💬
6325Ro 491-7523/F18----1件: 206 💬
6326Ro 491-7523/F19----1件: 206 💬
6327Ro 533-3787/F01- 06----1件: 13 💬
6328Ro 533-3787/F01-06----1件: 11 💬
6329Ro 549-0261/F04----1件: 97 💬
6330Ro 549-0261/F04-02----1件: 96 💬
6331Ro 549-0261/F08-02----1件: 96 💬
6332RO 551-6922----1件: 46 💬
6333Ro 723-4292/F02----1件: 8 💬
6334Ro106-1443----1件: 43 💬
6335Ro47-0203 / ACT-050088----2件: 51, 86 💬
6336Ro487-7533----1件: 46 💬
6337RO487-7533/F01-F05----1件: 46 💬
6338RO487-7533/F10-04----2件: 46, 51 💬
6339RO4917523 0.5 mg----1件: 206 💬
6340RO4917523 1.5 mg----1件: 206 💬
6341RO5490261 / F02----1件: 97 💬
6342RO7034067 / F12----1件: 3 💬
6343RO7034067 / F13----1件: 3 💬
6344RO7034067/F06 + solvente (RO----1件: 3 💬
6345RO7034067/F07 + solvente (RO----1件: 3 💬
6346RO7049665/IgG-IL2/ IgG-IL2ND2----1件: 95 💬
6347RO7112689/F03-10----2件: 62, 109 💬
6348RO7239361 (BMS-986089)----1件: 113 💬
6349RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL)----1件: 113 💬
6350RO7239361 Injections, 35 mg/Syringe (50 mg/mL)----1件: 113 💬
6351RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL)----1件: 113 💬
6352RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL)----1件: 113 💬
6353RO7490677 160 mg/8 ml----1件: 85 💬
6354RO7490677 160 mg/8mL----1件: 85 💬
6355RO7490677 160mg/8mL----1件: 85 💬
6356RO7490677 320 mg/16 ml (2nd generation)----1件: 85 💬
6357RO7490677 320mg/16mL (1st generation)----1件: 85 💬
6358RO7490677 320mg/16mL (2nd generation)----1件: 85 💬
6359RO7490677/ F01-02----1件: 85 💬
6360ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 51 💬
6361ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
6362RoActemra 162 mg1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 51 💬
6363RoActemra 162 mg solution for injection in pre-filled syringe1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
6364RoActemra 162 mg solution injectable en seringue préremplie1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
6365RoActemra 162 mg soluzione iniettabile in siringa preriempita1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 50 💬
6366RoActemra 20 mg/ml concentrado para solución para perfusión1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
6367RoActemra 20 mg/ml Concentrate for solution for infusion1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
6368RoActemra 20 mg/ml concentrate for solution for infusion.1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
6369ROACTEMRA 20 mg/ml, concentrado para solución para perfusión1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬3件: 46, 107, 271 💬
6370RoActemra 20mg/ml1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 40 💬
6371RoActemra® 20mg/ml Konzentrat1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 266 💬
6372RoActemra®EV Product Code: PRD823211件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
6373Rob 803 (9-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxali----1件: 46 💬
6374Rob 803 (capsules 12.5 mg)----1件: 46 💬
6375Rob 803 (capsules 15 mg)----1件: 46 💬
6376Rob 803 (capsules 25 mg)----1件: 46 💬
6377Rob 803 (capsules 6.25 mg)----1件: 46 💬
6378Rob 803 12.5mg capsule----1件: 46 💬
6379Rob 803 15mg capsule----1件: 46 💬
6380Rob 803 6.5mg capsule----1件: 46 💬
6381Rocuronium Bromide1件: Rocuronium---1件: 70 💬
6382Rodatristat ethyl 300 mg tablet BID----1件: 86 💬
6383Rodatristat ethyl 600 mg BID----1件: 86 💬
6384Roferon-A, 3miu1件: Interferon alfa-2a1件: Interferon alfa-2a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
6385Roferon-A, 4.5miu1件: Interferon alfa-2a1件: Interferon alfa-2a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
6386Roferon-A, 6miu1件: Interferon alfa-2a1件: Interferon alfa-2a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 56 💬
6387Roflumilast 500 Ug ORAL TABLET [Daliresp]1件: Roflumilast1件: Roflumilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 97 💬
6388Roflumilast Oral Tablet1件: Roflumilast1件: Roflumilast 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 299 💬
6389Rokan (r) Novo 120 mg----1件: 18 💬
6390Ropinirole controlled-release (REQUIP CR) for RLS1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6391Ropinirole monotherapy1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6392Ropinirole oral product1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6393Ropinirole PR, 2mg1件: Ropinirole1件: Ropinirole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6394Rosiglitazone maleate1件: Rosiglitazone1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬3件: 46, 75, 265 💬
6395Rosuvastatin 10 mg1件: Rosuvastatin1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 96 💬
6396Rosuvastatin 10mg1件: Rosuvastatin1件: Rosuvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 97 💬
6397ROT-TDS 8 mg/24 h----1件: 6 💬
6398Rotigotine (Reference product PR 2.1.1)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6399Rotigotine (Test product PR 2.3.1)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6400Rotigotine transdermal patch 2mg/24h(10cm2)1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6401Rotigotine, extended-release microspheres1件: Rotigotine1件: Rotigotine 💬1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6402Routine transdermal oestrogen patch----1件: 78 💬
6403Routine Treatment of CD----1件: 96 💬
6404RP 103----2件: 8, 19 💬
6405RPC-1063----1件: 13 💬
6406RPC1063 (equivalent to ozanimod1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
6407RPC1063 (equivalent to ozanimod HCl)1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
6408RPC1063 equiv to ozanimod HCI1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
6409RPC1063 equiv. to ozanimod HCI1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
6410RPH-104----1件: 266 💬
6411RS-BACLOFEN1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 10 💬
6412RSLV-132----2件: 49, 53 💬
6413RT234 - vardenafil inhalation powder1件: Vardenafil1件: Vardenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6414RTX-134----1件: 240 💬
6415Rufinamide oral suspension1件: Rufinamide1件: Rufinamide 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 144 💬
6416RVG 101614----1件: 60 💬
6417RVG 104433----1件: 107 💬
6418RVG 105155----1件: 60 💬
6419RVG 114681----1件: 96 💬
6420RVG 116648----1件: 96 💬
6421RVG 13760----1件: 298 💬
6422RVG 15375----1件: 75 💬
6423RVG 15790 or RVG 25480----1件: 78 💬
6424RVG 18236----2件: 75, 227 💬
6425RVG 18388----1件: 160 💬
6426RVG 51680----1件: 14 💬
6427RVG 55618----1件: 6 💬
6428RVG 56083----1件: 14 💬
6429RVT-101 35 mg----1件: 6 💬
6430RVT-1201----1件: 86 💬
6431RVT-1401----2件: 11, 61 💬
6432RVT-1601----1件: 85 💬
6433RVT-1601 (formerly, PA101B)----1件: 85 💬
6434RVT-1601 (in precedenza PA101B)----1件: 85 💬
6435RWJ-445380 100 mg----1件: 46 💬
6436RWJ-445380 200 mg----1件: 46 💬
6437RWJ-445380 300 mg----1件: 46 💬
6438RWJ-445380 capsule 100 mg----1件: 46 💬
6439RWJ-445380 capsules 150 mg----1件: 46 💬
6440RWJ-445380 Capsules 50 mg----1件: 46 💬
6441Rytary 145 mg----1件: 6 💬
6442Rytary 195 mg----1件: 6 💬
6443S 90049 - F36----1件: 6 💬
6444S 90049 - F38----1件: 6 💬
6445S(-)-3-[3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl]-N,4-dimethylbenzamide----1件: 46 💬
6446S-1226----1件: 299 💬
6447S-adenosyl-L-methionine1件: Methionine1件: Methionine 💬--1件: 93 💬
6448S-adenosyl-methionine (SAMe) capsules2件: Ademetionine,
Methionine		2件: Methionine ,
Ademetionine 💬		--1件: 93 💬
6449S-ketamine & midazolam3件: Esketamine,
Ketamine,
Midazolam		3件: Midazolam ,
Esketamine ,
Ketamine 💬		21件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		25件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 70 💬
6450S.c. apomorphine1件: Apomorphine1件: Apomorphine 💬2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6451S.c. injections of bovine intestinal Alkaline Phosphatase1件: Alkaline Phosphatase---1件: 46 💬
6452SA001 Mid dose----1件: 53 💬
6453SABRIL 500 mg, granules for oral solution1件: Vigabatrin1件: Vigabatrin 💬1件: ABAT 💬7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 158 💬
6454Sabril granules for oral use1件: Vigabatrin1件: Vigabatrin 💬1件: ABAT 💬7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 145 💬
6455Saccharomyces Boulardii Oral Tablet1件: Saccharomyces cerevisiae---1件: 51 💬
6456Safety observation----1件: 6 💬
6457Saffron 100----1件: 97 💬
6458Saffron 50----1件: 97 💬
6459Safinamide (as add-on therapy)1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6460Safinamide + Levodopa2件: Levodopa,
Safinamide		2件: Levodopa ,
Safinamide 💬		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
MAOB 💬		20件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6461Safinamide Mesilate1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6462SAFINAMIDE METANSOLFONATO1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
6463Safinamide metansolfonato (12 weeks)1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6464SAFINAMIDE METHANESULFONATE1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬2件: 6, 17 💬
6465Safinamide Methanesulfonate 100mg1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6466Safinamide Methanesulfonate 150mg1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6467Safinamide methansulfonate1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6468Safinamide, MAO-B inhibitor1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6469Safinimide 50-100 mg/day----1件: 6 💬
6470SAGE-718----2件: 6, 8 💬
6471SAIT101 (proposed rituximab biosimilar)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6472SAIT101 (rituximab biosimilar)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
6473SAIZEN - 1 FLACONCINO POLV. 8 MG + 1 CARTUCCIA. SOLV. INSERITI IN UN DISPOSITIVO PER LA RICOSTITUZIONE1件: Somatotropin---1件: 78 💬
6474Saizen® solution for injection (referred as Saizen®)----1件: 78 💬
6475Salazopyrin EN 500 mg enterotabletter----1件: 46 💬
6476Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet2件: Salbutamol,
Sulfate ion		1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 111 💬
6477Salbutamol Only Product in Oral Dose Form1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 111 💬
6478SALBUTAMOL SULFATE PH. EUR.2件: Salbutamol,
Sulfate ion		1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
6479Salbutamol WZF 4 mg1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
6480Salbutamol-ratiopharm® N metered-dose aerosol inhaler1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
6481Salbutamol-ratiopharm® N metereddose aerosol inhaler1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
6482Saline 0.9% inhalation solution----1件: 299 💬
6483Saline 0.9% NaCl----1件: 235 💬
6484Saline Nasal Mist----1件: 127 💬
6485Salofalk 1000mg Granu-Stix1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6486Salofalk 1000mg Granu-Stix®1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6487Salofalk 500 mg1件: Mesalazine1件: Mesalamine 💬--1件: 96 💬
6488Salofalk Granu-Stix 500 mg1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6489Salofalk® 1000mg Granu-Stix®1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6490Salofalk® 500 mg gastro-resistant tablet1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6491Salofalk® 500 mg tablets1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6492Salofalk® 500mg1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6493Salofalk® 500mg Granu-Stix®1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6494Samsca 15 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
6495Samsca 30 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
6496SAMSCA 7.5 mg oral tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
6497SAMSCA*10CPR 15MG1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
6498SAN-300 0.5 mg/kg QW----1件: 46 💬
6499SAN-300 1.0 mg/kg QW----1件: 46 💬
6500SAN-300 2.0 mg/kg QOW----1件: 46 💬
6501SAN-300 4.0 mg/kg QOW----1件: 46 💬
6502SAN-300 4.0 mg/kg QW----1件: 46 💬
6503Sandimmun 50 mg/ml, infuusiokonsentraatti----1件: 97 💬
6504SANDIMMUN NEORAL - 10 MG CAPSULE MOLLI 50 CAPSULE1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
6505SANDIMMUN NEORAL - 100 MG CAPSULE MOLLI 30 CAPSULE1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
6506SANDIMMUN NEORAL - 25 MG CAPSULE MOLLI 50 CAPSULE1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
6507SANDIMMUN NEORAL - 50 MG CAPSULE MOLLI 50 CAPSULE1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
6508SANDIMMUN NEORAL*30CPS 100MG1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
6509SANDIMMUN NEORAL*50CPS 25MG1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
6510Sandimmun Optoral----2件: 53, 113 💬
6511Sandostatin LAR 20 mg1件: Octreotide1件: Octreotide 💬1件: SSTR2 💬4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 227 💬
6512SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI----1件: 67 💬
6513Sapropterin dihydrochloride (6R-BH4)1件: Sapropterin1件: Sapropterin 💬--1件: 86 💬
6514Sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
6515Sapropterin, sapropterin dihydrochloride1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
6516Sapropterin, sapropterin hydrochloride1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
6517SAR402671, GZ402671 o GZ/SAR402671----2件: 19, 67 💬
6518SAR402671, GZ402671 or GZ / SAR402671----1件: 19 💬
6519SAR402671, GZ402671 or GZ/SAR402671----3件: 6, 19, 67 💬
6520SAR445088 (formerly BIVV020)----1件: 14 💬
6521Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]1件: Sarilumab1件: Sarilumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
6522Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#11件: Sarilumab1件: Sarilumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 84 💬
6523SAROGLITAZAR MAGNESIUM2件: Magnesium,
Saroglitazar		---1件: 93 💬
6524Saroglitazar Magnesium 1 mg2件: Magnesium,
Saroglitazar		---1件: 93 💬
6525Saroglitazar Magnesium 2 mg2件: Magnesium,
Saroglitazar		---1件: 93 💬
6526Saroglitazar magnesium 4 mg2件: Magnesium,
Saroglitazar		---1件: 93 💬
6527SARS-COV-2 mRNA Vaccine2件: CVnCoV,
SARS-CoV-2 mRNA vaccine		---1件: 13 💬
6528Sativex 2,7mg/2,5 mg Solucion para pulverizacion bucal2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
6529Sativex Oromucosal Spray2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
6530Sativex Oromucosal Spray (non-marketed)2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
6531Satralizumab (120 mg/PFS with NSD)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
6532Satralizumab (120 mg/vial)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
6533Satralizumab (120mg/vial)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
6534Satralizumab 120 mg1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
6535Satrazlizumab (RO5333787/ Enspryng /SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
6536SB-240563 (mepolizumab)1件: Mepolizumab1件: Mepolizumab 💬1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 45 💬
6537SB-497115-GR 12.5mg----1件: 63 💬
6538SB-497115-GR 50 mg----1件: 63 💬
6539SB-509----1件: 2 💬
6540SB-681323 oral tablets----1件: 46 💬
6541SB12 (proposed eculizumab biosimilar)1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
6542SB2 (infliximab biosimilar)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6543SB2 (proposed biosimilar to infliximab)1件: Infliximab1件: Infliximab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6544SB4 (etanercept biosimilar)1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 107, 271 💬
6545SB4 (proposed biosimilar to etanercept)1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6546SB5 (proposed biosimilar to adalimumab)1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6547SBC-1021件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
6548SBC-102, recombinant human lysosomal acid lipase1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
6549SBC-103----1件: 19 💬
6550SC belimumab 200 mg1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 49 💬
6551SC interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6552SC interferon beta-1b2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6553SC Peginterferon beta-1a1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
6554Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group)4件: Amitriptyline,
Fluoxetine,
Somatotropin,
Tramadol		3件: Fluoxetine ,
Amitriptyline ,
Tramadol 💬		3件: OPRM1,
SLC6A2,
SLC6A4 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 78 💬
6555SC treatment with IGSC, 10% with rHuPH20 followed by IV/IGSC, 10% only (safety)----1件: 65 💬
6556SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety)----1件: 65 💬
6557SC0062 medium dose----1件: 66 💬
6558SC12267 (4SC-101)1件: SC12267---3件: 46, 96, 97 💬
6559SCH 420814 10 mg----1件: 6 💬
6560SCH 420814 100 mg----1件: 6 💬
6561SCH-58235----1件: 260 💬
6562Scopolamine, atropine, edaravone and dexmedetomidine4件: Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine		4件: Atropine ,
Scopolamine ,
Dexmedetomidine ,
Edaravone 💬		8件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬
6563SCYX-7158----1件: 65 💬
6564SD-101----1件: 36 💬
6565SD-101 dermal cream (3%)----1件: 36 💬
6566SD-101 Dermal Cream (6%)----1件: 36 💬
6567SD-101-6.0 cream----1件: 36 💬
6568Seal oil----1件: 46 💬
6569Search for exocrine pancreatic insufficiency at week 0 and 12----1件: 96 💬
6570Search for polymorphisms of RASA1 gene----1件: 281 💬
6571Sebelipase alfa (SBC-102)1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
6572Sebelipase alfa 0.35 mg/kg1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
6573Sebelipase alfa 1 mg/kg1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
6574Sebelipase alfa 3 mg/kg1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
6575Secukinumab (150 mg)1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
6576Secukinumab (75 mg)1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
6577Secukinumab (AIN457) 150 mg s.c.1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
6578Secukinumab 150 mg1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 41 💬
6579Secukinumab 150 mg (2 injections per dose1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 269 💬
6580Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection.1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
6581Secukinumab 150 mg/1 mL Solution for injection1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬2件: 37, 271 💬
6582Secukinumab 150 mg/ml1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
6583Secukinumab 150 milligram [Cosentyx]1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
6584Secukinumab 150mg1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 37 💬
6585Secukinumab 300 mg1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 41 💬
6586Secukinumab 300 mg, s.c.1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 41 💬
6587Secukinumab 75 mg/0.5 ml Solution for injection1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬1件: 271 💬
6588Sedatives/Hypnotics,Other----1件: 107 💬
6589See D.3.9.3 'Other descriptive name' below----1件: 46 💬
6590Seladelpar 10 mg1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
6591Seladelpar 10 mg Capsule1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
6592Seladelpar 10 mg or less1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
6593Seladelpar 5 mg1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
6594Seladelpar 5 mg Capsule1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
6595Seladelpar 5-10 mg1件: Seladelpar1件: Seladelpar 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
6596Selective Nerve Root Block----1件: 70 💬
6597Selegiline HCl 5 PCH1件: Selegiline1件: Selegiline 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6598Selexipag, ACT-293987 (NS-304)1件: Selexipag1件: Selexipag 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6599Selumetinib (AZD6244 hyd sulfate) 25mg/m22件: Selumetinib,
Sulfate ion		1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
6600Selumetinib (AZD6244 hyd sulfate) 50mg/dose2件: Selumetinib,
Sulfate ion		1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
6601Selumetinib 10mg capsule1件: Selumetinib1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
6602Selumetinib capsules 10mg1件: Selumetinib1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
6603Selumetinib granules in sprinkle capsules for opening 5 mg1件: Selumetinib1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
6604Selumetinib granules in sprinkle capsules for opening 7.5 mg1件: Selumetinib1件: Selumetinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
6605Semi continuous intra-oral administration of LD/CD----1件: 6 💬
6606Senfrol monotherapy----1件: 6 💬
6607Serostim®[somatropin (rDNA origin) for injection]1件: Somatotropin---1件: 265 💬
6608SERUM ALBUMINE 5%----1件: 96 💬
6609Sesame oil1件: Sesame oil1件: Sesame oil 💬--1件: 3 💬
6610SESAME OIL, REFINED1件: Sesame oil1件: Sesame oil 💬--1件: 3 💬
6611Sezione * D.3.6.2.1 - valore: 400mg alla settimana 0, in seguito 200mg ogni due settimane----1件: 96 💬
6612SH U 555 C----1件: 13 💬
6613Sham O2 (medical air)2件: Medical air,
Oxygen		1件: Oxygen 💬--1件: 86 💬
6614Short Chain Fatty Acids (SCFA) Dietary Supplement----1件: 46 💬
6615Short-course Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
6616SHP 655 (BAX 930)----1件: 64 💬
6617SHR-1209----1件: 79 💬
6618SHR-1314----1件: 271 💬
6619SHR-1906----1件: 85 💬
6620SI-722----1件: 226 💬
6621Sialic acid (INN: aceneuramic acid)1件: Aceneuramic acid1件: Aceneuramic acid 💬--1件: 30 💬
6622Sialic acid, N-acetylneuraminic acid----1件: 30 💬
6623Sifalimumab 1,200 mg1件: Sifalimumab1件: Sifalimumab 💬13件: IFNA1,
IFNA10,
IFNA13,
IFNA14,
IFNA16,
IFNA17,
IFNA2,
IFNA21,
IFNA4,
IFNA5,
IFNA6,
IFNA7,
IFNA8 💬		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
6624Sifalimumab 200 mg1件: Sifalimumab1件: Sifalimumab 💬13件: IFNA1,
IFNA10,
IFNA13,
IFNA14,
IFNA16,
IFNA17,
IFNA2,
IFNA21,
IFNA4,
IFNA5,
IFNA6,
IFNA7,
IFNA8 💬		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
6625Sifalimumab 600 mg1件: Sifalimumab1件: Sifalimumab 💬13件: IFNA1,
IFNA10,
IFNA13,
IFNA14,
IFNA16,
IFNA17,
IFNA2,
IFNA21,
IFNA4,
IFNA5,
IFNA6,
IFNA7,
IFNA8 💬		25件: Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬1件: 49 💬
6626Sifrol 0,181件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6627Sifrol 0,71件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6628Sifrol, 0,35 mg Tablette1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6629Sifrol, 0,70 mg Tablette1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6630Sifrol, Mirapexin1件: Pramipexole1件: Pramipexole 💬3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6631Sildenafil (50 mg)1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 85 💬
6632Sildenafil (Acute-1 hour)1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299 💬
6633Sildenafil (Revatio) 20 mg TID1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6634Sildenafil 20 mg tablets1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 278 💬
6635Sildenafil 20mg and Bosentan 62.5mg2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
6636Sildenafil 40mg oral capsule1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299 💬
6637Sildenafil by injection1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 210 💬
6638Sildenafil Oral Suspension1件: Sildenafil1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294 💬
6639Sildenafil singly or in association with Bosentan2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
6640Sildenafil25 mg----1件: 17 💬
6641SIMPONI - 50 MG-SOLUZIONE PER INIEZIONE IN PENNA PRERIEMPITA-USO SOTTOCUTANEO-PENNA PRERIEMPITA(VETRO) -0.5 ML 3 (3X1) PENNE PRERIEMPITE1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6642Simponi 50 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte.1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6643SIMPONI 50 mg solución inyectable en pluma precargada1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
6644Simponi® (Golimumab)1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
6645SimvaHEXAL® 40 mg Filmtabletten----1件: 13 💬
6646Simvastatin 20 mg1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 46 💬
6647Simvastatin 20mg/5ml Oral Suspension1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 34 💬
6648Simvastatin 40 mg1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 86 💬
6649Simvastatin 40 mg film-coated tablets1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
6650Simvastatin 40 mg tablets1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 86 💬
6651Simvastatin in relapsing remitting multiple sclerosis1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
6652Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
6653Simvastatine Sandoz 40 mg filmomhulde tabletten1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
6654SIN LV Mediated ex vivo transduced autologous fibroblasts expressing codon-optimised COL7A1----1件: 36 💬
6655SIN RV-mediated COL7A1 corrected autologous skin equivalent----1件: 36 💬
6656SINEMET - 100 MG + 25 MG COMPRESSE 50 COMPRESSE DIVISIBILI2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6657SINEMET 10-1002件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6658SINEMET 100 mg + 25 mg compresse2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6659SINEMET 100 mg + 25 mg tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6660SINEMET 1252件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6661Sinemet 125 mg----1件: 6 💬
6662Sinemet 200mg/50mg1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6663SINEMET 25-1002件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6664Sinemet 25-100 Oral Tablet1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
6665SINEMET 25/1002件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6666Sinemet CR 25Mg-100Mg Extended-Release Tablet3件: Carbidopa,
Levodopa,
Manganese citrate		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6667SINEMET*50CPR 100MG+25MG2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6668Sinemet® 100/25----1件: 6 💬
6669Sinemet® 100/25 mg----1件: 6 💬
6670Sinemet® controlled release (Carbidopa/levodopa)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6671Sinemet® CR2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6672Sinemet® CR 100/25----1件: 6 💬
6673SINEMET® Plus 25 mg/100 mg Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6674Sinemet®25-1002件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6675Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg)----1件: 28 💬
6676Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre----1件: 65 💬
6677Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy----1件: 79 💬
6678Singulair (Montelukast Sodium)1件: Montelukast1件: Montelukast 💬1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 228 💬
6679Sinvastatina Sandoz 40 mg comprimidos revestidos por película----1件: 13 💬
6680Siponimod 0,25 mg1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
6681Siponimod 0.25 mg tablet1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 50 💬
6682Siponimod 0.5 mg tablet1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 50 💬
6683Siponimod 1 mg1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
6684Siponimod 1 mg tablet1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 50 💬
6685Siponimod 2 mg1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
6686Siponimod 2 mg tablet1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 50 💬
6687SIRIO*30CPR EFF 25MG+100MG----1件: 6 💬
6688Sirolimus (study drug)+ACE inhibitor + statin1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 66 💬
6689Sirolimus 0,1% crème1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 278, 280 💬
6690Sirolimus 1mg/mL1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 278, 280 💬
6691Sirolimus 2 MG1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 17 💬
6692Sirolimus and Hydroxychloroquine 200 mg2件: Hydroxychloroquine,
Sirolimus		2件: Sirolimus ,
Hydroxychloroquine 💬		1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 89 💬
6693Sirolimus and Hydroxychloroquine 400 mg2件: Hydroxychloroquine,
Sirolimus		2件: Sirolimus ,
Hydroxychloroquine 💬		1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 89 💬
6694Sirolimus Ointment1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 84 💬
6695Sirolimus Oral Liquid Product 1mg/mL1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 278 💬
6696Sirolimus Oral Product1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 89, 158 💬
6697Sirolimus, 2%1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 36, 192 💬
6698Sirukumab 100 mg1件: Sirukumab1件: Sirukumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
6699Sirukumab 50 mg1件: Sirukumab1件: Sirukumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
6700Sitagliptin and Metformin2件: Metformin,
Sitagliptin		2件: Metformin ,
Sitagliptin 💬		3件: DPP4,
PRKAA1,
PRKAA2 💬		21件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 233 💬
6701Site specific standard of care comparison----2件: 38, 39 💬
6702Sivatin 40 mg film-coated tablets----1件: 13 💬
6703SKF-101468A----1件: 6 💬
6704SKI-O-703----1件: 46 💬
6705SKI-O-703 capsule----1件: 46 💬
6706Skin biopsy----1件: 6 💬
6707SLIT(TM) Amikacin1件: Amikacin1件: Amikacin 💬--1件: 299 💬
6708Slow Dose Titration Group of Subcutaneous Treprostinil1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6709SLV308 (mono) hydro----1件: 6 💬
6710SLV308 (mono) hydrochlo----1件: 6 💬
6711SLV308 (mono) hydrochlori----1件: 6 💬
6712SLV308 (mono) hydrochloride----1件: 6 💬
6713SLV308 (mono)hydrochloride----1件: 6 💬
6714SLV308(mono)hydrochloride----1件: 6 💬
6715SM101 20mg/mL----1件: 63 💬
6716SM101 5mg/mL----1件: 63 💬
6717Smartject Device delivery of Golimumab1件: Golimumab1件: Golimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
6718SMOFKABIVEN - EMULSIONE PER INFUSIONE SENZA ELETTROLITI 1 SACCA BIOFINE MULTICOMPARTIMENTATE DA 493 ML2件: Medium-chain triglycerides,
Sodium glycerophosphate		1件: Sodium glycerophosphate 💬--1件: 66 💬
6719Smoking of cannabis1件: Medical Cannabis---2件: 96, 97 💬
6720SMP-114----1件: 46 💬
6721SNT-MC17----1件: 113 💬
6722SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
6723Sodium (R)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2H-pyran-4-yl)ethoxy)quinoline-4-ca----1件: 299 💬
6724Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate1件: Pyrrolidine---1件: 97 💬
6725Sodium acetate (1-13C)2件: Acetate,
Sodium acetate		1件: Sodium acetate 💬--1件: 251 💬
6726Sodium Bicarbonate1件: Sodium bicarbonate1件: Sodium bicarbonate 💬--1件: 299 💬
6727SODIUM BICARBONATE BP1件: Sodium bicarbonate1件: Sodium bicarbonate 💬--1件: 299 💬
6728Sodium Butyrate1件: Butyric Acid---1件: 46 💬
6729Sodium butyrate and zinc oxide2件: Butyric Acid,
Zinc oxide		1件: Zinc oxide 💬--1件: 156 💬
6730Sodium chloride (7%)2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 299 💬
6731SODIUM CHLORIDE 7%2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 299 💬
6732SODIUM CHLORIDE PH. EUR.2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 299 💬
6733Sodium Ethanoate (1- 13 C)1件: Acetic acid1件: Acetic acid, glacial 💬--1件: 251 💬
6734Sodium Ethanoate (1-13C)1件: Acetic acid1件: Acetic acid, glacial 💬--1件: 251 💬
6735Sodium fluoride 18F1件: Sodium fluoride1件: Sodium fluoride 💬--1件: 51 💬
6736Sodium Nitrate - double dose2件: Nitrate,
Sodium nitrate		1件: Nitric acid 💬--1件: 113 💬
6737Sodium Oxybate2件: Sodium oxybate,
gamma-Hydroxybutyric acid		1件: Sodium oxybate 💬--2件: 6, 149 💬
6738Sodium phosphate enema, oral rifaximin and polyethylene glycol3件: Phosphate ion,
Polyethylene glycol,
Rifaximin		2件: Rifaximin ,
Polyethylene glycol 3350 💬		--1件: 6 💬
6739Sodium Picosulfate, Magnesium Oxide and Citric Acid4件: Citric acid,
Magnesium,
Magnesium oxide,
Picosulfuric acid		2件: Magnesium oxide ,
Citric acid monohydrate 💬		--1件: 291 💬
6740Sodium Picosulfate/Magnesium Citrate Laxative4件: Magnesium,
Magnesium citrate,
Picosulfuric acid,
Polyethylene glycol		2件: Magnesium citrate ,
Polyethylene glycol 3350 💬		--1件: 97 💬
6741Sodium Pyruvate in 0.9% Sodium Chloride Solution2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--1件: 299 💬
6742Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth2件: Dextrose, unspecified form,
Sildenafil		1件: Sildenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6743Sodium Thiosulfate 10%----2件: 50, 51 💬
6744Sodium valproate 200 mg gastro-resistant tablets1件: Valproic acid1件: Valproic acid 💬7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 233 💬
6745Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate1件: Acetate---1件: 46 💬
6746Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate1件: Acetate---1件: 46 💬
6747Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen1件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 195 💬
6748Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen1件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 195 💬
6749SOL-116----1件: 46 💬
6750Solid food-based intervention----1件: 96 💬
6751SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 13, 62, 109 💬
6752SOLIRIS 300 mg concentrado para solución para perfusión1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 109 💬
6753Soliris 300 mg concentrate for solution for infusion1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
6754Soliris ™ (eculizumab)1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
6755SOLIRIS® (eculizumab) injection, for intravenous use1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
6756SOLU MEDROL----1件: 56 💬
6757SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----3件: 13, 14, 53 💬
6758SOLU MEDROL - 40 MG/ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 40 MG/ML----1件: 56 💬
6759SOLU MEDROL - 500 MG/8 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 500 MG+ FIALA SOLVENTE DA 8 ML----1件: 56 💬
6760Solu-Cortef 100 MG Injection3件: Hydrocortisone,
Hydrocortisone cypionate,
Hydrocortisone succinate		3件: Hydrocortisone ,
Hydrocortisone cypionate ,
Hydrocortisone succinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
6761Solu-Cortef, powder for solution for injection, 100mg, and 'Act-O-Vial'3件: Hydrocortisone,
Hydrocortisone cypionate,
Hydrocortisone succinate		3件: Hydrocortisone ,
Hydrocortisone cypionate ,
Hydrocortisone succinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
6762Solu-Medrol2件: Methylprednisolone,
Methylprednisolone hemisuccinate		2件: Methylprednisolone ,
Methylprednisolone hemisuccinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 13, 49, 50, 51, 53, 97, 211 💬
6763Solu-medrol inj. PSO LQF 40mg1件: Methylprednisolone hemisuccinate1件: Methylprednisolone hemisuccinate 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 50 💬
6764Solu-Medrone----3件: 51, 83, 162 💬
6765Solu-Medrone 125mg----1件: 46 💬
6766Solu-Medrone 2 Gram----1件: 46 💬
6767Solu-Medrone 2mg----1件: 46 💬
6768SOLU-MODERIN 1 g----1件: 13 💬
6769Solumedrol IM 125mg/2ml----1件: 13 💬
6770SOM230 LAR 10 mg----1件: 75 💬
6771SOM230 LAR 30 mg----1件: 75 💬
6772SOM230 LAR, 20 mg----1件: 75 💬
6773SOM230, 300micrograms----1件: 75 💬
6774SOM230, 600 micrograms----1件: 75 💬
6775SOM230, 900 micrograms----1件: 75 💬
6776SOM3355 (bevantolol hydrochloride)1件: Bevantolol---1件: 8 💬
6777SOM3355 100mg BID----1件: 8 💬
6778SOM3355 200mg BID----1件: 8 💬
6779Somapacitan 10 mg/1.5ml PDS2901件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78 💬
6780Somapacitan 10 mg/1.5ml PDS290S1件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78 💬
6781Somapacitan 15 mg/1.5 mL PDS2901件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 195 💬
6782Somapacitan 15 mg/1.5ml PDS2901件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78 💬
6783Somapacitan 5 mg/1.5 mL PDS2901件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 195 💬
6784Somapacitan 5 mg/1.5ml PDS2901件: Somapacitan1件: Somapacitan 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78 💬
6785Somatic gene-therapy by X-CGD----1件: 65 💬
6786Somatropin (DNA origin)1件: Somatotropin---1件: 19 💬
6787Somatropin (INN) recombinant DNA orgin, Escherichia coli2件: Escherichia coli,
Somatotropin		---1件: 78 💬
6788Somatropin (rDNA origin)1件: Somatotropin---1件: 78 💬
6789Somatropin (recombinant DNA origin produced in E. coli)1件: Somatotropin---1件: 78 💬
6790Somatropin - adult cohort1件: Somatotropin---1件: 193 💬
6791Somatropin - GH naïve pediatric cohort1件: Somatotropin---1件: 193 💬
6792Somatropin - GH treated cohort1件: Somatotropin---1件: 193 💬
6793Somatropin [rDNA origin] for injection1件: Somatotropin---2件: 46, 96 💬
6794Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate5件: Arginine,
Clonidine,
Estradiol,
Estradiol valerate,
Somatotropin		4件: Estradiol ,
Clonidine ,
Estradiol valerate ,
Arginine 💬		5件: ADRA2A,
ADRA2B,
ADRA2C,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Neuroactive ligand-receptor interaction, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
6795Somatuline Autogel 90 mg1件: Lanreotide---1件: 298 💬
6796Sortis 10 mg----1件: 93 💬
6797Sotatercept - 45 mg/vial1件: Sotatercept1件: Sotatercept 💬1件: ACVR2A 💬4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
6798Sotatercept - 60 mg/vial1件: Sotatercept1件: Sotatercept 💬1件: ACVR2A 💬4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
6799Sotatercept with prednisone boost2件: Prednisone,
Sotatercept		2件: Prednisone ,
Sotatercept 💬		2件: ACVR2A,
NR3C1 💬		5件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 284 💬
6800Sotrastaurin (INN) acetate2件: Acetate,
Sotrastaurin		1件: Sotrastaurin 💬4件: PRKCD,
PRKCE,
PRKCH,
PRKCQ 💬		29件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 97 💬
6801Soy bread----1件: 298 💬
6802Soya Bean oil1件: Bean---1件: 96 💬
6803Sparsentan tablets/ Over-encapsulated Sparsentan tablets1件: Sparsentan1件: Sparsentan 💬2件: AGTR1,
EDNRA 💬		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
6804Sparsentan tablets/Over-encapsulated Sparsentan tablets1件: Sparsentan1件: Sparsentan 💬2件: AGTR1,
EDNRA 💬		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
6805Sparsentan tablets/over-encapsulated Spasenten tablets1件: Sparsentan1件: Sparsentan 💬2件: AGTR1,
EDNRA 💬		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
6806Sparsentan tablets/Overencapsulated Sparsentan tablets1件: Sparsentan1件: Sparsentan 💬2件: AGTR1,
EDNRA 💬		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
6807Sparsentan/Over-encapsulated Sparsentan tablet1件: Sparsentan1件: Sparsentan 💬2件: AGTR1,
EDNRA 💬		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
6808Sparsentan/Over-encapsulated Sparsentan tablets1件: Sparsentan1件: Sparsentan 💬2件: AGTR1,
EDNRA 💬		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
6809SPD476 (mesalazine)1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6810SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine1件: Mesalazine1件: Mesalamine 💬--1件: 97 💬
6811SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM1件: Ioflupane I-123---1件: 2 💬
6812SPH3127 Tablets with Dose B----1件: 97 💬
6813Spheramine (BAY86-5280)1件: Spheramine---1件: 6 💬
6814SPI-1005 Ebselen 200mg Capsule x11件: Ebselen---1件: 299 💬
6815SPI-1005 Ebselen 200mg Capsule x21件: Ebselen---1件: 299 💬
6816SPI-1005 Ebselen 200mg Capsule x31件: Ebselen---1件: 299 💬
6817Spiriva Respimat 2.5 mcg1件: Tiotropium---1件: 299 💬
6818Spiriva Respimat 2.5 microgram1件: Tiotropium---1件: 299 💬
6819Spiriva Respimat 2.5 microgram, solution for inhalation1件: Tiotropium---1件: 299 💬
6820Sporanox 10 mg/ml Oral Solution1件: Itraconazole1件: Itraconazole 💬--1件: 299 💬
6821SPX-101----1件: 299 💬
6822SQJZ herbal mixtures----1件: 6 💬
6823SRP-5051----1件: 113 💬
6824SS-1----1件: 53 💬
6825Ss-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride1件: Cysteamine1件: Cysteamine 💬--1件: 19 💬
6826SSP-004184 100 mg----1件: 284 💬
6827SSP-004184 100 mg Capsule----1件: 284 💬
6828SSP-004184 250 mg----1件: 284 💬
6829SSP-004184 250 mg Capsule----1件: 284 💬
6830SSP-004184 375 mg----1件: 284 💬
6831SSP-004184 375 mg Capsule----1件: 284 💬
6832SSP-004184 50 mg----1件: 284 💬
6833SSP-004184 50 mg Capsule----1件: 284 💬
6834SSP-004184 500 mg----1件: 284 💬
6835SSP-004184 500 mg Capsule----1件: 284 💬
6836SSP-004184AQ 100 mg----1件: 284 💬
6837SSP-004184AQ 100 mg Capsule----1件: 284 💬
6838SSP-004184AQ 200 mg----1件: 284 💬
6839SSP-004184AQ 200 mg Capsule----1件: 284 💬
6840SSP-004184AQ 250 mg----1件: 284 💬
6841SSP-004184AQ 250 mg Capsule----1件: 284 💬
6842SSP-004184AQ 375 mg----1件: 284 💬
6843SSP-004184AQ 375 mg Capsule----1件: 284 💬
6844SSP-004184AQ 50 mg----1件: 284 💬
6845SSP-004184AQ 50 mg Capsule----1件: 284 💬
6846STA 5326 mesylate----1件: 46 💬
6847STA-5326----2件: 65, 96 💬
6848STA-5326 mesylate----1件: 96 💬
6849STA-6838, STA-5326 m, S38----1件: 96 💬
6850Stable weekly dose of methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
6851Stalevo (levodopa/ carbidopa/ entacapone)3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6852Stalevo 1003件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6853Stalevo 100 mg/ 25 mg/ 200 mg Filmtabletten3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6854Stalevo 100 mg/25 mg / 200 mg----1件: 6 💬
6855Stalevo 100/25/200 mg3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6856Stalevo 1503件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6857Stalevo 150/37.5/200 mg3件: Carbidopa,
Entacapone,
Levodopa		3件: Levodopa ,
Carbidopa ,
Entacapone 💬		7件: COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6858STALEVO*100CPR 100/25/200MG2件: Entacapone,
Levodopa		2件: Levodopa ,
Entacapone 💬		6件: COMT,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Steroid hormone biosynthesis, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6859STALEVO*100CPR 50/12,5/200MG2件: Entacapone,
Levodopa		2件: Levodopa ,
Entacapone 💬		6件: COMT,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Steroid hormone biosynthesis, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
6860Standard analgesia use [Oxygen]1件: Oxygen1件: Oxygen 💬--1件: 70 💬
6861Standard DMARDs (Disease Modifying Anti Rheumatic Drugs)----1件: 46 💬
6862Standard dose of HCQ----1件: 49 💬
6863Standard dose of rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 49 💬
6864Standard MS DMT----1件: 13 💬
6865Standard MS DMTs----1件: 13 💬
6866Standard Nutritional Supplement + PERT----1件: 299 💬
6867Standard of Care----8件: 6, 13, 49, 51, 63, 64, 79, 171 💬
6868Standard of Care (SoC)----1件: 85 💬
6869Standard of Care Chemotherapy----1件: 28 💬
6870Standard of Care for Haemophilia A----1件: 288 💬
6871Standard of Care FVIII Replacement therapy----1件: 288 💬
6872Standard of care IV antibiotic(s)----1件: 299 💬
6873Standard of Care Medications----1件: 171 💬
6874Standard of care therapy----1件: 28 💬
6875Standard of Care Treatment----3件: 53, 245, 246 💬
6876Standard of Care: UDCA1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
6877Standard therapy (without eltrombopag): HD-DXM1件: Eltrombopag---1件: 63 💬
6878Standard therapy of septic shock----1件: 60 💬
6879Standard-of-care treatment----1件: 49 💬
6880Standardized Ginkgo Biloba Extract (EGb 761 (r)1件: Ginkgo biloba---1件: 18 💬
6881Standart of care----1件: 96 💬
6882Standrd of Care treatment----1件: 64 💬
6883Start adalimumab in monotherapy1件: Adalimumab1件: Adalimumab 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
6884STELARA - 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6885STELARA - 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6886STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬2件: 96, 97 💬
6887STELARA 130 mg concentrate for solution for infusion1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6888Stelara 130mg / 26mL concentrate for solution for1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6889Stelara 130mg / 26mL concentrate for solution for infusion1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6890STELARA 90 mg solution for injection in pre-filled syringe1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6891Stelara 90mg/1ml solution for injecti1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6892Stelara 90mg/1ml solution for injection in pre-filled syringe (PFS)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
6893Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra3件: Infliximab,
Ustekinumab,
Vedolizumab		3件: Infliximab ,
Vedolizumab ,
Ustekinumab 💬		6件: IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
TNF 💬		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
6894Stem cell (HPC) implantation----1件: 2 💬
6895Sterile Normal Saline (0.9% NaCl)----2件: 62, 254 💬
6896STERILE PYROGEN-FREE ISOTONIC NACL SOLUTE (0.9% W / V)----1件: 299 💬
6897Steroid & Cyclosporin1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
6898STK-001 - Multiple Ascending Doses1件: Zorevunersen---1件: 140 💬
6899STK-001 - Single Ascending Doses1件: Zorevunersen---1件: 140 💬
6900STNM01 1.84 mg----1件: 97 💬
6901Study medication, azithromycin1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 299 💬
6902Study of the gene expression profile----1件: 51 💬
6903STW5-II (Iberogast N, BAY98-7410)----1件: 97 💬
6904Sub-Study: Nintedanib1件: Nintedanib1件: Nintedanib 💬8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 85 💬
6905Sub-Study: Pirfenidone1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85 💬
6906Subcutaneous (SC) Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
6907Subcutaneous Beloranib in Suspension1件: Beloranib---1件: 193 💬
6908Subcutaneous hydrocortisone 10mg1件: Hydrocortisone1件: Hydrocortisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
6909Subcutaneous tocilizumab 162mg/biweekly1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
6910Subcutaneous(SC) Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
6911Subjects will undergo the 123-I IBVM imaging visit----1件: 6 💬
6912Sublimated mare milk----1件: 93 💬
6913Sublingual tizanidine 12 mg1件: Tizanidine1件: Tizanidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
6914Submucosal Bevacizumab1件: Bevacizumab1件: Bevacizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 227 💬
6915Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus----1件: 90 💬
6916Subretinal injection of rAAV.hPDE6A----1件: 90 💬
6917Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP)----1件: 90 💬
6918Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes----1件: 90 💬
6919Subtenon injection of Wharton jelly derived mesenchymal stem cells----1件: 90 💬
6920Sulfasalazine + Hydroxychloroquine2件: Hydroxychloroquine,
Sulfasalazine		2件: Sulfasalazine ,
Hydroxychloroquine 💬		--1件: 46 💬
6921Sulfasalazine, SSZ1件: Sulfasalazine1件: Sulfasalazine 💬--1件: 271 💬
6922Sulfate, Magnesium2件: Magnesium,
Sulfate ion		---1件: 64 💬
6923Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]1件: Sulfur hexafluoride1件: Sulfur hexafluoride 💬--1件: 215 💬
6924Sulindac (HLX-0201), dose strength 11件: Sulindac1件: Sulindac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 206 💬
6925Sulindac (HLX-0201), dose strength 21件: Sulindac1件: Sulindac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 206 💬
6926Sulphasalazine 500 mg En-Tabs----1件: 271 💬
6927Sulphsalazine, Pentasa, Asacol, Colazide, Depentum----1件: 97 💬
6928Sunflower oil1件: Sunflower oil1件: Sunflower oil 💬--2件: 46, 299 💬
6929Sunitinib malate1件: Sunitinib1件: Sunitinib 💬9件: CSF1R,
FLT1,
FLT3,
FLT4,
KDR,
KIT,
PDGFRA,
PDGFRB,
RET 💬		36件: Acute myeloid leukemia, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬1件: 28 💬
6930Supportive therapy with: ACE-inhibitor / ARB / Statin----1件: 66 💬
6931Supressi. T-Diet plus Range----1件: 6 💬
6932Surgical infusion of AAV-GAD into the subthalamic nucleus----1件: 6 💬
6933Survival of Motor Neuron 2 (SMN2) Splicing Modulator Antisense Oligonucleotide----1件: 3 💬
6934Suspension containing 250 embryonated, viable Trichuris suis ova (TSO)/15ml----1件: 96 💬
6935Suspension containing 250 embryonated, viable TSO/15ml----1件: 96 💬
6936Suspension containing 2500 embryonated, viable Trichuris suis ova (TSO)/15ml----1件: 96 💬
6937Suspension containing 2500 embryonated, viable TSO/15ml----1件: 96 💬
6938SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML----1件: 97 💬
6939Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml----1件: 96 💬
6940Suspension de microbiote fécal----1件: 97 💬
6941Suspension media----1件: 13 💬
6942Suspension of 7500 embryonated, viable TSO/15ml----1件: 96 💬
6943Suspension of adipose derived autologous adult stem cells----1件: 96 💬
6944Suspension of autologous CD34+cells transduced with the G1XCGD viral vector----1件: 65 💬
6945Suspension of human autologous MSC 3P in 1,5 ml----1件: 2 💬
6946Suspension of human autologous MSC 3P in 1.5 ml----1件: 2 💬
6947Sustained-release oral dalfampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
6948Sutimlimab (BIVV009)1件: Sutimlimab1件: Sutimlimab 💬1件: C1S 💬5件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 61 💬
6949Switch to Myfortic1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49 💬
6950Symkevi 100mg/150mg Film-coated tablets2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
6951Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)3件: Aldosterone,
Angiotensin II,
Calcium		3件: Angiotensin II ,
Angiotensin II ,
Aldosterone 💬		3件: AGTR1,
AGTR2,
NR3C2 💬		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
6952Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)1件: Human immunoglobulin G---1件: 11 💬
6953SYN115 Tablets, 60 mg----1件: 6 💬
6954Synacthen Ampoules 250 mcg----1件: 113 💬
6955Synacthen Ampoules 250 microgrammi----1件: 113 💬
6956Synacthen Depot 1mg1件: Tetracosactide1件: Cosyntropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 222 💬
6957Synbiotic (Synergy I / B.longum)----1件: 96 💬
6958Synergy-1----1件: 97 💬
6959Synovial biopsy----1件: 46 💬
6960Synthetic 15-amino-acid macrocyclic peptide----1件: 62 💬
6961Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24----1件: 62 💬
6962Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 palmitoylated linker----1件: 62 💬
6963Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker----1件: 62 💬
6964Synthetic Human Parathyroid Hormone 1-341件: Parathyroid hormone1件: Parathyroid hormone 💬2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
6965Synthetic Oxytocin1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6966Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mRNA transcripts----2件: 2, 127 💬
6967Syntocinon 40 IU/ml nasal spray1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 6 💬
6968Syntocinon®/- Spray1件: Oxytocin1件: Oxytocin 💬1件: OXTR 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬1件: 193 💬
6969Systemic non-biological treatments----2件: 46, 271 💬
6970Sübetaholzwurzel 1ml/10ml----1件: 97 💬
6971Süßholzwurzel 1ml/10ml----1件: 97 💬
6972T 100 PARI----1件: 299 💬
6973T-Cell Depleted & CD34+Select/w/StemCell Enriched Product----1件: 65 💬
6974TA-650 10 mg/kg----1件: 46 💬
6975TA-650 3 mg/kg----1件: 46 💬
6976TA-650 6 mg/kg----1件: 46 💬
6977TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE----1件: 14 💬
6978TACHIPIRINA - 500 MG COMPRESSE20 COMPRESSE----2件: 13, 53 💬
6979Tachipirina CPR 500mg----1件: 13 💬
6980TACI - FC5----1件: 46 💬
6981Tacrolimus and MMF1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
6982Tacrolimus ointment1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 56 💬
6983Tacrolimus with Methotrexate2件: Methotrexate,
Tacrolimus		3件: Tacrolimus ,
Methotrexate ,
Tacrolimus 💬		7件: DHFR,
DHFR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		38件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
6984Tadalafil 20 MG1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113 💬
6985Tadalafil 20 mg film-coated tablets1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6986Tadalafil 40 mg1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6987Tadalafil oral suspension1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6988Tadalafil- Tablet or Oral suspension1件: Tadalafil1件: Tadalafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
6989Tafamidis meglumine2件: Meglumine,
Tafamidis		2件: Meglumine ,
Tafamidis 💬		1件: TTR 💬1件: Thyroid hormone synthesis 💬1件: 28 💬
6990Tafamidis meglumine 20 mg soft gelatin capsules3件: Gelatin,
Meglumine,
Tafamidis		4件: Gelatin ,
Meglumine ,
Donkey glue ,
Tafamidis 💬		1件: TTR 💬1件: Thyroid hormone synthesis 💬1件: 28 💬
6991Tafamidis Meglumine 20mg Soft Gelatin Capsule (Clinical trial image)3件: Gelatin,
Meglumine,
Tafamidis		4件: Gelatin ,
Meglumine ,
Donkey glue ,
Tafamidis 💬		1件: TTR 💬1件: Thyroid hormone synthesis 💬1件: 28 💬
6992Tafamidis Meglumine 20mg Soft Gelatin Capsule (Commerical image)3件: Gelatin,
Meglumine,
Tafamidis		4件: Gelatin ,
Meglumine ,
Donkey glue ,
Tafamidis 💬		1件: TTR 💬1件: Thyroid hormone synthesis 💬1件: 28 💬
6993TAK-079, TSF-021, TSF79----1件: 11 💬
6994TAK-7151件: TAK-715---1件: 46 💬
6995TAK-715 and methotrexate2件: Methotrexate,
TAK-715		1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
6996TAK-755----1件: 64 💬
6997TAK-755 or BAX930 or SHP655----1件: 64 💬
6998TAK-755 orBAX930 or SHP655----1件: 64 💬
6999TAK-771----2件: 14, 65 💬
7000TAK-783----1件: 46 💬
7001TAK-783 and methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
7002Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab tablets + amoxicillin + metronidazole (second-line eradication)3件: Amoxicillin,
Clarithromycin,
Metronidazole		4件: Amoxicillin ,
Clarithromycin ,
Metronidazole ,
Amoxicillin 💬		--1件: 63 💬
7003Taking peripheral blood samples----1件: 49 💬
7004Taliglucerase alfa - Recombinant human glucocerebrosidase1件: Taliglucerase alfa1件: Taliglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
7005Taltz (80 mg solution for injection in pre-filled syringe)1件: Ixekizumab1件: Ixekizumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬2件: 107, 271 💬
7006Tamoxifen 20mg Hexal® Filmtabletten1件: Tamoxifen1件: Tamoxifen 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 113 💬
7007Tamoxifen 40 mg daily for one year1件: Tamoxifen1件: Tamoxifen 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 2 💬
7008TAP-144-SR(3M)----1件: 1 💬
7009Tapering or discontinuation of etanercept1件: Etanercept1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
7010Target Sequencing by NGS ( Next-generation sequencing)----1件: 65 💬
7011Targinact 10 mg/5 mg prolonged-release tablets1件: Manganese citrate---2件: 6, 226 💬
7012Targinact 20 mg/10 mg prolonged-release tablets1件: Manganese citrate---1件: 6 💬
7013Targinact 20mg/10 mg prolonged-release tablets1件: Manganese citrate---1件: 226 💬
7014Targinact 5 mg/2.5 mg prolonged-release tablets1件: Manganese citrate---1件: 6 💬
7015Targinact 5mg/2.5 mg prolonged-release tablets1件: Manganese citrate---1件: 226 💬
7016Tasigna 150mg1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
7017Tasigna 50 mg1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
7018Tasigna® 150 mg1件: Nilotinib1件: Nilotinib 💬4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
7019Tasocitinib plus Methotrexate2件: Methotrexate,
Tofacitinib		2件: Methotrexate ,
Tofacitinib 💬		6件: DHFR,
DHFR2,
JAK1,
JAK2,
JAK3,
TYK2 💬		42件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7020TAT4 Gel concentration B----1件: 265 💬
7021Tau (18-F-AV-1451)----1件: 127 💬
7022Tauroursoursodeoxycholic acid, brand name Tudcabil----1件: 97 💬
7023Tavapadon 0.25 mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
7024Tavapadon 1mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
7025Tavapadon 5 mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
7026Tavapadon 5mg1件: Tavapadon1件: Tavapadon 💬2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
7027TAVT-18 (sirolimus)1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 158 💬
7028TBX-1400----1件: 65 💬
7029TC-MSC----2件: 36, 107 💬
7030TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)1件: Hydrogen---1件: 6 💬
7031TD-1058----1件: 85 💬
7032TD-1473----2件: 96, 97 💬
7033TD-1473 Dose A----1件: 97 💬
7034TD-1473 Dose B----1件: 97 💬
7035TD-1473 Dose C----1件: 97 💬
7036TD-5108 hydrochloride----1件: 99 💬
7037Tecfidera (BG00012)1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
7038Tecfidera (BG12)----1件: 13 💬
7039TECFIDERA - 240 MG - CAPSULA RIGIDA GASTRORESISTENTE - USO ORALE - BLISTER (PVC/PE/PVDC-PVC ALLUMINIO) - 56 CAPSULE----1件: 13 💬
7040Tecfidera® 120 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
7041Tecfidera® 120mg magensaftresistente Hartkapseln1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
7042Tecfidera® 240 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
7043Tecfidera® 240mg magensaftresistente Hartkapseln1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
7044TECHNETIUM (99MTC) EXAMETAZIME2件: Exametazime,
Technetium Tc-99m exametazime		1件: Exametazime 💬--1件: 6 💬
7045Teduglutide 0.1 mg dose1件: Teduglutide1件: Teduglutide 💬1件: GLP2R 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
7046Teduglutide 0.2 mg1件: Teduglutide1件: Teduglutide 💬1件: GLP2R 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
7047Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.1件: Teicoplanin1件: Teicoplanin 💬--1件: 299 💬
7048Telitacicept 160 mg----1件: 53 💬
7049Telitacicept 160mg----1件: 66 💬
7050Telitacicept 80 mg----1件: 53 💬
7051Tenofovir (TDF) and Emtricitabine (FTC)2件: Emtricitabine,
Tenofovir		2件: Emtricitabine ,
Tenofovir 💬		--1件: 325 💬
7052TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]2件: Tenofovir,
Tenofovir alafenamide		2件: Tenofovir ,
Tenofovir alafenamide 💬		--1件: 13 💬
7053Terazosin 5 MG1件: Terazosin1件: Terazosin 💬3件: ADRA1A,
ADRA1B,
ADRA1D 💬		7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 6 💬
7054Terguride 0,5mg tablet1件: Terguride1件: Terguride 💬2件: DRD2,
PRL 💬		12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 86 💬
7055Terguride 0.5 mg tablet1件: Terguride1件: Terguride 💬2件: DRD2,
PRL 💬		12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 86 💬
7056Teriflunomide 14 MG1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
7057Teriflunomide 14 MG Oral Tablet [Aubagio]1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
7058Teriparatide [rDNA origin] contains recombinant human parathyroid hormone (1-34)2件: Parathyroid hormone,
Teriparatide		2件: Parathyroid hormone ,
Teriparatide 💬		2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 70 💬
7059Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleava2件: Polyethylene glycol,
Teriparatide		2件: Polyethylene glycol 3350 ,
Teriparatide 💬		1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
7060Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker2件: Polyethylene glycol,
Teriparatide		2件: Polyethylene glycol 3350 ,
Teriparatide 💬		1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
7061Tesofensine/Metoprolol2件: Metoprolol,
Tesofensine		1件: Metoprolol 💬1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 193 💬
7062Tetanus + pnemococcal vaccines alone----1件: 46 💬
7063Tetanus toxoid (TT) containing vaccine (Td, Tdap)1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 13 💬
7064Tetanus toxoid adsorbed booster vaccine1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 46 💬
7065Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)3件: Clostridium tetani toxoid antigen (formaldehyde inactivated),
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated),
Pertussis vaccine		1件: Pertussis vaccine 💬--1件: 46 💬
7066Tetanus, diphtheria, and acellular pertussis vaccine1件: Pertussis vaccine1件: Pertussis vaccine 💬--1件: 13 💬
7067TETRACT-HIB - 1 SIRINGA PRECARICATA 0.5 ML----1件: 222 💬
7068Tetracycline - Statin - Antimycotic1件: Tetracycline1件: Tetracycline 💬--1件: 13 💬
7069Tetrahydro-6,6,9-tri methyl-3-penthyl-6 H-dibenzo[ b,d ]pyran-1-ol----1件: 298 💬
7070Tetrahydrobiopterin (BH4)1件: Sapropterin1件: Sapropterin 💬--1件: 240 💬
7071TETRAHYDROCANNABINOL Botanical Drug Substance (THC BDS)1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
7072TEV-48574 Dose Regiment B----2件: 96, 97 💬
7073Tezacaftor/Ivacaftor + Ivacaftor2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7074Tezacaftor/Ivacaftor 100mg/150mg2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7075Tezacaftor/Ivacaftor/100mg/150mg2件: Ivacaftor,
Tezacaftor		2件: Ivacaftor ,
Tezacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7076TG-1101----1件: 13 💬
7077Thalidomide 100mg1件: Thalidomide1件: Thalidomide 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
7078Thalidomide 150mg1件: Thalidomide1件: Thalidomide 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
7079THALIDOMIDE CELGENE - 50 MG CAPSULA RIGIDA - USO ORALE - BLISTER (PVC/PE/ACLAR/ALU) 28 CAPSULE1件: Thalidomide1件: Thalidomide 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
7080THALIDOMIDE CELGENE*28CPS 50MG1件: Thalidomide1件: Thalidomide 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 227 💬
7081Thalidomide, cyclophosphamide and prednisone3件: Cyclophosphamide,
Prednisone,
Thalidomide		4件: Cyclophosphamide ,
Prednisone ,
Thalidomide ,
Cyclophosphamide 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 331 💬
7082THC 5mg/ml and CBS 50mg/ml----1件: 96 💬
7083The 0.5 mL dose of vaccine contains 25 micrograms of each of the following 23 pneumococcal polysaccharide----1件: 222 💬
7084The Comprehensive Treatment Regimen of Traditional Chinese Medicine----1件: 222 💬
7085The effectiveness of Xeljanz in rheumatoid arthritis patients1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7086The generic name is warfarin and many producers will be involved1件: Warfarin1件: Warfarin 💬2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 49 💬
7087The gut mycobiota and microbiota profile----1件: 299 💬
7088The investigational medicinal product (IMP) may be labelled as either PF-04236921 106 mg/vial, Clonal SC lyophilized form” or PF-04236921 Powder for Injection, 106 mg/vial”. Supplies labelled with either nomenclature are equivalent.----1件: 96 💬
7089The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA----1件: 96 💬
7090The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA.----1件: 96 💬
7091The lung mycobiota and microbiota profile----1件: 299 💬
7092The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:----1件: 86 💬
7093The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:----1件: 86 💬
7094The Standard Steroid Treatment, Plasma Exchange and rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 85 💬
7095Therapy with disease-modifying anti rheumatic drugs (DMARD)----1件: 46 💬
7096THN102 Dosage B----1件: 6 💬
7097THRX-139060----2件: 96, 97 💬
7098THRX-199687 hydrochloride----1件: 99 💬
7099Thymosin alpha 1----1件: 299 💬
7100Thymosin Beta 41件: Thymosin beta-4---2件: 36, 53 💬
7101Thymosin Beta 4 eye drops1件: Thymosin beta-4---1件: 53 💬
7102Thyroxin, Triiodothyronine1件: Liothyronine1件: Liothyronine 💬2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 78 💬
7103TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED)----1件: 46 💬
7104Tildrakizumab 100 mg/ml1件: Tildrakizumab1件: Tildrakizumab 💬1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 271 💬
7105Time and attention + active fructooligosaccharide supplementation----1件: 96 💬
7106Time delay treatment of botulinum toxin----1件: 149 💬
7107Timolol Alcon 0.5% collyre1件: Timolol2件: Timolol ,
Timolol 💬		2件: ADRB1,
ADRB2 💬		11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
7108TIMOLOL MALEATE1件: Timolol2件: Timolol ,
Timolol 💬		2件: ADRB1,
ADRB2 💬		11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
7109Tin mesoporphyrin1件: Stannsoporfin1件: Stannsoporfin 💬2件: HMOX1,
HMOX2 💬		10件: Chemical carcinogenesis - reactive oxygen species, Ferroptosis, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatocellular carcinoma, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Pathways in cancer, Porphyrin metabolism 💬1件: 254 💬
7110Tiotropium bromide1件: Tiotropium---1件: 299 💬
7111Tiotropium Bromide (monohydrate)1件: Tiotropium---1件: 299 💬
7112Tiotropium bromide 5 mcg1件: Tiotropium---1件: 299 💬
7113Tiotropium bromide high1件: Tiotropium---1件: 299 💬
7114Tiotropium bromide low1件: Tiotropium---1件: 299 💬
7115Tiotropium bromide medium1件: Tiotropium---1件: 299 💬
7116TIOTROPIUM BROMIDE MONOHYDRATE1件: Tiotropium---1件: 299 💬
7117Tiotropium bromide-low dose-2.5mcg1件: Tiotropium---1件: 299 💬
7118Tiotropium Respimat 1.25 microgram solution for inhalation1件: Tiotropium---1件: 299 💬
7119Tiotropium Respimat 1.25 microgram, solution for inhalation1件: Tiotropium---1件: 299 💬
7120Tiotropium Respimat 1.25 micrograms solution for inhalation1件: Tiotropium---1件: 299 💬
7121Tiotropium Respimat® inhaler1件: Tiotropium---1件: 299 💬
7122TIS or TIP----1件: 299 💬
7123Tivanisiran sodium ophthalmic solution----1件: 53 💬
7124Tizanidine (sublingual or oral)1件: Tizanidine1件: Tizanidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
7125TL011, anti CD20, for the treatment of rheumatoid arthritis----1件: 46 💬
7126TLR7/8 Antagonist (10mg)----1件: 49 💬
7127TLR7/8 Antagonist (2.5mg)----1件: 49 💬
7128TMI-005 (WAY-177005)----1件: 46 💬
7129TMI-005 WAY-177005----1件: 46 💬
7130TNF alpha blockers----1件: 46 💬
7131TNF Antagonist (enbrel, humire, remicade, cimzia, symponi)3件: Certolizumab pegol,
Etanercept,
Infliximab		3件: Etanercept ,
Infliximab ,
Certolizumab pegol 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
7132TNF blockers (infliximab, adalimumab, etanercept)3件: Adalimumab,
Etanercept,
Infliximab		3件: Etanercept ,
Adalimumab ,
Infliximab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
7133TNF blockers monotherapy----1件: 46 💬
7134TNF Inhibitor (M0-M3)----1件: 46 💬
7135TNF Inhibitor (M3-M12)----1件: 46 💬
7136TNF-a antagonists, non-TNFs, DMARD non-biologics----2件: 46, 271 💬
7137TNF-a inhibitor OR JAK inhibitor----1件: 46 💬
7138TNF-alpha antagonist and other biotherapy----1件: 46 💬
7139TNF-blockers suspension in patients with rheumatoid arthritis----1件: 46 💬
7140TNR-001, TNFR:FC----1件: 271 💬
7141TNX-650, rhuMAb anti-IL13, aIL-13, MILR1444A----1件: 85 💬
7142To be confirmed----3件: 46, 65, 97 💬
7143To be determined----2件: 96, 113 💬
7144To be requested----2件: 96, 97 💬
7145TOBI 300 mg / 5 mL nebuliser solution1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7146TOBI 300 mg/5 ml Lösung für einen1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7147TOBI 300 mg/5 ml Lösung für einen Vernebler1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7148TOBI 300 mg/5 ml Nebuliser Solution1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7149TOBI 300 mg/5 ml solución para inhalación por nebulizador1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7150TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7151TOBI 300mg/ 5ml solución para inhalación con nebulizador1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7152TOBI 300mg/5mL Nebuliser Solution1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7153Tobi 300mg/5ml Nebuliser solution.1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7154Tobi 300mg/5ml Solución para inhalación por nebulizador.1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7155TOBI PODHALER - 28 MG POLVERE PER INALAZIONE CAPSULA RIGIDA USO INALATORIO BLISTER(ALU/ALU) 56 CAPSULE + 1 INALATORE1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7156TOBI Podhaler 28 mg Hartkapseln mit Pulver zur Inhalation1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7157TOBI Podhaler 28 mg inhalációs por, kemény kapszula1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7158TOBI PODHALER*448CPS 28MG+10IN1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7159TOBI*NEBUL 56F 1D 300MG/5ML1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7160TOBI™ Podhaler™ 112 mg inhaled twice daily----1件: 299 💬
7161Tobramycin / Bramitob1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7162Tobramycin / TOBI1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7163Tobramycin 100 PARI1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7164Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7165Tobramycin inhalation solution using a PARI LC® Plus nebulizer.1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7166Tobramycin injection 40mg/1ml1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7167Tobramycin solution for inhalation 300 mg1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7168Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution1件: Tobramycin1件: Tobramycin 💬--1件: 299 💬
7169Tobrineb/Bramitob----1件: 299 💬
7170Tocilizumab (Actemra or RoActemra)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7171Tocilizumab (MRA-SC)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 40 💬
7172Tocilizumab + Glucocorticoids (GCs)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
7173Tocilizumab + methotrexate(MTX)2件: Methotrexate,
Tocilizumab		2件: Methotrexate ,
Tocilizumab 💬		3件: DHFR,
DHFR2,
IL6R 💬		17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7174Tocilizumab 162 mg1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7175Tocilizumab 162Mg/0.9Ml Autoinjector1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41 💬
7176Tocilizumab 162mg/0.9ml jeringa SC1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7177Tocilizumab 162mg/0.9ml SC PFS SC1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7178Tocilizumab 162mg/0.9ml syringe SC1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7179Tocilizumab plus methotrexate2件: Methotrexate,
Tocilizumab		2件: Methotrexate ,
Tocilizumab 💬		3件: DHFR,
DHFR2,
IL6R 💬		17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7180Tocilizumab SC 162 mg/0.9 ml disposable auto-injector (AI)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7181Tocilizumab SC 162 mg/0.9 ml pre-filled syringe with safety device (PFS)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7182Tocilizumab SC 162 mg/0.9 ml prefilled syringe with safety device (PFS)1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 51 💬
7183Tocilizumab+Methotrexate(MTX)2件: Methotrexate,
Tocilizumab		2件: Methotrexate ,
Tocilizumab 💬		3件: DHFR,
DHFR2,
IL6R 💬		17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46 💬
7184Tocilizumab, Abatacept2件: Abatacept,
Tocilizumab		2件: Tocilizumab ,
Abatacept 💬		3件: CD80,
CD86,
IL6R 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
7185Tocovid Suprabio (HOV-12020)----1件: 6 💬
7186Tofacitinib (CP-690,550)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 96 💬
7187Tofacitinib (Xeljanz®) 11mg Prolonged Release Tablet1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7188Tofacitinib 10 mg1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 271 💬
7189Tofacitinib 10 MG [Xeljanz]1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
7190Tofacitinib 2 mg1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 271 💬
7191Tofacitinib 5 MG1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬4件: 11, 40, 46, 271 💬
7192Tofacitinib 5 MG [Xeljanz]1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 50 💬
7193Tofacitinib 5 mg twice daily1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 84 💬
7194Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 84 💬
7195Tofacitinib 5mg po bid1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7196Tofacitinib citrate (Proposed commercial formulation - debossed)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
7197Tofacitinib citrate (Proposed commercial formulation – debossed)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
7198Tofacitinib citrate (Proposed commercial formulation- debossed)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7199Tofacitinib citrate (Proposed commercialFormulation - debossed)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
7200Tofacitinib citrate( Phase III formulation)1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7201Tofacitinib or Baricitinib2件: Baricitinib,
Tofacitinib		2件: Tofacitinib ,
Baricitinib 💬		4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7202Tofacitinib with methotrexate2件: Methotrexate,
Tofacitinib		2件: Methotrexate ,
Tofacitinib 💬		6件: DHFR,
DHFR2,
JAK1,
JAK2,
JAK3,
TYK2 💬		42件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7203Tofacitinib without methotrexate2件: Methotrexate,
Tofacitinib		2件: Methotrexate ,
Tofacitinib 💬		6件: DHFR,
DHFR2,
JAK1,
JAK2,
JAK3,
TYK2 💬		42件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7204Tofacitinib/baricitinib2件: Baricitinib,
Tofacitinib		2件: Tofacitinib ,
Baricitinib 💬		4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7205Tolebrutinib 120mg----1件: 13 💬
7206Tolerogenic Dendritic cells loaded with myelin peptides1件: Myelin basic protein---1件: 13 💬
7207TOLVAPTAN (OPC-41061)1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7208TOLVAPTAN 151件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7209Tolvaptan 15 mg Tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7210Tolvaptan 15 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7211Tolvaptan 15mg1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7212Tolvaptan 30 mg Tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7213Tolvaptan 30 mg tablets1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7214TOLVAPTAN 45/151件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7215Tolvaptan 50mg Granules1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7216Tolvaptan 7.5 mg Tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7217Tolvaptan MR1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
7218Tolvaptan Oral Tablet1件: Tolvaptan1件: Tolvaptan 💬1件: AVPR2 💬3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 72 💬
7219Tominersen 100 mg----1件: 8 💬
7220Tominersen 60 mg----1件: 8 💬
7221Topical 0.1% Sirolimus1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 278 💬
7222Topical AmphiMatrix with nitroglycerin (MQX-503)1件: Nitroglycerin1件: Nitroglycerin 💬--1件: 51 💬
7223Topical beremagene geperpavec----1件: 36 💬
7224Topical BPM31510 3.0% Cream----1件: 36 💬
7225Topical calcipotriene 0.005% ointment1件: Calcipotriol1件: Calcipotriene 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 51 💬
7226Topical opiod----1件: 36 💬
7227Topical organogel with nitroglycerin1件: Nitroglycerin1件: Nitroglycerin 💬--1件: 51 💬
7228Topical timolol maleate1件: Timolol2件: Timolol ,
Timolol 💬		2件: ADRB1,
ADRB2 💬		11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227 💬
7229TORVAST*10CPR 10MG----1件: 13 💬
7230Total Body Irradiation----1件: 65 💬
7231Total Body Irradiation (TBI) (Plan 1)----2件: 60, 285 💬
7232TOTTIZIM - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 10 ML----1件: 299 💬
7233Toxicity, Pharmacokinetics----1件: 34 💬
7234Tozadenant (SYN115) 120 mg BID1件: Tozadenant1件: Tozadenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
7235Tozadenant (SYN115) 180 mg BID1件: Tozadenant1件: Tozadenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
7236Tozadenant (SYN115) 240 mg BID1件: Tozadenant1件: Tozadenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
7237Tozadenant (SYN115) 60 mg BID1件: Tozadenant1件: Tozadenant 💬1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6 💬
7238TP05 Coating B----1件: 97 💬
7239TPI 287 2 mg/m2----2件: 5, 7 💬
7240TPI-287 20 mg/m21件: TPI-287---2件: 5, 7 💬
7241TPI-287 6.3 mg/m21件: TPI-287---2件: 5, 7 💬
7242TPN-101----3件: 2, 127, 325 💬
7243TPN-101, 400 mg/day----2件: 2, 127 💬
7244TPO-RAs combining anti-CD 20 monoclonal antibody----1件: 63 💬
7245TRACLEER 125MG 56CPR RIV.1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 88 💬
7246TRACLEER 62,5 mg comprimidos recubiertos con película1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
7247TRACLEER 62,5MG 56CPR RIV.1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
7248TRACLEER*125MG 56CPR RIV.1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
7249TRACLEER*56CPR RIV 125MG1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 86, 88 💬
7250Trade name depends on the source of the product----1件: 76 💬
7251Trade name depends on the source of the product’----1件: 76 💬
7252Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant)----1件: 6 💬
7253Traditional treatment of CGD and TB----1件: 65 💬
7254Tralokinumab cohort 11件: Tralokinumab1件: Tralokinumab 💬1件: IL13 💬8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 85 💬
7255Tralokinumab is a human recombinant monoclonal antibody (MAb) of the subclass that specifically binds human IL-13, blocking interactions with the IL-13 receptor1件: Tralokinumab1件: Tralokinumab 💬1件: IL13 💬8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬1件: 85 💬
7256Tramadol hydrochloride + acetaminophen2件: Acetaminophen,
Tramadol		2件: Acetaminophen ,
Tramadol 💬		3件: OPRM1,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
7257Trametinib (0.5 mg)1件: Trametinib1件: Trametinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 2 💬
7258Trametinib (1 mg)1件: Trametinib1件: Trametinib 💬2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 2 💬
7259TransCon CNP 3.9 mg CNP-38/vial----1件: 276 💬
7260TransCon hGH (ACP-011) - 12,1mg----1件: 78 💬
7261TransCon hGH (ACP-011) - 12.1mg----1件: 78 💬
7262TransCon hGH (ACP-011) - 24.2mg----1件: 78 💬
7263TransCon hGH CT-301 (ACP-011) - 12,1mg----1件: 78 💬
7264TRANSCON PEG40 HGH, Transiently PEGylated hGH prodrug----1件: 78 💬
7265TransCon PTH mid-dose pen----1件: 235 💬
7266Transdermal fentanyl matrix, gabapentin2件: Fentanyl,
Gabapentin		2件: Fentanyl ,
Gabapentin 💬		6件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
OPRM1,
SLC6A1 💬		12件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 70 💬
7267Transduced CD34+ Cells----1件: 285 💬
7268Transduced CD34+ hematopoietic stem cell----2件: 19, 20 💬
7269Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL17A1-encoding retroviral vector----1件: 36 💬
7270Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL7A1-encoding retroviral vector----1件: 36 💬
7271Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a COL7A1-encoding retroviral vector, obtained from secondary culture of ex vivo expanded autologous human keratinocytes.----1件: 36 💬
7272Transduced patient CD34+ cells----1件: 65 💬
7273Translarna 1000 mg granules for oral suspension1件: Ataluren1件: Ataluren 💬--1件: 113 💬
7274Translarna 125 mg granules for oral suspension1件: Ataluren1件: Ataluren 💬--1件: 113 💬
7275Translarna 250 mg granules for oral suspension1件: Ataluren1件: Ataluren 💬--1件: 113 💬
7276Transplant Conditioning with Mobilization and Alemtuzumab1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 65 💬
7277Transplant Conditioning with Mobilization Only----1件: 65 💬
7278Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan4件: Alemtuzumab,
Fludarabine,
Melphalan,
Thiotepa		4件: Melphalan ,
Thiotepa ,
Alemtuzumab ,
Fludarabine 💬		2件: CD52,
RRM1 💬		6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
7279Transvamix (100mg/mL THC, 50mg/mL CBD)----1件: 36 💬
7280Trazodone Hydrochloride oral solution1件: Trazodone1件: Trazodone 💬4件: HTR2A,
HTR2B,
HTR2C,
SLC6A4 💬		6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 2 💬
7281Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms1件: Lansoprazole1件: Lansoprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 98 💬
7282Treatment Algorithm B----1件: 97 💬
7283Treatment B----2件: 34, 46 💬
7284Treatment BX1514M----1件: 58 💬
7285Treatment defined only by active substance----1件: 50 💬
7286Treatment of MTX----1件: 46 💬
7287Treatment of MTX and HCQ----1件: 46 💬
7288Treatment of MTX and TwHF----1件: 46 💬
7289Treatment of TCM----1件: 46 💬
7290Treatment of TwHF----1件: 46 💬
7291Treatment vs control bread----1件: 97 💬
7292Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor4件: Elexacaftor,
Ivacaftor,
Lumacaftor,
Tezacaftor		4件: Ivacaftor ,
Lumacaftor ,
Tezacaftor ,
Elexacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7293Treatment with mycophenolat mofetil----1件: 95 💬
7294Treatment with polyethylene glycol (Macrogol 4000)1件: Polyethylene glycol1件: Polyethylene glycol 3350 💬--1件: 299 💬
7295Treatment with systemic therapy (methotrexate)1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 162 💬
7296TREPROSTINIL SODIUM, UT-151件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
7297Treprostinil, UT-15, LRX-15, 15AU81, BW A15AU, U-62, 8401件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
7298Trexan inj 25 mg/ml----1件: 97 💬
7299Trexan+Salazopyrin+Oxiklorin+prednisolone1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
7300Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab2件: Infliximab,
Prednisolone		2件: Prednisolone ,
Infliximab 💬		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
7301Tri-O-acetyluridine1件: Uridine triacetate1件: Uridine triacetate 💬--1件: 21 💬
7302Triam 40 mg Lichtenstein----1件: 46 💬
7303Triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip)1件: Triamcinolone1件: Triamcinolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
7304Triamcinolone Hexacetonide 20 MG/ML1件: Triamcinolone1件: Triamcinolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 107 💬
7305Triapin& triapin Mite----1件: 19 💬
7306Trichuris suis Ova----4件: 13, 46, 96, 97 💬
7307Trichuris suis ova (eggs), embryonated, viable----1件: 13 💬
7308Trichuris suis ova (TSO)----2件: 96, 97 💬
7309Triheptanoin / Triheptanoina1件: Triheptanoin1件: Triheptanoin 💬--1件: 248 💬
7310Triheptanoin 1g/kg/day1件: Triheptanoin1件: Triheptanoin 💬--1件: 8 💬
7311Triheptanoin oil1件: Triheptanoin1件: Triheptanoin 💬--1件: 8 💬
7312TRIMETON - 10 MG/1 ML SOLUZIONE INIETTABILE 5 FIALE 1 ML----1件: 14 💬
7313TRIMETOPRIM + SULFAMETOSSAZOLO *----1件: 61 💬
7314Triomar™ (omega-3 fatty acids)1件: Omega-3 fatty acids---1件: 13 💬
7315Triptorelin embonate, Triptorelin pamoate1件: Triptorelin1件: Triptorelin 💬1件: GNRHR 💬2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76 💬
7316Triptorelin pamoate 15mg1件: Triptorelin1件: Triptorelin 💬1件: GNRHR 💬2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76 💬
7317Triptorlin or Leuprorelin1件: Leuprolide---1件: 76 💬
7318Triterpene dry extract from birch cork----1件: 36 💬
7319Trivalent chromium versus synthetic and/ or biological DMARDs1件: Chromium---1件: 46 💬
7320TRK-100STP----1件: 86 💬
7321TRK-170----1件: 96 💬
7322Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
7323Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
7324Tryptophan (TRP) depletion1件: Tryptophan1件: Tryptophan 💬--1件: 6 💬
7325TS-152----1件: 46 💬
7326TSHA-101----1件: 19 💬
7327TSHA-102----1件: 156 💬
7328TSO 7500----1件: 96 💬
7329TTI-101----1件: 85 💬
7330TTI-1612----1件: 226 💬
7331TU-1001件: TU-100---1件: 96 💬
7332Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab)4件: Adalimumab,
Etanercept,
Golimumab,
Infliximab		4件: Etanercept ,
Adalimumab ,
Infliximab ,
Golimumab 💬		2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
7333TV-1106----1件: 78 💬
7334TV-5010----1件: 13 💬
7335TV-5600----3件: 8, 13, 96 💬
7336TV-7110----1件: 2 💬
7337TV-7820----1件: 8 💬
7338TVP-1012----1件: 6 💬
7339TVP-1012 (1 mg/day) with levodopa1件: Levodopa1件: Levodopa 💬5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
7340TVP-1012 0.5mg----1件: 6 💬
7341TVP-1012 1mg----1件: 6 💬
7342Twice-daily dosage with 0.5% cyclosporine-A eyedrops1件: Cyclosporine1件: Cyclosporine 💬5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 90 💬
7343TYF-ADA gene-modified autologous stem cells----1件: 65 💬
7344TYF-IL-2Rg gene-modified autologous stem cells----1件: 65 💬
7345TYSABRI 300 mg concentrado para solución para perfusión1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
7346TYSABRI 300 mg concentrate for solution for infusion1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
7347TYSABRI 300 mg solution à diluer pour perfusion1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
7348Tysabri ® (Natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
7349TYSABRI*IV 1FL 300MG 15ML1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
7350Tysabri® (natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
7351TYVASO® (treprostinil) inhalation solution, for oral inhalation use1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 85 💬
7352UC-MSC+DMARDS----1件: 46 💬
7353UC-MSCs1件: Human Umbilical Cord Mesenchymal Stem Cells---2件: 46, 96 💬
7354UCB0107 (bepranemab)----1件: 5 💬
7355UK-92,480-10----1件: 86 💬
7356UK: Sativex Oromucosal Spray2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
7357ULTOMIRIS - 300 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 3 ML (100 MG / ML) - 1 FLACONCINO1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
7358Ultomiris 1,100 mg/11 mL1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
7359Ultomiris 300 mg/30 ml1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 66 💬
7360ULTOMIRIS ™ (ravulizumab-cwvz)1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 62 💬
7361Ultra small particles of iron oxide (USPIO)1件: Ferric oxide1件: Ferric oxide 💬--1件: 13 💬
7362Ultrase® MT12----1件: 299 💬
7363Ultrase® MT20----1件: 299 💬
7364Ultrasmall particles of iron oxide1件: Ferric oxide1件: Ferric oxide 💬--1件: 13 💬
7365Ultrasound-guided Suprascapular Nerve Block----1件: 149 💬
7366Umbilical Cord Based Allogenic Mesenchymal Stem Cell----1件: 113 💬
7367Umbilical Cord Blood----1件: 60 💬
7368Umbilical cord blood (UCB)----1件: 60 💬
7369Umbilical Cord Blood After Myeloablative Conditioning----1件: 60 💬
7370Umbilical Cord Blood After Reduced-Intensity Conditioning----1件: 60 💬
7371Umbilical cord blood mononuclear cells----1件: 97 💬
7372Umbilical Cord Blood Transplantation----1件: 60 💬
7373Umbilical Cord Blood Unit----1件: 333 💬
7374Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation----2件: 93, 296 💬
7375Umbilical cord derived Mesenchymal Stem Cells----1件: 13 💬
7376Umbilical Cord Mesenchymal Stem Cell----1件: 113 💬
7377Umbilical Cord Mesenchymal Stem Cell (UC-MSC)----1件: 90 💬
7378Umbilical cord mesenchymal stem cells----5件: 13, 46, 57, 97, 113 💬
7379Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 46 💬
7380Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein)1件: Genistein1件: Genistein 💬--1件: 299 💬
7381UNDIFFERENTIATED AUTOLOGOUS MESENCHYMAL STEM CELLS----1件: 13 💬
7382Unrelated BM with T cell depletion----1件: 65 💬
7383Unrelated cord blood----1件: 65 💬
7384Unrelated Umbilical Cord Blood Transplant----1件: 19 💬
7385Upadacitinib - Direct compression-yellow1件: Upadacitinib1件: Upadacitinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
7386Upadacitinib 12mg1件: Upadacitinib1件: Upadacitinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7387Upadacitinib 15mg1件: Upadacitinib1件: Upadacitinib 💬1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7388UR-12746-S----1件: 97 💬
7389Urbason 40 mg----1件: 13 💬
7390URBASON 40 mg comprimidos----1件: 13 💬
7391Urbason solubile forte 1000mg----1件: 13 💬
7392URBASON*IM EV 1F 250MG+1F 5ML----1件: 222 💬
7393Urbason® solubile forte 1000 mg----1件: 13 💬
7394Urinary levels of PIIINP as a marker of changes in renal function----1件: 299 💬
7395Urine samples taken to measure methotrexate and its major metabolite 7-OH-methotrexate level1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46 💬
7396Ursodeoxycholic acid (UDCA) 500 mg1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 46 💬
7397Ursodeoxycholic acid combination of immunosuppressive agents1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬2件: 93, 95 💬
7398Ursodeoxycholic acid combined with total glucosides of paeony1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
7399Ursodeoxycholic acid only1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
7400Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)2件: Methylprednisolone,
Ursodeoxycholic acid		2件: Methylprednisolone ,
Ursodiol 💬		2件: NR1H4,
NR3C1 💬		2件: Bile secretion, Neuroactive ligand-receptor interaction 💬1件: 93 💬
7401Ursodiol (ursodeoxycholic acid, UDCA)1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 97 💬
7402UrsoFalk® 250 mg tabletten.1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 96 💬
7403Ursofalk® 500 mg film-coated tablets1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
7404Ursofalk® 500 mg Filmtabletten1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
7405Ursofalk® capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
7406US TAP Bupivacaine/Epinephrine2件: Bupivacaine,
Epinephrine		2件: Epinephrine ,
Bupivacaine 💬		14件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 96 💬
7407USAN: sebelipasa alfa1件: Sebelipase alfa1件: Sebelipase alfa 💬1件: LIPA 💬3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬1件: 19 💬
7408USAN: sebelipase alpha----1件: 19 💬
7409Use of lipid-lowering drugs.----1件: 265 💬
7410Ustekinumab (approximately 6 mg/kg)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 49 💬
7411Ustekinumab + MTX (Group 2)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 46 💬
7412Ustekinumab + MTX (Group 3)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 46 💬
7413Ustekinumab 130 mg IV1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7414Ustekinumab 180 mg1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 93 💬
7415Ustekinumab 1mg/kg (IP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7416Ustekinumab 3 mg/kg (IP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7417Ustekinumab 4.5 mg/kg1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7418Ustekinumab 45 mg1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 93 💬
7419Ustekinumab 6 mg/kg (IP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7420Ustekinumab 90 mg1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬3件: 49, 93, 96 💬
7421Ustekinumab 90 mg (SC) Group 11件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7422Ustekinumab 90 mg (SC) Group 21件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7423Ustekinumab 90 mg SC q12w1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7424Ustekinumab 90 mg SC q8w1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7425Ustekinumab 90 milligram (mg)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 49 💬
7426Ustekinumab approximately 6 mg/kg (IV)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7427Ustekinumab Dose Based on BSA and Body Weight1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 97 💬
7428Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7429Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP)1件: Ustekinumab1件: Ustekinumab 💬3件: IL12A,
IL12B,
IL23A 💬		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 96 💬
7430Usual dopaminergic per os treatment----1件: 6 💬
7431UT-15 SR----1件: 51 💬
7432UT-15C----1件: 86 💬
7433UT-15C (treprostinil diethanolamine)1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
7434UT-15C 0.25 mg----1件: 86 💬
7435UT-15C 1 mg----1件: 86 💬
7436UT-15C 5 mg----1件: 86 💬
7437UT-15C LP----1件: 86 💬
7438UT-15C SR----2件: 51, 86 💬
7439UT-15C SR (treprostinil diethanolamine)1件: Treprostinil1件: Treprostinil 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
7440UT-15C-SR----2件: 51, 86 💬
7441UTTR1147A, IL22-Fc, IL-22Fc1件: Efmarodocokin alfa1件: Efmarodocokin alfa 💬1件: IL22 💬4件: Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬2件: 96, 97 💬
7442UVEDOSE 100 000 UI----1件: 13 💬
7443UVEDOSE 100 000 UI, solution buvable en ampoule----1件: 13 💬
7444UX143, BPS804----1件: 274 💬
7445UX701 (1.0 × 10^13 genome copies/kg)----1件: 171 💬
7446UX701 (2.0 × 10^13 genome copies/kg)----1件: 171 💬
7447UX701 (5.0 × 10^12 genome copies/kg)----1件: 171 💬
7448Vaccin grippal pandémique H1N1----1件: 299 💬
7449Vaccination with vaccine against hepatitis A and B----1件: 299 💬
7450Vaccine Vivotif + Vaccine Dukoral6件: Recombinant Cholera Toxin B Subunit,
Typhoid Vaccine Live,
Vibrio cholerae Inaba 48 classical biotype, heat inactivated,
Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, heat inactivated		---1件: 97 💬
7451Vaccine Vivotif + Vaccine Dukoral + oats7件: Oat,
Recombinant Cholera Toxin B Subunit,
Typhoid Vaccine Live,
Vibrio cholerae Inaba 48 classical biotype, heat inactivated,
Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, heat inactivated		---1件: 97 💬
7452VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B----3件: 61, 62, 66 💬
7453VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO----2件: 61, 62 💬
7454VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135)----3件: 61, 62, 66 💬
7455VAL-1221----1件: 256 💬
7456Valproate, Levocarnitine2件: Levocarnitine,
Valproic acid		2件: Valproic acid ,
Levocarnitine 💬		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
7457Vaminolac, komb.----1件: 97 💬
7458Vamorolone 0.25 mg/day/day1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
7459Vamorolone 0.25 mg/kg/day1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
7460Vamorolone 0.75 mg/day/day1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
7461Vamorolone 0.75 mg/kg/day1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
7462Vamorolone 2.0 mg/day/day1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
7463Vamorolone 2.0 mg/kg/day1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
7464Vamorolone 4% suspension for oral dosing1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
7465Vamorolone 6.0 mg/day/day1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
7466Vamorolone 6.0 mg/kg/day1件: Vamorolone1件: Vamorolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113 💬
7467Vancomycin Oral Capsule1件: Vancomycin1件: Vancomycin 💬--1件: 97 💬
7468Variation of behaviors of Parkinson's disease----1件: 6 💬
7469Vasomera (PB1046) Injection----1件: 86 💬
7470Vasopressin, Arginine2件: Arginine,
Vasopressin		2件: Vasopressin ,
Arginine 💬		3件: AVPR1A,
AVPR1B,
AVPR2 💬		5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 210 💬
7471Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S1件: AstraZeneca COVID-19 Vaccine---1件: 299 💬
7472VB-201 160mg1件: VB-201---1件: 97 💬
7473Vectra DA MBDA Test----1件: 46 💬
7474Vedolizumab 108 mg SC1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
7475Vedolizumab 300 mg1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
7476Vedolizumab 300 MG Injection [Entyvio]1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 96 💬
7477Vedolizumab 300 mg IV1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
7478Vedolizumab Intravenous (IV), Vedolizumab Subcutaneous (SC), Placebo IV1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
7479Vedolizumab IV 300 mg1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 96 💬
7480Vedolizumab IV, Placebo IV, Placebo SC1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
7481Vedolizumab IV, Placebo SC1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬1件: 97 💬
7482Vedolizumab SC 108 mg1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
7483Vedolizumab, Entyvio1件: Vedolizumab1件: Vedolizumab 💬2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
7484Vedolizumab, Ustekinumab, or Tofacitinib3件: Tofacitinib,
Ustekinumab,
Vedolizumab		3件: Vedolizumab ,
Ustekinumab ,
Tofacitinib 💬		9件: IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
JAK1,
JAK2,
JAK3,
TYK2 💬		65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Focal adhesion, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Yersinia infection 💬1件: 97 💬
7485Vehicle (SD-101 0%)----1件: 36 💬
7486Vehicle of ADX-102 Topical Dermal Cream----1件: 160 💬
7487Vehicle ophthalmic solution----1件: 53 💬
7488VELCADE*1FL 3,5MG2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
7489VELCADE*EV 1FL 3,5MG 1MG/ML2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 61 💬
7490Velmanase Alfa (e.g. Lamazym)1件: Velmanase alfa1件: Velmanase alfa 💬1件: MAN2B1 💬2件: Lysosome, Other glycan degradation 💬1件: 19 💬
7491Veltuzumab solution 75mg/ml1件: Veltuzumab1件: Veltuzumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46 💬
7492Venetoclax MTD with Dexamethasone2件: Dexamethasone,
Venetoclax		2件: Dexamethasone ,
Venetoclax 💬		2件: BCL2,
NR3C1 💬		44件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28 💬
7493Venetoclax Oral Tablet, 200 mg1件: Venetoclax1件: Venetoclax 💬1件: BCL2 💬43件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28 💬
7494Venetoclax Oral Tablet, 400 mg1件: Venetoclax1件: Venetoclax 💬1件: BCL2 💬43件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28 💬
7495Venglustat malate1件: Venglustat1件: Venglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 6, 19, 67 💬
7496Venglustat malato1件: Venglustat1件: Venglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬2件: 19, 67 💬
7497Venous blood sample----1件: 46 💬
7498Ventavis (Iloprost, BAYQ6256)1件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
7499Ventavis 101件: Iloprost1件: Iloprost 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
7500Ventoline oral solution 0,4mg/ml----1件: 111 💬
7501Ventolin® Evohaler1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
7502Ventolin¿ Evohaler¿1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299 💬
7503Verorab® (PVRV----1件: 65 💬
7504Verum arm receiving Vitamin D oil1件: Vitamin D---1件: 13 💬
7505VESIcare 10Mg Tablet----1件: 13 💬
7506VEYVONDI 1300 IU powder and solvent for solution for injection1件: Vonicog alfa1件: Vonicog alfa 💬--1件: 288 💬
7507VEYVONDI 1300I IU powder and solvent for solution for injection1件: Vonicog alfa1件: Vonicog alfa 💬--1件: 288 💬
7508VEYVONDI 1300IU powder and solvent for solution for injection1件: Vonicog alfa1件: Vonicog alfa 💬--1件: 288 💬
7509VFEND 40 mg/ml powder for oral suspension1件: Voriconazole1件: Voriconazole 💬--1件: 299 💬
7510Viaskin Milk 500 mcg1件: Cow milk---1件: 98 💬
7511VIB7734, MEDI7734----1件: 49 💬
7512Vibrox 100mg Capsules----1件: 167 💬
7513Vigabatrin: Vigabatrin new ST formulation then Sabril®1件: Vigabatrin1件: Vigabatrin 💬1件: ABAT 💬7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 145 💬
7514Vigantol Oel----3件: 13, 96, 97 💬
7515Vigantol Oel TM----2件: 96, 97 💬
7516VIGANTOL OIL----1件: 13 💬
7517VigantOL oil plus interferon beta-1a (Rebif)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
7518Vigantol® Oil----1件: 13 💬
7519Vigantol® Öl 20.000 I.E./ml----1件: 13 💬
7520Vimizim® (elosulfase alfa)1件: Elosulfase alfa1件: Elosulfase alfa 💬1件: GALNS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
7521VIMOVO 500/20----1件: 107 💬
7522Vinblastine, vincristine, prednisone, daunorubicin4件: Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		4件: Prednisone ,
Daunorubicin ,
Vinblastine ,
Vincristine 💬		12件: NR3C1,
TOP2A,
TOP2B,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Platinum drug resistance, Prion disease, Salmonella infection 💬1件: 65 💬
7523Vincristine Sulfate (Oncovin)2件: Sulfate ion,
Vincristine		1件: Vincristine 💬9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 34 💬
7524VIOKASE 16----1件: 298 💬
7525Viokase 16 (pancrelipase) + Nexium2件: Esomeprazole,
Pancrelipase		2件: Pancrelipase ,
Esomeprazole 💬		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 298 💬
7526Viokase® 16----1件: 298 💬
7527VIREAD - 245 MG 30 COMPRESSE RIVESTITE CON FILM IN FLACONE USO ORALE----1件: 46 💬
7528VIREAD 30 CPR 245 MG----1件: 46 💬
7529Viscous/swallowed budesonide1件: Budesonide1件: Budesonide 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
7530Vitamin AD sig: 1 tablet/tid----1件: 90 💬
7531Vitamin B sig: 10mg/tid----1件: 90 💬
7532Vitamin B11件: Thiamine1件: Thiamine 💬--1件: 145 💬
7533Vitamin B121件: Cyanocobalamin4件: Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--4件: 6, 201, 229, 299 💬
7534Vitamin B12 Supplementation1件: Cyanocobalamin4件: Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--1件: 6 💬
7535Vitamin B12, B9, B6, C supplementation1件: Cyanocobalamin4件: Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--1件: 229 💬
7536Vitamin B21件: Riboflavin1件: Riboflavin 💬--1件: 97 💬
7537Vitamin B3----1件: 107 💬
7538Vitamin B61件: Pyridoxine1件: Pyridoxine 💬--2件: 6, 206 💬
7539Vitamin B71件: Biotin1件: Biotin 💬--1件: 8 💬
7540Vitamin D 100ug1件: Vitamin D---1件: 298 💬
7541Vitamin D 10ug1件: Vitamin D---1件: 298 💬
7542Vitamin D 25(OH)D1件: Vitamin D---1件: 49 💬
7543Vitamin D in arm B1件: Vitamin D---1件: 46 💬
7544Vitamin D Oil1件: Vitamin D---1件: 299 💬
7545Vitamin D2 ( calciferol )2件: Ergocalciferol,
Vitamin D		1件: Ergocalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 49 💬
7546Vitamin D3 - high dose1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 6 💬
7547Vitamin D3: 3000 or 4000 UI/day then 2,000 UI/day1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 96 💬
7548VITAMIN E - TGPS1件: Vitamin E1件: Vitamin E 💬--1件: 299 💬
7549Vitamin K supplementation, dose #11件: Phylloquinone---1件: 299 💬
7550Vitamin K supplementation, dose #21件: Phylloquinone---1件: 299 💬
7551Vitamin: Choline Bitartrate (2-hydroxyethyl) trimethylammonium salt 1:11件: Choline1件: Choline 💬--1件: 299 💬
7552VITAMINA D3 KERN PHARMA SOLUCIÓN OLEOSA----1件: 13 💬
7553Vitamins: B6, B12, and folate1件: Folic acid1件: Folic acid 💬--1件: 49 💬
7554ViviGen Cellular Bone Matrix----1件: 70 💬
7555Vizamyl (flutemetamol(F-18))2件: Flutemetamol,
Flutemetamol (18F)		---3件: 5, 7, 127 💬
7556VOLANESORSEN SODIUM, ApoC-III Antisense Oligonucleotide1件: Volanesorsen1件: Volanesorsen 💬1件: APOC3 💬2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265 💬
7557VOLIBRIS 10 mg comprimidos recubiertos con película1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
7558VOLIBRIS 5 mg comprimidos recubiertos con película1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
7559VOLIBRIS® (ambrisentan)1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
7560VOLIBRIS™ tablets1件: Ambrisentan1件: Ambrisentan 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
7561Volixibat (formely SHP626, LUM002 or SAR548304B)1件: Volixibat1件: Volixibat 💬--1件: 94 💬
7562Voncento, Biostate®2件: Antihemophilic factor human,
Von Willebrand factor human		---1件: 288 💬
7563VPD-737----1件: 36 💬
7564VPRIV - 400 U - POLVERE PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO1件: Velaglucerase alfa1件: Velaglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
7565VPRIV 400 Units powder for solution of infusion1件: Velaglucerase alfa1件: Velaglucerase alfa 💬1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
7566VR040/Aspirair® inhaler----1件: 6 💬
7567VSN16R 100mg----1件: 13 💬
7568VTX002 is not biologic----1件: 97 💬
7569VX-121----1件: 299 💬
7570VX-121/TEZ/D-IVA----1件: 299 💬
7571VX-121/tezacaftor/deutivacaftor2件: Deutivacaftor,
Tezacaftor		2件: Tezacaftor ,
Deutivacaftor 💬		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7572VX-147----1件: 222 💬
7573VX-152----1件: 299 💬
7574VX-445 / TEZ / IVA----1件: 299 💬
7575VX-445 / TEZ / IVA FDC----1件: 299 💬
7576VX-509----1件: 46 💬
7577VX-522 mRNA therapy----1件: 299 💬
7578VX-561----1件: 299 💬
7579VX-561 (CTP-656)----1件: 299 💬
7580VX-659/ TEZ/IVA1件: VX-659---1件: 299 💬
7581VX-661 / VX-770----1件: 299 💬
7582VX-661, VRT-893661----1件: 299 💬
7583VX-661/ivacaftor (VX-770) 100mg/150 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7584VX-661/ivacaftor 100 mg/ 150 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7585VX-661/ivacaftor 100mg/150 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7586VX-661/ivacaftor 100mg/150mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7587VX-661/ivacaftor 50 mg/ 75 mg1件: Ivacaftor1件: Ivacaftor 💬1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
7588VX-661/VX-770----1件: 299 💬
7589VX-661/VX-770 (TEZ/IVA)----1件: 299 💬
7590VX-7021件: VX-702---1件: 46 💬
7591VX-745----1件: 8 💬
7592VX-77----1件: 299 💬
7593VX-770----1件: 299 💬
7594VX-770, VRT-8130077----1件: 299 💬
7595VX-770, VRT-813077----1件: 299 💬
7596VX-809 & VX-770----1件: 299 💬
7597VX-809 / VX-770----1件: 299 💬
7598VX-809, VRT-826809----1件: 299 💬
7599VX-809/VX-770----1件: 299 💬
7600Vyondys 531件: Golodirsen1件: Golodirsen 💬1件: DMD 💬4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
7601Warfarin+ Vitamin K2件: Phylloquinone,
Warfarin		1件: Warfarin 💬2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 46 💬
7602WATER FOR INJECTIONS, EP1件: Water1件: Water 💬--1件: 299 💬
7603WAY-130799----1件: 13 💬
7604WAY-177005----1件: 46 💬
7605WD-1603----1件: 6 💬
7606WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
7607WD-1603 Carbidopa-Levodopa Extended-Release Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
7608WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
7609Wellbutrin (bupropion)1件: Bupropion1件: Bupropion 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 96 💬
7610Whale blubber oil----1件: 46 💬
7611Wharton Jelly Mesenchymal stem cells----1件: 97 💬
7612Wharton's jelly derived mesenchymal stem cell----1件: 90 💬
7613WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS----1件: 36 💬
7614WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS----1件: 2 💬
7615Wheat bran2件: Wheat,
Wheat bran		1件: Wheat 💬--1件: 6 💬
7616Wheat/milk free diet (W/MFD) group1件: Wheat1件: Wheat 💬--1件: 53 💬
7617White chocolate (0% cocoa)1件: Cocoa---1件: 6 💬
7618Whole blood sample----1件: 177 💬
7619Wilate 10002件: Antihemophilic factor human,
Von Willebrand factor human		---1件: 288 💬
7620WILATE 1000 I.U.1件: Von Willebrand factor human---1件: 288 💬
7621Wilate 5002件: Antihemophilic factor human,
Von Willebrand factor human		---1件: 288 💬
7622WILATE 500 I.U.1件: Von Willebrand factor human---1件: 288 💬
7623WILATE® 4501件: Von Willebrand factor human---1件: 288 💬
7624WIN-1001X----1件: 6 💬
7625Withhold IS (B cell depletion therapy)----7件: 13, 35, 46, 49, 50, 51, 107 💬
7626Withhold IS (MMF or MPA)----7件: 13, 35, 46, 49, 50, 51, 107 💬
7627Withhold IS (MTX)----7件: 13, 35, 46, 49, 50, 51, 107 💬
7628WJ-MSCs1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36 💬
7629Wound topically irrigated with 500mg TXA----1件: 70 💬
7630WVE-120101----1件: 8 💬
7631WVE-120102----1件: 8 💬
7632XADAGO - 100 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
7633XADAGO - 50 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE1件: Safinamide1件: Safinamide 💬1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
7634XCEL-MC-ALPHA----1件: 13 💬
7635XELJANZ 5 mg film-coated tablets1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
7636Xeljanz 5mg1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7637Xeljanz 5mg film-coated tablets1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 97 💬
7638XELJANZ 5Mg Tablet1件: Tofacitinib1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7639Xeljanz® 11mg Prolonged Release Tablet2件: Manganese citrate,
Tofacitinib		1件: Tofacitinib 💬4件: JAK1,
JAK2,
JAK3,
TYK2 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
7640Xenon-1291件: Xenon2件: Xenon ,
Xenon Xe 133 💬		--1件: 299 💬
7641XGEVA - 120 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 1.7 ML 4 FLACONCINI1件: Denosumab1件: Denosumab 💬1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
7642XmAb®5871----1件: 46 💬
7643Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung1件: Omalizumab1件: Omalizumab 💬1件: FCER1A 💬4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬1件: 299 💬
7644XYZAL - 20 COMPRESSE RI1件: Levocarnitine1件: Levocarnitine 💬--1件: 53 💬
7645Yellow Fever vaccine (17D)1件: Yellow fever vaccine1件: Yellow fever vaccine 💬--8件: 40, 44, 46, 50, 51, 52, 53, 107 💬
7646YISAIPU® ( An etanercept biosimilar)2件: Etanercept,
Yisaipu		1件: Etanercept 💬2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
7647YONDELIS 0,25 mg polvo para concentrado para solución para perfusión1件: Trabectedin1件: Trabectedin 💬--1件: 159 💬
7648Yondelis 0.25 mg powder for concentrate for solution for infusion.1件: Trabectedin1件: Trabectedin 💬--1件: 159 💬
7649YONDELIS 1 mg polvo para concentrado para solución para perfusión1件: Trabectedin1件: Trabectedin 💬--1件: 159 💬
7650Yondelis 1 mg powder for concentrate for solution for infusion.1件: Trabectedin1件: Trabectedin 💬--1件: 159 💬
7651YRA-1909 high dose----1件: 46 💬
7652YRA-1909 low dose----1件: 46 💬
7653YRA-1909 mid dose----1件: 46 💬
7654Z-521----1件: 238 💬
7655Zanubrutinib 80 MG1件: Zanubrutinib1件: Zanubrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 300 💬
7656Zatolmilast/ BPN147701件: Zatolmilast1件: Zatolmilast 💬1件: PDE4D 💬5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬1件: 206 💬
7657Zavesca (Miglustat)1件: Miglustat1件: Miglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
7658ZAVESCA 84CPS 100MG1件: Miglustat1件: Miglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
7659Zavesca® Prescription1件: Miglustat1件: Miglustat 💬1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 256 💬
7660ZEPOSIA® (ozanimod)1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 97 💬
7661Zestoretic 10,201件: Lisinopril2件: Lisinopril ,
Lisinopril 💬		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 19 💬
7662Zhu-Bai formula----1件: 224 💬
7663ZIBREN*20BUST 500MG----1件: 2 💬
7664Zinc oxide1件: Zinc oxide1件: Zinc oxide 💬--1件: 156 💬
7665ZITHOMAX 40 mg/ml ENFANTS----1件: 299 💬
7666ZITHROMAX 250 mg1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--1件: 299 💬
7667ZK 157046----1件: 13 💬
7668Zoenasa-1:4----1件: 97 💬
7669Zofran - no intubation----1件: 98 💬
7670Zoledronic Acid 5Mg/Bag 100Ml Inj1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 5, 6, 17 💬
7671Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion, generic medicinal product1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
7672Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion, generic medicinal product.1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
7673Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion,generic medicinal product1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
7674ZOLEDRONIC ACID MONOHYDRATE1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
7675Zoledronic acid, pravastatin2件: Pravastatin,
Zoledronic acid		3件: Zoledronic acid ,
Pravastatin ,
Zoledronic acid 💬		2件: FDPS,
HMGCR 💬		6件: AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 333 💬
7676Zolgensma 2 x 1013 vector genomes/mL solution for infusion1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬1件: SMN1 💬-1件: 3 💬
7677Zolgensma 2 x 1013 vg (vector genomes)/mL solution for infusion1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬1件: SMN1 💬-1件: 3 💬
7678Zoloft 50Mg Tablet----1件: 8 💬
7679Zomacton 10 mg/ml1件: Somatotropin---1件: 78 💬
7680Zostavax (varicella zoster virus) vaccine1件: Varicella zoster vaccine (live/attenuated)---1件: 46 💬
7681ZSP1603 12.5 mg----1件: 85 💬
7682ZSP1603 25 mg----1件: 85 💬
7683ZSP1603 50 mg----1件: 85 💬
7684ZSP1603 7.5 mg----1件: 85 💬
7685ZUGLIMET - 500 MG COMPRESSE RIVESTITE CON FILM 30 COMPRESSE IN BLISTER PVC/AL----1件: 67 💬
7686ZX008 - 0.2 mg/kg/day----1件: 140 💬
7687ZX008 - 0.8 mg/kg/day----1件: 140 💬
7688ZX008 0.2 or 0.8 mg/kg/day----1件: 144 💬
7689ZX008 0.2 to 0.8 mg/kg/day----2件: 140, 144 💬
7690ZYN002 - CBD Transdermal Gel----1件: 206 💬
7691ZYN002 - transdermal gel----1件: 206 💬
7692ZYTIGA - 250 MG - COMPRESSA - USO ORALE - FLACONE 120 COMPRESSE1件: Abiraterone---1件: 75 💬